0000862668-12-000004.txt : 20121114 0000862668-12-000004.hdr.sgml : 20121114 20121114173018 ACCESSION NUMBER: 0000862668-12-000004 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20120930 FILED AS OF DATE: 20121114 DATE AS OF CHANGE: 20121114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ESCALON MEDICAL CORP CENTRAL INDEX KEY: 0000862668 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 330272839 STATE OF INCORPORATION: PA FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-20127 FILM NUMBER: 121205779 BUSINESS ADDRESS: STREET 1: 435 DEVON PARK ROAD STREET 2: BUILDING 100 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 6106886830 MAIL ADDRESS: STREET 1: 435 DEVON PARK ROAD STREET 2: BUILDING 100 CITY: WAYNE STATE: PA ZIP: 19087 FORMER COMPANY: FORMER CONFORMED NAME: INTELLIGENT SURGICAL LASERS INC DATE OF NAME CHANGE: 19930328 10-Q 1 esmc_2012930-10q2013.htm FORM 10-Q ESMC_2012.9.30-10Q 2013

 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 
 

 FORM 10-Q
QUARTERLY PERIOD PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 
 

For the Quarterly Period ended September 30, 2012
Commission File Number 0-20127

 
 

Escalon Medical Corp.
(Exact name of registrant as specified in its charter)

 
 

Pennsylvania
 
33-0272839
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
435 Devon Park Drive, Building 100, Wayne, PA 19087
(Address of principal executive offices, including zip code)
(610) 688-6830
(Registrant’s telephone number, including area code)

 
 

N/A
Former name, former address and former fiscal year, if changed since last report
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  x    No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer," and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

 


Large accelerated filer
 
o
 
Accelerated filer
 
o
 
 
 
 
 
 
Non-accelerated filer
 
o (Do not check if a smaller reporting company)
 
Smaller reporting company
 
x
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  o    No  x
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 7,526,430 shares of common stock, $0.001 par value, outstanding as of November 13, 2012.




 
TABLE OF CONTENTS
 
 
Page
 

Item I.
 


 

 
 
Item 2.
Item 3.
Item 4T.
 
 
 
 

Item 1.
Item 1A.
Item 6.
 


1


Item 1. Condensed Consolidated Financial Statements
ESCALON MEDICAL CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
 
September 30,
2012
 
June 30,
2012
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
550,359

 
$
890,623

Accounts receivable, net
930,392

 
1,343,823

Inventory, net
1,793,585

 
1,434,260

Other current assets
171,891

 
199,312

Assets of discontinued operations
3,730,051

 
4,012,725

Total current assets
7,176,278

 
7,880,743

Property and equipment, net
12,718

 
12,954

Goodwill
125,027

 
125,027

Trademarks and trade names
605,006

 
605,006

Patents, net
11,345

 
14,852

Non-current assets of discontinued operations
1,001,687

 
1,111,883

Total assets
$
8,932,061

 
$
9,750,465

LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Current portion of long-term debt
$
4,149,516

 
$
4,149,516

Related party note payable
300,000

 
300,000

Accounts payable
672,991

 
660,274

Accrued expenses
1,118,724

 
1,335,744

Liabilities of discontinued operations
1,482,493

 
1,617,814

Total current liabilities
7,723,724

 
8,063,348

Accrued post-retirement benefits
1,042,252

 
1,042,252

Total long-term liabilities
1,042,252

 
1,042,252

Total liabilities
8,765,976

 
9,105,600

Shareholders equity:
 
 
 
Preferred stock, $0.001 par value; 2,000,000 shares authorized; no shares issued
—

 
—

Common stock, $0.001 par value; 35,000,000 shares authorized; 7,526,430 issued and outstanding
7,526

 
7,526

Common stock warrants
132,114

 
132,114

Additional paid-in capital
69,386,143

 
69,369,658

Accumulated deficit
(68,782,247
)
 
(68,348,811
)
Accumulated other comprehensive loss
(577,451
)
 
(515,622
)
Total shareholders’ equity
166,085

 
644,865

Total liabilities and shareholders’ equity
$
8,932,061

 
$
9,750,465

See notes to condensed consolidated financial statements

2

ESCALON MEDICAL CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)

 
For the Three Month Ended September 30,
 
2012
 
2011
Net revenues:
 
 
 
Product revenue
$
2,269,577

 
$
2,406,580

Revenues, net
2,269,577

 
2,406,580

Costs and expenses:
 
 
 
Cost of goods sold
1,196,398

 
1,224,428

Marketing, general and administrative
1,405,586

 
1,381,882

Research and development
264,198

 
219,551

Total costs and expenses
2,866,182

 
2,825,861

Loss from operations
(596,605
)
 
(419,281
)
Other (expense) income
 
 
 
Gain related to litigation settlement
63,589

 
—

Income of Ocular Telehealth Management, LLC
1,192

 
699

Interest income
24

 
43

Interest expense
(92,596
)
 
(82,491
)
Total other (expense) income
(27,791
)
 
(81,749
)
Net loss from continuing operations before taxes
(624,396
)
 
(501,030
)
Benefit of income taxes
—

 
—

Net loss from continuing operations
(624,396
)
 
(501,030
)
Net income (loss) from discontinued operations
190,960

 
(288,619
)
Net loss
$
(433,436
)
 
$
(789,649
)
Net income (loss) per share
 
 
 
Basic:
 
 
 
Continuing operations
$
(0.08
)
 
$
(0.06
)
Discontinued operations
0.02

 
(0.04
)
Net (loss)
$
(0.06
)
 
$
(0.10
)
Diluted:
 
 
 
Continuing operations
$
(0.08
)
 
$
(0.06
)
Discontinued operations
0.02

 
(0.04
)
Net (loss)
$
(0.06
)
 
$
(0.10
)
Weighted average shares—basic
7,526,430

 
7,526,430

Weighted average shares—diluted
7,526,430

 
7,526,430

See notes to condensed consolidated financial statements

3

ESCALON MEDICAL CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(UNAUDITED)


For the three months ended September 30,


2012
 
2011
Net loss
$
(433,436
)
 
$
(789,649
)
Foreign currency translation
(61,829
)
 
97,776

  Total comprehensive loss
$
(495,265
)
 
$
(691,873
)
 
 
 
 
See notes to condensed consolidated financial statements



ESCALON MEDICAL CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’ EQUITY
FOR THE THREE-MONTHS ENDED SEPTEMBER 30, 2012
(UNAUDITED)

 
Common Stock
 
Common
Stock
Warrants
 
Additional
Paid-in
Capital
 
Accumulated
Deficit
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Total Shareholders' Equity
 
Shares
 
Amount
 
  
 
 
 
 
 
 
 
 
Balance at June 30, 2012
7,526,430

 
$
7,526

 
$
132,114

 
$
69,369,658

 
$
(68,348,811
)
 
$
(515,622
)
 
$
644,865

Net loss
—

 
—

 
—

 
—

 
(433,436
)
 
—

 
(433,436
)
Foreign currency translation
—

 
—

 
—

 
—

 
—

 
(61,829
)
 
(61,829
)
Compensation expense
—

 
—

 
—

 
16,485

 
—

 
—

 
16,485

Balance at September 30, 2012
7,526,430

 
$
7,526


$
132,114


$
69,386,143


$
(68,782,247
)

$
(577,451
)

$
166,085

See notes to condensed consolidated financial statements

4

ESCALON MEDICAL CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
 
For the Three Months

Ended September 30,
 
2012
2011
Cash Flows from Operating Activities:
 
 
Net loss
$
(433,436
)
$
(789,649
)
Adjustments to reconcile net loss to cash provided by operating activities of continuing operations:
 
 
(Income) loss from discontinued operations
(190,960
)
288,619

Depreciation and amortization
3,743

3,707

Compensation expense related to stock options
16,485

23,898

Income of Ocular Telehealth Management, LLC
(1,192
)
(699
)
Change in operating assets and liabilities:
 
 
Accounts receivable, net
413,431

973,365

Inventory, net
(359,325
)
(385,307
)
Other current and long term-assets
28,612

(55,708
)
Accounts payable and accrued expenses
(204,303
)
194,162

Net cash (used in) provided by operating activities from continuing operations
(726,945
)
252,388

Net cash (used in) provided by operating activities from discontinued operations
455,942

(211,860
)
Net cash (used in) provided by operating activities
(271,003
)
40,528

Cash Flows from Investing Activities:
 
 
Purchase of fixed assets
—

(4,172
)
Net cash (used in) investing activities from continuing operations
—

(4,172
)
Net cash (used in) investing activities from discontinued operations
(8,618
)
(2,755
)
Net cash (used in) investing activities
(8,618
)
(6,927
)
Cash Flows from Financing Activities:
 
 
Proceeds from related party note payable
—

134,488

Principal payments on long-term debt
—

(88,555
)
Net cash provided by financing activities from continuing operations
—

45,933

Effect of exchange rate changes on cash and cash equivalents
(60,643
)
(122,803
)
Net (decrease) in cash and cash equivalents
(340,264
)
(43,269
)
Cash and cash equivalents, beginning of period
890,623

1,915,214

Cash and cash equivalents, end of period
$
550,359

$
1,871,945

Supplemental Schedule of Cash Flow Information:
 
 
Interest paid
$
—

$
82,491

See notes to condensed consolidated financial statements

5

Escalon Medical Corp. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(UNAUDITED)

1. Basis of Presentation

 Escalon Medical Corp. (“Escalon” or the “Company” ) is a Pennsylvania corporation initially incorporated in California in 1987, and reincorporated in Pennsylvania in November 2001. Within this document, the “Company” collectively shall mean Escalon and its wholly owned subsidiaries: Sonomed, Inc. (“Sonomed”), Trek, Inc. (“Trek”), Escalon Vascular Access, Inc. (“Vascular”), Escalon Medical Europe GmbH (“EME”), Escalon Digital Vision, Inc. (“EMI”), Escalon Pharmaceutical, Inc. (“Pharmaceutical”), Escalon Holdings, Inc. (“EHI”), Escalon IP Holdings, Inc., Escalon Vascular IP Holdings, Inc., Sonomed IP Holdings, Inc., Drew Scientific Holdings, Inc., Drew Scientific Inc., and Drew Scientific Group, Plc (“Drew”) and its subsidiaries. All intercompany accounts and transactions have been eliminated.

On October 3, 2012 the Company sold its Clinical Diagnostics Business to ERBA Diagnostics, Inc. The Escalon Clinical Diagnostics Business ("ECD") consists of Drew Scientific, Inc., and its wholly owned subsidiaries JAS Diagnostics, Inc. ("JAS") and Drew Scientific Limited Co. The sales price was $6,500,000 in cash. The sale of this business will have a material effect on earnings in subsequent periods. ECD prior period amounts are presented as discontinued operations (see footnote 10 to the Notes to Condensed Consolidated Financial Statements for additional information).

On October 18, 2012, the Company and its debt holder reached an agreement whereby the Company paid the balance of the seller-provided financing plus accrued interest related to the purchase of certain assets of BH Holdings, S.A.S ("Biocode" or "BHH") of $4,367,604 with a one-time payment of $2,487,480 resulting in a gain on extinguishment of debt of $1,880,124. The repayment of the debt has reduced the Company's debt related to Biocode to zero.

As a result of these transactions the Company expects to realize total gains of approximately $4,200,000 during the three month period ending December 31, 2012. The Company expects that the total gain will bring the Company back into compliance with the minimum $2,500,000 stockholders' equity requirement for continued listing on the NASDAQ Capital Market as set forth in Listing Rule 5550(b).
    
The Company operates in the healthcare market, specializing in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology. The Company and its products are subject to regulation and inspection by the United States Food and Drug Administration (the “FDA”). The FDA and other governmental authorities require extensive testing of new products prior to sale and have jurisdiction over the safety, efficacy and manufacture of products, as well as product labeling and marketing.

Management reviews financial information, allocates resources, and manages the business as two segments: Sonomed-Escalon and Escalon Medical Corp (“Corporate”). The Sonomed-Escalon segment consists of Sonomed, Inc., EMI and Trek, all of which are engaged in the development and sale of Ophthalmic medical devices. The Escalon Medical Corp. segment includes the administrative corporate operations of the consolidated group.

2.               Stock-Based Compensation

Valuations are based upon highly subjective assumptions about the future, including stock price volatility and exercise patterns. The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model. Expected volatilities are based on the historical volatility of the Company's stock. The Company uses historical data to estimate option exercise and employee terminations. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury yield curve in effect at the time of the grant.

The Company has historically granted options under the Company's option plans with an option exercise price equal to the closing market value of the stock on the date of the grant and with vesting, primarily for Company employees, either in equal annual amounts over a two- to five-year period or immediately, and, primarily for non-employee directors, immediately.

As of September 30, 2012 and 2011 total unrecognized compensation cost related to non-vested share-based compensation arrangements granted to employees under the 2004 Equity Incentive Plan was $38,271 and $104,212, respectively. The remaining cost is expected to be recognized over a weighted average period of 1.31 years. For the three-month period ended September, 2012 and 2011, $16,485 and $23,898 was recorded as compensation expense, respectively.
 

6

The Company did not receive any cash from share option exercises under stock-based payment plans for the three month periods ended September, 2012 and 2011. The Company did not realize any tax effect, which would be a reduction in its tax rate, on options due to the full valuation allowances established on its deferred tax assets.

The Company measures compensation expense for non-employee stock-based compensation based on the fair value of the options issued, as this is more reliable than the fair value of the services received. Fair value is measured as the value of the Company's common stock on the date that the commitment for performance by the counterparty has been reached or the counterparty's performance is complete. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital. There was no non-employee compensation expense for the three-month periods ended September 30, 2012 and 2011.

3. Net Income (Loss) earnings per Share

The following table sets forth the computation of basic and diluted net loss per share:
 
 
Three Months Ended September 30,
 
 
2012
 
2011
 
 
 
 
 
Numerator:
 
 
 
 
  Numerator for basic and diluted earnings per share
 
 
 
 
(Loss) from continuing operations
 
$
(624,396
)
 
$
(501,030
)
Income (Loss) from discontinued operations
 
190,960

 
(288,619
)
 Net (loss)
 
$
(433,436
)
 
$
(789,649
)
Denominator:
 
 
 
 
  Denominator for basic earnings per share - weighted average shares
 
7,526,430

 
7,526,430

  Effect of dilutive securities:
 
 
 
 
    Stock options and warrants
 
—

 
—

    Shares reserved for future exchange
 
—

 
—

 Denominator for diluted earnings per share - weighted average and assumed conversion

 
7,526,430

 
7,526,430

 
 
 
 
 
Net (loss) income per share
 
 
 
 
   Basic:
 
 
 
 
      Continuing operations
 
$
(0.08
)
 
$
(0.06
)
      Discontinued operations
 
0.02

 
(0.04
)
 
 
$
(0.06
)
 
$
(0.10
)
   Diluted:
 
 
 
 
      Continuing operations
 
$
(0.08
)
 
$
(0.06
)
      Discontinued operations
 
0.02

 
(0.04
)
 
 
$
(0.06
)
 
$
(0.10
)


4. Legal Proceedings

The Company, from time to time is involved in various legal proceedings and disputes that arise in the normal course of business. These matters have previously and may in the future pertain to intellectual property disputes, commercial contract

7

disputes, employment disputes, and other matters. The Company does not believe that the resolution of any of these matters has had or is likely to have a material adverse impact on the Company's business, financial condition or results of operations.

5. Segment Reporting
        
During the three-month periods ended September 30, 2012 and 2011, the Company's continuing operations were classified into two principal reportable business units that provide different products or services.
 
Management reviews financial information, allocates resources, and manages the business as two segments: Sonomed-Escalon and Escalon Medical Corp. (“Corporate”). The Sonomed-Escalon segment consists of Sonomed, Inc., EMI and Trek, all of which are engaged in the development and sale of Ophthalmic medical devices. The Corporate segment includes the administrative corporate operations of the consolidated group. The ECD segment which consists of Drew Scientific, Inc., and its wholly owned subsidiary JAS, was reported under discontinued operations beginning with this Form 10-Q for three months ended September 30, 2012 and prior period segment information has been reclassified to conform with the current year presentation.

Separate management of each unit is required because each business unit is subject to different marketing, production and technology strategies.
The table below sets forth the loss from continuing operations for the three months ended September 30, 2012 and 2011(in thousands).
 
 
 
Sonomed-Escalon
 
Corporate
 
Total
 
 
2012
 
2011
 
2012
 
2011
 
2012
 
2011
Revenues, net:
 
 
 
 
 
 
 
 
 
 
 
 
Product revenue
 
$
2,270

 
$
2,407

 
$
—

 
$
—

 
$
2,270

 
$
2,407

Total revenue, net
 
2,270

 
2,407

 
—

 
—

 
2,270

 
2,407

Costs and expenses:
 
 
 
 
 
 
 
 
 
 
 
 
Cost of goods sold
 
1,196

 
1,224

 
—

 
—

 
1,196

 
1,224

Marketing, general & admin
 
964

 
886

 
441

 
496

 
1,406

 
1,382

Research & development
 
264

 
220

 
—

 
—

 
264

 
220

Total costs and expenses
 
2,424

 
2,330

 
441

 
496

 
2,866

 
2,826

(Loss) income from operations
 
(154
)
 
77

 
(441
)
 
(496
)
 
(597
)
 
(419
)
Other (expense) and income:
 
 
 
 
 
 
 
 
 
 
 
 
Other income
 
—

 
—

 
64

 
—

 
64

 
—

Equity in OTM
 
—

 
—

 
1

 
1

 
1

 
1

Interest expense
 
—

 
—

 
(93
)
 
(82
)
 
(93
)
 
(82
)
Total other (expense) and income
 
—

 
—

 
(28
)
 
(81
)
 
(28
)
 
(81
)
(Loss) income before taxes
 
(155
)
 
77

 
(469
)
 
(577
)
 
(624
)
 
(500
)
Income taxes benefit from continuing operations
 
—

 
—

 
—

 
—

 
—

 
—

Net (loss) income from continuing operations
 
$
(155
)
 
$
77

 
$
(469
)
 
$
(577
)
 
$
(624
)
 
$
(500
)


The Company operates in the healthcare market, specializing in the development, manufacture and marketing of ophthalmic medical devices and pharmaceuticals. The business segments reported above are the segments for which separate financial information is available and for which operating results are evaluated regularly by executive management in deciding how to allocate resources and assessing performance. The accounting policies of the business segments are the same as those described in the summary of significant accounting policies in Form 10-K for the year ended June 30, 2012. For the purposes of this illustration, corporate expenses, which consist primarily of executive management and administrative support functions, are allocated across the business segments based upon a methodology that has been established by the Company, which includes a number of factors and estimates and that has been consistently applied across the business segments. These expenses are otherwise included in the corporate segment.


8

During the three-month periods ended September 30, 2012 and 2011, Sonomed-Escalon derived its revenue from the sale of A-Scans, B-Scans, pachymeters, Digital imaging products, ISPAN™ gas products and various disposable ophthalmic surgical products.


6. Related Party Transactions
Escalon and a member of the Company’s Board of Directors are founding and equal members of Ocular Telehealth Management, LLC (“OTM”). OTM is a diagnostic telemedicine company providing remote examination, diagnosis and management of disorders affecting the human eye. OTM’s initial solution focuses on the diagnosis of diabetic retinopathy by creating access and providing annual dilated retinal examinations for the diabetic population. OTM was founded to harness the latest advances in telecommunications, software and digital imaging in order to create greater access and a more successful disease management for populations that are susceptible to ocular disease. Through September 30, 2012, Escalon had invested $444,000 in OTM and owned 45% of OTM. No additional investments were made during the quarter ended September 30, 2012. The Company provides administrative support functions to OTM. For the three-month periods ended September 30, 2012 and 2011 the Company recorded a gain of $1,000 and $1,000, respectively. At September 30, 2012 OTM had total assets, liabilities and equity of $12,000, $80,000 and ($68,000), respectively.
As of September 30, 2012 Richard J. DePiano, Sr., the Company’s Chief Executive Officer, participated in an accounts receivable factoring program that was implemented by the Company. Under the program, Mr. DePiano advanced the Company $300,000 which represented 80% of an amount due from certain Drew customers. The receivables were not eligible to be sold to the Company’s usual factoring agent. Interest on the transaction is 1.25% per month, which is equal to the best price offered by the Company’s usual factoring agent. The transaction excluded fees typically charged by the factoring agent and provided much needed liquidity to the Company. As of September 30, 2012 and 2011 interest expense of $32,216 and $3,762 was accrued, respectively. Related party interest expense for the three month periods ended September 30, 2012 and 2011 was $11,250 and $3,762 respectively. The entire amount due of $332,216 was paid in full on October 5, 2012.

7.     Recently Issued Accounting Standards

In May 2011, the FASB issued ASU No. 2011-04 which provides a consistent definition of fair value in GAAP and International Financial Reporting Standards and ensures that their respective fair value measurement and disclosure requirements are the same (except for minor differences in wording and style). The amendments change certain fair value measurement principles and enhance the disclosure requirements particularly for level 3 fair value measurements. The standard became effective for the Company the current fiscal year and should be applied prospectively. The adoption of this ASU did not have a material impact on the Company's condensed consolidated financial statements.

In June 2011, the FASB issued ASU No. 2011-05 which requires an entity to present all non-owner changes in stockholders' equity either in a single continuous statement of comprehensive income or in two separate but consecutive statements. ASU 2011-05 eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholders' equity. This standard became effective for the Company in the current fiscal year and should be applied retrospectively. The adoption of this ASU did not have a material impact on the Company's condensed consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-08, Intangibles-Goodwill and Other (Topic 350): Testing Goodwill for Impairment, which simplifies how an entity tests goodwill for impairment. Under that option, an entity no longer would be required to calculate the fair value of a reporting unit unless the entity determines, based on that qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. The amendments became effective for the company for goodwill impairment tests performed during the current fiscal year and should be applied prospectively. The Company believes the adoption of this ASU will not have a material impact on the Company's condensed consolidated financial statements.

8. Fair Value Measurements
On July 1, 2008, the Company adopted the FASB-issued authoritative guidance for the fair value of financial assets and liabilities. This standard defines fair value and establishes a hierarchy for reporting the reliability of input measurements used to assess fair value for all assets and liabilities. The FASB issued authoritative guidance defines fair value as the selling price that would be received for an asset, or paid to transfer a liability, in the principal or most advantageous market on the measurement date. The hierarchy established prioritizes fair value measurements based on the types of inputs used in the valuation technique. The inputs are categorized into the following levels:
Level 1—Observable inputs such as quoted prices in active markets for identical assets or liabilities.

9

Level 2—Directly or indirectly observable inputs for quoted and other than quoted prices for identical or similar assets and liabilities in active or non-active markets.
Level 3—Unobservable inputs not corroborated by market data, therefore requiring the entity to use the best available information available in the circumstances, including the entity’s own data.
Certain financial instruments are carried at cost on the consolidated balance sheets, which approximates fair value due to their short-term, highly liquid nature. These instruments include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and related party note payable.
The Company analyzed the fair value of the outstanding debt based on the remaining maturity of the note for the Biocode debt and other Level 3 measurements. By “other level 3 measurements” the Company is referring to “unobservable inputs not corroborated by market data, therefore requiring the entity to use the best available information available in the circumstances, including the entity’s own data”. The Company included this reference because in determining the estimated fair value of our debt we first attempted to use a “commonly accepted valuation methodology” of applying rates currently available to the Company for debt with similar terms and remaining maturities. The debt currently on the Company’s balance sheet is related to the acquisition of Biocode Hycell on December 31, 2008. The acquisition was 100% financed by the seller. Management concluded that given the financial state of the Company and the overall state of the credit markets there is no financial institution that would make available funds to the Company for the 100% financing of a foreign entity with similar terms and remaining maturities, or in fact, on any terms. The Company then considered whether there was any “level 3” considerations, as defined above, which might aid the Company in determining the fair market value of this unique form of debt. The Company determined that there was not and came to the conclusion that given the weakened state of the Company and overall market conditions there was no other source of financing available to the Company, from any source on any terms, other than the willing seller of the Biocode assets.
On October 18, 2012, the Company and its debt holder reached an agreement whereby the Company paid the balance of the seller-provided financing plus accrued interest related to the purchase of certain assets of Biocode of $4,367,604 with a one-time payment of $2,487,480 resulting in a gain on extinguishment of debt of $1,880,124. The repayment of the debt has reduced the Company's debt related to Biocode to zero. The gain on the extinguishment of debt will be recognized in the the three month period ending December 31, 2012. Based on this information it appears that the fair market value of the outstanding debt was less than the book value at September 30, 2012.


9. Continuing Operations

The accompanying condensed consolidated financial statements have been prepared on the going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

On October 3, 2012 the Company sold its Clinical Diagnostics Business to ERBA Diagnostics, Inc. The ECD consisted of Drew Scientific, Inc., and its wholly owned subsidiaries JAS and Drew Scientific Limited Co. The sales price was $6,500,000 in cash and the transaction generated a gain on sale of approximately $2,300,000.

On October 18, 2012, the Company and its debt holder reached an agreement whereby the Company paid the balance of the seller-provided financing plus accrued interest related to the purchase of certain assets of Biocode of $4,367,604 with a one-time payment of $2,487,480 resulting in a gain on extinguishment of debt of $1,880,124. The repayment of the debt has reduced the Company's debt related to Biocode to zero.

As a result of these transactions the Company expects to realize total gains of approximately $4,200,000 during the three month period ending December 31, 2012. The Company expects that the total gain will bring the Company back into compliance with the minimum $2,500,000 stockholders' equity requirement for continued listing on the NASDAQ Capital Market as set forth in Listing Rule 5550(b).
The Company expects that these transactions will provide the Company with sufficient cash to fund its operations over the next 12 months.

On June 29, 2012, the Company received a letter from the NASDAQ Listing Qualifications Staff indicating that the Company is not in compliance with the $1.00 minimum closing bid price requirement under the NASDAQ Listing Rules (the "Listing Rules"). The Listing Rules require listed securities to maintain a minimum bid price of $1.00 per share. If a NASDAQ-listed company trades below the minimum bid price requirement for 30 consecutive business days, it is notified of the deficiency. Based upon the Staff's review, the Company no longer meets this requirement. The Listing Rules provide the

10

Company with a compliance period of 180 calendar days, or until December 26, 2012 in which to regain compliance with this requirement.

To regain compliance with the minimum bid price requirement, the Company must have a closing bid price of $1.00 per share or more for a minimum of ten consecutive business days during this compliance period. In the event that the Company does not regain compliance within this period, it may be eligible for additional time to regain compliance by satisfying certain requirements. However, if it appears to the Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, the Staff will notify the Company that its securities will be delisted from the NASDAQ Capital Market. The Company may still appeal the Staff's determination to delist its securities to a Hearing Panel. During any appeal process, the Company's common stock would continue to trade on the NASDAQ Capital Market. The NASDAQ notification letter has no immediate effect on the listing or trading of the Company's common stock on the NASDAQ Capital Market. The Company is currently looking at all of the options available with respect to regaining such compliance.


10. Discontinued Operations

BH Holdings, S.A.S

On January 12, 2012 BHH initiated the filing of an insolvency declaration with the Tribunal de Commerce de Rennes, France ("Commercial Court").  The Commercial Court on January 18, 2012 opened the liquidation proceedings with continuation of BHH's activity for 3 months and named an administrator to manage BHH. Since Drew no longer has a controlling financial interest in BHH it was deconsolidated in the December 31, 2011 quarterly consolidated financial statements and prior period amounts are presented as discontinued operations.
The following table summarizes the results of discontinued operations of BHH for the three months ended September 30, 2012 and 2011 (in thousands):

 For three months ended September 30,
2012
 
2011
Revenue, net
$
—

 
$
999

Cost of goods sold
—

 
407

Marketing, general and administrative
—

 
892

Research & development
—

 
—

Total Costs and expenses
—

 
1,299

Loss from discontinued operations
$
—

 
$
(300
)

Assets and liabilities of discontinued operations of BHH included in the consolidated balance sheets are summarized as follows at September 30, 2012 and June 30, 2012 (in thousands):


 
September 30,
 
June 30,

2012

 
2012
Assets
$
—

 
$
—

Total assets
—

 
—

Liabilities
 
 
 
Accounts payable
—

 
—

Accrued expenses
—

 
—

Accrued lease termination costs
338

 
338

Total liabilities
338

 
338

Net assets of discontinued operations
$
(338
)
 
$
(338
)
Discontinued operation of ECD

11

On October 3, 2012 the Company sold its Clinical Diagnostics Business to ERBA Diagnostics, Inc. The ECD consisted of Drew Scientific, Inc., and its wholly owned subsidiaries JAS and Drew Scientific Limited Co. The sale of this business will have a material effect on earnings in subsequent periods.
The following table summarizes the results of discontinued operations for the three months ended September 30, 2012 and 2011 (in thousands):
 
For the three months ended September 30,
2012
 
2011
Revenue, net
$
3,637

 
$
3,614

Cost of goods sold
2,194

 
2,344

Marketing, general and administrative
1,176

 
1,097

Research & development
76

 
162

Total Costs and expenses
3,446

 
3,603

Net income from discontinued operations
$
191

 
$
11


Assets and liabilities of discontinued operations of ECD included in the consolidated balance sheets are summarized as follows at September 30, 2012 and June 30, 2012 (in thousands):
 
September 30,
 
June 30,
 
2012
 
2012
Assets
 
 
 
Accounts receivable
$
1,621

 
$
1,555

Inventory
1,997

 
2,348

Other assets
112

 
110

Total current assets
3,730

 
4,013

Furniture and fixture
287

 
323

Non-current accounts receivable
69

 
69

Goodwill
93

 
93

Intangible assets
553

 
627

Total non-current assets
1,002

 
1,112

Total Assets
8,462

 
9,137

Liabilities
 
 
 
Accounts payable
536

 
691

Accrued expenses
609

 
589

Total liabilities
1,144

 
1,280

Net assets of discontinued operations
$
7,317

 
$
7,858



ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
Forward Looking Statements

Certain statements contained in, or incorporated by reference in, this report are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, which provide current expectations or forecasts of future events. Such statements can be identified by the use of terminology such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “possible,” “project,” “should,” “will,” and similar words or expressions. The Company's forward-looking statements include certain information relating to general business strategy, growth strategies, financial results, liquidity, discontinued operations, product development, the introduction of new products, the potential markets and uses for the Company's products, the Company's regulatory filings with the FDA, acquisitions, the development of joint venture opportunities, intellectual property and patent protection and infringement, the loss of revenue due to the expiration on termination of certain agreements, the effect of competition on the structure of the markets in which the Company competes, increased legal, accounting and Sarbanes-Oxley compliance costs, compliance with Nasdaq continued listing qualifications, defending the

12

Company in litigation matters and the Company's cost saving initiatives. The reader must carefully consider forward-looking statements and understand that such statements involve a variety of risks and uncertainties, known and unknown, and may be affected by assumptions that fail to materialize as anticipated. Consequently, no forward-looking statement can be guaranteed, and actual results may vary materially. It is not possible to foresee or identify all factors affecting the Company's forward-looking statements, and the reader therefore should not consider the list of such factors contained in its periodic report on Form 10-K for the year ended June 30, 2012 and this Form 10-Q quarterly report to be an exhaustive statement of all risks, uncertainties or potentially inaccurate assumptions.

Executive Overview—Three Months Ended September 30, 2012 and 2011.

The following highlights are discussed in further detail within this Form 10-Q. The reader is encouraged to read this
Form 10-Q in its entirety to gain a more complete understanding of factors impacting Company performance and financial
condition.
• Product revenue from continuing operations decreased approximately $137,000 or 5.7% during the three-month period ended September 30, 2012 as compared to the same period of last fiscal year. The decrease is related to sales decreases
in EMI's digital imaging cameras offset by a slight increase in Sonomed's ultrasound products.

• Cost of goods sold as a percentage of product revenue from continuing operations increased to approximately 52.7%
of product revenues during the three-month period ended September 30, 2012 as compared to approximately 50.9% of
product revenue for the same period of last fiscal year.

• Total operating expenses increased approximately 4.4% during the three-month period ended September 30, 2012 as
compared to the same period of prior fiscal year. This was due to decreased marketing, general and administrative
expenses of 1.7% and an increase of 20.0% in research and development expenses.

Company Overview

The following discussion should be read in conjunction with interim condensed consolidated financial statements and
the notes thereto, which are set forth in Item 1 of this report.

The Company operates in the healthcare market specializing in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the areas of ophthalmology, diabetes and hematology. The Company and its products are subject to regulation and inspection by the FDA. The FDA requires extensive testing of new products prior to sale and has jurisdiction over the safety, efficacy and manufacture of products, as well as product labeling and marketing. The Company's Internet address is www.escalonmed.com.
Critical Accounting Policies
The preparation of financial statements requires management to make estimates and assumptions that impact amounts reported therein. The most significant of those involve the application of FASB-issued authoritative guidance concerning Revenue Recognition, Goodwill and Other Intangible Assets, discussed further in the notes to consolidated financial statements included in the Form 10-K for the year ended June 30, 2012. The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America, and, as such, include amounts based on informed estimates and judgments of management. For example, estimates are used in determining valuation allowances for deferred income taxes, uncollectible receivables, obsolete inventory, sales returns and rebates, warranty liabilities and purchased intangible assets. Actual results achieved in the future could differ from current estimates. The Company used what it believes are reasonable assumptions and, where applicable, established valuation techniques in making its estimates.
Revenue Recognition
The Company recognizes revenue from the sale of its products at the time of shipment, when title and risk of loss transfer. The Company provides products to its distributors at agreed wholesale prices and to the balance of its customers at set retail prices. Distributors can receive discounts for accepting high volume shipments. The discounts are reflected immediately in the net invoice price, which is the basis for revenue recognition. No further material discounts are given.
 
The Company's considerations for recognizing revenue upon shipment of product to a distributor are based on the following:
 

13

 
 
Persuasive evidence that an arrangement (purchase order and sales invoice) exists between a willing buyer (distributor) and the Company that outlines the terms of the sale (company information, quantity of goods, purchase price and payment terms). The buyer (distributor) does not have a right of return.
 
 
 
Shipping terms are ex-factory shipping point. At this point the buyer (distributor) takes title to the goods and is responsible for all risks and rewards of ownership, including insuring the goods as necessary.
 
 
 
The Company's price to the buyer (distributor) is fixed and determinable as specifically outlined on the sales invoice. The sales arrangement does not have customer cancellation or termination clauses.
 
 
 
The buyer (distributor) places a purchase order with the Company; the terms of the sale are cash, COD or credit. Customer credit is determined based on the Company's policies and procedures related to the buyer's (distributor's) creditworthiness. Based on this determination, the Company believes that collectibility is reasonably assured.
The Company assesses collectibility based on creditworthiness of the customer and past transaction history. The Company performs ongoing credit evaluations of its customers and does not require collateral from its customers. For many of the Company's international customers, the Company requires an irrevocable letter of credit to be issued by the customer before the purchase order is accepted.
Valuation of Intangible Assets
The Company annually evaluates for impairment its intangible assets and goodwill in accordance with SFAS 142, “Goodwill and Other Intangible Assets,” or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. These intangible assets include goodwill, trademarks and trade names. Recoverability of these assets is measured by comparison of their carrying amounts to future discounted cash flows the assets are expected to generate. If identifiable intangibles are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the assets exceeds its fair market value. The Company does not amortize intangible assets with indefinite useful lives, rather such assets are required to be tested for impairment at least annually or sooner whenever events or changes in circumstances indicate that the assets may be impaired. The Company performs its intangible asset impairment tests on or about June 30, of each year. Any such impairment charge could be significant and could have a material adverse impact on the Company's financial statements if and when an impairment charge is recorded.
Income/(Loss) Per Share
The Company computes net income/(loss) per share under the provisions of FASB issued authoritative guidance.
Under the provisions of FASB issued authoritative guidance, basic and diluted net income/(loss) per share is computed by dividing the net income/(loss) for the period by the weighted average number of shares of common stock outstanding during the period. The calculation of diluted net income/(loss) per share excludes potential common shares if the impact is anti-dilutive. Basic earnings per share are computed by dividing net income/(loss) by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share are determined in the same manner as basic earnings per share, except that the number of shares is increased by assuming exercise of dilutive stock options and warrants using the treasury stock method.

Taxes
Estimates of taxable income of the various legal entities and jurisdictions are used in the tax rate calculation. Management uses judgment in estimating what the Company's income tax will be for the year. Since judgment is involved, there is a risk that the tax rate may significantly increase or decrease in any period.
In determining income/(loss) for financial statement purposes, management must make certain estimates and judgments. These estimates and judgments occur in the calculation of certain tax liabilities and in the determination of the recoverability of certain deferred tax assets, which arise from temporary differences between the tax and financial statement recognition of revenue and expense. FASB issued authoritative guidance concerning accounting for income taxes also requires that the deferred tax assets be reduced by a valuation allowance, if based on the available evidence, it is more likely that not that all or some portion of the recorded deferred tax assets will not be realized in future periods.

14

In evaluating the Company's ability to recover the Company's deferred tax assets, management considers all available positive and negative evidence including the Company's past operating results, the existence of cumulative losses and near-term forecasts of future taxable income that is consistent with the plans and estimates management is using to manage the underlying businesses.
Through September 30, 2012, the Company has recorded a valuation allowance against the Company's net operating losses for all of the deferred tax asset due to uncertainty of their realization as a result of the Company's earnings history, the number of years the Company's net operating losses and tax credits can be carried forward, the existence of taxable temporary differences and near-term earnings expectations. The amount of the valuation allowance could decrease if facts and circumstances change that materially increase taxable income prior to the expiration of the loss carryforwards. Any reduction would reduce (increase) the income tax expense (benefit) in the period such determination is made by the Company.
The Company has adopted FASB issued guidance related to accounting for uncertainty in income taxes, which provides a comprehensive model for the recognition, measurement, and disclosure in financial statements of uncertain income tax positions that a company has taken or expects to take on a tax return. Under the FASB guidance a company can recognize the benefit of an income tax position only if it is more likely than not (greater than 50%) that the tax position will be sustained upon tax examination, based solely on the technical merits of the tax position. Otherwise, no benefit can be recognized. The tax benefits recognized are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. Additionally, companies are required to accrue interest and related penalties, if applicable, on all tax exposures for which reserves have been established consistent with jurisdictional tax laws. The Company has elected to recognize interest expense and penalties related to uncertain tax positions as a component of its provision for income taxes.
Stock-Based Compensation
Stock-based compensation expense for all stock-based compensation awards granted after July 1, 2006 is based on the grant-date fair value estimate in accordance with the provisions of the FASB issued guidance. The Company recognizes these compensation costs on a straight-line basis over the requisite service period of the award.
Valuations are based on highly subjective assumptions about the future, including stock price volatility and exercise patterns. The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model. Expected volatilities are based on the historical volatility of the Company's stock. The Company uses historical data to estimate option exercise and employee terminations. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury yield curve in effect at the time of the grant.


Results of Operations
Three Months Ended September 30, 2012 and 2011
The following table shows consolidated product revenue by business segment, as well as identifying trends in business segment product revenues for the three months ended September 30, 2012 and 2011.
Table amounts are in thousands:
 
Three Months Ended September 30,
 
2012
 
2011
 
% Change
Product Revenue:
 
 
 
 
 
Sonomed-Escalon
$
2,270

 
$
2,407

 
(5.7
)%
Total
$
2,270

 
$
2,407

 
(5.7
)%
Consolidated product revenue from continuing operations decreased approximately $137,000 or 5.7%, to $2,270,000 during the three months ended September 30, 2012 as compared to same period of the last fiscal year. The decrease in revenue is attributed to a decrease in EMI’s digital imaging cameras and AXIS image management systems offset by slight increase in Sonomed’s ultrasound products.

The following table presents consolidated cost of goods sold by reportable business segment and as a percentage of related segment product revenues for the three months ended September 30, 2012 and 2011. Table amounts are in thousands:
 

15

 
Three Months Ended June 30,
 
2012
 
%
 
2011
 
%
Cost of Goods Sold:
 
 
 
 
 
 
 
Sonomed-Escalon
$
1,196

 
52.7
%
 
$
1,224

 
50.9
%
Total
$
1,196

 
52.7
%
 
$
1,224

 
50.9
%

Consolidated cost of goods sold from continuing operations totaled approximately $1,196,000, or 52.7%, of product revenue from continuing operations, for the three months ended September 30, 2012, as compared to $1,224,000, or 50.9%, of product revenue from continuing operations, for the same period of the prior fiscal year. The increase of 1.8% in cost of goods sold as a percentage of revenue is due mainly to the product mix sold during the current period.
The following table presents consolidated marketing, general and administrative expenses as well as identifying trends in business segment marketing, general and administrative expenses for the three months ended September 30, 2012 and 2011. Table amounts are in thousands:
 
 
Three Months Ended September 30,
 
2012
 
2011
 
% Change 
Marketing, General and Administrative:
 
 
 
 
 
Sonomed-Escalon
$
753

 
$
684

 
10.0
 %
Escalon Medical
653

 
698

 
(6.5
)%
Total
$
1,406

 
$
1,382

 
1.7
 %

Consolidated marketing, general and administrative expenses from continuing operations increased $24,000, or 1.7%, to $1,406,000 during the three months ended September 30, 2012, as compared to the same period of the prior fiscal year.
Marketing, general and administrative expenses in the Sonomed-Escalon business segment increased $69,000, or 10%, to $753,000, as compared to the same period last fiscal year. The increase is due to an increase in sales people and related sales and marketing expenses and also an increase in business taxes.
Marketing, general and administrative expenses in the corporate decreased $45,000, or 6.5% to $653,000, as compared to the same period last fiscal year. The decrease is due to decreased expense in payroll, legal and accounting, investor relations and compensation expense related to stock options.
The following table presents consolidated research and development expenses from continuing operations by reportable business segment and as a percentage of related segment product revenues for the three months ended September 30, 2012 and 2011. Table amounts are in thousands:
 
 
Three Months Ended September 30,
 
2012
 
2011
 
% Change  
Research and Development:
 
 
 
 
 
Sonomed Escalon
$
264

 
$
220

 
20.0
%
Total
$
264

 
$
220

 
20.0
%
Consolidated research and development expenses from continuing operations increased $44,000, or 20.0% of product revenue, to $264,000 during the three-month period ended September 30, 2012, as compared to the same period of the prior fiscal year. Research and development expenses were primarily expenses associated with the planned introduction of new or enhanced products in the Sonomed-Escalon business units. The increase is related to increased engineering staff and related expenses necessary as Sonomed-Escalon researches and develops its next generation of diagnostic ultra-sound instruments.

For the three-month period ended September 30, 2012 and 2011 the Company had net income and net loss from discontinued operations of $191,000 and $289,000, respectively. The current year amount for income from discontinued operations is related to the discontinued operations of the ECD segment. The prior year amount for loss from discontinued operations includes a loss from discontinued operations of BHH of $300,000 offset by income from discontinued operations of the ECD segment of $11,000.
The Company recognized a gain of $1,000 related to its investment in Ocular Telehealth Management (“OTM”) during both of the three-month periods ended September 30, 2012 and 2011. OTM is an early stage privately held company. OTM began

16

operations during the three-month period ended September 30, 2004. (See note 6 of the notes to the September 30, 2012 condensed consolidated financial statements.)
Interest expense was $93,000 and $82,000 for the three-month periods ended September 30, 2012 and 2011, respectively. The increase is related to the accrued interest related to related-party note payable. Interest accrued on the related party note payable at September 30, 2012 was $32,216 (see Note 6 of the notes to the September 30, 2012 condensed consolidated financial statements).








Liquidity and Capital Resources
The following table presents overall liquidity and capital resources as of September 30, 2012 and June 30, 2012. Table amounts are in thousands:
 
 
September 30, 2012
 
June 30, 2012
Current Ratio:
 
 
 
Current assets
$
7,176

 
$
7,881

Less: Current liabilities
7,724

 
8,063

Working capital
$
(548
)
 
$
(182
)
Current ratio
0.9 to 1

 
1.0 to 1

Debt to Total Capital Ratio:
 
 
 
Notes payable and current maturities
$
4,450

 
$
4,450

Total debt
4,450

 
4,450

Total equity
166

 
645

Total capital
$
4,616

 
$
5,095

Total debt to total capital
96.4
%
 
87.3
%

Working Capital Position
Working capital decreased $366,000 as of September 30, 2012, and the current ratio decreased to 0.9 to 1 from 1.0 to 1 when compared to June 30, 2012.
Debt to Total Capital Ratio increased to 96.4% as of September 30, 2012 from 87.3% when compared to June 30, 2012 as a result of the reduction of the total equity of $479,000 to $166,000 at September 30, 2012 from $645,000 at June 30, 2012 due mainly to the net loss of $433,000.
Subsequent Events
    
On October 3, 2012 the Company sold its Clinical Diagnostics Business to ERBA Diagnostics, Inc. The ECD consisted of Drew Scientific, Inc., and its wholly owned subsidiaries JAS and Drew Scientific Limited Co. The sales price was $6,500,000 in cash and the transaction generated a gain on sale of approximately $2,300,000.

17
Escalon Medical Corp.
Form 10-Q Quarterly Report



On October 18, 2012, the Company and its debt holder reached an agreement whereby the Company paid the balance of the seller-provided financing plus accrued interest related to the purchase of certain assets of Biocode of $4,367,604 with a one-time payment of $2,487,480 resulting in a gain on extinguishment of debt of $1,880,124. The repayment of the debt has reduced the Company's debt related to Biocode to zero.

As a result of these transactions the Company expects to realize total gains of approximately $4,200,000 during the three month period ending December 31, 2012. The Company expects that the total gain will bring the Company back into compliance with the minimum $2,500,000 stockholders' equity requirement for continued listing on the NASDAQ Capital Market as set forth in Listing Rule 5550(b).

The Company expects that these transactions will provide the Company with sufficient cash to fund its operations over the next 12 months.


Cash Used In or Provided By Operating Activities
During the three-month periods ended September 30, 2012 and 2011, the Company generated cash outflows and inflows from operating activities of $271,000 and $41,000 respectively. The net decrease in cash used in operating activities of approximately $312,000 for the three-month period ended September 30, 2012, as compared to the same period in the prior fiscal year is due primarily to the following factors:
For the three-month period ended September 30, 2012, the Company had a net loss of $433,000, which includes net income from discontinued operations of $191,000, and experienced net cash in flows from a decrease in accounts receivable of $413,000, a decrease in current and long-term assets of $29,000, and non-cash expenditures on depreciation and amortization and compensation expense related to stock options of approximately $4,000 and $16,000, respectively. These cash in-flows were partially offset by a decrease in accounts payable, accrued expenses and other liabilities of $204,000 and an increase in inventory of $360,000.
For the three-month period ended September 30, 2011, the Company had a net loss of $790,000, which includes a net loss from discontinued operations of $289,000, and experienced net cash in flows from a decrease in accounts receivable of $973,000, increase in accounts payable, accrued expenses and other liabilities of $194,000, and non-cash expenditures on depreciation and amortization and compensation expense related to stock options of approximately $4,000 and $24,000, respectively. These cash in-flows were partially offset by an increase in current and long-term assets and inventory of $56,000 and $385,000, respectively.
Cash flow from operations also included $456,000 provided by operating activities from discontinued operations and $212,000 used in operating activities from discontinued operations for the three months ended September 30, 2012 and 2011, respectively. These cash inflows and outflows are not expected to recur in future periods.
Cash Flows Used In Investing and Financing Activities
Cash flows used in investing activities of $9,000 is related to purchase of fixed assets in discontinued operations during the three-month period ended September 30, 2012.
Cash flows used in investing activities of $7,000 is related to purchase of fixed assets during the three-month period ended September 30, 2011, among which $4,000 is related to the purchase of fixed assets in continuing operations.
There was no cash provided by or used in financing activities during the three-month period ended September 30, 2012.
Cash flows provided by financing activities of $46,000 were related to proceeds of $134,000 from a related party note payable offset by the scheduled long-term debt payment of $89,000 during the three-month period ended September 30, 2011.

Debt History
On December 31, 2008, Drew acquired certain assets of Biocode for $5,900,000 (4,200,000 Euros) plus acquisition costs of approximately $300,000. The sales price was payable in cash of approximately $324,000 (approximately 231,000 Euros) and $5,865,000 in debt from Drew. The seller-provided financing is collateralized by certain assets of Biocode. Biocode assets were vertically integrated into the Company’s clinical diagnostics business that includes Drew and JAS.
On April 29, 2011 the Company amended its seller financed debt in connection with the Biocode transaction. Under the terms of the debt refinancing, the Company agreed to pay the balance of the seller provided financing of 3,375,000 Euros by

18

the sum per month in euros having an exchange value of $50,000 United States Dollars as of the date of payment. Interest remained unchanged and will accrue on the outstanding amount of the purchase price at an interest rate of 7% per year on the basis of the actual days elapsed and a 365 day year. The first payment under the amended agreement was paid on May 31, 2011. Upon the 60th month after this Amendment, the Company agreed to pay the balance of the outstanding amount in euros in full in one payment. At the time of the refinancing, the current portion of our long-term debt was reduced from approximately $2,600,000 to $252,000.
On January 12, 2012 BH Holdings, S.A.S.  ("BHH") a wholly owned subsidiary of Drew, initiated the filing of an insolvency declaration with the Tribunal de Commerce de Rennes, France ("Commercial Court").  The Commercial Court on January 18, 2012 opened the liquidation proceedings with continuation of BHH's activity for three months and named an administrator to manage BHH. Because BHH is no longer controlled by Drew it was deconsolidated in the December 31, 2011 quarterly consolidated financial statements and prior period amounts are presented as discontinued operations (see footnote 10 to the Notes to Condensed Consolidated Financial Statements for additional information). This debt was guaranteed by Escalon, and as a result of the insolvency declaration the debt has been transferred to Escalon.
On May 11, 2012, the holder of debt incurred by the Company in connection with its acquisition of BHH informed the Company that it intends to declare the entire amount in default, seek a judgment from a French Court and then enforce the Company’s guarantee for payment. Consequently the Company has recorded the entire debt of $4,149,516 as a current liability.
On October 18, 2012, the Company and its debt holder reached an agreement whereby the Company paid off the balance of the seller-provided financing of $4,367,604 with a one-time payment of $2,487,480 resulting in a gain on extinguishment of debt of $1,880,124. The repayment of the debt has reduced the Company's debt related to Biocode to zero.
As of September 30, 2012 Richard J. DePiano, Sr., the Company’s Chief Executive Officer, participated in an accounts receivable factoring program that was implemented by the Company. Under the program, Mr. DePiano advanced the Company $300,000 which represented 80% of an amount due from certain Drew customers. The receivables were not eligible to be sold to the Company’s usual factoring agent. Interest on the transaction is 1.25% per month, which is equal to the best price offered by the Company’s usual factoring agent. The transaction excluded fees typically charged by the factoring agent and provided much needed liquidity to the Company. As of September 30, 2012 and 2011 interest expense of $32,216 and $3,762 was accrued, respectively. Related party interest expense for the three month periods ended September 30, 2012 and 2011 was $11,250 and $3,762 respectively. The entire amount due of $332,216 was paid in full on October 5, 2012.

Continuing Operations

The accompany condensed financial statements have been prepared on the going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

On October 3, 2012 the Company sold its Clinical Diagnostics Business to ERBA Diagnostics, Inc. The Escalon Clinical Diagnostics Business ("ECD") consisted of Drew Scientific, Inc., and its wholly owned subsidiaries JAS Diagnostics, Inc. ("JAS") and Drew Scientific Limited Co. The sales price was $6,500,000 in cash and the transaction generated a gain on sale of approximately $2,300,000.

On October 18, 2012, the Company and its debt holder reached an agreement whereby the Company paid the balance of the seller-provided financing plus accrued interest related to the purchase of certain assets of Biocode of $4,367,604 with a one-time payment of $2,487,480 resulting in a gain on extinguishment of debt of $1,880,124. The repayment of the debt has reduced the Company's debt related to Biocode to zero.

As a result of these transactions the Company expects to realize total gains of approximately $4,200,000 during the three month period ending December 31, 2012. The Company expects that the total gain will bring the Company back into compliance with the minimum $2,500,000 stockholders' equity requirement for continued listing on the NASDAQ Capital Market as set forth in Listing Rule 5550(b).
 
The Company expects that these transactions will provide the Company with sufficient cash to fund its operations over the next 12 months.

Off-Balance Sheet Arrangements and Contractual Obligations

The Company was not a party to any off-balance sheet arrangements during the three periods ended September 30, 2012 and 2011.


19
Escalon Medical Corp.
Form 10-Q Quarterly Report


The following table presents the Company's contractual obligations as of September 30, 2012 (excluding interest):

 
 
 
 
 Less than
 
 
 
3-5
 
More than
 
 
 Total
 
 1 Year
 
 1-3 Years
 
Years
 
 5 Years
 
 
 
 
 
 
 
 
 
 
 
Related Party Note Payable
 
$
300,000

 
$
300,000

 
$
—

 
$
—

 
$
—

Long-term debt
 
4,149,516

 
4,149,516

 
—

 
—

 
—

Operating lease agreements
 
2,598,967

 
642,632

 
1,109,310

 
847,025

 
—

Total
 
$
7,048,483

 
$
5,092,148

 
$
1,109,310

 
$
847,025

 
$
—



Item 3.    Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk

The table below provides information about the Company's financial instruments consisting of fixed interest rate debt obligations. For debt obligations, the table represents principal cash flows and related interest rates by expected maturity dates.


 
Due during the 12 month period ending September 30,
 
Interest Rate
2013

2014

2015

2016

2017

Total
Related Party Note
15
%
$
300,000

 
 
 
 
$
300,000

Note Payable -Escalon
7
%
$
4,149,516

—

—

—

—

$
4,149,516

 
 
 
 
 
 
 
 

Item 4T. Controls and Procedures

(A)    Evaluation of Disclosure Controls and Procedures

The Company's management, with the participation of the Company's Chief Executive Officer and Principal Financial and Accounting Officer, have established disclosure controls and procedures to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to the officers who certify the Company's financial reports and to other members of senior management and the Board of Directors.

Based on their evaluation of the effectiveness of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of September 30, 2012, the Chief Executive Officer and Principal Financial and Accounting Officer of the Company have concluded that such disclosure controls and procedures are effective to ensure that the information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that information required to be disclosed in the reports that the Company files or submits under the Exchange Act is accumulated and communicated to the Company's management, including its Chief Executive Officer and Principal Financial and Accounting Officer, to allow timely decisions regarding required disclosure.

(B)    Internal Control over Financial Reporting

There have not been any changes in the Company's internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act), during the first fiscal quarter ended September 30, 2012 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Item 1.    Legal Proceedings

See footnote 4 of the notes to the condensed consolidated financial statements for further information regarding the Company's legal proceedings (see footnote 10 for details on the court proceedings related to the insolvency declaration at BHH).


20

Item 1A. Risk Factors

There are no material changes from the risks previously disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2012.


Item 6.    Exhibits

31.1    Certificate of Chief Executive Officer under Rule 13a-14(a).
31.2    Certificate of Principal Financial and Accounting Officer under Rule 13a-14(a).
32.1
Certificate of Chief Executive Officer under Section 1350 of Title 18 of the United States Code.
32.2
Certificate of Principal Financial and Accounting Officer under Section 1350 of Title 18 of the United States Code.

Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
 
 
 
Escalon Medical Corp.
 
 
 
 
(Registrant)
 
 
 
 
 
 
 
Date: November 14, 2012
 
By:
 
/s/ Richard J. DePiano
 
 
 
 
Richard J. DePiano
 
 
 
 
Chairman and Chief Executive Officer
 
 
 
 
 
Date: November 14, 2012
 
By:
 
/s/ Robert O’Connor
 
 
 
 
Robert O’Connor
 
 
 
 
Chief Financial Officer




21
 EX-31.1 2 esmc_2012930-10q2013ex311.htm SECTION 302 CEO CERTITIFCATION ESMC_2012.9.30-10Q 2013 Ex.31.1


Exhibit 31.1
Certification of Principal Executive Officer
I, Richard J. DePiano, certify that:
1.
I have reviewed this quarterly report on Form 10Q of Escalon Medical Corp.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
/s/    Richard J. DePiano
 
Richard J. DePiano,
 
Chief Executive Officer
 
Date: November 14, 2012
 


 EX-31.2 3 esmc_2012930-10q2013ex312.htm SECTION 302 CFO CERTIFICATION ESMC_2012.9.30-10Q 2013 Ex.31.2


Exhibit 31.2
Certification of Principal Financial Officer
I, Robert M. O’Connor, certify that:
1.
I have reviewed this quarterly report on Form 10Q of Escalon Medical Corp.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
/s/    Robert M. O’Connor
 
Robert M. O’Connor
 
Chief Financial Officer
 
Date: November 14, 2012
 


 EX-32.1 4 esmc_2012930-10q2013ex321.htm SECTION 906 CEO CERTIFICATION ESMC_2012.9.30-10Q 2013 Ex.32.1


Exhibit 32.1
Certification pursuant to 18 U.S.C. Section 1350,
as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Richard J. DePiano, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.
The Quarterly Report of Escalon Medical Corp. on Form 10Q for the quarterly period ended September 30, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 14, 2012
 
/s/    Richard J. DePiano
 
Richard J. DePiano
 
Chief Executive Officer
 


 EX-32.2 5 esmc_2012930-10q2013ex322.htm SECTION 906 CFO CERTIFICATION ESMC_2012.9.30-10Q 2013 Ex.32.2


Exhibit 32.2
Certification pursuant to 18 U.S.C. Section 1350,
as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Robert M. O’Connor, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.
The Quarterly Report of Escalon Medical Corp. on Form 10-Q for the quarterly period ended September 30, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 14, 2012
 
/s/    Robert M. O’Connor
 
Robert M. O’Connor
 
Chief Financial Officer
 


 EX-101.INS 6 esmc-20120930.xml XBRL INSTANCE DOCUMENT 0000862668 2011-07-01 2011-09-30 0000862668 us-gaap:StockOptionsMember 2011-07-01 2011-09-30 0000862668 esmc:BhHoldingsSASMember 2011-07-01 2011-09-30 0000862668 esmc:EcdMember 2011-07-01 2011-09-30 0000862668 us-gaap:ChiefExecutiveOfficerMember 2011-07-01 2011-09-30 0000862668 us-gaap:EquityMethodInvesteeMember esmc:OtmMember 2011-07-01 2011-09-30 0000862668 esmc:SonomedEscalonMember 2011-07-01 2011-09-30 0000862668 us-gaap:CorporateMember 2011-07-01 2011-09-30 0000862668 esmc:BhHoldingsSASMember 2012-01-17 2012-01-18 0000862668 2012-07-01 2012-09-30 0000862668 us-gaap:StockOptionsMember 2012-07-01 2012-09-30 0000862668 esmc:BhHoldingsSASMember 2012-07-01 2012-09-30 0000862668 esmc:EcdMember 2012-07-01 2012-09-30 0000862668 us-gaap:ChiefExecutiveOfficerMember 2012-07-01 2012-09-30 0000862668 us-gaap:EquityMethodInvesteeMember esmc:OtmMember 2012-07-01 2012-09-30 0000862668 esmc:SonomedEscalonMember 2012-07-01 2012-09-30 0000862668 us-gaap:CorporateMember 2012-07-01 2012-09-30 0000862668 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-07-01 2012-09-30 0000862668 us-gaap:AdditionalPaidInCapitalMember 2012-07-01 2012-09-30 0000862668 us-gaap:CommonStockMember 2012-07-01 2012-09-30 0000862668 us-gaap:RetainedEarningsMember 2012-07-01 2012-09-30 0000862668 us-gaap:WarrantMember 2012-07-01 2012-09-30 0000862668 2012-10-01 2012-12-31 0000862668 esmc:EcdMember 2012-10-01 2012-12-31 0000862668 esmc:BiocodeHycellMember 2008-12-31 0000862668 2010-06-30 0000862668 2011-09-30 0000862668 esmc:BhHoldingsSASMember 2011-09-30 0000862668 us-gaap:EquityMethodInvesteeMember esmc:OtmMember 2011-09-30 0000862668 2011-12-31 0000862668 2012-06-30 0000862668 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-06-30 0000862668 us-gaap:AdditionalPaidInCapitalMember 2012-06-30 0000862668 us-gaap:CommonStockMember 2012-06-30 0000862668 us-gaap:RetainedEarningsMember 2012-06-30 0000862668 us-gaap:WarrantMember 2012-06-30 0000862668 2012-09-30 0000862668 2012-11-13 0000862668 esmc:SalesPriceComponentCashAtClosingMember esmc:EcdMember 2012-09-30 0000862668 esmc:BhHoldingsSASMember 2012-09-30 0000862668 esmc:EcdMember 2012-09-30 0000862668 us-gaap:ChiefExecutiveOfficerMember 2012-09-30 0000862668 us-gaap:EquityMethodInvesteeMember esmc:OtmMember 2012-09-30 0000862668 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-09-30 0000862668 us-gaap:AdditionalPaidInCapitalMember 2012-09-30 0000862668 us-gaap:CommonStockMember 2012-09-30 0000862668 us-gaap:RetainedEarningsMember 2012-09-30 0000862668 us-gaap:WarrantMember 2012-09-30 xbrli:pure esmc:segment xbrli:shares iso4217:USD iso4217:USD xbrli:shares 660274 672991 930392 1343823 1118724 1335744 -577451 -515622 69386143 69369658 0 16485 0 0 16485 0 23898 16485 8932061 9750465 7176278 7880743 0 0 8462000 9137000 3730051 4012725 4012725 1111883 1001687 1111883 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Escalon Medical Corp. (&#8220;Escalon&#8221; or the &#8220;Company&#8221; ) is a Pennsylvania corporation initially incorporated in California in 1987, and reincorporated in Pennsylvania in November 2001. Within this document, the &#8220;Company&#8221; collectively shall mean Escalon and its wholly owned subsidiaries: Sonomed, Inc. (&#8220;Sonomed&#8221;), Trek, Inc. (&#8220;Trek&#8221;), Escalon Vascular Access, Inc. (&#8220;Vascular&#8221;), Escalon Medical Europe GmbH (&#8220;EME&#8221;), Escalon Digital Vision, Inc. (&#8220;EMI&#8221;), Escalon Pharmaceutical, Inc. (&#8220;Pharmaceutical&#8221;), Escalon Holdings, Inc. (&#8220;EHI&#8221;), Escalon IP Holdings, Inc., Escalon Vascular IP Holdings, Inc., Sonomed IP Holdings, Inc., Drew Scientific Holdings, Inc., Drew Scientific Inc., and Drew Scientific Group, Plc (&#8220;Drew&#8221;) and its subsidiaries. All intercompany accounts and transactions have been eliminated. </font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:9pt;"></font><font style="font-family:inherit;font-size:10pt;">On October 3, 2012 the Company sold its Clinical Diagnostics Business to ERBA Diagnostics, Inc. The Escalon Clinical Diagnostics Business ("ECD") consists of Drew Scientific, Inc., and its wholly owned subsidiaries JAS Diagnostics, Inc. ("JAS") and Drew Scientific Limited Co. The sales price was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$6,500,000</font><font style="font-family:inherit;font-size:10pt;"> in cash. The sale of this business will have a material effect on earnings in subsequent periods. ECD prior period amounts are presented as discontinued operations (see footnote 10 to the Notes to Condensed Consolidated Financial Statements for additional information). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 18, 2012, the Company and its debt holder reached an agreement whereby the Company paid the balance of the seller-provided financing plus accrued interest related to the purchase of certain assets of BH Holdings, S.A.S ("Biocode" or "BHH") of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$4,367,604</font><font style="font-family:inherit;font-size:10pt;"> with a one-time payment of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,487,480</font><font style="font-family:inherit;font-size:10pt;"> resulting in a gain on extinguishment of debt of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,880,124</font><font style="font-family:inherit;font-size:10pt;">. The repayment of the debt has reduced the Company's debt related to Biocode to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">zero</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of these transactions the Company expects to realize total gains of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$4,200,000</font><font style="font-family:inherit;font-size:10pt;"> during the three month period ending December 31, 2012. The Company expects that the total gain will bring the Company back into compliance with the minimum </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,500,000</font><font style="font-family:inherit;font-size:10pt;"> stockholders' equity requirement for continued listing on the NASDAQ Capital Market as set forth in Listing Rule 5550(b). </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company operates in the healthcare market, specializing in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology. The Company and its products are subject to regulation and inspection by the United States Food and Drug Administration (the &#8220;FDA&#8221;). The FDA and other governmental authorities require extensive testing of new products prior to sale and have jurisdiction over the safety, efficacy and manufacture of products, as well as product labeling and marketing. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management reviews financial information, allocates resources, and manages the business as </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> segments: Sonomed-Escalon and Escalon Medical Corp (&#8220;Corporate&#8221;). The Sonomed-Escalon&#160;segment consists of Sonomed, Inc., EMI and Trek, all of which are engaged in the development and sale of Ophthalmic medical devices. The Escalon Medical Corp. segment includes the administrative corporate operations of the consolidated group.</font></div></div> 890623 550359 1915214 890623 1871945 -340264 -43269 -8618 -2755 -211860 455942 0.001 0.001 35000000 35000000 7526430 7526430 7526430 7526430 7526 7526 -691873 -495265 1196398 1224428 0 1196398 1224428 0 2866182 2825861 2424000 441000 496000 2330000 -4200000 3707 3743 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock-Based Compensation</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuations are based upon highly subjective assumptions about the future, including stock price volatility and exercise patterns. The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model. Expected volatilities are based on the historical volatility of the Company's stock. The Company uses historical data to estimate option exercise and employee terminations. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury yield curve in effect at the time of the grant.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has historically granted options under the Company's option plans with an option exercise price equal to the closing market value of the stock on the date of the grant and with vesting, primarily for Company employees, either in equal annual amounts over a two- to five-year period or immediately, and, primarily for non-employee directors, immediately.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of September 30, 2012 and 2011 total unrecognized compensation cost related to non-vested share-based compensation arrangements granted to employees under the 2004 Equity Incentive Plan was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$38,271</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$104,212</font><font style="font-family:inherit;font-size:10pt;">, respectively. The remaining cost is expected to be recognized over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1.31</font><font style="font-family:inherit;font-size:10pt;"> years. For the three-month period ended September, 2012 and 2011, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$16,485</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$23,898</font><font style="font-family:inherit;font-size:10pt;"> was recorded as compensation expense, respectively. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company did not receive any cash from share option exercises under stock-based payment plans for the three month periods ended September, 2012 and 2011. The Company did not realize any tax effect, which would be a reduction in its tax rate, on options due to the full valuation allowances established on its deferred tax assets.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company measures compensation expense for non-employee stock-based compensation based on the fair value of the options issued, as this is more reliable than the fair value of the services received. Fair value is measured as the value of the Company's common stock on the date that the commitment for performance by the counterparty has been reached or the counterparty's performance is complete. The fair value of the equity instrument is charged directly to compensation&#160;expense and additional paid-in capital. There was no non-employee compensation expense for the three-month periods ended September 30, 2012 and 2011.</font></div></div> 1555000 1621000 0 0 691000 536000 0 0 589000 609000 2344000 2194000 0 407000 93000 93000 553000 627000 2348000 1997000 3603000 3446000 1299000 0 11000 191000 0 -300000 112000 110000 338000 338000 69000 69000 287000 323000 3614000 3637000 999000 0 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Discontinued Operations</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BH Holdings, S.A.S</font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:32px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">On January 12, 2012 BHH initiated the filing of an insolvency declaration with the Tribunal de Commerce de Rennes, France ("Commercial Court").&#160; The Commercial Court on January 18, 2012 opened the liquidation proceedings with continuation of BHH's activity for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3</font><font style="font-family:inherit;font-size:10pt;"> months and named an administrator to manage BHH</font><font style="font-family:inherit;font-size:12pt;">. </font><font style="font-family:inherit;font-size:10pt;">Since Drew no longer has a controlling financial interest in BHH it was deconsolidated in the December 31, 2011 quarterly consolidated financial statements and prior period amounts are presented as discontinued operations. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the results of discontinued operations of BHH for the three months ended September&#160;30, 2012 and 2011 (in thousands): </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:681px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="464px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="92px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="92px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;For three months ended September 30,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">999</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods sold</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">407</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketing, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">892</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research&#160;&amp; development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Costs and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,299</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss from discontinued operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(300</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets and liabilities of discontinued operations of BHH included in the consolidated balance sheets are summarized as follows at September&#160;30, 2012 and June 30, 2012 (in thousands): </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:680px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="465px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="91px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="92px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued lease termination costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">338</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">338</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">338</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">338</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets of discontinued operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(338</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(338</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Discontinued operation of ECD</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 3, 2012 the Company sold its Clinical Diagnostics Business to ERBA Diagnostics, Inc. The ECD consisted of Drew Scientific, Inc., and its wholly owned subsidiaries JAS and Drew Scientific Limited Co. The sale of this business will have a material effect on earnings in subsequent periods</font><font style="font-family:Arial;font-size:9pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the results of discontinued operations for the three months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;"> and 2011 (in thousands):</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.70992366412213%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="67%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the three months ended September 30,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2011</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,637</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,614</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods sold</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,194</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,344</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketing, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,176</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,097</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research&#160;&amp; development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Costs and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,446</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,603</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income from discontinued operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">191</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Assets and liabilities of discontinued operations of ECD included in the consolidated balance sheets are summarized as follows at September&#160;30, 2012 and June 30, 2012 (in thousands): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:629px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="360px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="119px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="119px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,621</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,555</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,997</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,348</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,730</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,013</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixture</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">287</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">323</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-current accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">553</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">627</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total non-current assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,002</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,112</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,462</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,137</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">536</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">691</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">609</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">589</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,144</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,280</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets of discontinued operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,858</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> -0.10 -0.06 -0.06 -0.10 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;padding-left:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income/(Loss) Per Share </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company computes net income/(loss) per share under the provisions of FASB issued authoritative guidance. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the provisions of FASB issued authoritative guidance, basic and diluted net income/(loss) per share is computed by dividing the net income/(loss) for the period by the weighted average number of shares of common stock outstanding during the period. The calculation of diluted net income/(loss) per share excludes potential common shares if the impact is anti-dilutive. Basic earnings per share are computed by dividing net income/(loss) by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share are determined in the same manner as basic earnings per share, except that the number of shares is increased by assuming exercise of dilutive stock options and warrants using the treasury stock method. </font></div><div style="line-height:120%;text-align:justify;padding-left:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the computation of basic and diluted net loss per share: </font></div><div style="line-height:120%;padding-top:12px;text-align:center;text-indent:32px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.59375%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="50%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="21%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="21%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Numerator:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;Numerator for basic and diluted earnings per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(624,396</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(501,030</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (Loss) from discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">190,960</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(288,619</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Net (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(433,436</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(789,649</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denominator:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;Denominator for basic earnings per share - weighted average shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,526,430</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,526,430</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;Effect of dilutive securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Stock options and warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Shares reserved for future exchange</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Denominator for diluted earnings per share - weighted average and assumed conversion</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,526,430</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,526,430</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Basic:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.08</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;Discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.04</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.10</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Diluted:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.08</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;Discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.04</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.10</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> -60643 -122803 38271 104212 444000 0.45 0 -68000 80000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July&#160;1, 2008, the Company adopted the FASB-issued authoritative guidance for the fair value of financial assets and liabilities. This standard defines fair value and establishes a hierarchy for reporting the reliability of input measurements used to assess fair value for all assets and liabilities. The FASB issued authoritative guidance defines fair value as the selling price that would be received for an asset, or paid to transfer a liability, in the principal or most advantageous market on the measurement date. The hierarchy established prioritizes fair value measurements based on the types of inputs used in the valuation technique. The inputs are categorized into the following levels:</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1&#8212;Observable inputs such as quoted prices in active markets for identical assets or liabilities.</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2&#8212;Directly or indirectly observable inputs for quoted and other than quoted prices for identical or similar assets and liabilities in active or non-active markets.</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3&#8212;Unobservable inputs not corroborated by market data, therefore requiring the entity to use the best available information available in the circumstances, including the entity&#8217;s own data.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain financial instruments are carried at cost on the consolidated balance sheets, which approximates fair value due to their short-term, highly liquid nature. These instruments include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and related party note payable.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company analyzed the fair value of the outstanding debt based on the remaining maturity of the note for the Biocode debt and other Level 3 measurements. By &#8220;other level 3 measurements&#8221; the Company is referring to &#8220;unobservable inputs not corroborated by market data, therefore requiring the entity to use the best available information available in the circumstances, including the entity&#8217;s own data&#8221;. The Company included this reference because in determining the estimated fair value of our debt we first attempted to use a &#8220;commonly accepted valuation methodology&#8221; of applying rates currently available to the Company for debt with similar terms and remaining maturities. The debt currently on the Company&#8217;s balance sheet is related to the acquisition of Biocode Hycell on December&#160;31, 2008. The acquisition was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">100%</font><font style="font-family:inherit;font-size:10pt;"> financed by the seller. Management concluded that given the financial state of the Company and the overall state of the credit markets there is </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">no</font><font style="font-family:inherit;font-size:10pt;"> financial institution that would make available funds to the Company for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">100%</font><font style="font-family:inherit;font-size:10pt;"> financing of a foreign entity with similar terms and remaining maturities, or in fact, on any terms. The Company then considered whether there was any &#8220;level 3&#8221; considerations, as defined above, which might aid the Company in determining the fair market value of this unique form of debt. The Company determined that there was not and came to the conclusion that given the weakened state of the Company and overall market conditions there was no other source of financing available to the Company, from any source on any terms, other than the willing seller of the Biocode assets. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 18, 2012, the Company and its debt holder reached an agreement whereby the Company paid the balance of the seller-provided financing plus accrued interest related to the purchase of certain assets of Biocode of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$4,367,604</font><font style="font-family:inherit;font-size:10pt;"> with a one-time payment of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,487,480</font><font style="font-family:inherit;font-size:10pt;"> resulting in a gain on extinguishment of debt of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,880,124</font><font style="font-family:inherit;font-size:10pt;">. The repayment of the debt has reduced the Company's debt related to Biocode to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">zero</font><font style="font-family:inherit;font-size:10pt;">. The gain on the extinguishment of debt will be recognized in the the three month period ending December 31, 2012. Based on this information it appears that the fair market value of the outstanding debt was less than the book value at September 30, 2012.</font></div></div> 14852 11345 0 63589 0 0 63589 0 1880124 125027 125027 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;padding-left:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Valuation of Intangible Assets </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company annually evaluates for impairment its intangible assets and goodwill in accordance with SFAS 142, &#8220;Goodwill and Other Intangible Assets,&#8221; or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. These intangible assets include goodwill, trademarks and trade names. Recoverability of these assets is measured by comparison of their carrying amounts to future discounted cash flows the assets are expected to generate. If identifiable intangibles are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the assets exceeds its fair market value. The Company does not amortize intangible assets with indefinite useful lives, rather such assets are required to be tested for impairment at least annually or sooner whenever events or changes in circumstances indicate that the assets may be impaired. The Company performs its intangible asset impairment tests on or about June&#160;30,&#160;of each year. Any such impairment charge could be significant and could have a material adverse impact on the Company's financial statements if and when an impairment charge is recorded. </font></div></div> -501030 -624396 -468937 -577846 -155459 76816 -0.08 -0.06 -0.08 -0.06 -288619 190960 0.02 -0.04 0.02 -0.04 699 1192 1192 699 0 0 -699 1192 0 0 0 0 0 0 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;padding-left:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Taxes </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimates of taxable income of the various legal entities and jurisdictions are used in the tax rate calculation. Management uses judgment in estimating what the Company's income tax will be for the year. Since judgment is involved, there is a risk that the tax rate may significantly increase or decrease in any period. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In determining income/(loss) for financial statement purposes, management must make certain estimates and judgments. These estimates and judgments occur in the calculation of certain tax liabilities and in the determination of the recoverability of certain deferred tax assets, which arise from temporary differences between the tax and financial statement recognition of revenue and expense. FASB issued authoritative guidance concerning accounting for income taxes also requires that the deferred tax assets be reduced by a valuation allowance, if based on the available evidence, it is more likely that not that all or some portion of the recorded deferred tax assets will not be realized in future periods. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In evaluating the Company's ability to recover the Company's deferred tax assets, management considers all available positive and negative evidence including the Company's past operating results, the existence of cumulative losses and near-term forecasts of future taxable income that is consistent with the plans and estimates management is using to manage the underlying businesses. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Through September&#160;30, 2012, the Company has recorded a valuation allowance against the Company's net operating losses for all of the deferred tax asset due to uncertainty of their realization as a result of the Company's earnings history, the number of years the Company's net operating losses and tax credits can be carried forward, the existence of taxable temporary differences and near-term earnings expectations. The amount of the valuation allowance could decrease if facts and circumstances change that materially increase taxable income prior to the expiration of the loss carryforwards. Any reduction would reduce (increase) the income tax expense (benefit) in the period such determination is made by the Company. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has adopted FASB issued guidance related to accounting for uncertainty in income taxes, which provides a comprehensive model for the recognition, measurement, and disclosure in financial statements of uncertain income tax positions that a company has taken or expects to take on a tax return. Under the FASB guidance a company can recognize the benefit of an income tax position only if it is more likely than not (greater than 50%) that the tax position will be sustained upon tax examination, based solely on the technical merits of the tax position. Otherwise, no benefit can be recognized. The tax benefits recognized are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. Additionally, companies are required to accrue interest and related penalties, if applicable, on all tax exposures for which reserves have been established consistent with jurisdictional tax laws. The Company has elected to recognize interest expense and penalties related to uncertain tax positions as a component of its provision for income taxes. </font></div></div> 194162 -204303 -413431 -973365 385307 359325 55708 -28612 605006 605006 82491 92596 0 82491 0 92596 3762 11250 82491 0 1793585 1434260 24 43 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Legal Proceedings </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company, from time to time is involved in various legal proceedings and disputes that arise in the normal course of business. These matters have previously and may in the future pertain to intellectual property disputes, commercial contract disputes, employment disputes, and other matters. The Company does not believe that the resolution of any of these matters has had or is likely to have a material adverse impact on the Company's business, financial condition or results of operations.</font></div></div> 8765976 9105600 9750465 8932061 8063348 7723724 1042252 1042252 338000 338000 1280000 1144000 1482493 1617814 4149516 4149516 0 45933 -8618 -6927 -4172 0 40528 -271003 252388 -726945 -433436 -789649 0 0 -433436 0 0 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May&#160;2011, the FASB issued ASU No.&#160;2011-04 which provides a consistent definition of fair value in GAAP and International Financial Reporting Standards and ensures that their respective fair value measurement and disclosure requirements are the same (except for minor differences in wording and style). The amendments change certain fair value measurement principles and enhance the disclosure requirements particularly for level 3 fair value measurements. The standard became effective for the Company the current fiscal year and should be applied prospectively. The adoption of this ASU did not have a material impact on the Company's condensed consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June&#160;2011, the FASB issued ASU No.&#160;2011-05 which requires an entity to present all non-owner changes in stockholders' equity either in a single continuous statement of comprehensive income or in two separate but consecutive statements. ASU 2011-05 eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholders' equity. This standard became effective for the Company in the current fiscal year and should be applied retrospectively. The adoption of this ASU did not have a material impact on the Company's condensed consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In September 2011, the FASB issued ASU No. 2011-08, Intangibles-Goodwill and Other (Topic 350): Testing Goodwill for Impairment, which simplifies how an entity tests goodwill for impairment. Under that option, an entity no longer would be required to calculate the fair value of a reporting unit unless the entity determines, based on that qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. The amendments became effective for the company for goodwill impairment tests performed during the current fiscal year and should be applied prospectively. The Company believes the adoption of this ASU will not have a material impact on the Company's condensed consolidated financial statements.</font></div></div> -27791 -81749 -27791 0 -81749 0 300000 300000 2 -596605 -419281 -496000 -154000 77000 -441000 199312 171891 -61829 97776 0 -61829 0 0 -61829 0 4172 1042252 1042252 0.001 0.001 2000000 2000000 0 0 0 0 134488 0 300000 0 0 -624396 -501030 -468937 -155459 76816 -577846 12718 12954 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> Continuing Operations</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying condensed consolidated financial statements have been prepared on the going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">On October 3, 2012 the Company sold its Clinical Diagnostics Business to ERBA Diagnostics, Inc. The ECD consisted of Drew Scientific, Inc., and its wholly owned subsidiaries JAS and Drew Scientific Limited Co. The sales price was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$6,500,000</font><font style="font-family:inherit;font-size:10pt;"> in cash and the transaction generated a gain on sale of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,300,000</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 18, 2012, the Company and its debt holder reached an agreement whereby the Company paid the balance of the seller-provided financing plus accrued interest related to the purchase of certain assets of Biocode of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$4,367,604</font><font style="font-family:inherit;font-size:10pt;"> with a one-time payment of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,487,480</font><font style="font-family:inherit;font-size:10pt;"> resulting in a gain on extinguishment of debt of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,880,124</font><font style="font-family:inherit;font-size:10pt;">. The repayment of the debt has reduced the Company's debt related to Biocode to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">zero</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of these transactions the Company expects to realize total gains of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$4,200,000</font><font style="font-family:inherit;font-size:10pt;"> during the three month period ending December 31, 2012. The Company expects that the total gain will bring the Company back into compliance with the minimum </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,500,000</font><font style="font-family:inherit;font-size:10pt;"> stockholders' equity requirement for continued listing on the NASDAQ Capital Market as set forth in Listing Rule 5550(b). </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company expects that these transactions will provide the Company with sufficient cash to fund its operations over the next </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">12</font><font style="font-family:inherit;font-size:10pt;"> months.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 29, 2012, the Company received a letter from the NASDAQ Listing Qualifications Staff indicating that the Company is not in compliance with the $1.00 minimum closing bid price requirement under the NASDAQ Listing Rules (the "Listing Rules"). The Listing Rules require listed securities to maintain a minimum bid price of $1.00 per share. If a NASDAQ-listed company trades below the minimum bid price requirement for 30 consecutive business days, it is notified of the deficiency. Based upon the Staff's review, the Company no longer meets this requirement. The Listing Rules provide the Company with a compliance period of 180 calendar days, or until December 26, 2012 in which to regain compliance with this requirement.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To regain compliance with the minimum bid price requirement, the Company must have a closing bid price of $1.00 per share or more for a minimum of ten consecutive business days during this compliance period. In the event that the Company does not regain compliance within this period, it may be eligible for additional time to regain compliance by satisfying certain requirements. However, if it appears to the Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, the Staff will notify the Company that its securities will be delisted from the NASDAQ Capital Market. The Company may still appeal the Staff's determination to delist its securities to a Hearing Panel. During any appeal process, the Company's common stock would continue to trade on the NASDAQ Capital Market. The NASDAQ notification letter has no immediate effect on the listing or trading of the Company's common stock on the NASDAQ Capital Market. The Company is currently looking at all of the options available with respect to regaining such compliance.</font></div></div> 332216 0.0125 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Related Party Transactions</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Escalon and a member of the Company&#8217;s Board of Directors are founding and equal members of Ocular Telehealth Management, LLC (&#8220;OTM&#8221;). OTM is a diagnostic telemedicine company providing remote examination, diagnosis and management of disorders affecting the human eye. OTM&#8217;s initial solution focuses on the diagnosis of diabetic retinopathy by creating access and providing annual dilated retinal examinations for the diabetic population. OTM was founded to harness the latest advances in telecommunications, software and digital imaging in order to create greater access and a more successful disease management for populations that are susceptible to ocular disease. Through September&#160;30, 2012, Escalon had invested </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$444,000</font><font style="font-family:inherit;font-size:10pt;"> in OTM and owned </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">45%</font><font style="font-family:inherit;font-size:10pt;"> of OTM. No additional investments were made during the quarter ended September 30, 2012. The Company provides administrative support functions to OTM. For the three-month periods ended September 30, 2012 and 2011 the Company recorded a gain of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. At September&#160;30, 2012 OTM had total assets, liabilities and equity of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$12,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$80,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">($68,000)</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of September 30, 2012 Richard J. DePiano, Sr., the Company&#8217;s Chief Executive Officer, participated in an accounts receivable factoring program that was implemented by the Company. Under the program, Mr.&#160;DePiano advanced the Company </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$300,000</font><font style="font-family:inherit;font-size:10pt;"> which represented </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">80%</font><font style="font-family:inherit;font-size:10pt;"> of an amount due from certain Drew customers. The receivables were not eligible to be sold to the Company&#8217;s usual factoring agent. Interest on the transaction is </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1.25%</font><font style="font-family:inherit;font-size:10pt;">&#160;per month, which is equal to the best price offered by the Company&#8217;s usual factoring agent. The transaction excluded fees typically charged by the factoring agent and provided much needed liquidity to the Company. As of September 30, 2012 and 2011 interest expense of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$32,216</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3,762</font><font style="font-family:inherit;font-size:10pt;"> was accrued, respectively. Related party interest expense for the three month periods ended September 30, 2012 and 2011 was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$11,250</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3,762</font><font style="font-family:inherit;font-size:10pt;"> respectively. The entire amount due of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$332,216</font><font style="font-family:inherit;font-size:10pt;"> was paid in full on October 5, 2012.</font></div></div> 88555 0 2487480 264198 219551 0 0 219551 264198 -68348811 -68782247 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;padding-left:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue Recognition </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue from the sale of its products at the time of shipment, when title and risk of loss transfer. The Company provides products to its distributors at agreed wholesale prices and to the balance of its customers at set retail prices. Distributors can receive discounts for accepting high volume shipments. The discounts are reflected immediately in the net invoice price, which is the basis for revenue recognition. No further material discounts are given. </font></div><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's considerations for recognizing revenue upon shipment of product to a distributor are based on the following: </font></div><div style="line-height:120%;text-align:justify;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:83.59375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td width="5%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="93%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Persuasive evidence that an arrangement (purchase order and sales invoice) exists between a willing buyer (distributor) and the Company that outlines the terms of the sale (company information, quantity of goods, purchase price and payment terms). The buyer (distributor) does not have a right of return.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:83.59375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td width="5%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="93%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shipping terms are ex-factory shipping point. At this point the buyer (distributor) takes title to the goods and is responsible for all risks and rewards of ownership, including insuring the goods as necessary.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:82.8125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td width="4%" rowspan="1" colspan="1"></td><td width="3%" rowspan="1" colspan="1"></td><td width="93%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's price to the buyer (distributor) is fixed and determinable as specifically outlined on the sales invoice. The sales arrangement does not have customer cancellation or termination clauses.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:83.59375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td width="5%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="93%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The buyer (distributor) places a purchase order with the Company; the terms of the sale are cash, COD or credit. Customer credit is determined based on the Company's policies and procedures related to the buyer's (distributor's) creditworthiness. Based on this determination, the Company believes that collectibility is reasonably assured.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company assesses collectibility based on creditworthiness of the customer and past transaction history. The Company performs ongoing credit evaluations of its customers and does not require collateral from its customers. For many of the Company's international customers, the Company requires an irrevocable letter of credit to be issued by the customer before the purchase order is accepted. </font></div></div> 2406580 2269577 0 2269577 2406580 0 2269577 2406580 2270000 0 0 2407000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the results of discontinued operations of BHH for the three months ended September&#160;30, 2012 and 2011 (in thousands): </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:681px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="464px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="92px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="92px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;For three months ended September 30,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">999</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods sold</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">407</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketing, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">892</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research&#160;&amp; development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Costs and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,299</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss from discontinued operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(300</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets and liabilities of discontinued operations of BHH included in the consolidated balance sheets are summarized as follows at September&#160;30, 2012 and June 30, 2012 (in thousands): </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:680px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="465px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="91px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="92px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued lease termination costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">338</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">338</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">338</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">338</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets of discontinued operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(338</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(338</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 3, 2012 the Company sold its Clinical Diagnostics Business to ERBA Diagnostics, Inc. The ECD consisted of Drew Scientific, Inc., and its wholly owned subsidiaries JAS and Drew Scientific Limited Co. The sale of this business will have a material effect on earnings in subsequent periods</font><font style="font-family:Arial;font-size:9pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the results of discontinued operations for the three months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;"> and 2011 (in thousands):</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.70992366412213%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="67%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the three months ended September 30,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2011</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,637</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,614</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods sold</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,194</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,344</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketing, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,176</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,097</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research&#160;&amp; development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Costs and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,446</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,603</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income from discontinued operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">191</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Assets and liabilities of discontinued operations of ECD included in the consolidated balance sheets are summarized as follows at September&#160;30, 2012 and June 30, 2012 (in thousands): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:629px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="360px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="119px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="119px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,621</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,555</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,997</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,348</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,730</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,013</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixture</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">287</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">323</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-current accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">553</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">627</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total non-current assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,002</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,112</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,462</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,137</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">536</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">691</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">609</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">589</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,144</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,280</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets of discontinued operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,858</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:center;text-indent:32px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.59375%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="50%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="21%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="21%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Numerator:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;Numerator for basic and diluted earnings per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(624,396</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(501,030</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (Loss) from discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">190,960</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(288,619</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Net (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(433,436</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(789,649</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denominator:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;Denominator for basic earnings per share - weighted average shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,526,430</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,526,430</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;Effect of dilutive securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Stock options and warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Shares reserved for future exchange</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Denominator for diluted earnings per share - weighted average and assumed conversion</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,526,430</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,526,430</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Basic:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.08</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;Discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.04</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.10</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Diluted:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.08</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;Discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.04</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.10</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below sets forth the loss from continuing operations for the three months ended September&#160;30, 2012 and 2011(in thousands).</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td width="30%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Sonomed-Escalon</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Corporate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2011</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2011</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2011</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenues, net:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,407</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,407</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total revenue, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,270</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,407</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,270</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,407</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Costs and expenses:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods sold</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,196</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,224</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,196</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1,224</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketing, general&#160;&amp; admin</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">964</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">886</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">441</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">496</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,406</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1,382</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research&#160;&amp; development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">264</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">220</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">264</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">220</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total costs and expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,424</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,330</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">441</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">496</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,866</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,826</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Loss) income from operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(154</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">77</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(441</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(496</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(597</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(419</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other (expense) and income:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity in OTM</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(93</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(82</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(93</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(82</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total other (expense) and income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(28</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(28</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(81</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Loss) income before taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(155</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">77</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(469</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(577</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(624</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(500</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income taxes benefit from continuing operations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net (loss) income from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(155</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">77</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(469</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(577</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(624</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment Reporting</font></div><div style="line-height:120%;text-indent:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three-month periods ended September 30, 2012 and 2011, the Company's continuing operations were classified into </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> principal reportable business units that provide different products or services. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management reviews financial information, allocates resources, and manages the business as </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> segments: Sonomed-Escalon and Escalon Medical Corp. (&#8220;Corporate&#8221;). The Sonomed-Escalon&#160;segment consists of Sonomed, Inc., EMI and Trek, all of which are engaged in the development and sale of Ophthalmic medical devices. The Corporate segment includes the administrative corporate operations of the consolidated group. The ECD segment which consists of Drew Scientific, Inc., and its wholly owned subsidiary JAS, was reported under discontinued operations beginning with this Form 10-Q for three months ended September 30, 2012 and prior period segment information has been reclassified to conform with the current year presentation.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Separate management of each unit is required because each business unit is subject to different marketing, production and technology strategies.</font></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below sets forth the loss from continuing operations for the three months ended September&#160;30, 2012 and 2011(in thousands).</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td width="30%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Sonomed-Escalon</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Corporate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2011</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2011</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2011</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenues, net:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,407</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,407</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total revenue, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,270</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,407</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,270</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,407</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Costs and expenses:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods sold</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,196</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,224</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,196</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1,224</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketing, general&#160;&amp; admin</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">964</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">886</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">441</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">496</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,406</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1,382</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research&#160;&amp; development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">264</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">220</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">264</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">220</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total costs and expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,424</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,330</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">441</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">496</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,866</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2,826</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Loss) income from operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(154</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">77</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(441</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(496</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(597</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(419</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other (expense) and income:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity in OTM</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(93</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(82</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(93</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(82</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total other (expense) and income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(28</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(28</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(81</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Loss) income before taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(155</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">77</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(469</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(577</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(624</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(500</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income taxes benefit from continuing operations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net (loss) income from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(155</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">77</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(469</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(577</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(624</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company operates in the healthcare market, specializing in the development, manufacture and marketing of ophthalmic medical devices and pharmaceuticals. The business segments reported above are the segments for which separate financial information is available and for which operating results are evaluated regularly by executive management in deciding how to allocate resources and assessing performance. The accounting policies of the business segments are the same as those described in the summary of significant accounting policies in Form 10-K for the year ended June 30, 2012. For the purposes of this illustration, corporate expenses, which consist primarily of executive management and administrative support functions, are allocated across the business segments based upon a methodology that has been established by the Company, which includes a number of factors and estimates and that has been consistently applied across the business segments. These expenses are otherwise included in the corporate segment.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three-month periods ended September 30, 2012 and 2011, Sonomed-Escalon derived its revenue from the sale of A-Scans, B-Scans, pachymeters, Digital imaging products, ISPAN&#8482; gas products and various disposable ophthalmic surgical products.</font></div></div> 1405586 1381882 885785 441146 496097 964440 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;padding-left:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock-Based Compensation </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense for all stock-based compensation awards granted after July&#160;1, 2006 is based on the grant-date fair value estimate in accordance with the provisions of the FASB issued guidance. The Company recognizes these compensation costs on a straight-line basis over the requisite service period of the award. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuations are based on highly subjective assumptions about the future, including stock price volatility and exercise patterns. The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model. Expected volatilities are based on the historical volatility of the Company's stock. The Company uses historical data to estimate option exercise and employee terminations. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury yield curve in effect at the time of the grant.</font></div></div> P1Y3M22D 7526430 7526430 2300000 16485 23898 166085 644865 7526 132114 -68348811 -515622 69386143 7526 -68782247 69369658 -577451 132114 132114 132114 7526430 7526430 7526430 7526430 0.8 1 -338000 -338000 7858000 7317000 P3M 162000 76000 0 0 6500000 6500000 1176000 1097000 892000 0 2500000 0 0 3762 32216 4367604 false --06-30 Q1 2013 2012-09-30 10-Q 0000862668 7526430 Yes Smaller Reporting Company 7526430 ESCALON MEDICAL CORP. No No EX-101.SCH 7 esmc-20120930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2108100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Condensed Consolidated Statements Of Comprehensive (Loss) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1006000 - Statement - Consolidated Statement of Other Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated Statements Of Operations link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Statements Of Shareholders' Equity and Comprehensive Loass link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 2405401 - Disclosure - Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2125100 - Disclosure - Note 10. Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 2425404 - Disclosure - Note 10. Discontinued Operations (Assets and Liabilities of Discontinued Operations - BH Holdings, S.A.S) (Details) link:presentationLink link:calculationLink link:definitionLink 2425406 - Disclosure - Note 10. Discontinued Operations Assets and Liabilities of Discontinued Operations -ECD (Details) link:presentationLink link:calculationLink link:definitionLink 2425402 - Disclosure - Note 10. Discontinued Operations (BH Holdings, S.A.S) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2425408 - Disclosure - Note 10. Discontinued Operations Gain on sale (Details) link:presentationLink link:calculationLink link:definitionLink 2425407 - Disclosure - Note 10. Discontinued Operations Results of discontinued operation -ECD (Details) link:presentationLink link:calculationLink link:definitionLink 2425403 - Disclosure - Note 10. Discontinued Operations (Results of Discontinued Operations - BH Holdings, S.A.S) (Details) link:presentationLink link:calculationLink link:definitionLink 2425405 - Disclosure - Note 10. Discontinued Operations (Results of Discontinued Operations - ECD) (Details) link:presentationLink link:calculationLink link:definitionLink 2325301 - Disclosure - Note 10. Discontinued Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Note. 1 Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Note. 1 Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Note. 1 Basis of Presentation (Tables) link:presentationLink link:calculationLink link:definitionLink 2116101 - Disclosure - Note 2. Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Note 2. Stock-Based Compensation Basis of Presentation (Notes) link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Note 2. Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Note 3. Earning per Share link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Note 3. Earning per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Note 3. Earning per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Note 4. Legal proceeding link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - Note 4. Legal proceeding (Details) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - Note 4. Legal proceeding (Tables) link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - Note 5. Segment Reporting link:presentationLink link:calculationLink link:definitionLink 2420402 - Disclosure - Note 5. Segment Reporting (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2420403 - Disclosure - Note 5. Segment Reporting (Segments Statements of Operations) (Details) link:presentationLink link:calculationLink link:definitionLink 2320301 - Disclosure - Note 5. Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - Note 6. Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 2421401 - Disclosure - Note 6. Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - Note 7. Recently Issued Accounting Standards link:presentationLink link:calculationLink link:definitionLink 2222201 - Disclosure - Note 7. Recently Issued Accounting Standards (Policies) link:presentationLink link:calculationLink link:definitionLink 2322302 - Disclosure - Note 7. Recently Issued Accounting Standards (Tables) link:presentationLink link:calculationLink link:definitionLink 2123100 - Disclosure - Note 8. Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2423401 - Disclosure - Note 8. Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 2124100 - Disclosure - Note. 9 Continuing operations link:presentationLink link:calculationLink link:definitionLink 2424402 - Disclosure - Note. 9 Continuing operations (Details) link:presentationLink link:calculationLink link:definitionLink 2324301 - Disclosure - Note. 9 Continuing operations (Tables) link:presentationLink link:calculationLink link:definitionLink 2126100 - Disclosure - Sigificant accounting policies link:presentationLink link:calculationLink link:definitionLink 2426408 - Disclosure - Sigificant accounting policies (Details) link:presentationLink link:calculationLink link:definitionLink 2226204 - Disclosure - Sigificant accounting policies Income (Loss) Per Share (Policies) link:presentationLink link:calculationLink link:definitionLink 2226201 - Disclosure - Sigificant accounting policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2226202 - Disclosure - Sigificant accounting policies Revenue Recognition (Policies) link:presentationLink link:calculationLink link:definitionLink 2226206 - Disclosure - Sigificant accounting policies Stock-based Compensation (Policies) link:presentationLink link:calculationLink link:definitionLink 2326307 - Disclosure - Sigificant accounting policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2226205 - Disclosure - Sigificant accounting policies Taxes (Policies) link:presentationLink link:calculationLink link:definitionLink 2226203 - Disclosure - Sigificant accounting policies Valuation of Intangible Assets (Policies) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 esmc-20120930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 esmc-20120930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 esmc-20120930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Award Type [Domain] Award Type [Domain] Stock Options [Member] Stock Options [Member] Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Remaining Contractual Term Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Remaining Contractual Term Allocated Share-based Compensation Expense Allocated Share-based Compensation Expense Discontinued Operations and Disposal Groups [Abstract] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Table] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Table] Disposal Group Name [Axis] Disposal Group Name [Axis] Disposal Groups, Including Discontinued Operations, Name [Domain] Disposal Groups, Including Discontinued Operations, Name [Domain] BH Holdings, S.A.S [Member] BH Holdings, S.A.S [Member] BH Holdings, S.A.S [Member] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Assets [Abstract] Assets [Abstract] Cash Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents Accounts receivable, net Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Inventory Disposal Group, Including Discontinued Operation, Inventory Other Assets, Current Disposal Group, Including Discontinued Operation, Other Current Assets Fixed Assets Disposal Group, Including Discontinued Operation, Property, Plant, and Equipment, Net Intangible Assets Disposal Group, Including Discontinued Operation, Intangible Assets, Net Other assets Disposal Group, Including Discontinued Operation, Other Assets Total assets Assets of Disposal Group, Including Discontinued Operation Liabilities [Abstract] Liabilities [Abstract] Accounts payable Disposal Group, Including Discontinued Operation, Accounts Payable Disposal Group, Including Discontinued Operation, Accrued Liabilities Disposal Group, Including Discontinued Operation, Accrued Liabilities Other current liabilities Disposal Group, Including Discontinued Operation, Other Current Liabilities Total liabilities Liabilities of Disposal Group, Including Discontinued Operation Net assets of discontinued operations Assets (Liabilities) of Disposal Group, Including Discontinued Operation, Net Assets (Liabilities) of Disposal Group, Including Discontinued Operation, Net Statement of Other Comprehensive Income [Abstract] Related Party Transactions [Abstract] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Equity Method Investee, Name [Axis] Equity Method Investee, Name [Axis] Equity Method Investee, Name [Domain] Equity Method Investee, Name [Domain] Ocular Telehealth Management (OTM) [Member] OTM [Member] Ocular Telehealth Management (OTM) [Member] Related Party [Axis] Related Party [Axis] Related Party [Domain] Related Party [Domain] Equity Method Investee [Member] Equity Method Investee [Member] Richard J. DePiano [Member] Chief Executive Officer [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Investment held in a company Equity Method Investment, Aggregate Cost Ownership percentage Equity Method Investment, Ownership Percentage Equity in OTM Income (Loss) from Equity Method Investments Assets Equity Method Investment, Summarized Financial Information, Assets Liabilities Equity Method Investment, Summarized Financial Information, Liabilities Stockholders' equity Equity Method Investment Summarized Financial Information, Equity Advanced amount related party transaction Proceeds from Related Party Debt Advance amount related party transaction, percentage of receivable Accounts Receivable Securitization, Percentage of Receivable Accounts Receivable Securitization, Percentage of Receivable Monthly interest rate related party transaction Related Party Transaction, Rate Total accrued interest, related party Total accrued interest, related party Total accrued interest, related party Accrued interest Interest Expense, Related Party Related Party Transaction, Amounts of Transaction Related Party Transaction, Amounts of Transaction Earnings Per Share [Abstract] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Income(loss) from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Net loss Net Income (Loss) Attributable to Parent Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic Proceeds from Stock Options Exercised Proceeds from Stock Options Exercised Shares reserved for future exchange Shares reserved for future exchange Shares reserved for future exchange Weighted Average Number of Shares Outstanding, Diluted Weighted Average Number of Shares Outstanding, Diluted Income (Loss) from Continuing Operations, Per Basic Share Income (Loss) from Continuing Operations, Per Basic Share Income (Loss) from Discontinued Operations, Net of Tax, Per Basic Share Income (Loss) from Discontinued Operations, Net of Tax, Per Basic Share Earnings Per Share, Basic Earnings Per Share, Basic Income (Loss) from Continuing Operations, Per Diluted Share Income (Loss) from Continuing Operations, Per Diluted Share Income (Loss) from Discontinued Operations, Net of Tax, Per Diluted Share Income (Loss) from Discontinued Operations, Net of Tax, Per Diluted Share Earnings Per Share, Diluted Earnings Per Share, Diluted Significant Accounting Policies [Abstract] Significant Accounting Policies [Abstract] Stock-based Compensation [Abstract] Stock-based Compensation [Abstract] Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Related Party Transactions Related Party Transactions Disclosure [Text Block] Accounting Policies [Abstract] New Accounting Pronouncements and Changes in Accounting Principles [Text Block] New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Commitments and Contingencies Disclosure [Abstract] Schedule of Future Minimum Rental Payments for Operating Leases Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Business Segments [Axis] Business Segments [Axis] Segment [Domain] Segment [Domain] Escalon Clinical Diagnostics [Member] Escalon Clinical Diagnostics [Member] The Escalon Clinical Diagnostics (“ECD”) segment consists of Drew Scientific, Inc., and its wholly owned subsidiaries JAS Diagnostics, Inc. (“JAS”) and Biocode Hycel (“Biocode”). ECD develops and sells clinical diagnostic instruments, reagents and chemistries [Member] Sonomed-Escalon [Member] Sonomed-Escalon [Member] Sonomed develops, manufactures and markets ultrasound systems for diagnostic or biometric applications in ophthalmology. The systems are of four types: A-Scans, B-Scans, High Frequency B-Scans (“UBMs”) and pachymeters [Member] Corporate [Member] Corporate [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Product revenue Sales Revenue, Goods, Net Revenues, net Revenue, Net Cost of goods sold Cost of Goods Sold Marketing, general and administrative Selling, General and Administrative Expense Research and development Research and Development Expense Goodwill Impairment Goodwill, Impairment Loss Total costs and expenses Costs and Expenses Loss from operations Operating Income (Loss) Loss (gain) on sales of assets Gain (Loss) on Disposition of Assets Gain (Loss) Related to Litigation Settlement Gain (Loss) Related to Litigation Settlement Interest income Investment Income, Interest Interest Expense Interest Expense Total other (expense) income Nonoperating Income (Expense) (Loss) and income before taxes Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Income taxes benefit from continuing operations Income Tax Expense (Benefit) Net (loss) from continuing operations Revenue Recognition [Abstract] Revenue Recognition, Policy [Policy Text Block] Revenue Recognition, Policy [Policy Text Block] 9. Discontinued Operations [Abstract] 9. Discontinued Operations [Abstract] Assets of discontinued operations Assets of Disposal Group, Including Discontinued Operation, Current Accounts Receivable, Gross, Noncurrent Disposal Group, Including Discontinued Operation, Other Noncurrent Assets Goodwill Disposal Group, Including Discontinued Operation, Goodwill Non-current from discontinued operations Assets of Disposal Group, Including Discontinued Operation, Noncurrent Assets Accounts payable Accounts Payable, Current Accrued Liabilities, Current Accrued Liabilities, Current Liabilities Assets of Disposal Group, Including Discontinued Operation, Current Income Statement [Abstract] Net revenues: Revenue, Net [Abstract] Other revenue Other Revenue, Net Costs and expenses: Costs and Expenses [Abstract] Other (expense) income: Other Income and Expenses [Abstract] Equity in Ocular Telehealth Management, LLC Interest expense Net loss from continuing operations before taxes Benefit of income taxes Net loss Net income (loss) per share Basic: Earnings Per Share, Basic [Abstract] Net income (loss) Diluted: Earnings Per Share, Diluted [Abstract] Discontinued operations Net income (loss) Weighted Average Number of Shares Outstanding, Diluted 4. Legal Proceedings [Abstract] 4. Legal Proceedings [Abstract] Entities [Table] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Entity Information [Line Items] Entity Information [Line Items] Business Description and Basis of Presentation [Text Block] Business Description and Basis of Presentation [Text Block] Continuing Operations [Abstract] Continuing operations [Abstract]. Taxes [Abstract] Taxes [Abstract] Income Tax, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] Fair Value Disclosures [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Biocode Hycell [Member] Biocode Hycell [Member] Biocode Hycell [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Acquisition, percentage of purchase price financed by seller Acquisition of Assets, Percentage of Purchase Price Financed By Seller Acquisition of Assets, Percentage of Purchase Price Financed By Seller Total BHH debt oustanding, accrued interest included Total BHH debt oustanding, accrued interest included Total BHH debt oustanding, interest included Repayments of Long-term Debt Repayments of Long-term Debt Gains (Losses) on Extinguishment of Debt Gains (Losses) on Extinguishment of Debt Long-term Debt, Unclassified [Abstract] Long-term Debt Details [Table] Schedule of Capitalization, Long-term Debt [Table] Significant Acquisitions, by Name of Acquisition [Axis] Significant Acquisitions, by Name of Acquisition [Axis] Significant Acquisitions, by Name of Acquisition [Axis] Significant Acquisitions, by Name of Acquisition [Domain] Significant Acquisitions, by Name of Acquisition [Domain] Significant Acquisitions, by Name of Acquisition [Domain] Drew [Member] Drew [Member] Drew [Member] Long-term Debt Terms [Line Items] Long-term Debt Terms [Line Items] Long-term Debt Terms [Line Items] Acquired assets Acquisition of Assets, Cost of Assets Acquired Acquisition of Assets, Cost of Assets Acquired Acquisition costs Acquisition of Assets, Transaction Costs Acquisition of Assets, Transaction Costs Sales price payable in cash Acquisition of Assets, Cost of Assets Acquired, Cash Paid Acquisition of Assets, Cost of Assets Acquired, Cash Paid Sales price payable in debt from Drew Acquisition of Assets, Cost of Assets Acquired, Liabilities Incurred Acquisition of Assets, Cost of Assets Acquired, Liabilities Incurred Provided debt refinancing Loans Payable Monthly repayments of financing Debt Instrument, Periodic Payment Interest rate Debt Instrument, Interest Rate, Stated Percentage Interest period in days Debt Instrument, Interest Period Interest period Repayment terms Debt Instrument, Term Debt Instrument, Term Long-term debt repayments, number of payments Debt Instrument, Number of Balloon Payments, End of Term Debt Instrument, Number of Balloon Payments, End of Term Earnings Per Share [Text Block] Earnings Per Share [Text Block] Basis of Presentation [Abstract] Basis of Presentation [Abstract] Liquidation period Bankruptcy Proceedings, Operating Period During Liquidation Liquidation Period Deconsolidation, Gain (Loss), Amount Deconsolidation, Gain (Loss), Amount 1. Basis of Presentation [Abstract] 1. Basis of Presentation [Abstract] ECD [Member] ECD [Member] The Escalon Clinical Diagnostics (“ECD”) segment consists of Drew Scientific, Inc., and its wholly owned subsidiaries JAS Diagnostics, Inc. (“JAS”) and Biocode Hycel (“Biocode”). ECD develops and sells clinical diagnostic instruments, reagents and chemistries [Member] Revenues Revenues Troubled Debt Restructuring, Debtor, Current Period [Table] Troubled Debt Restructuring, Debtor, Current Period [Table] Troubled Debt Restructuring, Debtor, Current Period [Line Items] Troubled Debt Restructuring, Debtor, Current Period [Line Items] Minimum requirement for stock holders' equity Minimum requirement for stock holders' equity Minimum requirement for stock holders' equity Disposal Group, Including Discontinued Operation, Sales Price, Fixed Component Disposal Group, Including Discontinued Operation, Sales Price, Fixed Component Disposal Group, Including Discontinued Operation, Sales Price, Fixed Component Significant Acquisitions and Disposals, Gain (Loss) on Sale or Disposal, Pretax Significant Acquisitions and Disposals, Gain (Loss) on Sale or Disposal, Pretax Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Segment Reporting Segment Reporting Disclosure [Text Block] Schedule of Contractual Obligations [Table] Schedule of Contractual Obligations [Table] Schedule of Contractual Obligations [Table] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Performance Guarantee [Member] Performance Guarantee [Member] Schedule of Contractual Obligations [Line Items] Schedule of Contractual Obligations [Line Items] Schedule of Contractual Obligations [Line Items] 2013 Operating Leases, Future Minimum Payments Due, Next Twelve Months 2014 Operating Leases, Future Minimum Payments, Due in Two Years 2015 Operating Leases, Future Minimum Payments, Due in Three Years 2016 Operating Leases, Future Minimum Payments, Due in Four Years 2017 Operating Leases, Future Minimum Payments, Due in Five Years Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Total Operating Leases, Future Minimum Payments Due Leases, Operating [Abstract] Leases, Operating [Abstract] Rent expense Operating Leases, Rent Expense Estimated annual lease payment Guarantor Obligations, Guaranteed Operating Lease Operating Leases, Guaranteed Lease Payment, Estimated Annual Lease Payment Accrued lease termination cost Loss Contingency, Accrual Carrying Value, Current 2. Stock-Based Compensation [Abstract] 2. Stock-Based Compensation [Abstract] Revenue, net Disposal Group, Including Discontinued Operation, Revenue Cost of goods Disposal Group, Including Discontinued Operation, Costs of Goods Sold Market, general and administrative Disposal Group, Including Discontinued Operation, Selling, General and Administrative Expense Disposal Group, Including Discontinued Operation, Selling, General and Administrative Expense Research and development Disposal Group, Including Discontinued Operation, Research and Development Expense Disposal Group, Including Discontinued Operation, Research and Development Expense Total Costs and expenses Disposal Group, Including Discontinued Operation, Operating Expense Income (loss) from discontinued operations Disposal Group, Including Discontinued Operation, Operating Income (Loss) Loss on liquidation of net assets from discontinued operations Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax Income (Loss) before income taxes Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax Income Tax Discontinued Operation, Tax Effect of Discontinued Operation Net income Statement of Financial Position [Abstract] Statement [Table] Statement [Table] Statement, Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Statement [Line Items] Statement [Line Items] ASSETS Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accounts receivable, net Accounts Receivable, Net, Current Inventory, net Inventory, Net Other current assets Other Assets, Current Total current assets Assets, Current Property and equipment, net Property, Plant and Equipment, Net Prime Diagnostics receivable Accounts Receivable, Net, Noncurrent Goodwill Goodwill Trademarks and trade names Indefinite-Lived Intangible Assets (Excluding Goodwill) Patents, net Finite-Lived Intangible Assets, Net Covenant not to compete and customer lists, net Covenant Not to Compete and Customer List, Net Covenant not to compete and customer list, net. Total assets Assets LIABILITIES AND SHAREHOLDERS' EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Current portion of long-term debt Long-term Debt, Current Maturities Related party note payable Notes Payable, Related Parties, Current Accrued expenses Liabilities of discontinued operations Liabilities of Disposal Group, Including Discontinued Operation, Current Total current liabilities Liabilities, Current Long-term debt, net of current portion Long-term Debt, Excluding Current Maturities Accrued post-retirement benefits Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent Total long-term liabilities Liabilities, Noncurrent Total liabilities Liabilities Shareholders equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, $0.001 par value; 2,000,000 shares authorized; no shares issued Preferred Stock, Value, Issued Common stock, $0.001 par value; 35,000,000 shares authorized; 7,526,430 issued and outstanding at June 30, 2012 and June 30, 2011 Common Stock, Value, Issued Common stock warrants Warrants and Rights Outstanding Additional paid-in capital Additional Paid in Capital Accumulated deficit Retained Earnings (Accumulated Deficit) Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Total shareholders' equity Stockholders' Equity Attributable to Parent Total liabilities and shareholders' equity Liabilities and Equity Income (Loss) Per Share [Abstract] Income (Loss) Per Share [Abstract] Earnings Per Share, Policy [Policy Text Block] Earnings Per Share, Policy [Policy Text Block] Statement of Stockholders' Equity [Abstract] Statement, Equity Components [Axis] Equity Components [Axis] Total Shareholders' Equity [Domain] Equity Component [Domain] Common Stock [Member] Common Stock [Member] Common Stock Warrants [Member] Warrant [Member] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Accumulated Deficit [Member] Retained Earnings [Member] Accumulated Other Comprehensive Income (Loss) [Member] Accumulated Other Comprehensive Income (Loss) [Member] Balance Balance, shares Shares, Outstanding Net loss Foreign currency translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Expired warrants Adjustments to Additional Paid in Capital, Warrants Expired Adjustments to Additional Paid in Capital, Warrants Expired Compensation expense Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Balance Balance, shares Foreign currency translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Total comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Fair Value Measurements Fair Value Disclosures [Text Block] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Common stock, par value Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Common stock, shares outstanding Common Stock, Shares, Outstanding Schedule of Discontinued Operations Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block] Quarterly Financial Information [Text Block] Quarterly Financial Information [Text Block] Nature of Operations [Text Block] Nature of Operations [Text Block] Document And Entity Information [Abstract] Document and entity information [Abstract]. Entities [Table] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Voluntary Filers Entity Current Reporting Status Entity Current Reporting Status Entity Public Float Entity Public Float Company overview [Abstract] Company overview [Abstract] Goodwill and Intangible Assets, Policy [Policy Text Block] Goodwill and Intangible Assets, Policy [Policy Text Block] Number of Operating Segments Number of Operating Segments Gain on sale of assets Statement of Cash Flows [Abstract] Cash Flows from Operating Activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net (loss) Adjustments to reconcile net loss to cash provided by operating activities of continuing operations: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Income from discontinued operations Depreciation and amortization Depreciation, Depletion and Amortization Loss on disposal of assets Compensation expense related to stock options Stock or Unit Option Plan Expense Change in accrued post-retirement benefits Increase (Decrease) in Pension and Postretirement Obligations Loss of Ocular Telehealth Management, LLC Change in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable, net Increase (Decrease) in Accounts Receivable Inventory, net Increase (Decrease) in Inventories Other current and long-term assets Increase (Decrease) in Other Operating Assets Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Net cash (used in) operating activities from continuing operations Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash (used in) provided by operating activities from discontinued operations Cash Provided by (Used in) Operating Activities, Discontinued Operations Net cash (used in) operating activities Net Cash Provided by (Used in) Operating Activities Cash Flows from Investing Activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Investment in Ocular Telehealth Management, LLC Payments to Acquire Interest in Subsidiaries and Affiliates Purchase of fixed assets Payments to Acquire Productive Assets Net cash (used in) investing activities from continuing operations Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net cash (used in) investing activities from discontinued operations including proceeds from sale of vascular assets Cash Provided by (Used in) Investing Activities, Discontinued Operations Net cash (used in) investing activities Net Cash Provided by (Used in) Investing Activities Cash Flows from Financing Activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from related party note payable Principal payments on long-term debt Net cash used in financing activities from continuing operations Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash used in/provided by financing activities from discontinued operations Cash Provided by (Used in) Financing Activities, Discontinued Operations Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Net (decrease) increase in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Supplemental Schedule of Cash Flow Information: Supplemental Cash Flow Information [Abstract] Interest paid Interest Paid Discontinued Operations Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Disposal Group, Including Discontinued Operation, Sales Price Component [Axis] Disposal Group, Including Discontinued Operation, Sales Price Component [Axis] Disposal Group, Including Discontinued Operation, Sales Price Component [Axis] Disposal Group, Including Discontinued Operation, Sales Price Component [Domain] Disposal Group, Including Discontinued Operation, Sales Price Component [Domain] Disposal Group, Including Discontinued Operation, Sales Price Component [Domain] Sales Price Component, Cash at Closing [Member] Sales Price Component, Cash at Closing [Member] Sales Price Component, Cash at Closing [Member] Segment [Domain] Deconsolidation, Gain (Loss), Amount Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Legal Matters and Contingencies [Text Block] Legal Matters and Contingencies [Text Block] EX-101.PRE 11 esmc-20120930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R39.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 10. Discontinued Operations Gain on sale (Details) (ECD [Member], USD $)
 3 Months Ended
Dec. 31, 2012
Sep. 30, 2012
ECD [Member]
    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Significant Acquisitions and Disposals, Gain (Loss) on Sale or Disposal, Pretax   $ 2,300,000
Deconsolidation, Gain (Loss), Amount $ 4,200,000  
XML 13 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note. 9 Continuing operations (Details) (USD $)
 3 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Sep. 30, 2011
Troubled Debt Restructuring, Debtor, Current Period [Line Items]      
Minimum requirement for stock holders' equity   $ 2,500,000  
Total BHH debt oustanding, accrued interest included   4,367,604  
Repayments of Long-term Debt 2,487,480 0 88,555
Gains (Losses) on Extinguishment of Debt 1,880,124    
ECD [Member]
      
Troubled Debt Restructuring, Debtor, Current Period [Line Items]      
Disposal Group, Including Discontinued Operation, Sales Price, Fixed Component   6,500,000  
Significant Acquisitions and Disposals, Gain (Loss) on Sale or Disposal, Pretax   $ 2,300,000  
XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 10. Discontinued Operations (Tables)
 3 Months Ended
Sep. 30, 2012
BH Holdings, S.A.S [Member]
  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Schedule of Discontinued Operations
The following table summarizes the results of discontinued operations of BHH for the three months ended September 30, 2012 and 2011 (in thousands):

 For three months ended September 30,
2012
 
2011
Revenue, net
$
—

 
$
999

Cost of goods sold
—

 
407

Marketing, general and administrative
—

 
892

Research & development
—

 
—

Total Costs and expenses
—

 
1,299

Loss from discontinued operations
$
—

 
$
(300
)

Assets and liabilities of discontinued operations of BHH included in the consolidated balance sheets are summarized as follows at September 30, 2012 and June 30, 2012 (in thousands):


 
September 30,
 
June 30,

2012

 
2012
Assets
$
—

 
$
—

Total assets
—

 
—

Liabilities
 
 
 
Accounts payable
—

 
—

Accrued expenses
—

 
—

Accrued lease termination costs
338

 
338

Total liabilities
338

 
338

Net assets of discontinued operations
$
(338
)
 
$
(338
)
ECD [Member]
  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Schedule of Discontinued Operations
On October 3, 2012 the Company sold its Clinical Diagnostics Business to ERBA Diagnostics, Inc. The ECD consisted of Drew Scientific, Inc., and its wholly owned subsidiaries JAS and Drew Scientific Limited Co. The sale of this business will have a material effect on earnings in subsequent periods.
The following table summarizes the results of discontinued operations for the three months ended September 30, 2012 and 2011 (in thousands):
 
For the three months ended September 30,
2012
 
2011
Revenue, net
$
3,637

 
$
3,614

Cost of goods sold
2,194

 
2,344

Marketing, general and administrative
1,176

 
1,097

Research & development
76

 
162

Total Costs and expenses
3,446

 
3,603

Net income from discontinued operations
$
191

 
$
11


Assets and liabilities of discontinued operations of ECD included in the consolidated balance sheets are summarized as follows at September 30, 2012 and June 30, 2012 (in thousands):
 
September 30,
 
June 30,
 
2012
 
2012
Assets
 
 
 
Accounts receivable
$
1,621

 
$
1,555

Inventory
1,997

 
2,348

Other assets
112

 
110

Total current assets
3,730

 
4,013

Furniture and fixture
287

 
323

Non-current accounts receivable
69

 
69

Goodwill
93

 
93

Intangible assets
553

 
627

Total non-current assets
1,002

 
1,112

Total Assets
8,462

 
9,137

Liabilities
 
 
 
Accounts payable
536

 
691

Accrued expenses
609

 
589

Total liabilities
1,144

 
1,280

Net assets of discontinued operations
$
7,317

 
$
7,858
XML 16 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 10. Discontinued Operations (Results of Discontinued Operations - ECD) (Details) (ECD [Member], USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
ECD [Member]
    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Revenue, net $ 3,637 $ 3,614
Cost of goods 2,194 2,344
Market, general and administrative 1,176 1,097
Research and development 76 162
Total Costs and expenses 3,446 3,603
Income (loss) from discontinued operations $ 191 $ 11
XML 17 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 2. Stock-Based Compensation
 3 Months Ended
Sep. 30, 2012
2. Stock-Based Compensation [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
2.               Stock-Based Compensation

Valuations are based upon highly subjective assumptions about the future, including stock price volatility and exercise patterns. The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model. Expected volatilities are based on the historical volatility of the Company's stock. The Company uses historical data to estimate option exercise and employee terminations. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury yield curve in effect at the time of the grant.

The Company has historically granted options under the Company's option plans with an option exercise price equal to the closing market value of the stock on the date of the grant and with vesting, primarily for Company employees, either in equal annual amounts over a two- to five-year period or immediately, and, primarily for non-employee directors, immediately.

As of September 30, 2012 and 2011 total unrecognized compensation cost related to non-vested share-based compensation arrangements granted to employees under the 2004 Equity Incentive Plan was $38,271 and $104,212, respectively. The remaining cost is expected to be recognized over a weighted average period of 1.31 years. For the three-month period ended September, 2012 and 2011, $16,485 and $23,898 was recorded as compensation expense, respectively.
 
The Company did not receive any cash from share option exercises under stock-based payment plans for the three month periods ended September, 2012 and 2011. The Company did not realize any tax effect, which would be a reduction in its tax rate, on options due to the full valuation allowances established on its deferred tax assets.

The Company measures compensation expense for non-employee stock-based compensation based on the fair value of the options issued, as this is more reliable than the fair value of the services received. Fair value is measured as the value of the Company's common stock on the date that the commitment for performance by the counterparty has been reached or the counterparty's performance is complete. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital. There was no non-employee compensation expense for the three-month periods ended September 30, 2012 and 2011.
EXCEL 18 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\S.3DV.&$Q8U\T9F,P7S1A-F)?.3'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,E]3=&]C:T)A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?-%],96=A;%]P#I%>&-E;%=O#I%>&-E M;%=O#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,3!?1&ES8V]N=&EN=65D7T]P97)A=&EO;CPO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-I9VEF:6-A;G1?86-C M;W5N=&EN9U]P;VQI8VEE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-I9VEF:6-A;G1?86-C;W5N=&EN9U]P;VQI8VEE#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I7;W)K#I%>&-E M;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,U]%87)N:6YG7W!E#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?-5]396=M96YT M7U)E<&]R=&EN9U].87)R83PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?-5]396=M96YT7U)E<&]R=&EN9U]396=M93PO>#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO M=&5?,3!?1&ES8V]N=&EN=65D7T]P97)A=&EO;C,\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I%>&-E M;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/DYO=&5?,3!?1&ES8V]N=&EN M=65D7T]P97)A=&EO;C8\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I!8W1I=F53:&5E=#XP M/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2!296=I'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^4V5P(#,P+`T*"0DR,#$R/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`Q,SQS<&%N/CPO'0^43$\2!796QL+6MN M;W=N(%-E87-O;F5D($ES'0^3F\\2!6;VQU;G1A'0^665S M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2P@;F5T/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF5D/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XS-2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'!E;G-E'!E;G-E2!I M;B!/8W5L87(@5&5L96AE86QT:"!-86YA9V5M96YT+"!,3$,\+W1D/@T*("`@ M("`@("`\=&0@8VQA&5S/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S"P@4&5R($)A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S.3DV.&$Q8U\T M9F,P7S1A-F)?.3'0O:'1M;#L@8VAA2!T'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XQ-BPT.#4\7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!O<&5R871I;F<@86-T:79I=&EEF%T:6]N/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XS+#'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!O<&5R871I;F<@86-T:79I=&EE M2!N;W1E('!A>6%B;&4\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA2!T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0@0FQO8VM=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M(#PO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M'0M:6YD96YT.C0X<'@[9F]N="US:7IE.C$P<'0[/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`P,#`P,#MT97AT+61E8V]R871I;VXZ;F]N93L^)#$L.#@P+#$R-#PO M9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.C$P<'0[/BX@5&AE(')E<&%Y;65N="!O9B!T:&4@9&5B="!H87,@2=S(&1E8G0@'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M:6YD96YT.C0X<'@[9F]N="US:7IE.C$P<'0[/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^07,@ M82!R97-U;'0@;V8@=&AE2!E>'!E8W1S('1H870@=&AE('1O=&%L(&=A:6X@=VEL;"!B2!B86-K(&EN=&\@8V]M<&QI86YC92!W:71H('1H92!M:6YI M;75M(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P,#`P,#MT97AT+61E8V]R871I;VXZ M;F]N93L^)#(L-3`P+#`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`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UE6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5&AE(&9O M;&QO=VEN9R!T86)L92!S971S(&9O6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+71O M<#HQ,G!X.W1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C,R<'@[9F]N M="US:7IE.C$P<'0[/CQD:78@'0M:6YD96YT.C!P>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`\+V9O;G0^/"]D:78^/"]T9#X\=&0@#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`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`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`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^-RPU,C8L-#,P/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[)B,Q M-C`[)B,Q-C`[0F%S:6,Z/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[)B,Q-C`[)B,Q-C`[ M)B,Q-C`[)B,Q-C`[)B,Q-C`[0V]N=&EN=6EN9R!O<&5R871I;VYS/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M*#`N,#@\+V9O;G0^/"]D:78^/"]T9#X\=&0@#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*#`N,#0\+V9O;G0^/"]D:78^/"]T9#X\=&0@#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+7)I9VAT.C)P>#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[)B,Q-C`[)B,Q-C`[ M)B,Q-C`[)B,Q-C`[)B,Q-C`[0V]N=&EN=6EN9R!O<&5R871I;VYS/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M*#`N,#@\+V9O;G0^/"]D:78^/"]T9#X\=&0@#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*#`N,#0\+V9O;G0^/"]D:78^/"]T9#X\=&0@#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+7)I9VAT.C)P>#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`@("`\=&%B;&4@8VQAF4Z,3!P=#MF;VYT+7=E:6=H=#IB M;VQD.SY396=M96YT(%)E<&]R=&EN9SPO9F]N=#X\+V1I=CX\9&EV('-T>6QE M/3-$;&EN92UH96EG:'0Z,3(P)3MT97AT+6EN9&5N=#HY-G!X.V9O;G0M6QE/3-$;&EN M92UH96EG:'0Z,3(P)3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M2=S(&-O M;G1I;G5I;F<@;W!E3II;FAE'0M:6YD96YT.C0X<'@[9F]N="US M:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O M=W-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.CAP=#MF;VYT+7=E:6=H=#IB;VQD.SXR,#$Q/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R M.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M=V5I9VAT.F)O;&0[/C(P,3(\+V9O M;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC M96YT97([9F]N="US:7IE.CAP=#L^/&9O;G0@3II;FAEF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`C,#`P,#`P.V)O6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A M9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXF(S@R,3([/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXF(S@R,3([/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXR+#(W,#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[ M8F]R9&5R+6)O='1O;3HQ<'@@"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q M/CQD:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD M:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^,C8T/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E M:6=H=#IB;VQD.SXR,C`\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T M6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SY4 M;W1A;"!C;W-T#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZF4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXR+#0R M-#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HQ<'@@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXR+#@V-CPO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MF;VYT+7=E:6=H=#IB;VQD.SXH3&]S#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O M=W-P86X],T0Q/CQD:78@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXI/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H M=#IB;VQD.SXH-#DV/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,C$R M.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`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`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`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`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#LG M(')O=W-P86X],T0Q/CQD:78@#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.R<@'0M86QI9VXZF4Z,3!P=#L^*#@R/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZF4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXF(S@R M,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A M8VMG"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;FF4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD M.SXH,C@\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MF;VYT+7=E:6=H=#IB;VQD.SXI/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT M+7=E:6=H=#IB;VQD.SXW-SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR M<'@[8F]R9&5R+71O<#HQ<'@@#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.R<@'0M86QI9VXZF4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HQ<'@@6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R M9&5R+6)O='1O;3HQ<'@@6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R<@'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[ M8F]R9&5R+6)O='1O;3HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,C$R.SPO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,C$R.SPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E M:6=H=#IB;VQD.SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.V)A8VMGF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM M86QI9VXZ=&]P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MF;VYT+7=E:6=H=#IB;VQD.SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R<@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E M:6=H=#IB;VQD.SXH,34U/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`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`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MF;VYT+7=E:6=H=#IB;VQD.SXH-#8Y/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+7)I9VAT.C)P>#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+6)O='1O;3HR M<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`P,#`P,#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXH-3`P/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`L,#`P/"]F M;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^(&%N9"`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`Q,BX\ M+V9O;G0^/"]D:78^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`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`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P M=#LG/CQD:78@#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE2!F;W(@2!O9B!I;G!U="!M M96%S=7)E;65N=',@=7-E9"!T;R!A2P@:6X@=&AE M('!R:6YC:7!A;"!O6QE/3-$;&EN M92UH96EG:'0Z,3(P)3MP861D:6YG+71O<#HV<'@[=&5X="UA;&EG;CIJ=7-T M:69Y.W1E>'0M:6YD96YT.C,R<'@[9F]N="US:7IE.C$P<'0[/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^3&5V M96P@,28C.#(Q,CM/8G-E#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MT97AT+6%L:6=N.FIU#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE28C.#(Q-SMS(&]W;B!D871A+CPO M9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D M:6YG+71O<#HQ,G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HS M,G!X.V9O;G0M2!L:7%U:60@ M;F%T=7)E+B!4:&5S92!I;G-T6%B;&4L(&%C8W)U960@97AP96YS97,@86YD(')E;&%T960@<&%R='D@ M;F]T92!P87EA8FQE+CPO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$;&EN92UH M96EG:'0Z,3(P)3MP861D:6YG+71O<#HQ,G!X.W1E>'0M86QI9VXZ:G5S=&EF M>3MT97AT+6EN9&5N=#HS,G!X.V9O;G0M2`F(S@R,C`[;W1H97(@;&5V96P@,R!M96%S M=7)E;65N=',F(S@R,C$[('1H92!#;VUP86YY(&ES(')E9F5R2!I;F-L=61E M9"!T:&ES(')E9F5R96YC92!B96-A=7-E(&EN(&1E=&5R;6EN:6YG('1H92!E M28C.#(R,3L@;V8@87!P;'EI;F<@2!F;W(@9&5B="!W:71H M('-I;6EL87(@=&5R;7,@86YD(')E;6%I;FEN9R!M871U6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C M;W)A=&EO;CIN;VYE.SXQ,#`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`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA2!&:6YA M;F-I86P@26YF;W)M871I;VX@6U1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`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`P,#`P,#MT97AT+61E8V]R871I M;VXZ;F]N93L^)#(L-#@W+#0X,#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!R97-U;'1I;F<@:6X@ M82!G86EN(&]N(&5X=&EN9W5I6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD,2PX.#`L M,3(T/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^+B!4:&4@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO M;CIN;VYE.SYZ97)O/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+B`\+V9O;G0^/"]D:78^/&1I=B!S M='EL93TS1&QI;F4M:&5I9VAT.C$R,"4[=&5X="UA;&EG;CIJ=7-T:69Y.V9O M;G0M#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO M;CIN;VYE.SXD-"PR,#`L,#`P/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&1U6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A M=&EO;CIN;VYE.SXD,BPU,#`L,#`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`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`C,#`P,#`P.V)A8VMG'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[ M8F]R9&5R+6)O='1O;3HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^.3DY/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$9F]N="US:7IE.C$P<'0[/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^3&]S M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A M9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[ M<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`C,#`P M,#`P.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HQ M<'@@"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^3&EA M8FEL:71I97,\+V9O;G0^/"]D:78^/"]T9#X\=&0@8V]L#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^06-C;W5N=',@<&%Y86)L93PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!C;VQS<&%N/3-$,B!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$9F]N="US:7IE.C$P<'0[/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M06-C'!E;G-E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZF4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^,S,X/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`P,#`P,#MP861D:6YG+6QE M9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[)R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D M:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MP861D:6YG+7)I9VAT.C)P>#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#LG(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P M,#`P,#`[<&%D9&EN9RUT;W`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`Z,3!P>#L^/'1A8FQE(&-E;&QP861D:6YG/3-$ M,"!C96QL#L@#LG(')O=W-P M86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E'0M86QI M9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.V)A8VMG"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HQ<'@@#LG(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@#MP M861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`P M,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#LG(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O M='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$;&EN92UH96EG:'0Z,3(P)3MT M97AT+6%L:6=N.F-E;G1EF4Z,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN M9&5N=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P M=#MM87)G:6XM;&5F=#IA=71O.VUA"!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\+W1D/CQT9"!W:61T:#TS1#1P>"!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\+W1D/CQT9"!W:61T:#TS1#5P>"!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\+W1D/CQT9"!W:61T:#TS1#EP>"!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\+W1D/CQT9"!W:61T:#TS1#$Q.7!X(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CPO=&0^/'1D('=I9'1H/3-$-'!X(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE M/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^4V5P M=&5M8F5R(#,P+#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE'1U#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,C@W/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,S(S/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR M<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^.3,\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^26YT86YG:6)L92!A#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAEF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M86QI9VXZF4Z,3!P=#L^.2PQ,S<\+V9O;G0^/"]D:78^/"]T9#X\ M=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^3&EA8FEL:71I97,\+V9O;G0^/"]D:78^/"]T9#X\ M=&0@8V]L#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@ M'0M86QI9VXZF4Z,3!P=#L^-C`Y/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^-3@Y/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A M8VMG"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,2PR.#`\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^3F5T(&%S#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^-RPS,3<\+V9O;G0^/"]D:78^/"]T9#X\=&0@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`[/"]F;VYT/CPO9&EV/CQD:78@'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&1I=B!S='EL M93TS1'!A9&1I;F#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE&ES=',@8F5T M=V5E;B!A('=I;&QI;F<@8G5Y97(@*&1I'0M86QI9VXZ:G5S=&EF>3MF;VYT M+7-I>F4Z-'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.C1P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CQD:78@'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I M>F4Z,3!P=#L^/&1I=B!S='EL93TS1'!A9&1I;F3I4:6UE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`[/"]F;VYT M/CPO9&EV/CQD:78@'0M86QI M9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&1I=B!S='EL93TS1'!A9&1I M;F#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@3II;FAEF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE2!A M2!B87-E9"!O;B!C2!P97)F;W)M2!O9B!T M:&4@0V]M<&%N>2=S(&EN=&5R;F%T:6]N86P@8W5S=&]M97)S+"!T:&4@0V]M M<&%N>2!R97%U:7)E2!T:&4@8W5S=&]M97(@8F5F;W)E('1H92!P=7)C M:&%S92!O7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!497AT($)L;V-K M73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3I4:6UE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+71O<#HQ M.'!X.W1E>'0M86QI9VXZ:G5S=&EF>3MP861D:6YG+6QE9G0Z-C1P>#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ M:G5S=&EF>3MT97AT+6EN9&5N=#HV-'!X.V9O;G0M2!C;VUP87)I2!S=6-H M(&EM<&%I7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!497AT($)L;V-K73PO=&0^ M#0H@("`@("`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`@("`\ M=&%B;&4@8VQA&5S("A0;VQI8VEE2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@'0M86QI9VXZ:G5S=&EF>3MP861D:6YG+6QE9G0Z-C1P M>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE&5S M(#PO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP M861D:6YG+71O<#HV<'@[=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:6YD96YT M.C8T<'@[9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^17-T:6UA=&5S(&]F('1A>&%B M;&4@:6YC;VUE(&]F('1H92!V87)I;W5S(&QE9V%L(&5N=&ET:65S(&%N9"!J M=7)I2=S(&EN8V]M92!T87@@=VEL;"!B92!F;W(@=&AE M('EE87(N(%-I;F-E(&IU9&=M96YT(&ES(&EN=F]L=F5D+"!T:&5R92!I'0M:6YD96YT.C8T<'@[9F]N="US M:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^26X@9&5T97)M:6YI;F<@:6YC;VUE+RAL;W-S*2!F M;W(@9FEN86YC:6%L('-T871E;65N="!P=7)P;W-E2!D:69F97)E;F-E"!A2!A M('9A;'5A=&EO;B!A;&QO=V%N8V4L(&EF(&)A'0M M:6YD96YT.C8T<'@[9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^26X@979A;'5A=&EN M9R!T:&4@0V]M<&%N>2=S(&%B:6QI='D@=&\@2=S(&1E9F5R"!A2=S('!A&ES=&5N8V4@;V8@8W5M=6QA=&EV92!L;W-S97,@86YD(&YE M87(M=&5R;2!F;W)E8V%S=',@;V8@9G5T=7)E('1A>&%B;&4@:6YC;VUE('1H M870@:7,@8V]N6QE/3-$;&EN92UH M96EG:'0Z,3(P)3MP861D:6YG+71O<#HQ,G!X.W1E>'0M86QI9VXZ:G5S=&EF M>3MT97AT+6EN9&5N=#HV-'!X.V9O;G0M2=S(&YE="!O<&5R871I;F<@;&]S"!A"!C&ES=&5N8V4@;V8@=&%X86)L92!T M96UP;W)A'!E8W1A=&EO;G,N(%1H92!A;6]U;G0@;V8@=&AE('9A;'5A=&EO;B!A;&QO M=V%N8V4@8V]U;&0@9&5C2!I;F-R96%S92!T87AA8FQE(&EN M8V]M92!P69O6QE/3-$;&EN92UH96EG:'0Z,3(P M)3MP861D:6YG+71O<#HQ,G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN M9&5N=#HS,G!X.V9O;G0M2!H87,@=&%K96X@;W(@97AP96-TF4@=&AE(&)E;F5F:70@;V8@86X@:6YC M;VUE('1A>"!P;W-I=&EO;B!O;FQY(&EF(&ET(&ES(&UO2!O;B!T:&4@=&5C:&YI8V%L(&UE2P@8V]M<&%N M:65S(&%R92!R97%U:7)E9"!T;R!A8V-R=64@:6YT97)E7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!;4&]L M:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`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`@("`\=&%B M;&4@8VQA'0@ M0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T M>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z M,3!P=#LG/CQD:78@#MF M;VYT+7-I>F4Z,3!P=#L^/&1I=B!S='EL93TS1'!A9&1I;F'0M M86QI9VXZ;&5F=#LG/CQT#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0W('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^,C`Q,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP M861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$9F]N="US:7IE.C$P<'0[/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[)B,Q-C`[3G5M97)A=&]R(&9O#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`P,#`P,#MP861D:6YG+7)I9VAT.C)P>#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+7)I9VAT.C)P>#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$9F]N="US:7IE.C$P<'0[/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[1&5N;VUI;F%T;W(@9F]R(&1I;'5T960@96%R;FEN9W,@<&5R('-H87)E M("T@=V5I9VAT960@879EF4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^3F5T("AL;W-S*2!I;F-O;64@ M('!E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`[)B,Q-C`[)B,Q M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A M9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[ M<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^*#`N,#8\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I M;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#`N,3`\+V9O;G0^/"]D M:78^/"]T9#X\=&0@#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL M93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[)B,Q M-C`[)B,Q-C`[1&EL=71E9#H\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`[)B,Q-C`[)B,Q M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[1&ES8V]N=&EN=65D(&]P97)A=&EO;G,\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR M<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A M9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[ M<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^*#`N,#8\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I M;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#`N,3`\+V9O;G0^/"]D M:78^/"]T9#X\=&0@#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CPO='(^/"]T86)L93X\+V1I M=CX\+V1I=CX\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA#MT97AT+6EN9&5N=#HT.'!X.V9O;G0M M6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.7!T.SXF(S$V,#L\+V9O M;G0^/"]D:78^/&1I=B!S='EL93TS1&QI;F4M:&5I9VAT.C$R,"4[9F]N="US M:7IE.C$P<'0[/CQD:78@'0M M:6YD96YT.C!P>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P M>#L^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0W('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#L@'0M M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M=V5I9VAT.F)O M;&0[/E-O;F]M960M17-C86QO;CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0W('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M M=V5I9VAT.F)O;&0[/D-O#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0W('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O M;G0M=V5I9VAT.F)O;&0[/E1O=&%L/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^ M)B,Q-C`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$ M=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^4')O9'5C="!R979E;G5E/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MB86-K M9W)O=6YD+6-O;&]R.B-C8V5E9F8[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^,BPR-S`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`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`C,#`P M,#`P.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB M;VQD.SXR+#0P-SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@ M"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X M="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O M=W-P86X],T0Q/CQD:78@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#LG(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXI/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXH-#$Y/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^)B,Q-C`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`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD M:78@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^*#DS/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N M/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$;W9E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MF;VYT+7=E:6=H=#IB;VQD.SXH,C@\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXI/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR M<'@[8F]R9&5R+71O<#HQ<'@@#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`P,#`P,#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXW-SPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O M;3HS<'@@9&]U8FQE(",P,#`P,#`[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF M;VYT+7=E:6=H=#IB;VQD.SXI/"]F;VYT/CPO9&EV/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD M:78@#MT M97AT+6%L:6=N.FQE9G0[=&5X="UI;F1E;G0Z-#AP>#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAEF4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C0X<'@[9F]N="US M:7IE.C$P<'0[/CQD:78@'0M M:6YD96YT.C!P>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P M>#L^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL"!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\+W1D/CQT9"!W:61T:#TS1#EP>"!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\+W1D/CQT9"!W:61T:#TS1#DR<'@@6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,2PR M.3D\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0MF4Z,3!P=#L^/&9O M;G0@3II;FAE#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@'0M M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ8V5N=&5R.V9O;G0M M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$9F]N="US:7IE.C$P<'0[ M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.V)O6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HQ<'@@"!S;VQI9"`C,#`P,#`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`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`C,#`P,#`P.V)A M8VMG6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R M9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X M.W!A9&1I;F#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@#MP861D M:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#,S.#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[ M8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUR:6=H M=#HR<'@[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#LG(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D M/CPO='(^/"]T86)L93X\+V1I=CX\+V1I=CX\9&EV('-T>6QE/3-$;&EN92UH M96EG:'0Z,3(P)3MP861D:6YG+71O<#HQ,G!X.W1E>'0M:6YD96YT.C,R<'@[ M9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SX\+V9O;G0^ M/"]D:78^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3I4:6UE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O M;3HV<'@[<&%D9&EN9RUT;W`Z-G!X.W1E>'0M86QI9VXZ;&5F=#MT97AT+6EN M9&5N=#HT.'!X.V9O;G0M#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SY397!T M96UB97(F(S$V,#LS,"P@,C`Q,CPO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!A;F0@,C`Q,2`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MF;VYT+7=E:6=H=#IB;VQD.SXR,#$Q/"]F;VYT/CPO9&EV/CPO=&0^/"]T M6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^4F5V96YU92P@;F5T/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MB86-K M9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[ M8F]R9&5R+6)O='1O;3HQ<'@@#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,RPV,S<\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P M,#`P.V)A8VMG6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#LG M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/"]T'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$;&EN92UH96EG:'0Z,3(P)3MT97AT+6%L:6=N.FQE9G0[9F]N M="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^("`@("`@("`@("`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`S,"P\+V9O;G0^/"]D:78^ M/"]T9#X\+W1R/CQT#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC M96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`Q,CPO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O M=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^07-S971S/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`C,#`P,#`P.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+7)I9VAT.C)P>#L@#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@6QE/3-$)W9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`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`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`C,#`P,#`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`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP M861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N M/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O M='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5D($-O;7!O;F5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$&5D($-O;7!O;F5N M=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA65E M(%-E65T(%)E8V]G M;FEZ960\+W1D/@T*("`@("`@("`\=&0@8VQAF5D('5N9&5R(%-T;V-K($]P=&EO;B!0;&%N65A'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5S M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V,C0L,SDV*3QS<&%N M/CPO'!E;G-E2!I;B!/5$T\+W1D/@T*("`@("`@("`\=&0@ M8VQA'!E;G-E M*2!I;F-O;64\+W1D/@T*("`@("`@("`\=&0@8VQA&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M/B@T-C@L.3,W*3QS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2!42!I;B!/5$T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!T2!T3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!I;B!/5$T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S.3DV.&$Q8U\T9F,P M7S1A-F)?.3'0O M:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!S96QL97(\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$6UE;G1S(&]F($QO;F'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'1I;F=U:7-H;65N="!O9B!$96)T/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L.#@P+#$R-#QS<&%N M/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6UE;G1S(&]F($QO;F'1I;F=U:7-H;65N="!O9B!$96)T/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#@X,"PQ,C0\'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S.3DV.&$Q8U\T9F,P7S1A M-F)?.3'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S M.3DV.&$Q8U\T9F,P7S1A-F)?.3'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!$:7-P;W-A;"!'3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\S.3DV.&$Q8U\T9F,P7S1A-F)?.3'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4\+W1D/@T*("`@("`@ M("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\S.3DV.&$Q8U\T9F,P7S1A-F)?.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'!E;G-E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S M.3DV.&$Q8U\T9F,P7S1A-F)?.3'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\S.3DV.&$Q8U\T9F,P7S1A-F)?.3'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC&UL/@T*+2TM+2TM M/5].97AT4&%R=%\S.3DV.&$Q8U\T9F,P7S1A-F)?.3 XML 19 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 5. Segment Reporting (Narrative) (Details)
 3 Months Ended
Sep. 30, 2012
segment
Segment Reporting [Abstract]  
Number of Operating Segments 2
XML 20 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 3. Earning per Share (Details) (USD $)
 3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]    
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ (624,396) $ (501,030)
Income(loss) from discontinued operations 190,960 (288,619)
Net loss (433,436) (789,649)
Weighted Average Number of Shares Outstanding, Basic 7,526,430 7,526,430
Proceeds from Stock Options Exercised $ 0 $ 0
Shares reserved for future exchange 0 0
Weighted Average Number of Shares Outstanding, Diluted 7,526,430 7,526,430
Income (Loss) from Continuing Operations, Per Basic Share $ (0.08) $ (0.06)
Income (Loss) from Discontinued Operations, Net of Tax, Per Basic Share $ 0.02 $ (0.04)
Earnings Per Share, Basic $ (0.06) $ (0.10)
Income (Loss) from Continuing Operations, Per Diluted Share $ (0.08) $ (0.06)
Income (Loss) from Discontinued Operations, Net of Tax, Per Diluted Share $ 0.02 $ (0.04)
Earnings Per Share, Diluted $ (0.06) $ (0.10)
XML 21 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 5. Segment Reporting (Segments Statements of Operations) (Details) (USD $)
 3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Segment Reporting Information [Line Items]    
Product revenue $ 2,269,577 $ 2,406,580
Revenues, net 2,269,577 2,406,580
Cost of goods sold 1,196,398 1,224,428
Marketing, general and administrative 1,405,586 1,381,882
Research and development 264,198 219,551
Total costs and expenses 2,866,182 2,825,861
Loss from operations (596,605) (419,281)
Gain (Loss) Related to Litigation Settlement 63,589 0
Equity in OTM 1,192 699
Interest income 24 43
Interest Expense (92,596) (82,491)
Total other (expense) income (27,791) (81,749)
(Loss) and income before taxes (624,396) (501,030)
Income taxes benefit from continuing operations 0 0
Net (loss) from continuing operations (624,396) (501,030)
Sonomed-Escalon [Member]
    
Segment Reporting Information [Line Items]    
Product revenue 2,269,577 2,406,580
Revenues, net 2,270,000 2,407,000
Cost of goods sold 1,196,398 1,224,428
Marketing, general and administrative 964,440 885,785
Research and development 264,198 219,551
Total costs and expenses 2,424,000 2,330,000
Loss from operations (154,000) 77,000
Gain (Loss) Related to Litigation Settlement 0 0
Equity in OTM 0 0
Interest Expense 0 0
Total other (expense) income 0 0
(Loss) and income before taxes (155,459) 76,816
Income taxes benefit from continuing operations 0 0
Net (loss) from continuing operations (155,459) 76,816
Corporate [Member]
    
Segment Reporting Information [Line Items]    
Product revenue 0 0
Revenues, net 0 0
Cost of goods sold 0 0
Marketing, general and administrative 441,146 496,097
Research and development 0 0
Total costs and expenses 441,000 496,000
Loss from operations (441,000) (496,000)
Gain (Loss) Related to Litigation Settlement 63,589 0
Equity in OTM 1,192 699
Interest Expense (92,596) (82,491)
Total other (expense) income (27,791) (81,749)
(Loss) and income before taxes (468,937) (577,846)
Income taxes benefit from continuing operations 0 0
Net (loss) from continuing operations $ (468,937) $ (577,846)
XML 22 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 6. Related Party Transactions (Details) (USD $)
 3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Related Party Transaction [Line Items]    
Equity in OTM $ 1,192 $ 699
Advanced amount related party transaction 0 134,488
Related Party Transaction, Amounts of Transaction 332,216  
Richard J. DePiano [Member]
    
Related Party Transaction [Line Items]    
Advanced amount related party transaction 300,000  
Advance amount related party transaction, percentage of receivable 80.00%  
Monthly interest rate related party transaction 1.25%  
Total accrued interest, related party 32,216 3,762
Accrued interest 11,250 3,762
Ocular Telehealth Management (OTM) [Member] | Equity Method Investee [Member]
    
Related Party Transaction [Line Items]    
Investment held in a company   444,000
Ownership percentage   45.00%
Equity in OTM 1,192 (699)
Assets 0  
Liabilities 80,000  
Stockholders' equity $ (68,000)  
XML 23 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note. 1 Basis of Presentation
 3 Months Ended
Sep. 30, 2012
Entity Information [Line Items]  
Business Description and Basis of Presentation [Text Block]
Basis of Presentation

 Escalon Medical Corp. (“Escalon” or the “Company” ) is a Pennsylvania corporation initially incorporated in California in 1987, and reincorporated in Pennsylvania in November 2001. Within this document, the “Company” collectively shall mean Escalon and its wholly owned subsidiaries: Sonomed, Inc. (“Sonomed”), Trek, Inc. (“Trek”), Escalon Vascular Access, Inc. (“Vascular”), Escalon Medical Europe GmbH (“EME”), Escalon Digital Vision, Inc. (“EMI”), Escalon Pharmaceutical, Inc. (“Pharmaceutical”), Escalon Holdings, Inc. (“EHI”), Escalon IP Holdings, Inc., Escalon Vascular IP Holdings, Inc., Sonomed IP Holdings, Inc., Drew Scientific Holdings, Inc., Drew Scientific Inc., and Drew Scientific Group, Plc (“Drew”) and its subsidiaries. All intercompany accounts and transactions have been eliminated.

On October 3, 2012 the Company sold its Clinical Diagnostics Business to ERBA Diagnostics, Inc. The Escalon Clinical Diagnostics Business ("ECD") consists of Drew Scientific, Inc., and its wholly owned subsidiaries JAS Diagnostics, Inc. ("JAS") and Drew Scientific Limited Co. The sales price was $6,500,000 in cash. The sale of this business will have a material effect on earnings in subsequent periods. ECD prior period amounts are presented as discontinued operations (see footnote 10 to the Notes to Condensed Consolidated Financial Statements for additional information).

On October 18, 2012, the Company and its debt holder reached an agreement whereby the Company paid the balance of the seller-provided financing plus accrued interest related to the purchase of certain assets of BH Holdings, S.A.S ("Biocode" or "BHH") of $4,367,604 with a one-time payment of $2,487,480 resulting in a gain on extinguishment of debt of $1,880,124. The repayment of the debt has reduced the Company's debt related to Biocode to zero.

As a result of these transactions the Company expects to realize total gains of approximately $4,200,000 during the three month period ending December 31, 2012. The Company expects that the total gain will bring the Company back into compliance with the minimum $2,500,000 stockholders' equity requirement for continued listing on the NASDAQ Capital Market as set forth in Listing Rule 5550(b).
    
The Company operates in the healthcare market, specializing in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology. The Company and its products are subject to regulation and inspection by the United States Food and Drug Administration (the “FDA”). The FDA and other governmental authorities require extensive testing of new products prior to sale and have jurisdiction over the safety, efficacy and manufacture of products, as well as product labeling and marketing.

Management reviews financial information, allocates resources, and manages the business as two segments: Sonomed-Escalon and Escalon Medical Corp (“Corporate”). The Sonomed-Escalon segment consists of Sonomed, Inc., EMI and Trek, all of which are engaged in the development and sale of Ophthalmic medical devices. The Escalon Medical Corp. segment includes the administrative corporate operations of the consolidated group.
XML 24 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 8. Fair Value Measurements (Details) (USD $)
 3 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Sep. 30, 2011
Dec. 31, 2008
Biocode Hycell [Member]
Business Acquisition [Line Items]        
Acquisition, percentage of purchase price financed by seller       100.00%
Total BHH debt oustanding, accrued interest included   $ 4,367,604    
Repayments of Long-term Debt 2,487,480 0 88,555  
Gains (Losses) on Extinguishment of Debt $ 1,880,124      
XML 25 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (USD $)
Sep. 30, 2012
Jun. 30, 2012
ASSETS    
Cash and cash equivalents $ 550,359 $ 890,623
Accounts receivable, net 930,392 1,343,823
Inventory, net 1,793,585 1,434,260
Other current assets 171,891 199,312
Assets of discontinued operations 3,730,051 4,012,725
Total current assets 7,176,278 7,880,743
Property and equipment, net 12,718 12,954
Goodwill 125,027 125,027
Trademarks and trade names 605,006 605,006
Patents, net 11,345 14,852
Non-current from discontinued operations 1,001,687 1,111,883
Total assets 8,932,061 9,750,465
LIABILITIES AND SHAREHOLDERS' EQUITY    
Current portion of long-term debt 4,149,516 4,149,516
Related party note payable 300,000 300,000
Accounts payable 672,991 660,274
Accrued expenses 1,118,724 1,335,744
Liabilities of discontinued operations 1,482,493 1,617,814
Total current liabilities 7,723,724 8,063,348
Accrued post-retirement benefits 1,042,252 1,042,252
Total long-term liabilities 1,042,252 1,042,252
Total liabilities 8,765,976 9,105,600
Shareholders equity:    
Preferred stock, $0.001 par value; 2,000,000 shares authorized; no shares issued 0 0
Common stock, $0.001 par value; 35,000,000 shares authorized; 7,526,430 issued and outstanding at June 30, 2012 and June 30, 2011 7,526 7,526
Common stock warrants 132,114 132,114
Additional paid-in capital 69,386,143 69,369,658
Accumulated deficit (68,782,247) (68,348,811)
Accumulated other comprehensive loss (577,451) (515,622)
Total shareholders' equity 166,085 644,865
Total liabilities and shareholders' equity $ 8,932,061 $ 9,750,465
XML 26 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements Of Cash Flows (USD $)
 3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash Flows from Operating Activities:    
Net (loss) $ (433,436) $ (789,649)
Adjustments to reconcile net loss to cash provided by operating activities of continuing operations:    
Income from discontinued operations (190,960) 288,619
Depreciation and amortization 3,743 3,707
Compensation expense related to stock options 16,485 23,898
Loss of Ocular Telehealth Management, LLC (1,192) (699)
Change in operating assets and liabilities:    
Accounts receivable, net 413,431 973,365
Inventory, net (359,325) (385,307)
Other current and long-term assets 28,612 (55,708)
Accounts payable and accrued expenses (204,303) 194,162
Net cash (used in) operating activities from continuing operations (726,945) 252,388
Net cash (used in) provided by operating activities from discontinued operations 455,942 (211,860)
Net cash (used in) operating activities (271,003) 40,528
Cash Flows from Investing Activities:    
Purchase of fixed assets 0 (4,172)
Net cash (used in) investing activities from continuing operations 0 (4,172)
Net cash (used in) investing activities from discontinued operations including proceeds from sale of vascular assets (8,618) (2,755)
Net cash (used in) investing activities (8,618) (6,927)
Cash Flows from Financing Activities:    
Proceeds from related party note payable 0 134,488
Principal payments on long-term debt 0 (88,555)
Net cash used in financing activities from continuing operations 0 45,933
Effect of exchange rate changes on cash and cash equivalents (60,643) (122,803)
Net (decrease) increase in cash and cash equivalents (340,264) (43,269)
Cash and cash equivalents, beginning of period 890,623  
Cash and cash equivalents, end of period 550,359 1,871,945
Supplemental Schedule of Cash Flow Information:    
Interest paid $ 0 $ 82,491
XML 27 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 10. Discontinued Operations (Results of Discontinued Operations - BH Holdings, S.A.S) (Details) (USD $)
 3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Net income $ 190,960 $ (288,619)
BH Holdings, S.A.S [Member]
    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Revenue, net 0 999,000
Cost of goods 0 407,000
Market, general and administrative 0 892,000
Research and development 0 0
Total Costs and expenses 0 1,299,000
Income (loss) from discontinued operations $ 0 $ (300,000)
XML 28 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Sigificant accounting policies Stock-based Compensation (Policies)
 3 Months Ended
Sep. 30, 2012
Stock-based Compensation [Abstract]  
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Stock-Based Compensation
Stock-based compensation expense for all stock-based compensation awards granted after July 1, 2006 is based on the grant-date fair value estimate in accordance with the provisions of the FASB issued guidance. The Company recognizes these compensation costs on a straight-line basis over the requisite service period of the award.
Valuations are based on highly subjective assumptions about the future, including stock price volatility and exercise patterns. The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model. Expected volatilities are based on the historical volatility of the Company's stock. The Company uses historical data to estimate option exercise and employee terminations. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury yield curve in effect at the time of the grant.
XML 29 R36.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 10. Discontinued Operations (Assets and Liabilities of Discontinued Operations - BH Holdings, S.A.S) (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2012
Jun. 30, 2012
Sep. 30, 2012
BH Holdings, S.A.S [Member]
Sep. 30, 2011
BH Holdings, S.A.S [Member]
Assets [Abstract]        
Accounts receivable, net $ 1,621 $ 1,555    
Inventory 1,997 2,348    
Other Assets, Current 112 110    
Fixed Assets 287 323    
Intangible Assets 553 627    
Total assets 8,462 9,137 0 0
Liabilities [Abstract]        
Accounts payable 536 691 0 0
Disposal Group, Including Discontinued Operation, Accrued Liabilities 609 589 0 0
Other current liabilities     338 338
Total liabilities 1,144 1,280 338 338
Net assets of discontinued operations $ 7,317 $ 7,858 $ (338) $ (338)
XML 30 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 5. Segment Reporting (Tables)
 3 Months Ended
Sep. 30, 2012
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The table below sets forth the loss from continuing operations for the three months ended September 30, 2012 and 2011(in thousands).
 
 
 
Sonomed-Escalon
 
Corporate
 
Total
 
 
2012
 
2011
 
2012
 
2011
 
2012
 
2011
Revenues, net:
 
 
 
 
 
 
 
 
 
 
 
 
Product revenue
 
$
2,270

 
$
2,407

 
$
—

 
$
—

 
$
2,270

 
$
2,407

Total revenue, net
 
2,270

 
2,407

 
—

 
—

 
2,270

 
2,407

Costs and expenses:
 
 
 
 
 
 
 
 
 
 
 
 
Cost of goods sold
 
1,196

 
1,224

 
—

 
—

 
1,196

 
1,224

Marketing, general & admin
 
964

 
886

 
441

 
496

 
1,406

 
1,382

Research & development
 
264

 
220

 
—

 
—

 
264

 
220

Total costs and expenses
 
2,424

 
2,330

 
441

 
496

 
2,866

 
2,826

(Loss) income from operations
 
(154
)
 
77

 
(441
)
 
(496
)
 
(597
)
 
(419
)
Other (expense) and income:
 
 
 
 
 
 
 
 
 
 
 
 
Other income
 
—

 
—

 
64

 
—

 
64

 
—

Equity in OTM
 
—

 
—

 
1

 
1

 
1

 
1

Interest expense
 
—

 
—

 
(93
)
 
(82
)
 
(93
)
 
(82
)
Total other (expense) and income
 
—

 
—

 
(28
)
 
(81
)
 
(28
)
 
(81
)
(Loss) income before taxes
 
(155
)
 
77

 
(469
)
 
(577
)
 
(624
)
 
(500
)
Income taxes benefit from continuing operations
 
—

 
—

 
—

 
—

 
—

 
—

Net (loss) income from continuing operations
 
$
(155
)
 
$
77

 
$
(469
)
 
$
(577
)
 
$
(624
)
 
$
(500
)
XML 31 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 32 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statement of Other Comprehensive Income (USD $)
 3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Net loss $ (433,436) $ (789,649)
Foreign currency translation (61,829) 97,776
Total comprehensive loss $ (495,265) $ (691,873)
XML 33 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (Parenthetical) (USD $)
Sep. 30, 2012
Sep. 30, 2011
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 2,000,000 2,000,000
Preferred stock, shares issued 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 35,000,000 35,000,000
Common stock, shares issued 7,526,430 7,526,430
Common stock, shares outstanding 7,526,430 7,526,430
XML 34 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 10. Discontinued Operations
 3 Months Ended
Sep. 30, 2012
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations
Discontinued Operations

BH Holdings, S.A.S

On January 12, 2012 BHH initiated the filing of an insolvency declaration with the Tribunal de Commerce de Rennes, France ("Commercial Court").  The Commercial Court on January 18, 2012 opened the liquidation proceedings with continuation of BHH's activity for 3 months and named an administrator to manage BHH. Since Drew no longer has a controlling financial interest in BHH it was deconsolidated in the December 31, 2011 quarterly consolidated financial statements and prior period amounts are presented as discontinued operations.
The following table summarizes the results of discontinued operations of BHH for the three months ended September 30, 2012 and 2011 (in thousands):

 For three months ended September 30,
2012
 
2011
Revenue, net
$
—

 
$
999

Cost of goods sold
—

 
407

Marketing, general and administrative
—

 
892

Research & development
—

 
—

Total Costs and expenses
—

 
1,299

Loss from discontinued operations
$
—

 
$
(300
)

Assets and liabilities of discontinued operations of BHH included in the consolidated balance sheets are summarized as follows at September 30, 2012 and June 30, 2012 (in thousands):


 
September 30,
 
June 30,

2012

 
2012
Assets
$
—

 
$
—

Total assets
—

 
—

Liabilities
 
 
 
Accounts payable
—

 
—

Accrued expenses
—

 
—

Accrued lease termination costs
338

 
338

Total liabilities
338

 
338

Net assets of discontinued operations
$
(338
)
 
$
(338
)
Discontinued operation of ECD
On October 3, 2012 the Company sold its Clinical Diagnostics Business to ERBA Diagnostics, Inc. The ECD consisted of Drew Scientific, Inc., and its wholly owned subsidiaries JAS and Drew Scientific Limited Co. The sale of this business will have a material effect on earnings in subsequent periods.
The following table summarizes the results of discontinued operations for the three months ended September 30, 2012 and 2011 (in thousands):
 
For the three months ended September 30,
2012
 
2011
Revenue, net
$
3,637

 
$
3,614

Cost of goods sold
2,194

 
2,344

Marketing, general and administrative
1,176

 
1,097

Research & development
76

 
162

Total Costs and expenses
3,446

 
3,603

Net income from discontinued operations
$
191

 
$
11


Assets and liabilities of discontinued operations of ECD included in the consolidated balance sheets are summarized as follows at September 30, 2012 and June 30, 2012 (in thousands):
 
September 30,
 
June 30,
 
2012
 
2012
Assets
 
 
 
Accounts receivable
$
1,621

 
$
1,555

Inventory
1,997

 
2,348

Other assets
112

 
110

Total current assets
3,730

 
4,013

Furniture and fixture
287

 
323

Non-current accounts receivable
69

 
69

Goodwill
93

 
93

Intangible assets
553

 
627

Total non-current assets
1,002

 
1,112

Total Assets
8,462

 
9,137

Liabilities
 
 
 
Accounts payable
536

 
691

Accrued expenses
609

 
589

Total liabilities
1,144

 
1,280

Net assets of discontinued operations
$
7,317

 
$
7,858
XML 35 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document And Entity Information (USD $)
 3 Months Ended
Sep. 30, 2012
Nov. 13, 2012
Dec. 31, 2011
Entity Information [Line Items]      
Entity Registrant Name ESCALON MEDICAL CORP.    
Entity Central Index Key 0000862668    
Current Fiscal Year End Date --06-30    
Entity Filer Category Smaller Reporting Company    
Document Type 10-Q    
Document Period End Date Sep. 30, 2012    
Document Fiscal Year Focus 2013    
Document Fiscal Period Focus Q1    
Amendment Flag false    
Entity Common Stock, Shares Outstanding   7,526,430  
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Public Float     $ 7,526,430
XML 36 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Sigificant accounting policies Revenue Recognition (Policies)
 3 Months Ended
Sep. 30, 2012
Revenue Recognition [Abstract]  
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition
The Company recognizes revenue from the sale of its products at the time of shipment, when title and risk of loss transfer. The Company provides products to its distributors at agreed wholesale prices and to the balance of its customers at set retail prices. Distributors can receive discounts for accepting high volume shipments. The discounts are reflected immediately in the net invoice price, which is the basis for revenue recognition. No further material discounts are given.
 
The Company's considerations for recognizing revenue upon shipment of product to a distributor are based on the following:
 
 
 
Persuasive evidence that an arrangement (purchase order and sales invoice) exists between a willing buyer (distributor) and the Company that outlines the terms of the sale (company information, quantity of goods, purchase price and payment terms). The buyer (distributor) does not have a right of return.
 
 
 
Shipping terms are ex-factory shipping point. At this point the buyer (distributor) takes title to the goods and is responsible for all risks and rewards of ownership, including insuring the goods as necessary.
 
 
 
The Company's price to the buyer (distributor) is fixed and determinable as specifically outlined on the sales invoice. The sales arrangement does not have customer cancellation or termination clauses.
 
 
 
The buyer (distributor) places a purchase order with the Company; the terms of the sale are cash, COD or credit. Customer credit is determined based on the Company's policies and procedures related to the buyer's (distributor's) creditworthiness. Based on this determination, the Company believes that collectibility is reasonably assured.
The Company assesses collectibility based on creditworthiness of the customer and past transaction history. The Company performs ongoing credit evaluations of its customers and does not require collateral from its customers. For many of the Company's international customers, the Company requires an irrevocable letter of credit to be issued by the customer before the purchase order is accepted.
XML 37 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements Of Operations (USD $)
 3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Net revenues:    
Product revenue $ 2,269,577 $ 2,406,580
Revenues, net 2,269,577 2,406,580
Costs and expenses:    
Cost of goods sold 1,196,398 1,224,428
Marketing, general and administrative 1,405,586 1,381,882
Research and development 264,198 219,551
Total costs and expenses 2,866,182 2,825,861
Loss from operations (596,605) (419,281)
Other (expense) income:    
Gain (Loss) Related to Litigation Settlement 63,589 0
Equity in Ocular Telehealth Management, LLC 1,192 699
Interest income 24 43
Interest expense (92,596) (82,491)
Total other (expense) income (27,791) (81,749)
Net loss from continuing operations before taxes (624,396) (501,030)
Benefit of income taxes 0 0
Net (loss) from continuing operations (624,396) (501,030)
Income(loss) from discontinued operations 190,960 (288,619)
Net loss $ (433,436) $ (789,649)
Basic:    
Income (Loss) from Continuing Operations, Per Basic Share $ (0.08) $ (0.06)
Income (Loss) from Discontinued Operations, Net of Tax, Per Basic Share $ 0.02 $ (0.04)
Net income (loss) $ (0.06) $ (0.10)
Diluted:    
Income (Loss) from Continuing Operations, Per Diluted Share $ (0.08) $ (0.06)
Discontinued operations $ 0.02 $ (0.04)
Net income (loss) $ (0.06) $ (0.10)
Weighted Average Number of Shares Outstanding, Basic 7,526,430 7,526,430
Weighted Average Number of Shares Outstanding, Diluted 7,526,430 7,526,430
XML 38 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 5. Segment Reporting
 3 Months Ended
Sep. 30, 2012
Segment Reporting [Abstract]  
Segment Reporting
Segment Reporting
        
During the three-month periods ended September 30, 2012 and 2011, the Company's continuing operations were classified into two principal reportable business units that provide different products or services.
 
Management reviews financial information, allocates resources, and manages the business as two segments: Sonomed-Escalon and Escalon Medical Corp. (“Corporate”). The Sonomed-Escalon segment consists of Sonomed, Inc., EMI and Trek, all of which are engaged in the development and sale of Ophthalmic medical devices. The Corporate segment includes the administrative corporate operations of the consolidated group. The ECD segment which consists of Drew Scientific, Inc., and its wholly owned subsidiary JAS, was reported under discontinued operations beginning with this Form 10-Q for three months ended September 30, 2012 and prior period segment information has been reclassified to conform with the current year presentation.

Separate management of each unit is required because each business unit is subject to different marketing, production and technology strategies.
The table below sets forth the loss from continuing operations for the three months ended September 30, 2012 and 2011(in thousands).
 
 
 
Sonomed-Escalon
 
Corporate
 
Total
 
 
2012
 
2011
 
2012
 
2011
 
2012
 
2011
Revenues, net:
 
 
 
 
 
 
 
 
 
 
 
 
Product revenue
 
$
2,270

 
$
2,407

 
$
—

 
$
—

 
$
2,270

 
$
2,407

Total revenue, net
 
2,270

 
2,407

 
—

 
—

 
2,270

 
2,407

Costs and expenses:
 
 
 
 
 
 
 
 
 
 
 
 
Cost of goods sold
 
1,196

 
1,224

 
—

 
—

 
1,196

 
1,224

Marketing, general & admin
 
964

 
886

 
441

 
496

 
1,406

 
1,382

Research & development
 
264

 
220

 
—

 
—

 
264

 
220

Total costs and expenses
 
2,424

 
2,330

 
441

 
496

 
2,866

 
2,826

(Loss) income from operations
 
(154
)
 
77

 
(441
)
 
(496
)
 
(597
)
 
(419
)
Other (expense) and income:
 
 
 
 
 
 
 
 
 
 
 
 
Other income
 
—

 
—

 
64

 
—

 
64

 
—

Equity in OTM
 
—

 
—

 
1

 
1

 
1

 
1

Interest expense
 
—

 
—

 
(93
)
 
(82
)
 
(93
)
 
(82
)
Total other (expense) and income
 
—

 
—

 
(28
)
 
(81
)
 
(28
)
 
(81
)
(Loss) income before taxes
 
(155
)
 
77

 
(469
)
 
(577
)
 
(624
)
 
(500
)
Income taxes benefit from continuing operations
 
—

 
—

 
—

 
—

 
—

 
—

Net (loss) income from continuing operations
 
$
(155
)
 
$
77

 
$
(469
)
 
$
(577
)
 
$
(624
)
 
$
(500
)



The Company operates in the healthcare market, specializing in the development, manufacture and marketing of ophthalmic medical devices and pharmaceuticals. The business segments reported above are the segments for which separate financial information is available and for which operating results are evaluated regularly by executive management in deciding how to allocate resources and assessing performance. The accounting policies of the business segments are the same as those described in the summary of significant accounting policies in Form 10-K for the year ended June 30, 2012. For the purposes of this illustration, corporate expenses, which consist primarily of executive management and administrative support functions, are allocated across the business segments based upon a methodology that has been established by the Company, which includes a number of factors and estimates and that has been consistently applied across the business segments. These expenses are otherwise included in the corporate segment.

During the three-month periods ended September 30, 2012 and 2011, Sonomed-Escalon derived its revenue from the sale of A-Scans, B-Scans, pachymeters, Digital imaging products, ISPAN™ gas products and various disposable ophthalmic surgical products.
XML 39 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 4. Legal proceeding
 3 Months Ended
Sep. 30, 2012
4. Legal Proceedings [Abstract]  
Legal Matters and Contingencies [Text Block]
Legal Proceedings

The Company, from time to time is involved in various legal proceedings and disputes that arise in the normal course of business. These matters have previously and may in the future pertain to intellectual property disputes, commercial contract disputes, employment disputes, and other matters. The Company does not believe that the resolution of any of these matters has had or is likely to have a material adverse impact on the Company's business, financial condition or results of operations.
XML 40 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 3. Earning per Share (Tables)
 3 Months Ended
Sep. 30, 2012
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
 
 
Three Months Ended September 30,
 
 
2012
 
2011
 
 
 
 
 
Numerator:
 
 
 
 
  Numerator for basic and diluted earnings per share
 
 
 
 
(Loss) from continuing operations
 
$
(624,396
)
 
$
(501,030
)
Income (Loss) from discontinued operations
 
190,960

 
(288,619
)
 Net (loss)
 
$
(433,436
)
 
$
(789,649
)
Denominator:
 
 
 
 
  Denominator for basic earnings per share - weighted average shares
 
7,526,430

 
7,526,430

  Effect of dilutive securities:
 
 
 
 
    Stock options and warrants
 
—

 
—

    Shares reserved for future exchange
 
—

 
—

 Denominator for diluted earnings per share - weighted average and assumed conversion

 
7,526,430

 
7,526,430

 
 
 
 
 
Net (loss) income per share
 
 
 
 
   Basic:
 
 
 
 
      Continuing operations
 
$
(0.08
)
 
$
(0.06
)
      Discontinued operations
 
0.02

 
(0.04
)
 
 
$
(0.06
)
 
$
(0.10
)
   Diluted:
 
 
 
 
      Continuing operations
 
$
(0.08
)
 
$
(0.06
)
      Discontinued operations
 
0.02

 
(0.04
)
 
 
$
(0.06
)
 
$
(0.10
)
XML 41 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Sigificant accounting policies Valuation of Intangible Assets (Policies)
 3 Months Ended
Sep. 30, 2012
Company overview [Abstract]  
Goodwill and Intangible Assets, Policy [Policy Text Block]
Valuation of Intangible Assets
The Company annually evaluates for impairment its intangible assets and goodwill in accordance with SFAS 142, “Goodwill and Other Intangible Assets,” or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. These intangible assets include goodwill, trademarks and trade names. Recoverability of these assets is measured by comparison of their carrying amounts to future discounted cash flows the assets are expected to generate. If identifiable intangibles are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the assets exceeds its fair market value. The Company does not amortize intangible assets with indefinite useful lives, rather such assets are required to be tested for impairment at least annually or sooner whenever events or changes in circumstances indicate that the assets may be impaired. The Company performs its intangible asset impairment tests on or about June 30, of each year. Any such impairment charge could be significant and could have a material adverse impact on the Company's financial statements if and when an impairment charge is recorded.
XML 42 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 8. Fair Value Measurements
 3 Months Ended
Sep. 30, 2012
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Fair Value Measurements
On July 1, 2008, the Company adopted the FASB-issued authoritative guidance for the fair value of financial assets and liabilities. This standard defines fair value and establishes a hierarchy for reporting the reliability of input measurements used to assess fair value for all assets and liabilities. The FASB issued authoritative guidance defines fair value as the selling price that would be received for an asset, or paid to transfer a liability, in the principal or most advantageous market on the measurement date. The hierarchy established prioritizes fair value measurements based on the types of inputs used in the valuation technique. The inputs are categorized into the following levels:
Level 1—Observable inputs such as quoted prices in active markets for identical assets or liabilities.
Level 2—Directly or indirectly observable inputs for quoted and other than quoted prices for identical or similar assets and liabilities in active or non-active markets.
Level 3—Unobservable inputs not corroborated by market data, therefore requiring the entity to use the best available information available in the circumstances, including the entity’s own data.
Certain financial instruments are carried at cost on the consolidated balance sheets, which approximates fair value due to their short-term, highly liquid nature. These instruments include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and related party note payable.
The Company analyzed the fair value of the outstanding debt based on the remaining maturity of the note for the Biocode debt and other Level 3 measurements. By “other level 3 measurements” the Company is referring to “unobservable inputs not corroborated by market data, therefore requiring the entity to use the best available information available in the circumstances, including the entity’s own data”. The Company included this reference because in determining the estimated fair value of our debt we first attempted to use a “commonly accepted valuation methodology” of applying rates currently available to the Company for debt with similar terms and remaining maturities. The debt currently on the Company’s balance sheet is related to the acquisition of Biocode Hycell on December 31, 2008. The acquisition was 100% financed by the seller. Management concluded that given the financial state of the Company and the overall state of the credit markets there is no financial institution that would make available funds to the Company for the 100% financing of a foreign entity with similar terms and remaining maturities, or in fact, on any terms. The Company then considered whether there was any “level 3” considerations, as defined above, which might aid the Company in determining the fair market value of this unique form of debt. The Company determined that there was not and came to the conclusion that given the weakened state of the Company and overall market conditions there was no other source of financing available to the Company, from any source on any terms, other than the willing seller of the Biocode assets.
On October 18, 2012, the Company and its debt holder reached an agreement whereby the Company paid the balance of the seller-provided financing plus accrued interest related to the purchase of certain assets of Biocode of $4,367,604 with a one-time payment of $2,487,480 resulting in a gain on extinguishment of debt of $1,880,124. The repayment of the debt has reduced the Company's debt related to Biocode to zero. The gain on the extinguishment of debt will be recognized in the the three month period ending December 31, 2012. Based on this information it appears that the fair market value of the outstanding debt was less than the book value at September 30, 2012.
XML 43 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 6. Related Party Transactions
 3 Months Ended
Sep. 30, 2012
Related Party Transactions [Abstract]  
Related Party Transactions
Related Party Transactions
Escalon and a member of the Company’s Board of Directors are founding and equal members of Ocular Telehealth Management, LLC (“OTM”). OTM is a diagnostic telemedicine company providing remote examination, diagnosis and management of disorders affecting the human eye. OTM’s initial solution focuses on the diagnosis of diabetic retinopathy by creating access and providing annual dilated retinal examinations for the diabetic population. OTM was founded to harness the latest advances in telecommunications, software and digital imaging in order to create greater access and a more successful disease management for populations that are susceptible to ocular disease. Through September 30, 2012, Escalon had invested $444,000 in OTM and owned 45% of OTM. No additional investments were made during the quarter ended September 30, 2012. The Company provides administrative support functions to OTM. For the three-month periods ended September 30, 2012 and 2011 the Company recorded a gain of $1,000 and $1,000, respectively. At September 30, 2012 OTM had total assets, liabilities and equity of $12,000, $80,000 and ($68,000), respectively.
As of September 30, 2012 Richard J. DePiano, Sr., the Company’s Chief Executive Officer, participated in an accounts receivable factoring program that was implemented by the Company. Under the program, Mr. DePiano advanced the Company $300,000 which represented 80% of an amount due from certain Drew customers. The receivables were not eligible to be sold to the Company’s usual factoring agent. Interest on the transaction is 1.25% per month, which is equal to the best price offered by the Company’s usual factoring agent. The transaction excluded fees typically charged by the factoring agent and provided much needed liquidity to the Company. As of September 30, 2012 and 2011 interest expense of $32,216 and $3,762 was accrued, respectively. Related party interest expense for the three month periods ended September 30, 2012 and 2011 was $11,250 and $3,762 respectively. The entire amount due of $332,216 was paid in full on October 5, 2012.
XML 44 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 7. Recently Issued Accounting Standards
 3 Months Ended
Sep. 30, 2012
Accounting Policies [Abstract]  
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]

In May 2011, the FASB issued ASU No. 2011-04 which provides a consistent definition of fair value in GAAP and International Financial Reporting Standards and ensures that their respective fair value measurement and disclosure requirements are the same (except for minor differences in wording and style). The amendments change certain fair value measurement principles and enhance the disclosure requirements particularly for level 3 fair value measurements. The standard became effective for the Company the current fiscal year and should be applied prospectively. The adoption of this ASU did not have a material impact on the Company's condensed consolidated financial statements.

In June 2011, the FASB issued ASU No. 2011-05 which requires an entity to present all non-owner changes in stockholders' equity either in a single continuous statement of comprehensive income or in two separate but consecutive statements. ASU 2011-05 eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholders' equity. This standard became effective for the Company in the current fiscal year and should be applied retrospectively. The adoption of this ASU did not have a material impact on the Company's condensed consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-08, Intangibles-Goodwill and Other (Topic 350): Testing Goodwill for Impairment, which simplifies how an entity tests goodwill for impairment. Under that option, an entity no longer would be required to calculate the fair value of a reporting unit unless the entity determines, based on that qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. The amendments became effective for the company for goodwill impairment tests performed during the current fiscal year and should be applied prospectively. The Company believes the adoption of this ASU will not have a material impact on the Company's condensed consolidated financial statements.
XML 45 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note. 9 Continuing operations
 3 Months Ended
Sep. 30, 2012
Continuing Operations [Abstract]  
Quarterly Financial Information [Text Block]
Continuing Operations

The accompanying condensed consolidated financial statements have been prepared on the going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

On October 3, 2012 the Company sold its Clinical Diagnostics Business to ERBA Diagnostics, Inc. The ECD consisted of Drew Scientific, Inc., and its wholly owned subsidiaries JAS and Drew Scientific Limited Co. The sales price was $6,500,000 in cash and the transaction generated a gain on sale of approximately $2,300,000.

On October 18, 2012, the Company and its debt holder reached an agreement whereby the Company paid the balance of the seller-provided financing plus accrued interest related to the purchase of certain assets of Biocode of $4,367,604 with a one-time payment of $2,487,480 resulting in a gain on extinguishment of debt of $1,880,124. The repayment of the debt has reduced the Company's debt related to Biocode to zero.

As a result of these transactions the Company expects to realize total gains of approximately $4,200,000 during the three month period ending December 31, 2012. The Company expects that the total gain will bring the Company back into compliance with the minimum $2,500,000 stockholders' equity requirement for continued listing on the NASDAQ Capital Market as set forth in Listing Rule 5550(b).
The Company expects that these transactions will provide the Company with sufficient cash to fund its operations over the next 12 months.

On June 29, 2012, the Company received a letter from the NASDAQ Listing Qualifications Staff indicating that the Company is not in compliance with the $1.00 minimum closing bid price requirement under the NASDAQ Listing Rules (the "Listing Rules"). The Listing Rules require listed securities to maintain a minimum bid price of $1.00 per share. If a NASDAQ-listed company trades below the minimum bid price requirement for 30 consecutive business days, it is notified of the deficiency. Based upon the Staff's review, the Company no longer meets this requirement. The Listing Rules provide the Company with a compliance period of 180 calendar days, or until December 26, 2012 in which to regain compliance with this requirement.

To regain compliance with the minimum bid price requirement, the Company must have a closing bid price of $1.00 per share or more for a minimum of ten consecutive business days during this compliance period. In the event that the Company does not regain compliance within this period, it may be eligible for additional time to regain compliance by satisfying certain requirements. However, if it appears to the Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, the Staff will notify the Company that its securities will be delisted from the NASDAQ Capital Market. The Company may still appeal the Staff's determination to delist its securities to a Hearing Panel. During any appeal process, the Company's common stock would continue to trade on the NASDAQ Capital Market. The NASDAQ notification letter has no immediate effect on the listing or trading of the Company's common stock on the NASDAQ Capital Market. The Company is currently looking at all of the options available with respect to regaining such compliance.
XML 46 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 10. Discontinued Operations (BH Holdings, S.A.S) (Narrative) (Details) (BH Holdings, S.A.S [Member])
 0 Months Ended
Jan. 18, 2012
BH Holdings, S.A.S [Member]
  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Liquidation period 3 months
XML 47 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Sigificant accounting policies Taxes (Policies)
 3 Months Ended
Sep. 30, 2012
Taxes [Abstract]  
Income Tax, Policy [Policy Text Block]
Taxes
Estimates of taxable income of the various legal entities and jurisdictions are used in the tax rate calculation. Management uses judgment in estimating what the Company's income tax will be for the year. Since judgment is involved, there is a risk that the tax rate may significantly increase or decrease in any period.
In determining income/(loss) for financial statement purposes, management must make certain estimates and judgments. These estimates and judgments occur in the calculation of certain tax liabilities and in the determination of the recoverability of certain deferred tax assets, which arise from temporary differences between the tax and financial statement recognition of revenue and expense. FASB issued authoritative guidance concerning accounting for income taxes also requires that the deferred tax assets be reduced by a valuation allowance, if based on the available evidence, it is more likely that not that all or some portion of the recorded deferred tax assets will not be realized in future periods.
In evaluating the Company's ability to recover the Company's deferred tax assets, management considers all available positive and negative evidence including the Company's past operating results, the existence of cumulative losses and near-term forecasts of future taxable income that is consistent with the plans and estimates management is using to manage the underlying businesses.
Through September 30, 2012, the Company has recorded a valuation allowance against the Company's net operating losses for all of the deferred tax asset due to uncertainty of their realization as a result of the Company's earnings history, the number of years the Company's net operating losses and tax credits can be carried forward, the existence of taxable temporary differences and near-term earnings expectations. The amount of the valuation allowance could decrease if facts and circumstances change that materially increase taxable income prior to the expiration of the loss carryforwards. Any reduction would reduce (increase) the income tax expense (benefit) in the period such determination is made by the Company.
The Company has adopted FASB issued guidance related to accounting for uncertainty in income taxes, which provides a comprehensive model for the recognition, measurement, and disclosure in financial statements of uncertain income tax positions that a company has taken or expects to take on a tax return. Under the FASB guidance a company can recognize the benefit of an income tax position only if it is more likely than not (greater than 50%) that the tax position will be sustained upon tax examination, based solely on the technical merits of the tax position. Otherwise, no benefit can be recognized. The tax benefits recognized are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. Additionally, companies are required to accrue interest and related penalties, if applicable, on all tax exposures for which reserves have been established consistent with jurisdictional tax laws. The Company has elected to recognize interest expense and penalties related to uncertain tax positions as a component of its provision for income taxes.
ZIP 48 0000862668-12-000004-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000862668-12-000004-xbrl.zip M4$L#!!0````(`-&+;D$SM@G!&*4``.71"0`1`!P`97-M8RTR,#$R,#DS,"YX M;6Q55`D``XH;I%"*&Z10=7@+``$$)0X```0Y`0``[%WK<]LXDO]^5?<_\+1W MNYDJRP9`$"2=2;;`UR9W2>R),[-WGZ8H$K(XH4@M2?DQ?_TU^)`I459L17:D MA)ZI6";QZ,>O&]T-D/KY[S?36+D261ZER:L!/D8#121!&D;)Y:O!KQ=#?F&_ M?3OX^^M__[>?_V,X_%_KXSO%28/Y5"2%8F?"+T2H7$?%1/FG&'E1#-WRX;!N M/3M5,34$%L(,":&CD([(F)A"(!KZ(\;&^M'-J6X@*D*$X4>C*-#,D:;K2*VC/*4$ZTM=RFG2[!(: M(_6D;M%T`,X_;V@M;X_\7#3-Y_GPTO=GBQYC/Q^5K>L;:UB0`X8K3-?CLY/J M9KMIM(GV)"_\)%A0<].A_EHM6V/3-$_*NP/0@J+\+#^>YL%$3/V/8JR4MTXG MF1B_&D@1#QLY'M_DX:"^7=S.Q*M!'DUG,K MG9NI3M;,5<\T$UF4AJOS@P2SP@'\OP:Z\1#IH*UFE+M[*YU$$K:ZF$,5W4T< MMCHT5UM3-Y=JD7U9BK_74/J=7_M9^`F4P&^B?''UHDB#SV>S`NP^?R^F(Y%] M`['?25-<2I>RN%S?"(&,FUDD2?X/7S>4N@S^?K!WS MCI:3=<1\S]!X"ZY^*BX*&%YR;/FQ=`L7$R$*GH0\#",I/C]VHCR(TWR>B=RZ MA3]F:>['_\C2^2R'(>*Y7"YD&Y@M2N8B/`/J_%+R)>:D:_C=FKQ)8]DPO^`7 MAXVXYQ';X+64V^D:N?5`_I9`=H.PA^^#X;N05@_:5=!^%+&,G\^!IMM/F9_D M?E!*S[IMWUE:M>U)),;NC0CF170ESL;C*!#98:/QX5*X6]LWB*&'V0Y@YOYK M#F)X+XI)&KY-KD1>"%')\2Y^!/B$\QB$WVTL!;MNB`_^5-SYT;-B^N,A]W[) M?@FXCZ'L:Y13^^V%=GJ#6C6HNY5SGD>)R/.+BO56C'"1)K#$AFY593ALF&]D MMT;+.GY[X#P..(LU/LUF*012XKN&S6(I7^:V!PV`1KUP?@]%]/L[<>G';LG3 M=Y5'`V^G*[SM6;);UEZQ_AA$5%V,IT"$>J!E4?)XNR)/9U=J7Q;=G[+H7D.C M+XON?UUICU:*'LA]6?2PRJ)[#=J^+/J]E$6_-YCU9=&^+/I-RZ)[;5!]671_ MRZ('#)R^+-J#9A-H*J=MI]-9FG1`PX-@/IV7J\Y9,1&9;):)B53*E:@"_N\$ M3NO$<`>G!\NA!]J60%NDA^=^!,&#[<^BPH]_#'!MXKT'U':`@LO3-"FKM3\$ MB#K\]L#9#C@?1>%#8!&Z?I;(\N@/@9[U3/<0V@Y"__0SR-N+'P(Y2[SV@`'` MD$/<:,;HT2*$_U7\1"+L=V"V,=D?:@=F7Q#[EB!DMA#;U"5X`'XS+R7>VJV. MTB`-Q9O;0,0'GMSSO=QE]+EP4CV=68#*D;&L\N;.#E2.T2_T(/S\G32D MP;#6JK=+:9!?\*%)8^4$XHZET9^%.:"E[!N>A7E^0/;[MOV^[0'LVSZ781Q& MMK8DC2>+:NTK,/K=JQ\<`/TNU+/O M0NTK%/K=I.]"\>KAE((V+B9^)_&Q>R%%E]>7PQ".3,?6)Q%-5199* M6ILK6A=^+/+S+`K$PKI:)X>[-VT_G_#"CM,<1EPIY_3;;@_P;65AY.L5U)QU M?I"&=ED6^KZW"Y_-C_6E_K[4WP/R8+UX[PV?!GS]8Z@'_!CJ0<"EWY;LMR6_ MX;;D,QE&O_7T'6T][1%@^JVG?=IZVA]@]%M//S@`^JVG;[SUM#]0Z+>>#E+Q M\R2JM)[,URAN*GQ9O7A=CP@?FZ&:.^WAY5AKQZY9OV?P,CJOFVPW?+D[M)'T MJLE6H\_S\)ZAZ^^E.OWUPMEVY'.1E7M;*S.$T14`?!4!LN.'^536B-).&O5@ MLMH863]B:SI').DT2C9/^"41K\[8';2YV^*[*[U6W)[.P2;/_5M_%`M[GF6` M'*4&]T?Y!5G-"44E%$$T]>/\U0`-2IE[D-(.B6NXAH9LQS`TV_94Q_`8TQR; M,>XP1S<'BIRU'*G4/F.(Z/3GD\T4;$6EW.J]ATJ76LQ%KN59&M9MCCR**RIU MRA&VC0Z5.C%-O!V5'T4@HBO9[(,HMJ"58,>P5,=1;5BK,&`['@AZE6*L4M4@ZI8D M9W,1OHO\411#-B'R+21L>H9K8\V0B#`PTICCLH9>2\>H0R_&ADZ60;N>BFV) MW61@%F>&QTV769:*31N;R"J)-4RB8Z9WA:MJ.MV*V"^E\._2/`?%G(T_^3>/ MD3=BMN&:F!`=:3IQ')?JM$(TX2I%9)6%H:;K5%LVO\?0MEO&-N@&N12\'N=4 M-TT;.;;F>:1B#%F.[G;-6AVD809.X`>3W9.5R>_3B>[(H,W`U#.I9FDZ MH+G"LL.H9W=6D!\-RU]=;+PO;K:886-,J488QX;*+55OO"YG3B<6[>7^%=7_ M>W0`TL?<56T5D@$3/)&JZV:%??#B!NKHH/='V]9:[U&`A@Q",.4:T6W7CGBY# M?MO0')5QXMB=[(JHAMD.TQ[$Q$X8W_:K5>[#B>9J7,6<<]UP'9L@YG')N&6Y MG)I69Y%:-=1M&,]S4>2/JH28*H'HV63-#R-BB($!=B"HTFU); M(<<8-#4'>:,JLK([? M=<0[<-(-`^E+J=F7B#H;/^(8]1K2]^<,;DN$0[6=`VF.3CTI09O9#-R29U9K MIZ&IV#/Q)M?]>!'M7L;[=,[Y/AF#Q9J:K3''U%076XQPM_(H!E,=9G3RI3V4 M\;V\J8@`2C@M?3FQF.8YQ-&);GD:(3IU.MZ2,H+0OG&XXF26.#0),33#TF"I M4EVJPC+-G(9#P^YFNR96]6_.X18N7M,T4S>IJE*/$(<[$$KKS0X`QVZGC*KJ M*D):9]W;ALPG8W?#XH&IR3%35609D"/8V)-K>[FB68X.X>PJNQ1&@_QBS]F] M5[N<,L>S9"7`)1!-:"ZA)D*62TQ/Y1"E[S.['](DV"(ZT#CD'ZZM,\\V$76X MBU"E8!,R%*.[+2`W,8Q.=+`EI4_)]`8CAK!,MQQF:1@QQ]:P;:MV9<2:J5&K MNW&#$(:(\@"8WH!MS#3"*>4V=QC!3/IIUF";VJA;CWQ"33=O'W1$'F11F11! M[`&Y2@3CGT/$`3W*`3X!V2[DU+9I$PU8\SBR0;\5DB&@U36# M#U[_-2Y>AM&5DA>WL7@U&,.(P[$_C>+;TT_15.3*!W&M?$RG?O*RO)='?XI3 MC&;%R\%?+XN7*]UCX&`X$='EI#C%!/W7O7WD]75S1LD$DO%BM5_YYW4U[@BB MIVJ@4C9*.E;:TI&CG\CV6TY5CJQT1CD!+I^1X46_4:8$L?"S5X,D3<3@9$'/ M-L1)L`S].+I,3F7M)!K?5I>B1!Y3.J7&[&:W#/C3VUM]WH[P7802? M%/EE)L?*BZH!K)F+%HLK^*629DHQ$4JKD4S:_>2VW>@G!3#@*^']*HZFP4!*3Y6_AD5$[@*_^1*F`9SF4(MZ=NT6-^_T;<[S]*94/XQ';U9UOI[ M=WU')[HLMS%_B^31MS7SNN_?KN]Y/O&SJ1^(>2%G7M-SN<'Z09H4;=W$;^Z9 M^.WY2K9^%="&0F1*"*.RM-3(CS>WIVN M\5AWCL9\B'_B&5C_?9WVWKMNI/ZKE[FS1#D+BE1Z,O5(D:%2Z;5J5Z7D`+<2 M#3;P6IJQ$_F720J\!;G2Q"M*D2KN1XNW;]9F\PD&:TQ@\Q@O!J[M#'Z2$0VL MZ46YJJ]@^*@%[XU>4?EO?K&&F!<#N#[X::UYO`.H2E]OIQ71N7QS@3*3KRY0 MKOV\B]]'2AL\?9J=_@65/Q4J(""MEZA3B;U*(?_)CC2$CJ#1;L(86)4"/Y_< M,27E6JY3HT;RUQ$8=VFUOC(%:Y6`4\1X#`N3`FH3]3:.'$H*6?QK+F/LZM0N MN`8%]"8%!6MU=4WQI[5KR`3<*`,SD"P(,6Q%PTJZJ(PI+W(AE'&:%DE:"`4C M"2@)PP_P9XDN.Y46E)?Z20"445@NS!YXER20Y"X*=SF,DRG^HEX'5,.%:3G1 M3T_EAOI`K^U(L%%YDJ,E5](8;2A&A0*&&T++3/CR<4FXI_B7F2@5"%8M,C&Z M7>H\\Z.PO#"JZK(5B`'0`N*G;#C+4GD<-U3&%2"22V46SW.Y2,G#>=7*)?(" M)BR/233XFLVS8.+GY7"!R.2V)<"TW&V!*]:;UG)[<0/N!)H^FW>@1RK3CQBBN_$.8/O%!,P>)A@6D.R!H&]+)3PG3^2(0N!-C1UY M/%!R/H\+"0*I3N52:E7ZL1MY;1[EDX;#$HK/R2D^,@QTA,ENM%?Y]$RT="9! M71D8>-M,A/-`A&U#^EMM?RT[J`$M/SZ7'/X46;HC"?3^_(G\.99/&5SI3?P9.^B:2\06$;,_H+\DNHZEP MGDF_(EDO)K!@*5-H-6GB'E&^\4UQ1%#5!E1<+800(WU:)ZR)7U1#+415Q6*C MQ21-EY$??):K6*K(_"N.RC6P]-VR%219T70^?4Z/O=,8-9>'0*J0(/^;(LJS M18`C^)U5(8$,Z>X"QQC2`RF@-*F"1'[A\%^4YM3S>S_[+`H9;<(Z+GN"D$"P M[^I.'^<0`FN:AEZ,=AP./E,=[0N?#H6AMD%4F8`H,PRIT0FXD&(2R/1A6FKS M2,G!9"+I6.IEO5KHKD2N2%`P`Z5U5PI@ME806I``-ONR2SB9@KO$4+.3R=L6>F\@6'!PLN'7>`YG2 M'S*!*CWBI3R=&S7UO$0R4_Y91[F_)F7J6>8PN>*E,H4J4]3YI<)#:=U`?S7` MBY6:HN?P=O6FI@RNEB.D\CBPB2R18@*>_7DQ2;/R097&Q&1D5!T65F#^ MRK3&2@+Y\8*C*KT#7LH,4@Y=YHM_@#O,09:58&&6*BCWQZ*X/9(I),@RJ`34 MTH\9-;+:?4H+_Z8)V$4YY"0B7RHT;C,$05)RQJ#<]822FN=Q-D*O43OW>U]F&[ M/+]N7V.IPKKXUO9E0Y5VNC+>G1NOIUPJABT5^H\4]_W;5&YS5GKV&]YJBNQV($1 M[4)/G:($[2+.I2Q,'V^TC.;SW:[KX[=*E[=:R[>0)J'\)<\R7X$XY#'FPO:S M[!:<3?.A.@Z)9Z%/.2ZE"&;N"9MSO*K!NT<8:9F6RCSJ`7V,F,TQ8I<@:V_`M.%@ M!:.6ZYB,V:KMV(;*3<=9G$&V*.V<0<:&CDVJ/0$3U>%^\)H0R^4"LK/R]R.? M6\,>4AV-4%4GP`KB-J5F<^2+FMUGI(;RT5OV15RMIVV'7)'-3^,Q>9J+&X9# M.79MC1ND/EV*-&;SSNF7(54)^Z+%/Y2I\[IL:]W^F@MH7[T/#U3+Y99X&:.N M/TK[2-T9ILNX:>F(J)[)7<,@AKGP";A[UGMH,&PL,[DUJ4_)]6;=>@C;-K9L MU[$TW2(.)D9U2-$@U,*D\X3JD.B:]FQ7D?@`="=M49'!` M\HGWT^_T`'HARQ8"&=!D-Q5;!M33=/=T]_2ONQ(5[E#K`,FV)1T.8N:,^@^*ABVR9$9$$1,QT>^1USLX8IN3EV[,[I/#B=-V\?, MI,0*,74<&3]6;I=-'!)Z-=@`D'F0QD.>_FMT'0G50]\-+,_%9FC+F,1A%F%> MM57*B+&.1SR-KOW>"P=;W[S!?;,=06AHTE"&@`[@1+FS;OUE^777G`D90I$= M0E\BI3G-QYT0RY0.M72OI;<)3ABFJ(2_2II=F]7BUALJ)&^M1C3G\N,?TG2> M?X8:M=/HI`%R+(L'#K'L(/`]RDBQ'TC:B4OJ20(D&-F&4>]]_6FT'7_O!$)_ M3[AA8'(/20=^W33(LT40.#7:,*84MT7;2X#_*M_VNJS-R.765`R6*E*M9?+S^*JD8%,<.@X3TC7%"'P[ MO&Y^%QZ""K4O2UVM+6"A'0CI>?BA5.S097)GKQ!!W`WJB*!69?&DM9THB["# M8LMU14"YC2R3NR&M5A:$]<3'*;*8.\F\["=P:A1G>Z9CX5!J"6%FP.3N[J^[ MD7#BU))FF#.&.-XE;OO[3Z3NN&GR38=+YY-`=[S`M[O9#]H/78ZOQH M>/\*+_89)]W46:RNE#\OHO(`4EZ;+>/_U!L%O"%QR5SA.Z;G>-P1.)#_^$'E M1T`OTCJ$WK2WJ7^=H!:6\$J>W71<-Y1>C_2H34Z$M*2\6$)H,5S'TI*=ABH- MEK`6K5]O=[L[J>I6)?N;=C^_%66R^0G@V<"$M*HM9$#C.(XK0EN@2OT\U_.' M#9Z%NL2SJS%.JTZ[Q$]G+N@PKU2\?Z/DR-@6-8TU?J5FJ:L")2`D#3%@5X4(HRS?/5PV-Y\9=T553=WJZ*8L&XVH6*.M02\_64 M0LG>`BI1H5XF^CO*9G$.`(GE,LJ2LCSF=AIGQI-*0*6WALJWW12D5$7Y4VA[ MEBL(&1R=/:B2%_`-B@)?=S&56MZUI M@N*]S:K+.MC[6-*?J2J=+>++BIM-_;]:Y,>=`L85.#9;M\L=<`K%?A7!%5UK M)BB./#PNTN<(:@8SA?($]A;/C2J"X4]%]63!_#OHJQL!OKJ$A1650V7Y-)`* M&!15%[U_BZII6C\W-;Y(JC9)RQ(*$>=_WMQ"6;:J.[I=(])R52M=ED*MG[*( M;]=`HG*%`(O;YNG_?_S\$2JL8$3`L_$<1Q"FKC(I4_)A)42N*N(&TLNG*:*/ MES3UJ=AO\-6*V\(,R)>-+$M#4$E0)5&K9%X6JFZ4HE(\Z2N MT0*EGN43(XI5/2^(GB)BFB3J/R7<4A7@2L7]FMX`?;?2]-T\RU>ZUB]YZP-4 M^2D,ABK2W/]2^>YOUHH]CZ4_)ODHOWGK/BW6E\3@2)$Q/D>/RQ)08I88;1`> M^0,JH2.K)"M:EQ8GHQOW1/ZRBWJ$%ZR&3LYW=JN=>U3[\[L235MI#VP'E21N MJ9",HJA1=(.%NE1`4TOC^)O4H\NBI@F?R!BI'6\,F'LY2*!))QCA5BB?0`GV M8]5/I(('/LA(MCAEE*(@-[B]771+DD8MUGZ4&P?^SY2M34H MWVKG,/Y*JI\N]O58J$\NG)77"S2KY#B5('<],LBSN^+ M0*'H:G`;91D85?G4HH5`JXZ2]HM>$-)R?-MA0U'W:;<%<^>.G;!O-ZS?Q(>Y MW#^A)DFAUE03%?G_AS2#7701PV0M"%Y?>D9>])K/*X6:RVUI9CMBK@0O(F:34`EE3$%C+J*"'- MZWS:VF16KQ#4?ZN="W0"N5%-;13<5WUY5K3H2=+==_VB1.P[`B\9H+J_?2I, MZI8A_->0LFISC@^A+[T MQ`M=X3G8<9E+7=^R!?>JOO2FJ$^ZZ#?'CQD_BR&?"`\+YG,/IBM*(9-JSDW3 M(B&W:VK.Q-E:?@$!>W&Y4+[&A!>:GD^8P-P1EJB6"S7H-1`H83U8[MX,SD$: M,1=3%`ANVF$8.ISCP'+"=9&."(_5I)W%K"[Y/@139CNNSZ6#@T."0L(#[)3H M$,EW^6^M:GD(?#]FT&R+")3;W;Z8SGI,\M]@=P`(G`.S;?O.]GPW?,"@DP'>Q@A M,PP#BU&^QIEA?F`:C_WN(@]/4+W^3MFX'>%B"Q$_"%S'Q*9OL0#2,!;U+,_D M]5E@@C1=9T5>^^L[MD?+K=@G'K9-9IL^9PAF[L'ZD!T&3DAJ^\4[KN^G9#E- M[F(9M13S7T[-'1'*B.O8(1;P/QNL-N2.F.F:PK8/M=IIO-8#I':Z[*/ST#S' M$I@1BGP'>=1R;0$3WZ!+#"58U.?,X\:JVNZRGZ3!2[/GT]35DXXSEI)KRKC9 MXXC!)"D;$R&X*T)>0QE*]XTN4T]8H60`PVE M8XU"7DN\(>F"O]\:UPTMWCBLMU^^'4>62ZV0F)28!$%#%[S&+=NL+D^$F8V- MQCZGNF-YK]UI(CTY;%JVR6E(<1":C*U[Z##/JW63D0%,XVS8Y5@^$+\NQ-)R M6J;"/V'+,0.'.!4B!GFB?NHD-Y#^,W\@L8QP2"!Y[/HF"\(PM!@QU_.1$?%J M6,^^L+W@)^"V^B3V;S#N+K="QT&0_I4^4A@BY%;&/?3J,S91XT.&`ZSJE.V] M-O`N=B2%%#$><-LWN4>8J`P\MX+Z5/GFASM7Q/>3AHB+@#@R''!MCP88[(77L((`PE!#;)]!-5URCMKE*JCYJ^YFT4,_:"0R@L#PV; M\=$-3!\2#%-B(6:[!%/IR?L(DE(4.S8R4?V,@C4/J0[1VO'*C]D_DU$J9$2) M@I`3;B'?)F#T:2`<1QK#`W4\_5CY;S`W-UL^`Z@*%`?05JJ1_ZDY9\XHJ25:_R.J]'6BCTI9=ONH02Q*%E#RK[&5T?5=S_E73S(BIRE^GC)R:) M?06;2/#N@G`+<[!_GB:K:?9LP`1LA1YS?_S1B*69BHLN#("6B]5\.YB+"GC4 M/%U(`S1[!BNXF!:*LAGO^0?,+DS49"Y``3Y$V0P&>AF_1TD";4'"3$'ROOE0 M_C%6<[I6V?+#MQ\W>+H*/;MS!<`'U^268[MA7E=2TKF(I;]:-,2#Z7RS*%(R M5M!6:G?Q5S4O^\?_A9G;:E9$T4_D4A!TT@[X7,$!BWF0R?2A'$R^&6M6C$`L MYMK!:L_YTK6@'8"O-Z']=D)JD"]SK?WC'2]9YP!\=^V!WS7'BCSUCE0^38%X#CP?JFP./GJ`1KN M_*>,6%:-7EY8?*E:AY#S-<3J1MWKK6*^4>\R7>7RD_S;3ZUT3>B>A5WN MU-"N)LK>3O_68W=V1;.2J_(A\/OV]R:`FE[LB"*":]8/+B1C%BT6Y36JKR;\ MGC].9]7OISN!4M#NXJ0@?JA]J;WQ#>+;^"^=9VR>??!YFUM%XQMQTSL;TVJ-=Y$OO>!2A)^B3(U9+F7J2[IODKD?3W7EDV]L<=%\Z&6K#7T&CC<6V'DEZS61#\<9 M6NISR2ZIX8;:J(W*G^J`X0>87#>XG;(=-KT3F-DSB8067+?27_AT'\_E7O(> M[8BTL)TD;/4^92\PLY%-_#*=_0D#DI/Y31D+S600=GO[#J*Y[P2T*9IE`FYB M)-&R+>7M0B!??!U]8>3_7(I[KPKF$2XV9)82VPXL(L<(GV(2N^%;7R2H4Z;MV3G<$D*\.[_Z(CGGVK'K"F'5?8!NAFSC'<";X7W/FP0* M^)5`H0F/3G#[!^$EC$5)^J[WYL\"/\:\^@I6J2JNE_[ASINTG'3A?:B#O*B8].;UW@T%KT:>OS5)6__ M4*/B5`?#MIB!ELMCJ?/8Z8#-6+2,V(-H=H.R7HL.&D4.+C0()NT:&*BAL@1N5 M?UF^"N_\>95$FUFE7>`\AS:&^%1DY]#I'S,RU>P5,O4=0)M((U/;6^1`DB"] MBQO>C`,<)EJO+;=`*WRXS05182'!:X-K'QUU)2T#_]&JX5 MO]8>`6]6.EV_\EH>YCW5MO`AM7H"5V`<\EM4-L;;6^TO=$U26^J MPYV>ZLV\:QA[726XK[6^&,*QL@Y[>U1PJS52:^3[;)4]\M>[Y.W6;+5.\E87 MY.(0+%]OF#78+4-+W`F,N\(@P9G-BA$)C]-G5>O7@5LRI/.LKCR+OFQ@VEWO MC[NN]6(\>C%TI[GE/26#2N7!`+_'IE2CS^8.2+&&NSUI%;MF%;O.6$CM6Y)E M>60LH^PA3HJA@S-H9C*4C.V[JAHA_%+)V+%H6O^4:L![EM:GJ]7/?FOX9J-[Y#=H*:2NDK5"G5JC5[EG; M#$+`CNT>.P0^:&F-ZM<:HM0_Z/:`0Q1X_E&&O&51Y5MF>X+`JF5>JN_6KXGQ MZVR9JJ8;96LKZ*+EI0]2U)[5>$(CEGZ@)U<"8F_X\?0N27.I`[GAKG*YOCPW MEJD1_.XZVW^<&#\ELX_&'_)ADE^J+5><0T\NR4`_B[X:GV>Q7%%\&\^*2R>J MRQ9\U]?[=+%X-M*OB;P\7WW)XWD\S:`=V,_.9W75W@.,7^*'&)[MI<4WYE.I M>O*+EO=Q;GRIJ/P:+Q;&_?0I,J;&PW0I>2+7(T.7:+8TY)N5\4(BWT,.G<3@ M6Z._5O+YAGSS<3JON[LO<=N!QV[Q6E2L_MB\2=AQ53!;E@G@8-$837ZG432G M6K=-RY5\9%&^6AP-#^03,G7I\CZ+(N-!7G*?&U$"K=K>S,L7J"P#S]*T*E[, MHUE:?/,G"/GV&LK46[J=2X)ZOI)%F$Z_WPZN\8L^(#:G$2=.=)'>1LRN3&W= ML^,5];8/6M'D3-@?;5,(3!BC"&-$_M&;CF?,_D>SOERHZ7WTTE\XS@6>E2QJ MR?-KT_2'+QOMIMVY6N];TDX2MF]-270`KR7IJ"2A;A+8D@=].FWJ=JS@4R2] MU(F11*?,#KQXS<6PIQ-UE&QJ<'PW^.;O9,)(:]._&[-S$%(']^D#^=XGUCLV MD'V1QD'8P#Z9.43?G6-]D9US+=GI[M^PJ_Q@UB;D(>_2=)ZKA'63D&)T<$4\ M0:(UI1J+;N@@^ZHU@E"M$6-*%K3)R']-LS^CI:1E8MQ%291!][AD;DSG#W$2 MYTLX6WKJI$'$>*I0T039K/.`:RR:IR/.2Y2`CTBY3-%>+FCLRC6$(*C;5'[W](N^`G^->;14[1('Q^BY)0L^/6B$%O:8>!$TQL1 M:GPK;7JC->)5#J075>^\Q3-+O+Z-9I/$);3U_4\SY[9O>TQ`W.@^O4ME7S M/[-H%L5/)XX`;9U1?6%+:R<.@SI0F##/16WOZ4/,G8-F_BKUX1>$QJ]IH/!7I4,CT:YH+%!>YWLQZY<.N[] M_M>E_%LYX:<+U1J?K6:`^F!J?1A7$-0F+PO8Y6R593`@ MH[M]Y**HKK>W.;VT-I*)35K31]T&5D=>[QUY:;6&^^C$1.^/Y+P*M1[ZYMTE M;\-5EL3+518I>,!M_#?\K!,N1Q,N7._I"FH63H<^OZG9#E-[F+H@Z&K.];W659K2M27%ZTCH/YL-H/3!X9;2U^/ M11^&'@*URKG1-M>M[0-2;+V)#URMQ021]LJ]M%KK#.XQ%OZR MZ1K=1*?[T:JR=S:O9P+4._YH^=&A12-NKCMH/4Z?NRJX&\]AKD7T>'3MXO?) MQ1^-:K$6QTZ-7;6TFPW[5@:#6+H<&#L\'3)U::R.'72=Q-I=XUH?="QTXC'+ MXKP$CD[*OO5DE5*=E.W#%M@C[1[NWJC5NE1KS'6GF_[NY./:L&$8>E':>&1` M9S?2J&<47\&,8GM"4$4]P_&]0[MT(;&FUH=@T-M]IK`'TMAN;D>>C5 MS__WW2J_N9M.'S_Y]:^UMW$BVWQ?8_T`8-W=W`=G;?).3S`!\[IW% M9#P[]BZ03P%-MBQN^%#XL$?Y];>JFY1(2Y9?DBU[.H$3B2*;5:>K3E5U-YMU ME/T#TLAY_9&]PQN,Q!^D$J?+3`*/9F7=5O0<4'&S,O[MPY__)$D_]:T%457` MU?476IW-HHJZ49W&^"9P1/$KG;X_\O&M=O^2?SGWCZ2$QFD>934K+M+D_5$8 MQ575 M=L,@5%1%]1Q/!0G#$.0U`M,"T$/ED?)VPCQ.XNWVX(*D`"EQB&PKBN*30/9Z MB8D=AH^TAWM)_`4*IWBQ-/9;L5X)2Q33M1U;-4,]\"V-*+8>R(&J$Y_8KFP> M?;A!+T.JN.,M[IO8:>TM]D/2EZWYM^$[V__;UDTZ78S#IZ'!23LB-?;UFDMS M469)_TAO7.;T[W_]5-;UWR2`5F+82EM9[KXZ&IM59(?2`G*=W6K(ATEG5/+* M'&+&`BPBGX,=U5(!I5C::9HQ38$VI9II"@4Z?&[@LGE57J4U4>FR39.HB.G);E"2E1>`Z=^/UGHB73`JQNTH>@1G';.F`<,3B4+??E!2``ATK M&M5<^P@,,$?YZ#=:Q6E-EQV$EMAI,V=I#[/#ZZBJ(EPGUM:]5@VVUE:+[NR< M@BTG3_#8YZ3J)^2?:SGD'5%S>XA]2'`U0E/5?8V$JF+HNJN;MNF;=J#91-5T MG>P]N.YU[@T,:EIF4*0S\\)L7F(#>T!7S8S9&W?>)9MLYDATX)5CO-M/_.C> M=CT,'ZJRQ3@']QE9-.F;[1K![T-!BK*"A'`L"IZS;)CC%-,LZ\YY?T2.V'+^^\/-(8^JR[3@0D*,*OL#?/B%';E.DV;VSE)/=,CV]!_ZJA.JR2R:U_1= M_V'-:E;"#T>MEU6HO7'^XA[CWDR@]T'.^G9<3'<7*H^\3G[L_1Y[X:-O M^#85?"7S(*]K#%+@LQ+7?-EE47L(M16ETL_PRZR6`H@\B70&R2-E&:-*)F]L M`O+@#$O@O>3UR\4JKORBB% M['K@X`W2_D%A=>"/LQX45L*NA%T=QB/3;VQQ89OCQ']9O7L[SB@<\,#Q$?8C M[.>MD_:>0%I^6A(WF^I>GR9:GS\5#BH<5!#\0>`C[$<0_/"Z;MGVC[^Z")[S`3X\\Q2,.$;,]/7`NN?<-[,\DVF=C&SFCG4!@$KQ,/ M3PN?>%PL5BQK8L@[V[1,Q.(#\J/]^`UN@<*?6A(,\SP5SEZV9W@5.Q8=U-X- M^T!L#XRNJ>I$V^&NX?=%[D&4_RJL3Q"<(#A!<`='<*9E3PQM9RFK(+@WD_#N M$RN?%F6>%F)YGIA]/YBX*>Q'V,\;H.T]@;3\-*#NP0*]T:*\;D^4X_4=6/AN M)L)CQ6#J/?94U!4#:F\QQ2"\0GB%\(JW$9WW"N&&:!U,IS1NQIN#T;BMV/M1 M1.DE4F=1>AT&/L)^!+D_E-PW?3J[=>M'X:PBO[PG')8B*SLC]X/Q(%%W";\0 M?O&]5EXO$HSYYLWP1ZLKFK#QTFG;M'RC[%E47(IGEP7["/8145GXA?`+$95W MY1PWYRAOWSIDTR0E%LWL_0K\93]P%%_^L17X?6DDR/%@R/&%EU4^-[7N?*+I M3OQ>Q2(_X9'"(X5'OB6/?"6)TN'N-2JP>DL3?0>%E;`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`-^]X']K,WSJ$)W"-,B*N(TRCX6 MT[+*F=LX=4UOQ(:.&%]G/QP;@XX(7,^W;1.HW/)<*W0-W=%ZPS?44+UI^'?: M_'VP?'J?\&O>3I\,NS%`.2"]=Q/"74B-W[AFD$]GJN9-V#B^Z#Y]/[ MY5,:7:09>WGOV^P<&;A*L2V/$,T*X%_/T4GO+[)JK`5R[)HG]LT`TW$'A5%: M_2?*6HISLEE9MQ6MEZG]K0GZ2I4PM$Q;-GT'TCCB!*X;>DP5PPX"V["./FR: M@NY*F_,TAR[^3*^EKV4>W3[",;@\2PMZW&VS*RODAUV54^PK?TD*U)59PAM" M<"2&CO0SC1`;1'K[//4V88=UIXQ5YJ`X_&];-^ETP0^E10(W>J?B.;LL&$\+ MZ9]MME@-_\@322'$FDC-C$J8YT7%0HJ20>8-1Z)& MNB[;+)$N4/"8IOV;\Z*""S&1X,L\2IG`#;+;E,*O2[$6$]"0-0U-`LYS`!JN MR#&[CI*KB.4M95M+0`J_T48J^"#:..8$$CC4:07F#] MT#?>+.9P:H]]AWYXG_M]O<]X`>?[A/)+\O^NWN=U>H'O3,3QF!Z&NHUG:#._MV7# MNR`&2`%#C&U@:KPW:V8J*8J)XV&]V<*QH=6^ZZ_+:& M'^+288=.7((%(3F!5XT1'>,'7^H4Q(JJ6QA@T`-P;E$6Q^/^>.U8JP.L_UVL MPUJ46+-757E15IA921>+GEB`12(6/BH*H"*;07I2]:2,"`,?@R\#&;`C%Q09 MZBH"M/D-ECG*Z"@[-TZKN,TQ1$"?(>'%69N,FUX*;OX(#G!=,'EVTQTO$J$] M6C41J+\*GVE1-U7+Z9:S9%6E:-_8)?62V2%58X/4O'NBC`4DX'&PSHET/4N1 M5^;SJOP&"6DS9O0$_CC;IK@_/L34XX96^03BPN4,W"P#MH9`5$3X4E?&VC4= MB<4[!D6K9\QUV`>Z&GB<@/?$98OG\FB'O3PX.(\6RR,5!ECZ#4><*'?$BJ?S M7<8W3*#Q2@@MBFH26G]"+9AQU(12#P>!O M.790E_[@+PRI/CMSTS(N$\H;6'%CY_^CJ'XBN0NI=RR%_,C/S#:!EKS'&:I-O<#[,<>`8IN>$'CJ&4^`_"C:_'^8KEW-UHR&L<9GG90'."AY$V5FKC"MGI6*9 ME9>+88?!78`1L@6*4C%.B-L*!,;(NL*J2\-Z%=F;)IE<:3-;1DW4J??5&]:X MS)_95:L[=-;;M3O"><1>W)8X`72R1#'80)TRW4")WK+_;Q%#EHT-^\`Q6("O MZARU*W2X*,,&KB';6F.1!SIT#-A6[_K9048;4/F7?%GS.US/R7U>)N2'I]Z+ M-=2%!^XI?7U!JQ/I9Z"22Y[>0T!86B/$BDM(5SCDJ]`"IM\L669%1IR'"1;E+_/KPFC8M+TU6=5D>_48'7C!MBZ3>Y`OX M_;6:#WMF$D@`%8'06/1T^@#7GO",',@KQI(52!9P89>,F1%@*EB*`DDWF!`D M)+1+S=&`T`?QK`&?9>.\%/FJOYP_+##!,HD7W)`+78"U]FE.CE%>8J7SB)O7 MN)M],!8QE.@?$F>W!7KI8FM?/&: M@IUA*[>Z8N^&G9S05,*(JQ[=LXOF-82->#C\`IK>1N43:5J5.<.]OVS0?9-A M[<0D3?D(!F>:7M*>>WG9=++N"J\F'SLMI-.X*2%J2+*%P4)6)FN=D38UCV.S M,@-+!)>(<+B8C=I<5I03[S7V2\?+_<7SWAS[V-;AQ]$\AKS\*D6J7G7;'`QF MF0ZG!70*9C8W(N$<^FT&R2`V%W>50S\8L`J,\/&Y*.I_M(EJF!-CPXKT1Q$5 MHZ((+),>0Y[$\GZ&\7.JI$PTRX2_]15+CU()^K'-V*@E=I9TB7T&G@?WAV.0 MELQZ!9FA/:>B\L2RR$16=M-WG#`K.NBRID\#P6;AEZ2-Z8BD_])YU\#*>QO& M(N*9S;']S)R.W=B/!_;J0KD3A?\`L$F3WX`ISN%D)Y3$O M!OL\5^+IK:R<2)*[J@W3>E3_0-X&^3Z-JGH9LVX+@1MJ3HPS&0Z;+R/"15G^ MUH]R-](95AU<&-()LWUUVMH*LZU343=FK2"(-_03CII_+$#,RQ3B&Y\7_DPW M+2_1;IN+\P-=5G13-XFEF(II*JKE\T5EMA+HX=I$J:Q9^F!-S79!GB3TED53 M6@@IDJ_(FDM,12:V$@96/[NKZ;:W)K2L#M<]/$3H?X#U?BKKNIM2/2\_0?9Q MR0SJC#9-MJPU'K#F3;8#Q0QMUS`43W9DT_#4@&-N*L31US`?S'W>2YQ=:+!] M*:+O$-O7->('FJKYCFJI(=?`E%W5*(+R6@! MSGQ&+]DXSFB2W"NK.1N'V3Z+K5DR:.O[H1LXQ)(#'4#@&'BF9P7^(?3B@_1G MD_=G95'F-`GJ.,K*8CL"JNNXFF>[CF-XON\IGJMP!"Q-,QPK.`0$U#U:@.5: M2N@1U;$L3S$TPU-,/OEO0<$6RFMK-U_*"QZ$P8.M@+BZ;X5$5Q1;=QQ--9VP M6X;F&YKL[('-:KR&UJ=%,$HG3J<^&V);TUZY37176/1Z@ M3=VV[?55E1#-B6(.1.SN>4])MJ0*I@G&;IF!:7G`?`:Z^-+<0]-=1^M!DCC% M6C#^4F9IO'C`:AS=,S7'40P2V+)A6PHNEP_D0'9#@,\Q@[VOQAE5\=;F*G[T M()"A[:Z,W[R&YS_+87#(;%<(2]V*S.>:N-VEHAOFCXHVRK*%1/F@?S_!#;^F M%:/$E,W2+94?S')?]I[`IKBA'.)+65CA?18Z9Y*L*9/AR-S2=?#J4S9(M`;K M9#3/4.&02$&OX$SX3\%7*O"G%=C,^F@>ALWOXTJ059&",YYLEJ);@!*Q2<"^ M8,+Q,9P*7,Y+WM2RGYWL-9W@>IJ$8M7#(6!?I2+*<:KB:]_DNTQ;E3*<&-3^`8[:9(\?D^OD"H[Y&* MLKG/N"M_+P&WBJW3^3CM%BQ,TVX.J]>SFQ9>#:["=8`-[WV:\%&L@2WPGP>U M)OT=K*<3@XF,FO&QU`WP=P5B)S#]%E.:U,S`UHK)&V.F)>V&1W-4@P",X#QP;N M'R7'T?5C`1Y*,4,)JS)?[15YNMQTR&7SROR\\^@;K2&-J2*0$G2L%A]!N_IS M66#HK4HV`OZQ'XM]6-'KNX'ER!YQ?,AE=$_U(&_@>8QE68Z_5BY!XB,3=9`L M[E&5E\-L>YGM>"0`Q-20F)H>:HI,N@<++%TU=7GMP8)C0]%4V_@N,-M/2><1 MW3-\SR.^KYJJ;/NAJ8?P3V"$EJ&0M:7IQYIAV:KYQA'?YS"*:;HZ,7VBFZ'L M!;*E&XK7(Z[JP5I][;GJN24+&(K[M0,+D:PYR-`*\/0![+ MNJ[I]AO'?+^#9;KA!X:FFJ[F.99L6HJFZ3WFNN6M,8MI6/)A6OD76KE1G<;L M`=I[1+3A,XOHXVZH:YZAFH9CFIX:N/W`,;%M=XQ"_ZP]6"#NV_L0-$9"[E;# M]3QGJ*$5J*JA$R_$X&B^_8N>W$HYJZUW-Z3IN.X=N#Y`5%<4U9LU[N&OA,F],I^+S3-%5ZT;(=+L[+K_WC00%?UO2P?-W3 MK?]G[TI[W$B.[%\A#"QV!I#&>1\+[`)Y>@=8>P1+QGZFU)1$FR(;9+=D_7M' M9%86BRPV*7:3.@;^,!JUNIL5D1579KYXP0@/G`:HSEU,UAG33OLB.=!!R>#[ M],$<\03!O]9Z'*_%B80(!;L61K/TG.O@8NXO[>SXLH-:8M6#VY=OLAQ/"=S& M:9XHCG(VNB(#N+=0\Z`=*6/6X0OCF]/4?IX!+`F0Y[.UE'!M(.$ MY8R%"""Y@5V4&$BIR;%*VVW!M'?2O3@K(C,WBP(OE>W.#L%6"@I4G96TVT M@ZVEI]&T+:7(G'T/*[!G`S\LUZ5HQ'JJ25/M/_6PY>SL_]ZI'1)* M2!=T5V%P0:BG)SUR),#CI#Q>0T@(G90239A`!%"00?"VHY'*C6J(:TEYS0R9 MC()*B5/C0%LH_%QV%;*CA>,J'T/H7>%-7*D*H%+1R+.!.A8VYB+2R!I`*CGI MOTL=SS\^YIKG3!CL1:V$+"\H=ST,3/GOTUK/UC(F%3US7#K+H\E,ZFP;&MU0 M,<(5/UK+LZ%E/C(ME_WZ_GF9EX+AX*Z&;+[ MP,>5%O()V/B;^T79X>\T(]\CE\/?[V_>533:LO6](ZSH4P/2;`$FG5CXL:TW MIC7;5JS+RSF"U+8?B+_R<;7XV,&=:E/R=`(R_V,+U.FE1*C.``FS*)W[ZUEI MI,/V]N[O\]H/67MNOF)OX\5?_:^[O:]U=?_XTP)*HY_+PAX`]&!OX>UJ@["K M#]OW^`'$K;W1K=UPUIM5-9/Z1C8-CO?`MR>K-V_NUST1P]9JAIV,^+Z&)#RE M`W/9=9%5=?K?J4P8^]"]]DDWA8P"$6+PD16OU9.B@(W,:BLL\BM`PEU_GMS, MWW;<#1NPO;M/L]G6SE&*0^O5`>J:0&O$DC42LQJ2?_D2#C'L%9X5JNU&CX)_ M+6"VWBEP+1:;50.^#?JY#BA:P7ZUU^[U9W"*+3'$%*FU\*G/$+VUPRJR[1J> M86=J_9GB:!^0AF,Q_\=L\;D^%R%]Y2_8IEQ`==BHB4?VNZ\&@5\'!2PNWB,Z MP2^Z!K@.-%G][VLV%U_#`3MH;NL]W\:Z9JYWJV;`HY;(`\;[88?HH2`_-Y7" MKG]QX+WS8EMH@DOD$,8OVNOE!:![T'1=Z(,*J\";Z:;V(G?OAEZC^7W[J'-[BNG":ONY)L]D.;SJOWZ]7]N_?;_LH= M+.B!/O7:6]NYVT%OGTRQ)W6SGW27L^%[[UYI8T;LNW?W;;&Q1]TONV#;@Z;G MZ\Z;N\>7A%RL:8_G`)X]ZZ8+3-Z#&:S6GZM*E;89?_ISU[9Z4MZ"YP;9*E$) M6-9TB6&ED6:!.LAK?L":FV4>3@*[EMU+6Z':]4*CHY:I`.J^H!HO?H7<;HN, MMX4\HSYB%VI<,W%5F7S28_O:Y;C)][)LK:G%PPR+L)&M,&8NQW61%^ M9+J(5WL>USA3AQF^S^F#?O:]G#[T&EC%88IO!4K'#8'>@]T&Z]E[6/W"/;BZ MF2WZNGA0?CP;WJV5G M\M-FR\^Z.FFS6LRV-%:5U!2Y)#^@R6R:TPT?\$OMEOD$]>8SI&QIVG4A:MN0 M42,)_FKW(YMAMP;NO;8M*,.:;8$P^\U=_\%%S6*:4@@X4K['\U3K8@4QD`BH%73X"O9NN/\$^E7^$U%N5#OMK](F*X99W63UU, M/^T1$^'RS!9]O\W6_GK16[A#%7K1ARZ]]9I==YDVEUTM.[('?)/%G0L5T'Y- M?W93Q$.G.:,SGQ+'8Y=Q?EVZCG;Q1251=,L;5WEF'F)>/WWD[6PD1`<>G>.6 M61,9#^U2G5)R`!TDJ-H]JW^$D%=1],2IN4I(VJ6!=?XL([W8\7$E0+CC]$KVV,EU` MBQ,W+\EIAKTA2DJF0;Z8>EZ&<.`N]+G5B%:]K!9XN[2$(O9\+^)<$Y8US2[; M**./W)+&IL\Y&1WED'\CR%+&/VTXRV5`7$29$I66:T^Y6U!B6_#Y, M#,26EK.CBWZ&V"6G_M:V`0?FK)Q>=N88"=Y:$%MSQTGBDK5EUS2,K$8B6\PQ M\0_)=!$]3@U(XTC(852D(1EAM&L#B*(2AV:),:/HT2#\)8JT7LV#?#+IG]TA MPV,:[I7Q.FI"+5>1J.`D7@$WNZ)C;U9$DEWD\7FR75BS8U//6/99>N&BY09\ M7&=;[UXU1;'^#G#A-W) M$SL//T^RX_8O8B!66>\EQ")!K6/;.42)VQ$ZPS*YVRSX9,FN=2\H,I>@CQ$Q MAFRBIH*F=B\HA3G&M?,DK:YY-^^$A/25O18YJIR9T#(V[[8IN&O:T75O<76B M*@N$44!BM#1P8F/#Y5$YYL6YU-NZ)LJ@C*64GIA(C80",4"\:O!_2>7H;3W! MMX:@I"L@R<+[^>QM^N?LS3T>7?_V]NTOP],A7H]8!PKA-4IG*8V['H4ABA2 MX#QA(5X@:^IYV2D%*@)2&,'F+)',6&E8JM1X7(M1S?!`5,$GGR'3\;SD,X%= MHD;0=H+'B1Q8WSOBE1]ES`-+=DB>6B)_/I,[,">;!<%UX=1XQ43LZ*H@[*I` MQMR!VG((U$.1M@\^0Z0C=1[1R0388U(E4H+=XN. MB521?O6PY)%$!-)JJ\"8E,8N*&\B"3T0D:0\JJR9V!7ND`B/%/1$UYIR4$,2 M!E49D\9$DS5K85HQ-UI*P<\5]/\0&_)G'$:PWN"$X=+9\6ZV?#,_:W"<*1MS M[R(SP<+6'`H;$--:D-,D[_*//3BN+-+DQ7J%Y#CEINC1-QV7O+3`WWN]GKQ9 MS*;K__X#,M[^X8^]/(\1[L2MBS#7NW7IZ,L+*S1>.N#_!S`@O.;8A3/=#MY& M=R5R>W_7P!,5!M)=9"V1,Q[&JK'_YW4TC^-_W-RNIL MPJ"V?L\&5T\]D_VDC/(K*(,R^:1O$3N70/B+0M->-#L^:_3!O4N6.&U80P4( M59!UE@71HU&C&I%V&$BQ5@_JX0>/=H\)="2%>N](3B[1D(2%-.6R3^U`(>OQ M@8*E!$NW\P2"-7UY!TM8R>\W#\S//2)EHE`L4Z@W+*/.6$,BC:UM#<0>%4)6 M2R*&Q[.GA'FBZ$?>..$22E\F.7,J>80G^AX-_8T(7][&R'GK#;3Q9_6 MJ_O;7QM\[&![[]&)\[6\W!Y/U)$8+W':$UY^]5?,`QYX_WGGX9OC3Q^ADG_I7MY8(XYW]GF!RV\H,$$+K3(+*K8BF?-X\AM.-\=FOW8Q;K2DO,? M8,GK40+3B7@MHNB2E)"H73`LR1I'`L1=CL8 M\;CDHT,DRO;F?G]GNNZ%SQU=D1#=Y21-,)!_%-5"NZHKU82ET8T@I4)\1[H^ M(J,:L$ZRX.B0<_&YW>G2_@ M7V9W8;IY_Z*;2.4__VV#%XRY#:9R./BXEEZK,973N02?7A"10P!E%(0+!I4U M;6@:*O1H'S6($$^3\ZHZGR""52Q`,:$4Y+L@@H&7*-MII[7C>0%"6LZ_JM[U M('#GL\Z]B>6CD&7U'D+OGFL[1*2N"(0 M;9)25L-?5[.L-6Q_K6IV&NCX M].`YTY20TQ'T@AI=Q!MU3BQ"G!&:GX&#SSN^FBQ-` M/IZ4SBQ)K9)P/":18IL"(?CXGN:;O;K_GZ[7T^7=";J23#ED72IMBAYV,X%T M`%VDJ*?^&-#MJ#:?7-\E!V%\N<(.FXI<6]Z$.IBE!^:7GYG#UN=V<1X`03(* MVWNNDI>T<$3 M-MWR35[/WJ"*,]"G6ZS5#@%")0CI3LK>SA%_6[K!)U79]VVR4>DCQ.["]:JM M^^)SMPK8F]MW0L\WQ6YNYC<%%K$/97@(PH!P!40MUC[#U6)^4_K_#K72'LL=/+W7B8*B7.I]5D M,P._PN[;U_>5X:/#Z0[-K&C6E)DMYJ5%>59I$CJ+'VA2_*A/]@5I4X0]*,BT M^G5K8]Z5_/@BH,_--V",!.N#CAUU\/;O[G3CY5W&3WX.?;Z?+'_7QSAO, ML\%(RLWS`Q,K?WJUNIV_F7!)?OZOR:MZ6C?I?PXM]-=^?ETC8MB`U2SF;_'$ MZOWJTS!2BD]&157SVFC`&/E]@I[>V]X#/:05G=GSVN%8_* MJ*.GP1JGG([&,:;:SE"3<0O4*^Z)QNOLN5>6)*-PJK3A7I-V M=F2#&XMKJ-XY$KNTN%>=\1<]018#&;ST@I%,B:^3N*B)0HVX&K[2N[E>-Q[V M::G,$A.:,!I3EDU=P=FQWLEOJ^FYKY5ZEZC)G$K"37".\USU)(;F<1?-]V7# M7_1:=S!&S-GHG(I!2"X%%4&K;E1ELCP>[;+\8E4AW72L'(-F-;PY6$#*Q%+@ MYA$8#II!ZJQH%DFR[,$*J6['MXR:,YH$AM?149KQ-G1>(^@2J0 M%4T(DJK@5>ONEGD\R/(YSF(9VOM%-+PNWX!.H`SWA('%$2M2)L(WEXY:C)E$ MJ!27U_'*=0&QE&C&4\I9!F((6FS#^-LXTE'K;_P6S[13SI*%\*6<=6"CW(?` M1+M.?+=V1I*85EUEQ\.W`G?;&L`[QA2TT)HY0012JR6&1_$72';CY+>-*8-\] M?]^JES9[@:/7XJ]E-FWKY#W]#S\I#SI_$%[KX(T-(FH/=1@+K>[Q M9FR3W\+Y7TP+!\+FUU8]ARBGNZZ?B#@ MJ11&!QC_8N_:FQ,WEOU74>4F=7:K6!]I]-[<[E_7^&(G*:^E?$=?@AEX.B@.S?5D M9FF&9]NB[3\P&,0K[7:@>LG^OL3C>=)9T2%_2?-E%B]%'8B/537Q1$R=^H*S M&U[=X*R[EBX#VS%5#AW5=WW3+Z>W64$[W]%J<.Z$XF-LPC:\)DTW`T>Q/!9` M0.X83!%@_"]>!Q9CH3?U@-=7^>FW ML'[8GLL4YF`,J.C,U36W&-6GN*:\+H2-F=MR+>YZ&6F=+$?=MARP[(H/<2Q$ MVF!D`D4+%;WL!]6UX&C+H3?D#A\V]$\\V6\9MA^:KF:9A@?NMZ7)ABR:1S!7 M+3>@?7/ZHN_^A\EK^=WM]+R*]JTBN'X2R9H=I&&4-@,'<,VC_Q M\H2]Z/8\+5!UPS--Q=%D%:3?+E%2`L>T-]"]@V).Q<'4;N40Q$P.=>S(81KX M5I@W*:%L7G[1M MMT%."$9.9DPU+!]"7M<627T@3;'U+,_S MF*5ZEN4&H*&5H@/2T3:,6U#;\4QWPIAPGU+02$]/VU=:%__H%W6%[04QY304T M.=";C9,\WA>_8'(`]" M;>?P2(9O%T47$#RW+PP47==TNP.>Z6VP=&B%+D17EJ?[#I,-5_;-8D4V>.VM M:T##4KJ0@9X&GH/6"3W%4P/5\TU+=57F<8YC)AC!-E"!CJU:+UL/855BB(B0 M49B=6X@4S3Z>F&IZ3/,5PPITR]!\$R(*L\1"]I16-K"M53=M2U;4]H.MVA:Z+\PFI M(_2Y=I,MD6&O2O56+J[5#P+YQIC%7I2SC8D9GY8S,JVE?K`4*QPYTE1 M&NI)S7#+))]R'QG_7!\._1QT;X7=V^4Y#'RS34A;E!^R+==SZ7J\3+'G0^5S M;AM=0\".$^HU\&#]-'G13Z*[>0KK'>=284NQA2+XPW7J?\3FD#$O^P\\OVP- MI4&(?@:J[V:<8/L$1%;\K1QC&;_K\3[%":S8#(9S3F_S9))$-#'K%^>&WK7V M`.ES\I#@L[U4]#U&V%NYR"!JDQZC#;C@>V[5.)VEVI7NXCDJ9AH_C).&41'@NDFB%XLL M_9L&2\)&'FWU;*1VN/I7#*X==,F+I5ZQ-HVW+D1Q@ND5WGJ(5F.,$T"CN13= M93'O5'R$+XF;`X>E!0[OH,FR'`"U[&]$4/;L@V@8+RT9>/[B-N;HL%:F"YXQ4W2<3JA/QZ-W[41Q,LC0]:ZD7::IQJ!',,77K%GH*OA]>6R7Y?;%`8K1C+E09698\ M4E@W9\?-#KIDY9'Q0>ZW2S$J'L=]3]::UNC/-2XO>!A^/-8^_!-GZ:"M3UM; M.SDUH:(D5<,C:JY`WM"^M1GA8M0T_+@$SPV%+W]#[T`;L2Y]HUI3ZO(>S)'T M`.^ZQZ[5)$5,#8+J\.,Q;VA6%6[FKJ1&)VJY6>6L\G*KQ*3R\DO*YM5H_!?: MJ)3::"$X0@M'JAO?]0!N\L/JX9@*NU./QQN.T M^&==,(F'A,/3X")BF'R%%TL)U:J@FP\\-5T)SZL:T"*E7V/>MSV'91V-LQ36 M#4>16'Z;>8$6NHS*NG?D$9Q%8O8F+SZC:=H4(5VA MK`1N0XLF5`^Y]`[_\EWCM>\$[E+SC>*9I)(P;Q"/P4!0T@K$Z@$4.@\82JHJ M:L`D4A MR2,AT]KFF34B!VRG_JG_<\MQ[&#J)LL]@%HN@#K:LMZ6+F060CU!T:@$$OD^ MGC\O*)7'E^1MO@21Y<(1?^4X3&L*JYS0MGG-E-A.I#JX_FVM MH41%09@5)`F=T)7`L*OT!4EC,EW7UP1$]8@#^/`1Q;)&M2\LG@\V=@T<3J#1 MU)0J]X[Q:X5Z7#P"0"#6PL*",&"<.&SAE8KT'2B`EN+?\4Z`?"'2/H9 M=@TW^4LTCV=7DL\YA#)8_,$TCQ!'XJW#Q6#W"/=V!210X=32&:"*W^K4\O6( M/W'5S8UG86DQZ@==G#P\Q),$D84X#$_QT-)QSNC+Z,?I-B)W$U,[:E%/#-'= M+$W_HBWA(&OB.SCB#H257Z-D1IQ$UE[;M]3)4JT@=!U#R9X?,:1=IJ8S5"Q'V MH.Q%2_H#.>/-RM>:-::*J_B^R335LPTY4'S5*D83F)8?&O7BPSF!,5`=M<+T MG=N#JWS1=N359*P][N)=0S.,0/<8P]HJ36=V8):5=X9NGO==O-@JB4\HKV_6 MP6[&`LW8_.[#,EW`"^!6[`BA.P];1,T073.``\`=QJ;^XT"2%E/,'W/)31'C M$&\.P8*.EVG&H5NG('4E(FN,6&OB693FNB:X5.G/>!;?@RD`_?9K-(_NA`/S M^;,GO2N^A,D_7O_Y:_F;\B-$&/`"JM)(FI27FN"?S&+4YV/8T3(>X-XSD@'6 M/45-_W=4F*]1\>DD%V-K"PHHZ9WD:8:9%BGB&&TBU72_>D#HNJ>8J&CL!('J M8DU`,51VFHY7.7"PL`_5U]'SH]L8Z<96E'FZB);W3^B=C+.8AW71&(TC45:M M(IK/<2<[^BS\7EM57B+)E=^P2!EX>&8;W+YY`9I'=0A+ MG&8;%T?V#A37G;A-H)TC#PA7$TMW]+^L MOJ:(NYE@P?"EZ0H7E<<1C=XMSP&74E%?#BK&C^6(!YP(1ROE["2>@"8W2U=W M]Q5H8@5]JLI%-%XP.H[W36A@">S'\3*NFM;I730>+`U"IIOY8RU#TW_H9@6H M$_[\]4J2?DOKCGQ23F0'KS;.D#G`^:NEE_^/NS"84X9E5R"9Q3$WW:\*#WN" MD4V^S#C\8[Y:((PD9OB*K'W*Z0F%,%$:^T,]C9V+[]SPI700",2YGO%!N:AJ M`HYZH]89K^':SI'P40V/'$$OG>4V]4#RA)J!7SKPN^Q1H]Y* ,PA_U*%F' M6W(TJJT.[T%PXX]%^+OO#0LI?]\'#YZOD^B0#[-!\_V1C._1'_P%`O[X"T2E MZ4BZR:Y&S[J/%`Y)93PDB8!H)%#UDP4Y.I@=GE-I)L9R(GE.P3$60Z9D#D"Y MWV71`W<2T,=!M&+R(^`!S3*8JQ*1."X^-I)^S6H(Z8+XPA-J5`<<3VJZ+-DJ MP=X%'/H1O01+[LY+0#:@B!Z\@)@GMHHL'E4>@L>]3!_`;R_*/@I.$0Y$/;^& M5OXVYH64(KNWB457.?K<%:.!=XJY^D]%+91P[^L%@,GQZAJ5*]:1$U9Q/Z:# MR= M$&X_NZN^8>TYM0@)WO.`&;%Y'$_H`ARL\T2,,VA(_[/JJW3'9E&1W?3J,%%V>&ZZR85>9<%Y5U:9S6M.^W2)J=]V]$? MM2A9449,/T._J,N3;A[NGP*['[,+E:(_JOAU*7^/-$@D(1=FNL(T?U7?JXL8 M=<^T_1X)VO7,KJB!S*^G]3'8^P(!!J&EAZ&KZ;H2VK)K&)Y98.Z83GO.H&7I M>B,1O9F*`VG=?JG@!09S3)<%OA-XMF&ZMFX6H(6:Y[>Z[>0>Z63/PB]Y3F!C M.ZGI^X&A,B6T--\S/2VP`H2<:XTZU2Q3LPX@-8^C;'SOS"<^3JA*J0WOL/$& M+FPI=G,S53$M7[-T2V"7FIX9N%[KLH89FF);=8JWT/(:LG?T5QNZ%6BV;H>A MH]F!XRN:7XPY\#2]U5_-%!N8_&AD]X2#&[J>Y3+#TZQ`U9EI,T\IL(QEM]UQ M*A]AO7TVG5N.H9F6H04N(D$IENYJ7@%Z`0S;XLUCK+?G%F[F!('CF%K@A:$6 MRKX>EH-#F1RTL$F.QM8]]^+;-%,8]#JBH^JJ!:JHO!7UV[!UKU)"3?#6&L:H M3\4=>[54,\55<0*J*P>6;L@R*"*O@`S25:>-+DX`]Y;2.+)=!+UZ`5N:V%TU M]%0#A,D&_G)\60O5L#"K"E,W(*3"V3"FF:]9P-=XOHK_`)?MCD^O_)+.DO'3 M'I?1OBX'K@H*0=9#YFG,,ID2*'Z(HP28:O4_\;21M[,VY^V*]V"1V4=#Z[M3 M56RK5-O7P\N]Z^LS=JSOA]9Y;D?U'O-4);4/YB&F?/W#.5#U^FO&J$>#Q8K\%GX<2__81S- MBT)CFE[*LZ=4+#>F^]/YG70/QR=]36:WW\$: MYGTU,IF',9[9SISUU2G1IZCP$6TY,&Q6*R$HY(<73_`SHRKG@DF0(P5_\X*_ M&G/3D=7&[6%.9C9+'^%A'WLZ0^VP'='Z/<,76(F&PI<+K2G.'7^O?P]'=V@: M$GQ/^>`EW8J,X]E,O(<,-_Z>+Z)Q\?O^]NTQF2SO/UKJE6ZKIO[#C[=4X_%A M#,<:+?+X8_%#JTZZHBPK?\**3J1G_I_OP$G+TD?^LU)A)RPGU8_9QB<00?_Y M3O^A\8#JP1L?5GV.'?@Y6]WK@\]1+P[@:XR77-%,;-AMN@3EWG0!\.JN?MSU MW_G[&R]EQ";XRDXR:SRX?FA'5XW-O3ZQW<$FKREHKX_WR02DLML^A0O8G^>Y MY_7[\P59@9#(<\$G&Z%T%04#%9S3XE*!&A%OR7HHA MR*31J\M'1.F)J$Z>&B)63S@1MV:_WI>P'HTZ^W2U1&7,71JLA,]+_`1TWMX5 M98=)548]PA(E/HH6WHH37?-1!9?`K]#H!DMTI]-311/5)KK*7@G1U$$GAH\& M/W"5S7?DDCQX,\V"8!\-\6JIU,,R#87Y+PWP#8>""RG#)#F+` M%__]@1=G/%&02']=I`G6>CA+T<.'O_*,P`;CMHS^0N-*J1:1_B"+R3&/13RF_F9"Y>3A:9ES;<2_=?3->N#<#"B+ZP6\.D`%*X!H M,ZG>]SV>1=C7-AC,;]1@#K'F8#$'BSE8S*-:S$VF<3&+Z+9<6DO^ED@YPLS^ M^$S"EH;:1?G]2/*N?;1RXRR>)!"N>J49I!?0!A>6%QL1ZA>;-4N.]2A%9R"! MFTQ6&94?-+!R:2'P]OI2_I6_%U_UB$A\'*Y=0$NE`OZF@;W21/FYC6=)_#46 M#=*HA;&>FCH5GWC<'.4I^@Q/V,D(1$W>QG;OV[?6:X$(]G3B?^O[59[N^H$4 MK%/Z2#QOGR\;72QP5)@!62L(`=V1$O?-Q3``SE?QUVBV*J`$6P4>Z.]5T$@< M0HU,+#`"-M1@.4OC([Q?^0&_L8580UT2G'EP/$#QD754.OH6_&XIR;+X:SHF M5T(`YR"Z,R><=TXE?%R>:,PI]^66AK.O`4.38":YJ#P!#MQ>!["I['U'`5BS M7NP&/5WQF9\PV;,^]F1WM;"GZU@C:X::KCBJ2@7DO$S/LFS;:DW&89ILZ/6Z M[$TT'$#E]E)LR]!4+[#T4#4457,-6];"@DI#;D^\8BIJL*V$^2U6MWWJ:99A* MZ/B:ZX>FH;H%IZJ&O&W$^GZKVU]1:#@^U0`B9-M4`C@(5S6*JF/F.NWMW\9D M>].V8UH@B+:,(\<"GZFFXYK,-`K6<%B[1V$K:QRX;WVQO:TXCF>9IB9K8$-, MV?286@S0"K2P79V/@\OEKM;6)[,;BLDL.;1E63,\SS/]@,G%`$7##UMJZTW. M:\\UF8J.H\+L4)5=10L\%V2YZ*50=:.W-?7<(:('KB7[,O,4!1>HPL]%OY9B MM5<%\F7NP8,X?&0UBZ^G?I(O4HBM?LK2U2+_5-R]86MB*H#)JZ%E\&=80+52 M7NE\U?[E_!SS;?=J+^NH@W/N?TQF^,;]Q;HISJ+Q( M1S99J%MAJ"B^ZP!+B9XS4W4,S5".VG6PUG1P!"3;>NVOQ!.3^>KA(KHWL#ED_9VOV.JM7350ZOY.^[J40^;RCC M,2*!9"^G_^Q2UL!H=\F<$QFMEFGQ`D]RT2L\JVU8"M#354;;>NT=,*8^#DQ. M'_Q!=N@G#Z95O]Q%GDG2OR-%1;^VQR"6NICCZ#VOM1&'8X_<=_WF:.N&"GD6 MVP42+M$43ZF`@>AAP[?GQH7"[77;T>B=[T7"R5VT#,RV@]F4`RX37JX3<:C3 M789XM1\$A,MX',?3Z87=<8G8:H2ME%T);Q\,^>QQG,I&?G^LW=O)F%MV\<#- M(K;M02-:3&&=W3T?O&^GPD$'!5S[;-#I:+23,[:#/AOTV6MVR[;M-]^O4^&< MU^JQ;RN$I<]Y:;XL&S4)&?:00('M"!0.V:,]W/ZS\!(N14A.3QY.SJ9?KEQH MLCG(PV7%^%WN)1\!![2,I+MX3D5[-/NF,7VD#T'J=#\OS?)R13WD12]- M;G;MT:7(U;G'7[WV$=(P/\SQB?%]'.I[^[3>4_`/!?-2V=QVSKT$27UNYUZ^ M"V%-&K,,;KR%\.PE/M,LM^XPP]=0J_$QQ?3\.E@H*>I*N ML*C[5;?SYZ#R>[JAW[*%1]ZQ\W`;=FW>6?#2$%:?4HG1H,4&+;9ER]ZI&X8S M][UKE11>"N>UAZL?&4CNO'OX^J?>R?-8I$QF240X.8ASM+MADX/O\@'N!!$# M?T,6)#RD8K)1CDVY'$&X[`R=(+@A[QNE24>[VCM_6N\#\3HTK M]NWL/'?Z+[DS53ZISM0W:-I4AL[4[A9Y)DF0DXL;7MP'>)%]?H>VZ@Y<-7#5 M\UQ5^&U#`K?/C-`W64BPF>&Z[(W_5DH*3D^^SE>+?ZL8`2\6NJ%^95<>YBW% M]N1OB+O+8E]"-^S0/3$4X!S3#`[Z9M`W@[X9:I)>5(<;[>O-O&D8^VV5X.Z" MOCB':^4A[#VA@MM!(@>)?!M3>4+^>I][^[DJS.@E;W7$73P'S77(Q;D[ MS1W;E`PKE<^F\?O2A.KBL[EG)%CG:YX&$?N61>S;C(7(;L&6Y7R0N9@##C3D MYW.'\J:BIJK6L9*QER)IIR=49VRS!GGZYN5I",76:P!FK[NU>*W078XC>41I MO'@'\XPD\G+MX2":@VB>;>S7YQ;B\'A>.K<%@*$?ANL(#N=4=O*D$&].IH;W M76_ZJBM0FU/AGQ?CUIR>@CHYOV'00H,6&K10KUJH4_2L^@8IN!UUC!T57^AH MC?1K>[+\UC6+G__[WZO\PUT4+3[>C._CR6H67T_])%^D>33[";SD1?Z)\*E@ M'7[-C;HNO2CX<_H0WRRC9?S_[%U=;^.VMGTOT/]`Y-[!S0!.J@];MC*3`1([ M.9BBTVF3O/2I4"3:UAE9C`P--W\4__K9O#WK$E_%[CV^<-6K3_[UV=_4S9Q_[YPO6]9\I`# MXGNG!Y>.FQS9%YIA76KF0-,[%VWM\KQO#*S.H&]9YP/;M/H'7U9YGS;+K;2* M@Z]">,9IZQGMK3FHJ\JR]CTDW]TDRE*LS!*9B9QI_6C"A>4A*T9)?#[J[_,G M$2)'!KXS"B/&%8^1\Y3QYV.,)!&YN#H_6_ZQ1?B+.B8W_&(7_4&6A,UG(@,; MGS\,8F[#:]?G3^0/?3<_M)7E5!/WNA]'0?!`HON0'\[26^9[OA.+Y&^_GEUG M1SV[`/G-G_CBVOTHOR,'"Q4W2L8^([?S5M[[04#&SATE#IEP!,8^?QX^4:5N M0J*0\-EAR-\#$WGCQ%WI/RF_/N'(\B/OY>3F-6N?BF_JX>$JX]<*G M2<:$L&">!H_?D^2IR!9)\EB&#\[+-%@[&>17B+-#DW%,*9GP0\:,T%`DYMO8 MEJ^TVX3L^AD6^=7TY\G_"K_H%;#9 MKG'VE@/BS1KSJKX]&0,KF_4N3VEG=X^[FFT;IF6U=SNA^*96'3 MBY[7KOJ&S7S`=[D&)8WS94K_Y>NB7307F_0L-7)<[JJEH(&[!DA:BR2]G.4* M;@.5UA;++2)Y1_DHM45"NDVER,HC;.I=BZHDUV*!Q=K:I_HW6Y8IK=9[87/6 M`G7B/(1?*+^,4K)`JH+&6FB@2C*GMW=N,56P\UXEVW[X5^^83E%95?@A1U'D MLM4J?<#6%>9AQ5A'PWR!R:;8\7U#3 MR56'25"YKF[&+>>.E]@E/HG_Q*-W-(BF(OZJ%,HU;<^IQ#YM3[:<8IH%.KW> MD5FHA;1/D[0R#9OOYQ8>P+Q0<*DIMO9G[VBKW:ZLSVO\4!3S/`5ZR2:1T]), MD'./YHDR[27V&]O'*CX;KNH@@3,EU6*,8+, M[(/,0&7>,=9Y_U;LTN+?BS_JALV5_E[(TK^\6&[FBUC*,K=NFR3_2>R/];-= MS?RG;",AS?;+BJ&X([:UWN;;I`D3^Z3YU>.E_9@><=ALMR;_)2%K]CQFS?HU M#2E9?/-LWV+Q':J;XZ%VNP>YG4=^F#?229-H_D7>LV;?Y!L,+<-^#"W?^9Y" MT^+6*;8'SBYZHJX7/K5=],1.@Y^R)IG'E!LM;KQ3K`1;K1\5E-!9%MV8"1`! M1(OSYL."&"Z:BUB>JNBND> M$%>[$5RIVC:O]AI3E_IW6Q9\E6XH5] M-E2@=BK0Z72@`I@>;6K;K^$=G[M&\4.1\>H^[5ZSL7L-DT&E0H8;0RZ1V$!> MW8*FDPOSWD_?$_[;K)Y3&=2J'8-T>>L0JKQC3/W4Z6IJR`<-?&C6)$BF+?-M MEVX:QZ)`1GG]2*6[NC9/O>>9=IV\LT#OTDC6FV/6#H_RL^P^&RUN'2@R\3/:I*/6ICJ&4:\KK$IE,+ MGLQ/OT?AT6(>^JYHGN8Z#$1W+,[K=*212)47C1F0.IU-[?A@&=+< MUTWA0]VG0#)MF4=WA,N>-41XE%[<1:LL*_Y^+P77B-3U[1)!ZQFM)086@]9- M[L#+KY)1/)$'V+Z1F7NM=G6E;?:;[34B-CKQFM/:;NFFO'`OT!H>W'4F_.TQ M:W013JN1JE(YS5,,0,K9!_C!U**0-1<9M*;.0UD!=\U9S.V8*(^.(;Y*0_S& M4,N26':JZ=3",%OT6[$HQ%)FP=CZ<4A#:"SF#HB36`S7>N`#YD);+K,$[W/@ MP"F[ZAS:N*=!9#AI1 MHW@/:A1W6Z9>TLIQ@\L4JZ=!R@TK(#00FJ="T^O(2P"]+T*S=3WT^>?/OZ3L M:.0XTY-K=TR]-*#?AP.?32/F!/_A`\HI^YI5\^9P&2P-*KXOQA3\YVA"KQ,G MH1,:)N=Y>>]K4=W[+/3..-#$84X@S@XBEL:4W7!#G@>1^^/+SS\1\OEE`RZ< M..0W9'_0^'KLQ/3<8;[+KS;P@S2AWHUXP,5%1'EQ\6JNZ/#T8&!HNOFG_M?- MX(#XWNG!I>,F1Q>#GJ5UNY9I6F>77:W?M\XZ5F?0M[K]KF&U.P=?GKWIY;?V M1D'M54!Y45!\F7^Z8-O+U\D%9VW'YG MV?&.]J%8:6RCX'EZT?L5/;'P#9OY@#692-9K$`?[/#:WN]MU)?GK!..84O*- M_S)FY(+W/!XI5,(=Q`/Q4$:ZY$ROJ%`.:)4&K8U#UFHJ];-IE*&MF9M!]A6T ME>+[`92R%7`%7*FQYZ1AJ[/I1/A+H_BD.60$`16W#_`#_#1=M$LRTN+30KC) MD/^_%>M066D9+U^)(G2V4D6F-"9,K%6!H"`H!%X)^P`_$/CE\PY_BQC[2(9Q M-"&S2`;>L!+B(\&]DE>YFA"U5:>@K$/+:+=,6]J._Y=@KQ$"/D(F(!.0B54R MT='TEB:OOO-^R,0>CL3RH%&R/"`K>G2LCZ@+U:(1^7P1NPA/0Q$EPR%J6:&4\K^MEIL^59J\UL9%BM! MT=NFV6I+3+NXJ>6VDOQ:H`\"!X&#P"DG<-V>W;+:TH:L$+C&#'C+M-6`AM'$ M#Q&>A]5W9?I-X`?X:8!LEV2DQ:!], MW33.$DQCZH6A,Z9>:M@'^(&X;RONJSY=)R(_7S3-(KFR?5/W3AP[X5:EFQ6S MJUI@;/3X,C='S]`-:>*N#(,P[P(OP(M]G7GMI#/.W)V$_Z?Q'?4R?^DP3=*8 M$OJO.W;"$?8N0WV@/NB5P0OP`KVR+'(\7Z-\/77(JD5*,6EV&$LG5'`GY-\R M/IE>:_BRG@CBJ(PX[CBLLFIIE;[0]*;]:A'D!T:"D6!DDQA9DX&2NKE&8:LF M+?0I92O@"KC"8G(YE6OS7Y?(KU&KQ]9>*`1 MT(C7-`+)UK?2"(S9MOHT0+IE54(':A?IR,5)6B%I571&G(=8&A"B<'?=1G?= MP.Y:.1+!/N^P#[*1(AOI;N9@2$4*=8.Z0=U44C>]NN!MJ%M=!KR["Q$9Y/OB M$"2"17XENE/@!_AI@*"KLN"`()&::9DJHX:]70!&D`C+-#B1ES_AC_U>1"Y/[[\_!,AGU]>Y)J.)C1,KN@TXB\U''T-AU$\R?Q` MYP^S'Q<7$1F*A1VOZ/#T8&!HNOFG_M?-X(#XWNG!I>,F1[JI=?7S3J<_..]U M^O:@T^ETK4*FYGXQI]01GZG]^0JFCBO*^W2Z8$?TJ-9 MNB_=T#X\@90N`)2]=S_DRIV11!&$R:20"=CDO"? M1-8K,HRC"9FYV9ZNCF;IHL5QR3BFE$SX,6-&*&^K1Z[I-*&36QH_=A&FUB+< MYD:6,YI_T`_]D)\:I8Q_P3X>KP7A.IL]/IE=S"#VEOW99HUY]:4_Z<*T9^]8 M_+U\T5#`.7B*"W',XL+Y^W-I$,R..3W0#K*_N9JX\[^WA^N][R7C$]L^U@RS M;78['^9:QG4J<*:,GLP_?'JN38]M6YX5/[I..BL='1M,K+,VG1Z8VH3=A8]SZY)._%\^_E\X)^,^]7$S?GZ"+E7;%C0@Y.SBI64[FY7 M4EP^ZJ*Q'+1D?^4U4GCK`R^_SG441A/J'5TP_FQO%$P#_``_P`_P`_RH:1_@!_@!?H`?X$=!^VP_C;UUW!^C.$I#3P0F M1_')_[@NI<-A<^:WV7E_Q)&7N@F)\VFM+#XJ9#VU@%B&D+UJ;%5`)F\+VENP MJD/^(J-E=.7M+E/]W8OSRLP=`J6!TD!I7E.:MM:%TD!IH#10FE*5)@=-S]"- M\NFF"@*@-]`;Z`WT!GH#O8'>-%MOX+.!TD!I*@JQ@_2L-0^\.MMH$0)85^W9 MG:_W95&LNU2GAJGWQFF\RP@[WSPGH`(:)G,\]88M:Y$KL>PQ%\@)M@.&6,!<0!<4`<$`?$J6,X(`Z( M`^)J83AEC`7$[0/B]C@J;C'-)]&0C*+(8\+IX\'/6;V?LXBM=N6JS,[36[HM MK>RY*ER`YQ^,>`S)ZTL>>/95H>H2IGVNJ*,6\H=K_*W>O2.!M%T M0D/D%\2BSP89EN7Y4)LB)^##/O/!D):?!'P`'VK/!X2/@1?@!7@!7H`7F$^` M#^##.UU[F&!(\-\IY#_?01$1]T6R-%F(4LBN]=6H-U,?RC1RO?)+R@LG+VSD MO4@\"9Z#YSODN6E6E^09/`?/P?-=\%QF("M8#I:#Y4JR7&),+5@.EH/E*K+< M:/4L\!P\!\\;SW,#/%=T5:/ABQ>'OT6,?21^Z$832H9Q-"'1E,9.XD>AM!4, MB.1NZUVI)7>'>J>R%8>7*-K67"J1]2,("4+*AU6WL@)S"C`+T4/@5]4=7H5. M>71X("0(^28AJ_.?@Y`@)`CY%B$[=F5C4!`2A`0AW^PA=1N$+)60"+#?U*3? M$WXP.9S%U7_,@NQSAS7JD5<53"O/ M$=LL?^O7,*$Q9&G>'R0*`Z_`*_`*O`*O9//JT#:KXM-+ MS&QKG!V2$+F#P#8);.L98!O8!K:A;P/;P+:FL&VU)Q:=74'#(2V>=)/F=>>C M5Y/C20.J.O9MKC3N:^VK'?C`]KL"5FG6@QI`#:`&4`.H`=1`TF3+Z"F#XZUF M8:I+QSNG:!`-B(:ZHM&KK-861`.B`=%HA&A@I%%/T8`H('"^HL&`5-[6GYIU MB+0O%UN_18Q]G*VUD%LZC&)*$N=?RF1!3H[!I'41]56XIH]>]$Y'-N8P"@%/ MP5.Y@.O*KG&J+.%J%.,/VC6==H=M2UHM4W2/X"EX6A)/._(Z2/`4/`5/2^*I M94C+E`V>@J?@:5G]J::!IRIYP!5:KBHW"4WF$L]\X>26AG3H)V081Q/>IC#Q MPY0WFT13&CN)'X72W.4*6;>^FEAIA,"^9=]H?/HM4!04!45!45`4%`5%05%0 M%!0%14%14!04!45!T7I2=+6?&)R5S]DZ!)57NACQ.TW(8;`<:%Z^'QWZMPU+ M3&"<-5N'P^$"\(%X8)PU6YC M$X3KS9787Q*'&V3E\2L^?_XE947+MCZJ4!_3Z\IJ,)#9,K.HWX.PA' M7\-A%$^R5N?3>T:& M?NCP%\C?G_^HZ"WB!%R6G82K9DQ9E,;\U;0R?$^R2[`,X8O7[+#Z`9?EDLM. M"+F.PFA"O:,+QL<649@]Y_SS-^J)$0=GVCB^_T3Q^/ MR0TWS+,+/B)E=E.A",QG`OK#^<$M\C5TCUODXMO7K`$W,?V1O0=QS/W8=\?$ MX8)!PQ&WOU"+[!5X](X&T32[J#B+.9Q^_(3OTS%G73#Q73*9/0$_-&?8329. ML\;/[2!BDX+4F[U9QYOX(6^@,/\=5ZG%T4OZQ>\B#A6/(B+<^*\>$9%MW$S9 M+2[Z@\7%\_8O/_4@YKWQM>OS7[G\N?.GSTJ?\2/NQU$0/)#H/N179>DM\SW? MB1_(KV?7+7+OL)G:\!]3SI68JPJ;J2S_:JF1MW3DAZ%0WGN?:W@R]AFYY#`G MNG;T)^&`SR6>9!+_AK1SJ>/'Y[W`DMD6K"%C1]R0AKQQ2[K.59TW31PU;P,W M6AIG$OA`'7Y%3C'^1W:-X]IHB3AOZQ58E1Z`OV4GP_3D414Y,*G#D2KZ+>(+ ME/V3^C%_B;?4=5)&\U^?=&_B,`[0_U(W$:_ZL7N;./$/*L9RK7E/Y\^T):'N M..1Z-WH@&<4X1CDO"QMN>3*CBZE+J683U)[U\EQY[CD1.%TYNF?(%H&.:P(< M9Y2C:VGWJ)Y%*>-?L(_%;?;X9'8Q@]@2AP$;3$>>^$BT9^]8_+U\ MT5`H4O`4%^*8Q87S]^?2()@=\EXQ/;/M8,LVUV M.Q_FNP?.E-&3^8=/SZ?,CVU;#AI^#&+OK(P?S@7\R[K?=+I"=K:2\[KCM%1L6]+8<%F"= M:1O[+)K;+2$MW!9;TUP^ZJ*Q'+2\XA!^YD$`AH"A;3'TZ*`">H">;=%S$R5. ML*EET-VCNR^1;.8[M["78,M=TU-XQ0`U0*T:J$DKP0>H`6I0-4!-":A!U0`U MJ!J@UBRH;:QJR-3TS'A7](Z&J8AT"VER`L96S]AJ&*F%K*<6$,L0,N73A`]7?O3@/Y1V@-%":72A-6Y.7LT[U=P^E@=)`:7:C-//T M!C*+Y*B.`.@-]`9Z`[V!WD!OH#?-UAOX;*`T4)K:I<>MN?2L-@^\.MMH$0)8 M5^W9G:_W95&LNU2GAJGW8RZJ'82=SZZ9I?)Z<4&UBBK+'4^]54YY8[O46.=` M3I!3R0$&R`ER@IS2R%F&YQ,4!45!45`4%`5%]X.BF'^"G""GLN3$_'/73G"% MEN@J]8[W(U%[1E22H/].:<@HDY;C02&3JBN-;Z9KJ="(=3"<,L8"XH`X(`Z( M`^+4,1P0!\0!<;4PG#+&`N+V`7%['!6WF.:+0IZC2!3K9GSZ#S]G]7[.(K;: ME:LR.T]OZ;8E"RFJ<`&>?S#B'8PPC#88`4:`$>5M304OP`OP`KP`+QK("\PI MP`@P8FU0!B894EQX"KF191KRFQ/_H`EO2XN,:$AC)UCBD_@D_A/'F_C22F0K M9,GZZI)4(^ZT"[K4^/WXH!:HM86=>CUI8V-0"]0"M1[/:[>EU38%M4`M M4&N)6O(\.J`6J`5J+;M+VQK(!7*!7-5X7LV>M++DC6=;':(J9=KKBC)N*7>\ MRM_JT3L:1-,)#9%?$(L^&V18EN=#;8J<@`_[S`=#6GX2\`%\J#T?$#X&7H`7 MX`5X`5Y@/@$^@`_O=.UA@B'!?Z>0__S_V;NVYL9M+/V^5?L?6*[=VDY5NP&[?AW,.0/(%/B*2]EZ6MJV(VB&[[B]'W?OJPVT:>;_>+[F][>2/-O(W\>)) MBW.+\Q?$.:7/]Y)GBW.+R6I1;E%N4[R3*M[BGUJ+U6[1W1OL/MN*0S^*-C77+H'U.PM("\CMAY5XM@_,[0"R[.XA MBZ_GGO">L2EO)SP+2`O(>P'Y?/US"T@+2`O(^P#IRF?+02T@+2`M(.^=(;&T M@'Q20-H-]@\UZ?$<3G;>M/OJOZLWV3<-:_L]\N>D1?M50?L=2QMQNVRXG3&6 MC3@;<3;B;,39B-L=P]F(LQ%G(V[W#;]2V::&FO&\*>MO-?/YNYCYU*U?, M85_S9'%A<6%Q87%A<7&W.>S;SRP<+!SL-&%Q87%AIPD+!PN'1VW#L/.&WA5?*CKJ7CIU7^=RT+,0LQ"S$+,0FQ7 M(&:_/VZ!98%E@66!98%E@66!98'U+0)K?>?5(NWI&K&OJ]_Z?CK7A2[GW4>( MMA4XEHB^S:?#GZS[8U\49G%E<65Q97%E<;5M7+V1]+GPU(^938WS@B"T[PZR M:-L"VCQBT6;19M%FYS:+-HNVUX*V]9U8.]D]TG#VM7A;-VGSW?G\UI?C;2U0 M=\>^KY<:O]5O7[U`#^S;_@+6DUG/LH%E`\L&E@TL&U@VV%*Q1;R=B>.-JK!= MIXZO+-$L:5C2V%W2\)[M6UN6-"QI6-)X%:1A,XW])`U+"G;C_#,E`UO%[?Y# M:&=>?)%E]L*N>T8;&M3Q/XRW&O/7K#K;COF M;!9B<6IQNMV`$]O^QNG.`FZ/]OA;V+UVV+UA?&O?,K73H\6IQ>D3X=3=W@1I M<6IQ:G'Z1#CE9&MORK8XM3BU.'VJ^10AB]-=ZH#OT'+5T[Z$IFZ)U[UPYUQ/ M]3";.\,BGX!,TWDVK4!L)Y_I(IEG^71K[?(=LN[^I?OV4A M:B%J(6HA:B%J(6HA:B%J(6HA:B%J(6HA:B%J(6HANI\07=\GMIC=/F;W85/Y MLRY&?-!SY\UX=:/YT_?1+?]M@E(**!WDU?E8;^\U9[L4@?_U[&;;OI7V;`_^ M@RWUC3UR9(G+$I0(&67?^LS7? M5LPUSJ;Z<-3HA0GZ[[^OV._?53G/AHOFIVP*]#;_GGG@CQ?O'EH%MJC`QY%V M5#X!2"W:Y6]=.MG4FPHG3:IBD\PHN,I_/:2ZL%]>'#MQA-!\EXTF6.A,],`QBKLY2N*39*BDF2ZJHFE_*=8Z0[KTHP4EDZI;XP]RB=0L_R8JX'3G(.,[!CY#-R+(\/ M\\+Y/,K2$?PT2XQ*SC";)E,C.0@-AR?U*K^3P6TODVQL,%D+<'5ENQ4`Y"YT M68UA5',;?9F,J\3I$0?&S*NB4SLI2]#/G`36M!9ODX2S.X M!BPY7VN8I262"5Q9PM]Y:?Q3ID5VK@>=P\IJ`FY9F'%*"+1L"-8&@=?="JZ( M02`'H\-_U-8QUR\@V!T-`3EP_K>::H>BMPY!F(#(<7O*K"IF<.]65K!S-AY# M.#>[*]X"B\/AVC'MMY;*MZW=TWQ:9N7?Y23QU=&@[/RA&L/F?P+5NVVIH8'@-<@]OS#,T`XH"'H_I@EZ6@!,:X+ M^)\PN\C,Y\\@)B]J]!?YH$KG<.3]V8G_H=V%%DLR^/VM"]+1F?)`MS,ITG,.P M^B/X*0!<_W'TG__A.#]<73`&+U_\I*?`WV-_.O"O44348*3>]`4#G.KACP?'`W3@9(,?#V*`[2&1$D7PCT)$N$2%7(J0NZ'BPO-" MQ.F!4TVS9K"J'!P<889HQY<>3>M(3GN<)S7\00=!-#=&>ICN;O-D,0QU[( M!>,4XH'Z..8*-Z'MRBB,>V9@#&/VDI']-&;`BB$)"H>,4<%<'L=,-6;@DI'` MZYE!%&"-0/FWCP)$&>IVX:0G+&&/I*0T#:KP.3 M?9E$"H[76>+QS/P;1G@/V?#47'PRAKGKQ*2FBUL)?*D((AZFX#\B$*-AI,+0 MBR(<<9]%L<<">7!T(SE8G<,_9A/(HS[HS\YI#BGGK3G`7;G%:FL#FT1B3;)Q MK>/&V?:RC?4=B[,YS)>'M:6=55,[CTZ@5I7DZW5<3:BVJ>**1DWFGJYJU";# M=\N)R>>D@-3KHH`2R&3:0\B)H*P9+ZX:L-AD88B;Y-OFY*J&)ARSOF<0:)7ET9%?IF5ICKI"KG8/PM@\+*" MH2^J;-"4?ZN5>:'3'`JUOW1=`]2DL*)"FI>0C=5EB\&9\KZ M/H7^LX([UYE_8:KN-O'LY*A-\6X[P8#)"T3#_]75>6U:4P,MG34"&:&:*JOS M?^NTKA2AY*XFL_;4\[R:UP885J9O\;8MF4PJ7(>-*4;!6)?Y&`8?9_-%4\1] MT45J"JQ9,H>8F;;MBI5(,/6UH;8V[&;)HBEZ@0.\FQ=U`KXB?.OM-K;^ MIVR4O!YPE:DC5RZ'($],!V,9W*U<2R/4%IG,QOE"0VVC"R#]QA/-N+H3V!PR M$N2M\3O<%7I60&";.KP&R55@9N;U1Z9$OGE)W9!9CIM#^>R`(Z$ZGQK7-?@$BI"%L\CT M&`BE*BYKO.OA$`9RDB:<:M';T6JA-ZY^-I\8U\RLYS<'J'\M_6H^`N_^I0?_ M!#@6-9,V0]?#1:UG3TSLGR;3"]W^8FJ\YKSR7S7X]<`'ADDN]*F>)##73R\4 M:%B8)F`R_@C^)O?/UEABG[(@N346+X^OXO":[N_K-);UD[<(F'F^,'KDTS4Y[&0"BAD=[D[>%".>1Z/0 M=95'N4`*$Q$2+U!<01%'HI7DK2:F\N`(ZEG.*+IAU54%-M4/?+M-_=Y_B%?+ M%5\27X0H)*X*<"0P9*EU>LI5R)!'MJ'A54O43YL)TX0#X"UL>ASC\B>(!//% MDN/I60+Q4G0'3@H]3[[<:9'F?6Y727LR-K/]V4CK>9TL#^J[)>.K1D<9++KQ M?RKR:E:^[V8G/[RF!\?+1]>N\OXH'=Q3`_N^CR,5<241Y4&,(3,.E:#" M5U`%Q+VJA]!Z'6_%E%]KJQNFOP[3QS5K,$4^=<.0!P111`,!I4Q3P2#7#Z3L MM3@XNU;7KY7A47+>W8J)O(`A-_"4[[MAC(@?RC:4981):_=?6/I@"MODPZJ M.APRI228A?MV'=_I44)L>YAW$4PP2\%DL:R%API0)B]/*8%P>>3_K]1X(Q M>V'-3H&IH-891$EA$H#R;A4C1EV$,8U#\)8G??">4=$/F!L2)7J!><@]RCP/ MXQ?6TD_3:E*-335R;!:/S&F%'@&K0(;93%MW*QY2'OLR8)11'U$1*M`6%)<" M\S"$WWJ*N]CEA&Q5[[RXX`C\9!*>4,)MZO>W=4304'(#*Y1&,O0C3&77J,>IT#BZJ74ZUT5)&66 M;NB[V/6C(!8N#5T5J%CQR(NZV0GHFW^%#`ZD MRPT((3#%$ZEF^B'?^\T&M_)4ISJ[-*V^,YU6!4RH?]6MDQ-=F(8J#'D\O#KG M3DH_U?7\=)(4\\5'P'V9-!O/@L7JD>M)V"C3PZC;T78\'&:I+N[K>W&%H]C% M%'(R1J,P0C`!-!$A/!J3U:*BV7)V<(3>P03^%7I?,]RRMW,\],M2S\O5:TZJ M(ATE;3X:E\%69[F`_WS(H6![C.0 MASU!0ASX`4901\8>#KVN68&]D*\Q$%Z:Y_':K1JIOO*7+#EOUV,,DZST[>YN MVYF74_5GJ9?I&P:CGR$S,$GTF7_6-_PA7;&[4"S&+@T$!I"B4,4Q;7(L<`>3 MM#=='E)(R4P+<3LV>U+[OU3?=A/[8Y\$R(N$Z8,#+?"8JJC;QB2`-/;9_C>R MM&MZTX#X@?)BGT,=;K:SL0"%4.%X$0JPVV__"2AV]D7O&_GT=;S)4(0NEE*Z M)!(1#E7@+_5&<<_?@F+Q-'H'R?2/HIK-T\5)D:=:UP%[W&V;/ZE769O]KK]D M?YI=#>U>A9O9`CT+/PUT]ND7?9&,([AG.U_>#H6K7)T&*)+@?0QE!HM5&+A^ M$_R4*12Y!T)NZ+N!G8ZU:5.8-(PRR!7ST8\<%O;BR\070NW2'IN M1#WB1YX7Q@2R4=_K+.R2N-?3PYQ<1=NV3/8<7J"[[`6)4.PC2@1V!3!\1"5; MQCD*2&])2W#KA"><9@"\)[^5C^)&YP";[^)_),3N=*"N"8X(4PEQ%01!Z MLGM$K"Y%O-Y6*HRDL(YYUEPAALQ9QB(B,N(L(/46MRY7"*G;6PXT3[R\$@_M M26*-$.$^-6LZ2!`H=.ARVP'Q)0M[3R<^AW-^A:.3:G)JGITH:G/%>;.?^.?' M;JP+8Q>0;Y" MY+L7G>+0]T(0-L2NRY390A?%(#(F081=S-;M&MY<3GD$$R8/@2.*8_!A4&HA!^'0*.<]'K@C()FB*UJ\%"Q&G4&.OO>!\89 MU*PS3F[?DW"U85\BAA&P>!#&4$!@H#B_6Q_B/LAX-`2]]`]_ZXU]=4M5%87Y M,3,/L/X.Q7@$I;AYG.?>N\.,KX0+3G6%@-+%),Q+#\MDV-YD[X4C8@/]@H$@XI] MC$%_J:(($=DN9GN<,D*"6@9RB.32,6MOU)?CXV+VD*"`](^Z8`(H9%TD86:E M[>U]+&/,37)^^-OU&YN1K^[7K%(H;1X$&K^?#O27?^@'/)(G)<[>I\T-,YO9/NV';@0NZ!?1%`V4]! M6@3E?B)F!/F0:"RQ=^F"3U07'-D(#(CI%//%])8'7".DG-P]\' M1[_K\II0:V]T4YPX&^M"0;!=Y,4#/!Q'+'!=5PH7N0'@G4-`=U((B='!T1F8 MV>R*6-ZW>^1R5;9K=[TITDEU/L[2>)PGZU9,R:U)IY0X(($RSXC)@&$H>'!' MQ(JS7N=@C1]7[GQ3J%-]4>?0T_D'\^ZI^Z<%ZH&3(*N7$5(@1$#\:!E8(E8' M1_\_UV!G1Q]_/P5?5Q=/($O!V3\H0`_9-:A6HCLH+#^G-*\DL0@2ED0D(&`= MZFIL[F3JZ.+JYFAB8NYD`%VI"#H"P<4,F(#\\I&M1[,`W?YP8#_#.R^_'-CA M2"S.SP/6J*#]W45$5!,&EBZ.;L[`X#%W=3%R,G4#U@ZPPA'8Y#9`=P<.BR#N M`79ULJW2\O-+\O)+4GV`'(4*L%!1/FA;=49)28&5OGYY>;E>15)1CEY^4;H^ ML,MKK`^2U@#3RA24M`'&F^C#]*4:04B@5P`4$L#!!0` M```(`-&+;D&VF=#`*A4``!E$`0`5`!P`97-M8RTR,#$R,#DS,%]C86PN>&UL M550)``.*&Z10BAND4'5X"P`!!"4.```$.0$``.U=6W/;N))^WZK]#UZ?9\6\ M7Z:2/>7$=HZKG$AE>\Z(,NC-/ERK'Y2CH\@P6D0)?,OQ[_?3$YOOEU>'O_] MO__S/S[_UV3RKZ_75T=G*5XN("F.OF6`"@B.'J/B[N@/\"^BF%3+)Y-UZ:/5 MO\@O__11#D=/>?1;CN]@@:Y2C(JRQ;NBN/_MY.3Q\?'3DY_%G])L?J(IBG[R M6FMO"?K3Y*78A/YJHFH37?WTE`?'1Z1?2U537%VA??\;0]7B^1Z^'.?1XCXF")QP5_$,"A3%733=DB!:X5ODQYV0W13` M2=TD@"0'VE">QE%`O[:;@ORWU&`:$G7N,[@C9:('N$IS!OT/EI.[R$K9[B#]=V5(%3AFSO"SKLT#LA2X/S? MRZAX+@>XC=$`,0TP/,1SZ>K+.H6T=$X&ZN+Y,@G3;%&"VM0/EKI"<>:NJ<)%I9]I`:IR%N6XG&27$+!_4BQUA2MYFN=0KA*N M(N23A7%!U@C3L+KLU[M_D$^#KIUO3F\8#2"C[4&!=(X#R=#LMB@C6O(EW&QCS=\B-JVC9X[S7T,Z]!< MWU#(($`?@Q/;'IE=`C^%OZ(\(DC-,LC)HHUIA==43ZAR;>C17%VHJBV,WEB; MFZ+:39'B/TE[4&XBR`Z"V>8-546K6($1+I!9G9)'!36#]'64+F MB!EDY0:41<5]=80IU0*^AJK"5&0?`^IK_YQ7.QJ[ M]*659'$=9"=T0U5N*EK7$%-OZ`QEQ?-MALB4AYF]6(V5Q:O9@A2L,K@I;5\# M)B:,GR_SG.PS3C%.E^61'&%A$J`L8%*;78I$Q6=I'+&<]1XF36)'V+_(MK*X M=<*Y0%'V3Q0OX0>@?)FMQB\6E>MK"E:PQ9?))(";NN[J8'Q)3-?.:5];4:QZ M+'1#NM+7\`#)DHC#Z3R)Z'?&HQO-4H5WK-IEPZ-S;)*%=Y!M M-&67($'A)SX?2:4@X>K3=4AIZ6EXF9"EW3PBZ*W.97ETJH7XRJZ2SN!E7$JX M(H7616FO>,1LKIJ$IP*2``+!C5;.2*]MERV3MN,4;\"];J\,EPU1[I?!K-P;=E1B,#NT.Q%D00,4*LF-`%D7>,/,WP49H%D'TY5H^/ M'B&:WQ7E/U<24(9WB+H9:[TN<9(O%ZL0JDE4P.*E?IBE"PF63R5#2CH]%()= M)K>/Z?\`RO+N''N313&!T+0L_C33/AK-.J$Z+*:15H$?UUZE45PLRS41?[;I M'Y!M77`=%-\NTF7&C6ZOP@@JIFO[(&`*-3X>V[K`.BRR10_\QK978=0("@8+ M\R>;^0')U@'6`9'M]@XR0&$!67>NO#*9?)`E$VS9\+J&DJ\+^:9OJJ$NH@=MAQ_#C_+=X1% MRJ:%WOUGG?]W"Y,%LH^U,!0P$\AQI_`S-A=PI"P(2AW+ZV?W:8[B[UFZO+], M<+PL(]2K[G>Q+@T/$4I`UTT7:YW6Q7TZ23@N)F2"*(-J%V1O7<`5V1`&VT?V M]1-*?47/-`R?=%<`960N+CIM/;@C)(,/W],T>(SBN,;R+T4\T[(!N<'(EQ&= M;-P!"QG6G&4I&8:*YUF,5@E5R.KVGGJ#ZK_MNFJ>Y>@!1H&`+UOF>J*3U3GC M4\^$W1`L^AOO6TI6KJ3YGVEQFY9!?`70/V)8F"DN882^CH:_L1_D*W%PB1G9QA`N'\..G]:KUH8AORV MHCS3]6UB,0%3@YRS#@Z#A`3,!KH7^9DF6,1VY$VNI_D!,L`0X+NRQ\(OV0#* M(-N[S%!DF"V#U#+0'.WR-E?($ M2C+-F_TVNX5)KU3'"5SM%S!_.POMM_3AT$@Q^+N4C0P6WRWMF8`,PPY'&U?> MU53;EN<"D0S3E_F`9NB9'CR^NZ1/<8A1GD=A!$$S)5I(\2P5N8YB"Q@=Y+C> M.%-%+'0RXP/6G6"/#-BLX&E.8#J*(V#5(,=?QYD8W%"2Q(&,+.5;K1SVUO$T ME_S1@M&>"?)G`C>@)*\?.1\2=I1,K*!A6^L60=>GPY#W,D4ZG)+IQ^3JJ2Q/ M^Q:J@2X@'%KZ,H77)J83.K+W,6RFKZQ0+M7]P/X5_!>'VJQF0],)*"G'BC2$ MG,">!&5(S2S-BPR*:)7;Z(QZO2'X"@GY1T&/R/*V`P87^9YENA;V@]'>D>5/ MLKYPE<')5L[B"H^CK3BNZ0>CC885ZE+E@I>D;=)RL2PW^?O>3*(77WY",0UO MT5/]YJF-)+)3P`J&\29^Z&KBW2V58/BDT"D(RLQ/*)ZA*+A,OJ'[J$!U)^5[ M:M#^(1TY`N@A9WCA30]N,$FYCY$N%FE20M!X]6*KJ*<;01`:A@!OK!RG&V?# M<\!'3N`Y9E^#;XH\UBP-GN?""28?IKFKF++(37Z?3S=S,9 M72+CJ&[GTES9LWS;,2U#P+9$CHN,,S&$(":#)W_0%/*K:][7%/1\NBSHL\/O M'SBH8$A=-<_6`Q0B:[1AN78R7=PZ_0@V$G5E/+ MTYU0"[1NE]L$G?M#\;;-J3O9?U_.LU35!RPB'8V<720W6VT?XG=$2=I%S3W[ MW(LT(^"OSW7P^Q<:R-A6_K0V6/"_R[Q,'_(5PI0^XE/W90AJT;,T9$.(1QM! M(HJ%P\%;VE3&\(ZWK,FC\I+^#+(H#8@9,IHPZ`Q6?]?-)BW$>+J*#$W5!Q@S M3'-8D"[,LO0A(MA_??X]IW<,7O,GG1+J/32%%+,+H4-N&-CZ:$-.Q9E]=Z82 MAZFLY",,VM>_\;WGPSM8+C&)[[A(%Q!8(H=_HFA1D8U_V(:=%D47^ MLJ"1Q[?IZTN(YZ1";>0"MS8\TW$T)Q1\(CGY-=G8IQ5D,/D,R!871V5'R+]C M6.]C3Q=4^?\K?U]#4I;JGN$@,+"(2VQR#D9[I)\@?&7FE[E-^-=IWX<< MM]^EE13`Y6\(5@?B/Z"XHR['!UB=`C20K[D^64)JENF*B%RV/]A"GA_"_0QU MNZFN6XULN]5)SP$IJB-@F>5\!&Z)`+@?:KTD2JX_4*JM1P9I2PMU7\".S_V` M9.J&;#\L*@_0W^!J>I:#30#IO0FZ&@IPQ*O*!R06)XS[G0+721VH4V3GWQR'NU)^D8W5,AA.(;6JXCP%\A*>"OY^@>/I@.BUE\@BD8 M!5.T@@"%HXTO$T6,@_G'">6^(LXJ>L0EXHQ9+@V&"ES5'&U"`$F,E`URCX/D M192@!'>;:#Q_[2M`8OI#5I%A MU!2-_5;(LQQ%0:HMXM1=U@+]4+OL/@=Y."CRA\BJH7Z5BV!5CGR!D)\_%1DB M]B!;B>SYD@!99H`E-0G&1+_Y95)`!GE=+BR!K7JF#:IBB\CM*X=\AU*F]1PN M$V(IHVZ:I"^'QJM>-5\)V%N'?/6.8X6&@'-/.30:C/UWWMSAA_A?@=I#81LG MJ_Y2(=@O&JYZP30K5E?Q3%]70S(7C'77((H=W."20XB5>LV3TE9)ST0&^1,* M\'?KDD*\!-F_*TQ24K]M=KQA$U51VK,TPU)<&.UQQU!7(GRPEG+3%<607\,# M)$N:K:Z&/ULE/0MK!OC::+V;G6VT?6&U,SY2Q@P:9L]N]*KBGJ6'*`1UM.\H M=;)457+&[@#)_M3I;?R<_7M_*5Y"I1@B3"_I00F.IN<$D)1@BS0O\UFOUS.U M\1-;13U#=7UKS!E[>`_T'!"29?-I6!+S)HWKSG6W2GHE@=&(LVYV,E"%M;N! M(\/8UY`#:8=&0YR1$2E.[^GFM7D_6%O/LQ"$5B#B@IFLC,PE_+`9VB131\DG^@H MXD%^]>R@V_%A7U$>X1;1JF5YSP@0.*H_P$@HILC(LA-<(E7?))41EJ;;YM7W M8>WW.%CZD"C53@@.;20_C%LM9'JF'1J^J8UVI!;-,K%8]G+#H51VXV$^>EOC M_4M&5RG*]UU_X/`\W5F*EU07NI`OY[;+)$RSE;G%M7J5)O-;R!9GX!=R6CFC MSUG&`H'\F1:@*O67\>2VNLJD0@S[+CW/-*PN^_7N'X2$]..].;VIQVK?B`SY M`I?CK.+J2CG*TM]X*RVV5;A/\@NG"?;KQ/T@/C`6/J2P8Y.F^7, MF*+D7=;7^N-^KNU0+#75]4=[=D`R8D%[0'QLQ91J/=BV?Z M)$KIU2#KES(.@=OD7M<"P<]U'-`%#)]RWK,9,%LYXSXPWEXF!4KF$U`TOP.SD?DXS=8)9! MPD.==#4T/%2D9V+#QCH2FVU;1#3.`)R>$D$?V-BX]2H"7P?26BB=0;"8K(MR M?)URZ-'=970XWL-C)?OK*IWDEKXTL$0$Q\CQ9(Z`F]TA'Q@]WWL>N'-TCW#Z M40=(R*T=.:[-H1.5'^Y"8W%XQ4R,:\F5<[#-Y#"EO>XR9J[/A68H[ZN9%'"YZ!L&IA$0^! M]I%V31J;=F?,GJPQM$5>J^P[W033189NV6BTW.V%-1W6>EQ,,##"KE-5\"'I M6EAY,A7:0MX@E45,::0XG(^'HSTP#KYBV'SUO(/4TL%EZX+SFHF\>3H.6G+` M?6#\+*]]LV5-Z2"U]'#9H3[:G*S2.-(AR+<[YO7Z$N: MTG<[\O+F^GHW6?9_CQ^RH_?I\);(#M8/5#\8[:/G`]G)]VR3WCA.L\BLW\)K M&SETD#R*#=8<4T`PI:2MU(#=I@+`[^ULL>'1BL@*._D]:*,%*OKZQPH MLW4*%+FM]7E:_$(,-17OM@<6-=S[)=6W-%/-$K9S2/QL\D@PN"@!2^:]E> M2\A8JQI7,$?Q^JMYMRB0TYJ4!>%VHS)@-6]@3AV4K[MSR+[-$-GWX+++/34K!6F;YG5)BOCY,L^79&1? MW>.A+*"#.,J"WMN?I7&$(]'&;]9#!@6="Q1E_T3Q$GX`RLF,M_%`J\PVI9#/ MK`L``00E#@``!#D!``#D75MSVSB6?M^J M_0_>S+/;N%^Z)CN%:Z^K/'$J3N_,/K%HB;:U+8E>DDKB^?4+4A)M)Y9,B1?) MZ9?$I@$0YSL?@7,.#H"__NW;;'KR)D_]:>+$YN.%K-D7IR8+(F+9'SR=5+SLZ]? MO_[R[3J;_I)FMV<(`'Q6U]I8HOSM=%WLM'QT"M$IAK]\R\?O3H)P\[QZ=X.7 MK(N7?QT7=86GA>G9\H]UT1^:_HJKLE!*>5;]M2Z:3UXJ&!J%9__\^\55!Y,(H4#^?SFS2;5>/^:\(TJ=M=3R_2^>WG))O9Y+IH.$QN MJ=)=OSZD10*!G>2C:AA>)./+^R2K0,A5GB?5$'TQB:_#Y%N$`?KRYN6R^NZ_ M@O[+^?E*7344<(AW'Q]2;C0>&)\?WS@,*L_T\B'.RL=?D@Z$;]3P,#+^%D_F ME_.K>-J%7!L;&T:63TF^F!:;:-0-;W=]QS%(WOG@UN)U1X''$%0XV*CU.;Z> M)JT$>]Y"Q[W6<3X)F'W,DCP8+XTLG=?J]=_#7=CR>O5N^XNNBG3T1WAK4IFL MP5[=M[8#D*]4[;:?]"JY+>W_3\E] MFI41B-7O^5//YO&CWD&,=BUW*R7[E$Q+=RTX_\7#YRP.W!SM*D_3-KKMN?#Q M)/OO>+I(_I[$^2);`K=#MQLUT&V?Y3*8M0@ZWXLY3>IO[G&A0:ST>(Z.:W! MV;._6UK:W.M`G,E\4GZ+%^'75?&R8QW&RI=O3[X5R7RUR'`F=3\[#_%._840(D50ZOQ>&(@$;B/+)$9:.3-!LGV?MW<%UU1>6=1N.;+)WUJYZT9ZB" M4.%!]0W^.IJFP4!^_Z[(%LGCP_"J0'HWK2;G\/DM+:77J/(4Q)LXOZZ07.2G MMW%\?U92Z"P)GN7Z246J4P!7ZW9_63V.+M(\?_9-ZHU8J8T4%&S9&%#@IFN):HQE)P$[UHR?3+EXUFU"-;^E3I5M9T@=Y/ M3)<#T>292&^.)0=BQ\(L:?6TIX0VI$(>3+ZY3;]C-V1/M\>E)M3?"O^T4RS>B"*/:UH^B/YVUMN& M$,&S!=.-T^6FHI'D85IAC)5R^C`?<*#=NIN.B4']LE)'&>Y'Y16@-_#TC/%K./\<,RI+](S"++JKC!1B-IMX8BC1DG@@+#@!>< M0TXP7,/!I/1'Q(F>@T.#`'AL?#J??_Z:_D\29]M"/SNW%3DN#;9.^3"T>DN( M1U:L02&*H2$MMC?%JKTQ/$)BA;8-L;3(;9^C^ MY,(_/;GV1?'XZ.731=89N^K&(F*IYX!1Z)RQTA*!>.UY`X!;D(O\[.3:%\0C MY-;D2WPH!;)=D1NN"6XJM>U$.HZKU#:MOSVL!/3$6^4&MT@-2P5U'S\J4PUG[IO9?+VMC'CQ?(1$;P*OF&K M@4..PR?+4HAA=43!HL[T])+>6P*S?P!XM:B79D^X7"_TC9\/5YLBP[NT$3D! MI`("(V:U%H:R8'[5RU->M0CN=Q[(Z5KC?8-UJ$P,-1IE830T<98]A$=5XOCK M8>7FC43(4PDDM!880S72TJHZC8$XW&*9H?/X3&^C1%]H/2'-7\^^`RI,:G]T ME,W;Z"B(9DF\W7"XWE%RL26Y=W/A"%B@('/$*T"@)$AQ*X.WR,/G2@5%L!$G M>Q9M4X+ORP4C@TSH/7,:04X,M,Y0N!:)"]0L-[G/9-XNU)%V",%Q)^G6HEV- MDGF<3=)7\G%?+!]1PA7"T!`J(!8F^"14K!%AD-FC2[UMJ]E-!&F!RF`3\[J/ MO\_S^V0TN9DDXU<3)#?6B8AEU&BO/`?6.(`54&@M),2.'&E"34>:^YX''6M,;4XG.LC],X[-`U: M@3&P;E>V?V,5?U<^&0TI0#640M$6L=G> M0C0=D:$/?(8;"4:C=!&Z^RD9):'KP>C]D!2OQV&V58NPL:F$,9(S&1ZL M1/$4M?C8.T]/Z5C#+6`8;JVV/+3SV12U;5GVA\*10B[,7`9Y)013WE/J9"V6 M4\VB5,,DB'2LW=9@#&S!58=YW:=Y//TM2Q?WY_/1=%$FFK]X4%:#47WO1B/# M=?!5/)#":^HLQY21-4P0L!8)W)VG?O1B"PX`VF&\@Z9>082QA#H`A[WSW@"C MH*H_%!T,X2/*V^C3&]@1A^&VNF9IH%_Q\'$:+P_A#:;J?>GS;I_VMU6+#!76 M(^@1`$QZ"A$2:BVJT+Y%F+?S?(R.5=XA+($.,.YK@;UH$=^31\Z#;I$9C`J_I>GXZ^1QM>P%G:^+1-H:;C!3&!`&K`HP M85V+P'R+332/6QJ/5+M[8C"@Z[;"-;F8?$G&Y_,BGM].`@F7\KMO*R.D@;IW M;2IR(+`Y6"L40"8(,I:*&A(+:9L=>\<>_>L9J\'HXS?+L-THV%XQ`AACZ\N= M8@X1PS'WZO%K$6W\1WCLLB`$,$F^`7*VF0,[`61C'=1LW'&N?K#YYC#APTLQ';M!M1 MZ9%PQ&+BN).`:4'72R>,6M]BYP@\]HCBD,`-S+)7Z1*A,`%2Z(U'FCJD$1&T MCHEK)7D+O1][K'$O!(;+UGV\YR2,;=6)Z\]O'&JPBZ-A$Z5U30&V@F!N+`P> M,D5@#0'BI$4*86_F0H<9`SW!=`BF-$\HV%PI`HXY3SU#*GP]1DLL'I?)$`2# MY@XVS=ON7(6;.=(.K@&S_1]OTVJ2UO]#Z;Y^_C%^*&-B3RXT*!D\C?.\2H![G1@[M!*5Q]P(387'GDJ- MH:8!Y!40#N`6B]+];?CHFS#]X3=XV'HE1?/EA%IX=GV MEA`QI!D[`*8'](!V\GPBS[$62FO'H%,24BXHKR=>"?#^5.DM<^(`'L^.,!W$ MTVD4*7VY0B0@D@!Y2+$V%')/K5LCQ2UKT,U7(K-'0/80TU.S\>E%X0BU1I;Q:0LPDMZYQ_`F-T*WV=;56QK( MD+/4WE`=@@?-M!\Q894WD@A%G-=&*`YJ>PLHW$;G/T4L=D>`AMN]N\]RS1:H M/'3$H_(*$"T(1\`B54>&#&H3.NDOH:-W'G2&UX`IP,E-$H:H)1JO;?M[H73$ M/>?".^XX9`IJ()!C:\$H5L>X-M.%FGY(_FV+S'![/]/9+)TWTO?W12,JF'78 M6*F9,DIP$4R:M4C2RQ;*[G%9MG-EMX1E,$W_(\[*X\#*P>[3Y/:NR"\715[$ M\S*HLD7KVZI%9F!`1U"-%RH?#RN((^G M'^/)^'QNXOM)$6]+`-Y0([)*&>N#H2.9A!)S"$P===$.M+`!>ULVZ8$#W:`S MF/H_E;<=!Y_5Q=F\O'=&C4:+V:):_BN]V=%DFR'X>N7(BD#U,.H99(QSSCIJ M2#W;27U,1XCW2(K.@1IR)6W=TRK@46:Q9LE=&07YDIS/1^DL*<\._)`4ES>? MXV_;U]=V:2E2#@:WV`=_"4!C@/?E%8`K0""1QW1$>)_#2:^H'=#/W,F_C!3@ M,(R7C$@K`%1`.;G^.H3FHH5?V=O"1P]D:`W,T22%MD@&C8`E,EC3DG$CC+`4 M!)MJ+;(EI,64TM]N@B%C35V@]H0H!SBV]6-<1D?ODF(R>K1$W]X9KHHJ(:'& M2$"*+#5.EHD1UC"/I2.ZF5OL@-8U9+#K%:BV2I:Y.%O_.G MM^L9KHW5\$LL4[/ZU3,"FN=H!AXAR�N"UD(H3^R;/<&VLN<8'=^X'TT_*B0-Q M8:\S7(>GPE&L^`0#[#*K$!E7H>R/279U%XRRQHM`FQJ(?)!4,@*UHM`(0HPA M9BT^U?*8KG3NP93H!:0#<:3J:JX6Q5V:3?X5+/*FW/B^8@29]\0ZB8G7RFM# M%7)K<8UNQKRD/8 M(K.UQP6D7CFP%S"'6"[>8[)H4#O2$B!CK2)(6R4T=-+5$V5Y4-91+B=UQHCN M$3H$-7:8([;4BB@5W`/LF,0X#(6JO%[\\1M0+?;K];B(U`<56B)S.`J\.C5L MJ!$YK!S7@`#HE+`^&,X$U*`QU>(&OQY7@?I3_5ZH'$[MS3)+ME6+O-9AYM,: M$FFIA(`!H6M1C3_.E9_^"+`_-(.']&L8+F\V+5V^W=@^(,X(2P3`/+CM5ODP M`#MJ!?1`![>^V;AT7+%]Y5V8,2BS6D%*J)&(BD>1V*"7=.Q\/UM3=6R/[>\& MP9\AML^U]8`A5=XI#H4*P`0D5H@P(@9=\&D3VV^LV4:Q_=U0>:-Q7$:4U\10 MHR0C8:8A4I`:,D_0FXSM-]9E)YQI*I'#UOBU,!32-Q*IW]1Z/BN7>U>JW:75B@AK_[R(O2M!TQ-1@4: M:ZZQ*[@?3#\I)]Y25&!X*APN*E!:7!^S],LDF%?ZX?>\O(ID=93>_%8%)^/+ M"[-Y8))P#FB''D"TO.&860;B&Q5/<9AO/@#;[OB9&[X`=>W1)8TN, M-X@[8`71%I!'87";E([>M-^GRK9'GW;":L"3`]81A_QS^BD)9NUH4MUJ]]CU MSVEW0TP?KXL,(0QA!Z7%2H#P'0,FUM"&/[0(+ALO&*[K*!X$N$6(NK\;`8^*0QVB.^R),I?W95?+ M@Y;=M_MDGF]?UWBI0J20-,!54=%GDY@'=+*SY(X M3VRR_/]\_GB@]_.SO"^OIY/;I2&XW:+?O;W(0$24]IJK_V?O2IO,83]MA3^S$?$*H5:RR(M225ZIRM_?7+R@5J3ITL(1#E.WHZ?'1)(IX M^0!D)O*`EAF%,`5V"PY2ALLQ)C6,BG,U4+^0X;FMUO//YO[+,H+WK7G$?+!1 M>>#]0`'$3`O`)4%:(2!I%\&$5!O#=#[EBJ51C(URV5&^X*[70_18GG*`_VWX M($$QC"W4#@ML&=*$*`\[&+1T"?M;L08E8R-;&:@OR+BN@5S$MIE].Q&#,N3U MT"H7<2.WK*VDJ[@B41WMIZY1U7R5@2PK(=B3W$F&[H*L:3?7113;\4X41]\+ M0D=%E&EBD+<<&JF$[R<+D4VH2US,3741GIR/V24/LC9T=K<'GW(D#!L@8&25 M,\8XHRQ$2A)#23=](6""1Z&85^HBE,D`W@B.I,>>IJWG]557R[,.J6,#!J,4 ME,`K:XR(_X,B_JF#AWD]QNZR%SVV,H(YPM@:L[UWBG^WNWC*$F>S;^!@+`6: M6R=8VZ55,(&9Z>!"DB;L:\4ZNHU*,:\*?[U\C&%3VG]+>H2L2>,&0+5N&PAS MBIEJ*V4C@SNP')`I$4+%VLB-BJPUX1_ASIIE%PU:"XX)>S6@0,':1GS M5"(KA`=("@.>^*NY3K`%BOGC*M*M*K@7M4KW3"F+53IXW$"]81PA:P322KFH MIT:%]1$L!7A"O&(Q[UU%)M;$=H2;8I8-,,(@L&8\ZA/84X@<@:R'`1B=4`Z] M6$3:*#>[-P)Y:3[YV6(2#?4\]N21P4+4.K!DV""+4#3*M`"=)1855I=2Y[%F ML93,]F0^P.II^*OEM&EN-@%)GYI-B\B/D]7]=]O\?HPQQUX+5'EJH"-*"V(` MMPXHT4V5*YZ@U]>V#[,(]%69_FS056/)I^;KHS7RX?;](3JO_5MOI*L",3;",\A_(8>P,'#@(+P@"GC!)* M$+?(N!XNAM`86X%49%E5<"]J[.V94A9C;_"X@5+'!786"D405!C$%=S+",J$ M3F:UC;T23*R)[0@WQ2P;8)!4`&",L#"N1J!@U!3Z.R_@1$+IG-K&WF4WNS<" M68U/[O:VF=Y_N'5_3;],%G?-IZ@T?EBTDU*+F_:7-I7@VV1^(LGC+<,$IXD1 MU,?I8Z&-9T*:WN[E`B5L6\72BRIRJB"458_+UU_[L5G-VGR4YY%T)T['H<,$ M#8B7`%-GE;(:".*<[/&.B^U\5A7+(*I\&!:"\L*L4A'#U>I[A&O3?>S-='KQ M?J!&:!Y/?\2A-5!CYV$?!.>L3RA=4BPYZ.(\2L.P7D[VP]>OVZJFDWE7S??= MXG:Y^F-;HOJT.W/@",%YZQTF4D.`+)<>HAT`W+$$&[%F<\"SZ],60:EB)/XV MJN+C9':L)=S3QP(5"DO`))2>1$6/*L7LCO%DE-4"$]KF+]?3G:U9*ZO"C@6P#D+6#1CD;!`8^Z$UY@!+YWS M>IB;M/#4WE@%W!KM2#2LM&24>Z$<]G`[)>&(&5C8_$)5P`>+XW@5\+=!,+F. M*N#;]=.VUB$D-*A:!CBE*OA@21\B M3`9TZCDHGG_KR2K0>Y\/1A&!O??12K;:<1'54M*ML=;.N9:JX&F2>^EIR`C5 M#\:'"_%@:$7P$=#@4CZ`7"J&_]S'.3\TL^"2[TM8#I]^.-A$Z%VJ+G@Z>U@Z!A!*4<\E:9U/ZFH)"DI M80>"EB!!VRMVB9UY:R@$53W/?:NQ///)'?4"O'RX#7YD3GE!+<%FZ\7NEX%1 M(.%RL&8SE_,]18F`U)-SZWM=?WBX7]]/%C=Q'SLFYI?/!DB`4P018*07A`/F M(.LF!;Q+4`%J9B*?+>5$/&K&,)W1D8_3];-YG(XKI0-\S\U4<%:S^Z; MS\WJVVS:;$.LVBHW=UN)GHI2*OVC@]&*$46]:55[(1@1NIML5ZDF81VH8P[J9_M?=\MM_WS2S[?**OWFYJN)? MA5<_^/V1X(7C+P3).&$(>*6QLDYQ:3QCU!KFH9)B8$.5;).:->M#T0JOG@G, M&(DXL?%KD82<<-Y]M,)0CS1L(`G_EPLW#8LK$>2X[OLO(K^*QST1]\-EBEA!%8*XP5@Y'J&/1X6)M20BN[[[:89-,P*23:K:_GWL]: MP^(_S63E%C;,R\:/NEJOCB_?9DX%;A062VK5]6B2PG(I^!W*,)VS*V=VEQ99N"B*%A-I9 M_?^*/^2`-)\^$I@"QIGXK1Q[RBCUM"W#L/UH;W1""$5VSV4!,29`45A^6S_3 M\5UW[[,!B_CYWD*(E22"Z3@7T$T#49'@;,CNZ2LHT11,"HMV=QSX^#>'/`H' MG@X>*(D`UT@X"J'B&#/1305#DG!-E3WCN:!XTU"I(N`M`X>+^,GS(7XXP,10 MJ"FEQE*#D.YUP'B6G"_D[.G(Q85\/BZ%Q*SBM]ULOF\^V1>J\NJ9@!CS7`(" M!'#6<-HUBE./NSMX@I9]3F0Z@H!?[=S.?_6"S_7'QN)NOEHKEYMUX_[`U`/?E. M8-19B[TA``#GG23&]TJ&]C;%374]?JH\X!25^?\LYP^+^\EJ:[X=OXE\\6R0 MF#I/D+"."PJLB?_*GKHHI8H1O!Z/51HH9;?TKO:W!=9<2FJ,`_/OP^GTW]?#G95\%E[W,! M(RP-8Q!$:]^Z:#88X?N]"**$6!AX/;ZK\P&I$KWRM%:M;;-)@#JR*S[.[Q>QV-ITL[C1Y?D@#]`9DSKC"@ZR5,+J+HV7*ZO&G^_GW: MS`_7!SCT:-"<`.N`5(!`!>,?."/=9R*@QM0MI+`\E2K!H_YV-\Q(M(9TF$82MBF-E<1HX5$T98G2<;K]1TNK^4A/ M^B3\#\5OGH?%E0AR7`?O1>27Z\RTJ^;/XT?E[HF`O5><00^=!]P38KUAW4:8>X(2\^7ORWE[V[7^K#Z?4&)>/QJ,8LQQQSF%DL<_:"OZ M,UZB%*NXX#5#BHC204A('MZI6%'?VO1"-LOU???[QW;)AQ.&A[T>`!$:<@X5 MDU@(@(2BJ)N.@W9,=>AR.\H*XI15[$]2V]M/.^CC&O!JP(8J:#&P3!,J`7%1 MH>NFP6E*]9GL2[B6N!,Q*K["-_T4]M=_/V>8P*AN8]*3WV?S34KDN\6TO0I-9<:>$8,@7EMN.?(08Q>_$^!^ MNT.:)&2I9;^,O"1)TJ%[HU5T_JW;^V7,\*U,!!% MVNM^*E+9A'"#[''XI6[1$O"H)MIVNN\6Z_O5DR#SV?3CML7J$5D??2\H*X'5 MVE""N75.0L9%[^I1/,%#G3UDOY3PV M@>&#!$NH`H3S.&]M*2)$0-R[([1(T">RQ_[7X4E&M!)\+WL_:4OA@]Z8(^\$ M1UN+A[!M8B^*"-'^PQ7W"=M!]NC_(AI!1G!R2;6=UC!9MD\&C(A#R@@#,&3Q M@X$RNX_T($&"V0/^*TCP#$ARR>VWAW;6'V[U9#Y?+A>/Y\G:+6X^W`Z7Z:E1 M@H$:QBU&"^VT!QI0)7H[EAB5L#'GC_FO(/#,>%4)./QM>=]`L+\O]*,ELGAJ MA'RXW?_L,T=F0N1BKJYV;1''OI):%,AD,6T^?VF:MB[8KA):.Y?Y@+9[M M((BGA17#MMYK%<:I6,Y*7Q"BH@XI44)$U!E2E%+(MT*@6+JZ+5>.=F8;)3-? MM50RU([T92NS@<$!JBT&/E(+&(1@S(=N:(07(/+(]:H?"4*VV@YSU`D(V^A]_8:/32FU)5 M*K_H^PJH<85`_>2L'4GL#R2*&\H%XM$JELI38EGWF=C3,;:M*2Z14Z%";\.L MVD;TZ#AX;*I^9']Y_F`P0#H%%<8"4.T%,LZ)SE1@#(XI0N^:+*DDE"]S>AW' MI(V<:/O4QU_:%D_?)O/6SS;T'#MG[(#BDFH[A!%`B:00<<%U!QKQM.Z)-HR: MYXK]V+%3`;LQ$DY-I\N'.)766[IQB+9W]I^::1/G&,VMWYJCE^`Y?TX@!DGI MH_Z@'-?<>,N,Z\#$2";LD<7Z?M4G8G8$VB=H)X#XT'.$$3*]9]K#[%SH5KC$S:=L':%CW9(IF'4J_'#4`[2UU47BPP M5$5=AE/2@64\2^@04:S=6'UN)>,V1I)]7"WC;^^_?YQ/MMUYHH;P];%K6AZZ M'?L)@9%H&4FDG1**:@>153OE69J$`J+%>I75)UY&!,=(P7>+^\GB;A8U@"VT MV9BW9^`@HG'?5@*#@ABAF4%:VEYG4C&E@CBH:\\`EZ%F"5G62;>)JALSKI27O3:`$IP"BG MG#FB"%.60][V*P!#M<]3P>))?>L30X&'$G4 MGNFHFYB#-*%^63&/PC5X7=.A'N/1UGE63N?YG#]HH)S[^(_"T7KF1$I%7`\3 MH"F)(<6GB6]Y:-8R_&#<`8PH7E0K5]NKFT4LK>IH8T MH5!'L8WO MB'-Y$+R$'I9+IS]WR*`!=5$H!DE`XR].*]ZK+%CP,>56ER!9)=P2$O$WYL>Y MG[G?:Y5GX""9)U7NM`8TH6D59PIZI&S"&+&03Q.>TX)7#6N=)3I M0H-)?9ETH;?)[R?,M_!6`@8$%UPZXC2`D/8`<0S]KW2A-]$H4^+%>5+Y1=]7 M0/W4Z4)C8^T8V'HUT=K&*4$QY!X00)0&6.@>3`IM@COEA\AH.5?9OZ20QLCX M8J'@FF/BA3/2<`09(D`HT2N&$;(17I']8/P]5Q9CI&G%.'-N@=:$"2L9TIPR M3GDG&2&'.KA^7#]V!>(F"V7,D7B/\\H;D/WBY=#!M5U9J.&.2VD)YM1+UT&&%4X(Y"F6WO&#,3J' M7,9(Y;\MES=_SG;W<6GL[48+@&#CVOA0B0!VEI-H0'3`M+F%(\P;^<$(>Z8H MQLC1JIETQ!NOA(I888LDD]Y1T\&%($G(1R^6I_*#,3==*F,VYG9G2%Y[;C=N M<$PI%%4IRMM^+4)QWCO5!<9P3)71KXG"-84R9@9G3@PD2E*HD<$*>86LULCZ M#A@+>$H'T^QUW7]PNKY1%F/4%:JDC#E&I74`&FV)H!I2Y&D'D]&RFAMY#R_]F[UN:V<27[C^[%^_$1C\:M6Y4[3B79 MVMI/+(U-.ZJQI8P>V61__8*222>V)9$B"5*/JJDIQQ8IX)P#H+O1:-`VFKS( M':1!:!G\J.5O5>'_F"R*7W_/KR2Y%)6GT>Z\7 ML*4XQX25D<03YYGC`NDXABF4)!CODMXA,9H3E;65.=")RF:DI3A1N#*_XJ^Y`_3!XA=FOU<\=!QW<^E1&FM5(<+/?8,XR]QW%A M*^X>C9,\M!1[I,;Y6^,\[Q>)$B!S7@;9!^.O*PVMYZQ23QA@4BD"O"!2<`JNV MS706I&ZSU=FU$W8\Q(>ND6H&0K((TJ64)T`F>I<$&$)"4L?!>^G*]4X&UN). MA.9;/V=A$(R:OPL\WVU9D(X&BE@P)GH<`2PN`6+A6IZ@H8PZ.NA]'"M7^;X! M:ES6W(6K=B1VI>`Z6$.]88*`D-P'*ZLEBZ(QV97)&#EDAC;#K`6UD]E?B_6W MU>W/CXOY;9YOFO'/U[W$ M]!H,-AI25AC*&<-1)W']8H''U=$@$4C-BPE.E8RQ["5:+H$:3(FA<4G0D@<4 M2A*THDE+-XUF+[&V,@?:2VQ&VK4ZZQC"GX1K+[2TQ@K`8#5E"I><.262ED$> M9?BSMJB'"7\VX^\"XT>!*H*8(<("15IQ0KPM`8I@V6OXLY&,NJIS>10K5_F^ M`>JBPY]C4VU7,3*XO=L?]*P^D#$OD''8&! M`5+)IIK/TX?9]'YZ6Q2&NOU[/5U.M_J>W94X;<(!13!C&Q*X691_^+C(5Y,? M>R:=UN_..%7"6$D=]H9:;@E06H)69"N,4%ZGX)&E)N8<(J?:,J]!,8>(T][A M^',U^A%M<5_R641.CU5BM[`/'CG]E"^CU;CKOJOK=5=#2),S28-&4AC-B0W* M,0_>194Z@JU].2%_#:CV&,;@D@K"O?*$L*+B67$U<4F"9.8R#V?45N9``=5F MI%T#JF,(J'JLJ-7.&1'="DEUL$*4G&%H4YKT3`*JM44]3$"U&7\7&)%B@#17 MU!B#"9*2662K21.L-M>`:B,9=12:.HZ5JWS?`'71`=6QJ7:`@"IE1%JO@Y(: M66N1"\$537(!!XMY6GWT&U"MC?[[`=5F2"6;:C[EW_/8Y7VF8/F1K,AM=47% M7&,LDJ/U5,D82R!),260LU(E1:YT@U:5HCKH&D1C+JR"4_CI6K?-\`==&!I+&IMJM`4LN#R1H( MC58B%=(+`=%2I,&5S:14MKDH86S!I=J,'#J8W`RS82:B_;`\AT/JSD&U7I:A MHAB^EI1+8KFPR'NL2UBD4)=^N?VQ'EGO3(Q1H&Z^+*)>Q15YR\]Q`':CU-=O MS3`#0$(5&6J4BT"$PZ@$RA+4HO;B6:3P)9!L2TJ.7S<;M/%S_AC?]_"O?!9_ M\;A!^2DROEQMJRO#CV_1U'EO,NWGBS*J+0Z2$JV5]-P$HDDUO./X;J':L[BF MHZEJ1\%2$B%_RI=Y_**O159W7"H>YYL;G[O3[][W9X'&54DZB8Q&`LG@G5,E M((R%%O;!6=P$TK=LNR1GC"9#5=IEMYX[>&M&XJ`&3S$5T8M@)(*FJA@?<-WB M_,E97!V2P&1H2"S MN&@DI8*/9B6EB-^VOSP)%B)19;=WI"C8_'Z^R+?]_++W:&#'WY1QB66TM+#@ MEE@LE95016D(Z!8UU<[B@OL6,A^0IF%U_S)(!]"Q49A M+CWS7G/CB:(`4@=+`K52"%VS],.IDC&6O%]JG<:<;\#`52"L*#Q)!+'>L4I3VJFD.4*CS/NM+>IA M\GZ;\7>!B9-!"VN8EU1+CN.TR1VA)4!,8W+-^VTDHZYJ&Q[%RE6^;X"ZZ+S? ML:FVJ[2/!@?(K33!""RB16A$A*+P>LLFQ57KG"X?JHW^^P?(FR$UQIWD7C)[ MB=+1P'&410>"(L28%;R$17&>MN3O^&):Q_IHHG$5F;P+)MJ3D(C-[!8!&R$6@O-#>VD@1*B'"B+>X6O(L,GN; MJG84+%U"9B]!-FA&E'UCFN2K-8G(5JXT6>1V9O`9&A)R:BUFR*SE_C`<'!.(PE"&PHT5!01 M*]'Q"CZ+S-Z4"CZ:E6MF[\&4.LF)=X$2Q8.T&'ND=;6B$>Q;;/R>169O"YD/ M2-,UL_<-@(X;`AB38#WAR(-FM%K](K$MSGF>169OISKOG9[!$\DV6]77++&$ M`K6>2HVI4P"6(@,&9'5W.`AUO;B^(NZG6N1`-A;,DQ2&H]%*MDJ\OGV:WZW?LPWD=?ZN!PQ>7Z)?I*- MG?AKSPHT0&LRSUP<4(AH#%@(:4(@MB3&2GGI]^('!LM'29W_[C8?[]GW?Y=#O8XP^OQWC\5;8]FOSOV?U\\31Y[L#. M4.;^!S*I&!%6!4KB`D0#96`X0A01PZ54-?WPSCHUS7=&`M]\)@N!(X.%D\A9 MQ+R+379ETQ6HI(/\W5A=5]#/NT$@1>"K+ML?\H?)XQ:;'?&H=SZ5"4<)\BY. M!Q);"`BX,;&_F%.E&9"D1Q-J!8U:4#;O"H:&9D>S26BG__GZ(YEB5`6,""X* MW"AK+,)EHZ,!)=E(XR&M\'\]<-MA<2)$CBLR,`A_`]G]=KV,B\MRZ:/1LIA^ MVZ`[NWO'4*ECMC=_608^8B"9!,RC$SNWNCM>FI.!-JA] M.WCIF,];@Z2JT5/3!&[R>$:]H8IQ[HV(%%"AN%4(&60D","R7N"S;[]^3T_L MS^<_'MI2/^)MF?-.$N="4$`]+@J/.KX%QPL4T/`F=S]4[W2#^T*N+U.]@S-0 MD\=\^7$QO_ M5L!?L!+'Y6>=OP"[$MX[+7"3Y5>SOTU7[^G,(:P%U=&/<(12H@7V MMNQ,"%@?+YXC]O#&+9Y>$$U<[_;\\P6#EB(2"]A+2YR5#/$7^)EI452DN:!' M9P6.FHL+3)XRUFEPU")O`Z:>*RE%"1#C.(S4B!RKC#K*HCJ.E:M\WP`U+LOS MPE4[0((8#[[8,%'.%V5'$S8DW:>U!/71^ML$V74E;!]KS#\6RO'+(. M]SZ7,4&TEPXYAIU3AF,2<-E9%'2+4L'-"QB-UJCK$L)T>MFV\>`2]=OGBMMO M*.4@<&QY*"ZD9AZ5G<&:PLU_!Q"=.._C-#C&0'=7J_]_(G1/ZZ=/ M^=_KZ6+3J3!??%[-;_\J4M;SQ1+B']Z]%*?)XQEB1@4D@G5$*2P8\KB8`[$D MU#),TQ)=+R^WEYW$'D%+'!$/TQ_Y714XZS0@_ONK,\+!82T54@`:E!71$BXQ M5I2F#6D.K9WT@"9;0OY8%Z#>W%?%D+J-I_SU9Y M=+Q66TGG[]7[;?Z23("02O$0@5'1O>*&JR+K\6/;BY/R"*@\]F@04! M5CJL"$3[VSDDBW@.9IHH+D2+&$5O51)[54?7B*6+K^?1-EK.'Z=W5:FZFT71 M$?,T7[]KNM9\,@-@5AF#E26,.!`A(%UT6".+O(8QWAW>JT2ZQ2M9RC/9^%YV MLMP:R?EL.8ZL9WCZ]CC_F>>?\\7W:1&QGBSR-ZTTCQM=Q9]N[C]%_!]FT__+ M[S[FB^G\;E-;_T.-!.F.OZDX[(2)=Y9C8,P3XK0DD6A"L!6:0SV[J_=&E68\9-R60X&W2 M@V][\ZX'4]#N%.VDT(^[N-BV6[&A!W9M?OM<)@)5X#@@S2T#$IS=1#(W"#`" M)Y&`G4H$\^Z`3!>S/QJZQ^2!C(27M M6OSGZQYN?KLTZ]77^:)H_7_-(OV_#.=B[E["CVC63Y?Y9I_R4S'W/_^F,+^? MA_U_Y].'KP52W_/%Y"'_E!=JF,X>7'2I%I/;U7KR6(2JR:'E>_@69HQ[H2VU M'GE:)'46%>0B@9PXICEB+8+*O>UECV54G2:%R<;@,P/YW?L$';X3K=X+,D2" MH5;Y8`U#`C//X<7$XK3%IEEO^^IC47`O"">+DE.8+(H!$2'9M'_`N/BV(Z]#V9Q40U>*,H<9(T)+SZVSENH2&$9KAO.31*$[(GAG4+D?Q,8=/*[2 M73?]N[G?K*YUT_]?/Y-9S;",=BP+X`@V2@2#2F0PB*3UQ8\,*G%]?0;KL%1)"1!W$[X&O>$T9G(X%Q MAD)'P?Q0X:Y7LV"=VH([G\F\H\BAX`SA`9#P3%)1=I)*E9;_FFY%/\9&5Q@- MYA@,GS?3DW^@`"DEE>%%MI(-L*GFB[B53/H`O%XIBG/T#YQ#8)S%EMA"GD%" MX;%N@4&,)HT5M_$/:A/E]$L.EG_H#9?AZW$XS`Z&PF< MFG^0D/F!&/^XF-]/5T7V]QZF7SZ4:1J1L`$;`HQC\-9A57;#H\3%9SKQ`(XU M)XX&)7'QN;W7H"__R%77P8%N$?8\T.ON.S'+. ME8J.$G&NV+@30KH21./;Q!;ZVW3M1UE#89KN#'&^>NGC'G']]KG,(DN]!HZ# MB!,R=LR\=(9[TV+JZ6]/LQ^!M,$E&9"'_-,2QS1?9E MW1U\-D-8.?!>^*"=8*2X<,]O.LV9`LG&>+2X/V.F4ZR.KS^PU>>G?)DOON=W M8;X(Z]5ZD<./VZ]%2M`[?-=Y+./.$DTH!ZI5=-\5"4B@^)^DQ<7MLD42=V_G MA#NFN@>8AEY+_/1Q72;J_#JE-5]-=KTIL]109!C"QBD=G.18\,H#I*Q%4D5O MAX?3KB<=(3>04^2VEG5L[XMI'7';0/9;_M1!U^?@FS+A''*6DV"=QE)BHZDI M`<%4M(B9JA.34K_(C=*_/DY4#=Z9>>D5QIXP3[@4-OH!&+^`%%H8,_JDY=4? MAH-MXA]RF=[]?$8#LBAXZ:BW2FH3HL%?=DY$W[%%Z`Z=F$*Z`&A<*]:ORW#; M->O7=V6XN-2[B'9[Y"6U5@A;.89Q4+0XU89/+>+;-WAC7;B.TE:CMV9>>4Z1 M5E(HH7$`0=3+T+.JS6U*YQS];0?C8.O7T*BM;5KNORZKL953XX.EI*2ZS5<0AXQ$4 M!;P\!B>TT=X))J4BE*EZ=8/Z3E4;ZC);0:3TX+""."R0!T:XV8(CJ?E>K_9HK8< M&MULT0S"=(?(;C_RA6MNP,CFOFJ:2NM6-J_U4'1T%TXKR/ M/%]M0+J[VNZ#K;GHXB>GM\7M3I.'V7RYFOY_>]?:X[2N1?^2WX^/?G*00(,` MW:]6:3,SU>TT*&TYS/GUUVXG88"V:9LX33D7"<24V-AKK^YL;^_']'`)GI/& M!1$-7D@ITUM/2-'?/LX%K M:!!SB!I+'9$:`0";AI)\++X5RTWQIBQGR=]T[)VZ MY_%`>41"N=0=QU!@&920-Z2%;M`,\CZK;E]\D.L.TE7D?[KHTX:0H41$.X,J M@Z'R)E6:KS=D!>U0C/:Z78#ZD/KY^`RHRE?KN_LM+3^5BV..V5^>#`HS`1FD M*@7`1W@$H:S1A-B-,2@WJ\"[X3/@<6D1YWQX4RR+:K+8-EA]BB)8K9/[]5O1 M7H?JM`F"8Y)0ZX#&-)HL@&!6^QX$DDQVT`?7;>USL3[(`=M@K$EQ@_$_>XSK MME&G+'_/%XNW3U\G\RHMN"6W8_^`0`!B0DCH0:H%'"TCZTF]O=36:(1QNEG)T`M, M@]H1J\C;%[(>D_^OCP8I++28>,P%D$I@A("KM^14%TOBNFUZNE@2'0`:3.9- MJ\*34KKV/!TP)0AJ*+SU*N4LZ6@JO;*1QA@8FU7RW3$:3NU'L-+Z[I:[EJ?S M76E.M5H51SN"'AV7TJZM)(9C3)3&A,6?;`,;NNPMS4:/FE\$%XC"8V@2A&LI8=$-]!ZZ3L< M./*%M&;E3`[8!N1,O<3=-NH>N4=ILG](D$QQRB&UVE/C@$/(B<;$PK:+T_HV M_9<](34@&7;K:_=)_/)DX$HK(>.ABGL#+/%,DN:2S8M.]Q6WZP]@Q1[$@_7W#?O12MTEQR9VW18]@75B+)E=!'Q*7;/ M?9Y\+U;N^[J:1#'-EY/J>0M7W'6*>HQ26&SW?<(;)=O_&I")KUNA(?11>/'@ M_].YWW2JVWB;#M+Q@#TPJ^-67KY]NEA&@;8S\K<101LHC5318#->(>:EL,V% M%.>XBX:[30]K/T`-QH1S"[9%6"S!QF%*$56""BMP3Z'.M^E7O1B;P5)EV,O9 M_<.D6C]_KB;+U60ZCJ28`PM[=T)"3-O08#CC`!`5%:Y7,!6,<"G)/TI6Q`.G M/TTQY4Z&.209_?S3OYR<#G/&?(%!2Y!3'GCI,&%>`VMJ@%`\C@T9474T(:8_ M41],ALF'V\C387Z4+][KI?G]TZ)(G5?;LF4Z3!LPHX(R+#F6S"F+#/6VQE=S M?`L-R+/0Z7#Y\=P8#Y?8>V#-K6D8QP<&C1#D1&!JC&9`0FRW=3BVVTV)]&// MQQE$U+_F`^>`](]GTI48U);AVC785(D8`BU@* MF),&3WF]MM@HIT\2`)?,($<8!C[^PE22!@8M MR:!1Z".V2+(A>A5BM;XI?G\X2&PY-!1*BK2EUD*C2;TM@\S8[8P<`CS"D4Z@ M_3&<&*?%,$XJC,B8;$U2/#PH4(P$BI!YCR#$0BM&7(.8U6.T,[H(ZP2[\")@ MA@M#?IP7]^Y[,=VDI(J[^_OYM*C:LU0/CPK6R[A%JAC@PHI4_!HVWQDF98-GB0GID0'_(7%$%I'.3>GBHBH<(2PJN/DL7_#8Z.(T$)<1)SPGW$08L9+UQ M3.BPM2/.IT2OCMG^\;HR4>[^7A;5ZG'^]4,TWN//D[V5Y\^>(S#)&;',*PT] M1SRB`9MOH(>L0YW#0?3(`*3ICMJ?%JV:J@("(`'60*:52(AVFY<2T2XQB=GB MTK)1)@=B5]8TGS9/3Y-J_D\Q\_/E9#F=3Q:OKKM;$RDNGS3`I'B=QY991J`3 MF@%5PT29Z1`9D"W4;6!=E`'&4;/MW7SR9;Z(TCR:N==QYN"I(#8:`\)&9:Y2 M>2HL:L"P]=.IM_AR[)!W;%C0R44&J<`\_E:61JA=O57E M:8<^@+K\65--IN8G6W<=B6LR_I7N/3\5T4T5T_]E2],=Q(5V> MU,\IL& M]LT2:/I"1%BM89X(JI#7C1HDK%-KKMOS"^<#;K`,#N$G\^H_D\6F>%],5IMJ MU]_DZND;=;UP-8WGN=7\)W$=8?*Q88$+EBI',P*%%])+"%S\#G.+.(.L;&:5,%A2"@%$AG&8=4:Q?1J&$Q#(^G>TD_PCT8ZYX% MKG'G:.S9L5\81QCW_(O.C9X!SGE`'I%I;744F-]O6G`J!]Y-&-G69[`C3X`^Y>P99QQ MCN,C25\N"CTOI^6L^.MY6BP6QS,@]CP:1.KP1Z1!!".AH1)Q@?4R&;%=JD3D M.D'TB'W9*SI=O-3-5NKZ?*]=H1\VU?1QLBH^5/-IL;MH*6:I7==B<5C:7>8, M.+Y8D5%24N41ASHHM2/C^E6Y6ZS6D^6L_GRX1>' MVMOE=+&9[6V=>OXDP1DCO6!(>.60(,J#J#.!TE)(@;D=8S1:_^3("=F`+JNO MD^>7)JKORN7#YZ)Z:KG^/#0D<(41$"Z2VSLBN2&8F[1%9057:)0M';(<8GL" M:#`.I,J?JQ0;5ZSNENY[*IP2P7CMY"A=6Q@"@A/&,/,*@T)\DJQM&FK M(Y(1D!%&BV5A1=](#>:3E/L*95W=)?FY*C=?%L4L(?SD[Q55XT7T`28D'BEYA8#*`P\;NUH,]O*.G6?7*7%;Z(!I9]WE1]\0#D@HI[&2&I!JO^S4C/?<&Y(],$H-97&=MY*1J)A?. M&+"WUE+%+`0J&J;:&&`:^4&,1N[Z'1N-RFM*Y?_T_0VHFTN MP0]S$LF(XN6D^(GSQRF_;8S[XG#_7LQ,^?2U7.YO"-37U$$1!X6"CFNJG/.2 M4X)KC)D$8W1W#TBFX1$>S-#Y-']8SN_GT\ER_3H.)378?-GTZD>+K;2YNZK^ MAP]5L9Y\/Q89UG7N0(RR*HJ+QF^C=E@Z[E$-&H:H0SYD-G_[L-Z6H2&^J3L\ M8X%"ADF)K/;..$:4C%NC6DI*'!MC%O>`2BTGEC=YN8>8,UP:!(0@'`*+.6K, M2R==A[C4;,G7PRJ;GI#[0V[]#!)6`NZQ]8)*9*3&KD&1JPZI+-D2IX>E2]\0 MGG`=^/)Y^N/+9%7$3_X'4$L#!!0````(`-&+;D%;3:L;J(```+RT!@`5`!P` M97-M8RTR,#$R,#DS,%]L86(N>&UL550)``.*&Z10BAND4'5X"P`!!"4.```$ M.0$``.1=;6_C.)+^?L#]!U[OA]L%G([>*(F#F5WHC;=]2'>"I`>[A\'!4&PF M,<:VHI\ABD?SY;T^K)7ID:;9( MUK]\TC]KGQ!;SY+Y8GW[RZ=?KTZ\J^#+ET]_^^N__LO/_W9R\D__\@R%R>QA MQ=8Y"E(6YVR.?BSR._0/=DT7R^+7LI.3S;=1]5/QX>\_\?]/'Y^?KM/EYR2]/34TS3QM?NO@-_C_G=1?.^$? MG>C&B:E_?LKFGU!AW#HKVV[12/WUIU??_V&6W]8)(:?EWS9?S19O?;%XK'[Z MSZ]G5Z6=)XMUEL?K&?M4L(%0Q4>:+-DENT'\SU\OOQR$1T[Y-T[7[)93?<'2 M13*_RN,T/XNOV;+`43[M+F4W;S]BF:9[3^`4$4Z1;G.*_O3.@_/G>_;+IVRQ MNE\6_)QV,4`"7*86\NM'J@9==;9H/8?H MPR\?JQJ\6LRPG2/)XZ7BSO'JD8=!+_G7SHJ?-M_DCS\BPV7K&W'=>3)[RMEZ MSN:5>.X]&RWFOWPJ?IH^9">W<7P_#1?9;)ED#RD[OPF2U3U;9V6$N61+#CY( MLCR[NHM3QN5^?A$_\S"6>==9GL:S?.KID>D1ZIL!U6W/,$W;MC3-,PS=MR,K ML*=EJU.V/OGUJ@99?M0KBD\B=+[V5,JRY"&=5=&N@,_C?&717[?`47*#=J&C M#794@I^@$OY)B1_5!J#?:A/^^^?3+3?[;DMF;_7$$OE-G%V7\#<\%F;HQBE; MYEG]R0G_Y$33-^']3VH(?^G)9-:W)RO'+/EP*$GK=VBOIWOI#"7IG*7%$*W^ MK3B=O=,%-M\XG27%X.,^/]GK#3=ILAK&VF20UZ4BN:#D38)?20D?NLT?E@6F MLFV?M[V+SDO3XM5A)1;_>?N=#3[O1YS.O\?72S;%D1-YAF7I@6^[CA_J%O8: M@*'O3/,FX+XK+?VA$E&9_,"(X8C4U(9PH=D5DSW1V;4&73^_I3JH-`G]5AIU M1'>&]G&[R#%.]XH%D;X]"Q)1E#GB2'#IW]DCB3,#&)X,_9X)1I^JA>)WO*=% M-K6IZ48!CC2"?2LR:.!3O6[$,B)-)(*(/1DX"E2O.$=3#!X+/*("+DA3.Q&& M8TA,2`7(`='`/1Z.Z)@<7R/1(DGPB8HN(SHBE9:J+;SU_*+H8]_B%0N35;Q8 M3VV;:IYOFQ;Q=>*3R'?L!JNGZT1H<#H$P!X5JD(D/,@_G]QQ@]I6MKEDZ-^5($!C*_R.)((.9GXSC-82(7=^2]2/+.)98UZU*I1-4&GA_J(2M['X M9HZ>6;XC@Q"1#:93*(QQ@_<'L&@'TQ6&BWLRGNH:`4%[QT>*A;!$R$3%'EPC MMN)P_1)A^6GF/>1W2')GPLFS5UGTQ-+9(F,7:6'I)<]^;3[AJZ:; MB>D_V.+VCEOZR-+XEETRGNU:K&^#9%V6]CS$R^\L71E3"X(#V`2="SNHKQ45:,L%>N!DH-V,$"KYF*":$512@DI. MFD\Y*W4&:8)J8M"&&=10@W:X09PTM0PR-LW5U',CKY<+2]M=#UD?`+UE]5N0DV?WN0%CWQ']E4,ZAG^FY(?<_2 M;-T*<;1=F<.F+528I:9)Z'J(&N7AVLX-4M%2+D6,MZSQZI]LP5(&!3S#5(6U M8NY8N9A:ZD>BYZJM>EE@!D%::S7D.S0*X5VL']C\_+Y0Y%*CO?6\^(O[)(N7 M_Y$F#_?;+1ENX!BN[EI.Z+E^A`W="#&EM,""3>I@++"/2F6SL!NG:J1H"Q7% MZSFJP:(*[;"[I`3H?&=;%(1C1O(N@YGWQL8G.!I;O]U?UK-DQ:[R0EYX-9(? M+_E>]:L[QO("BS>?+SBN>+G=IY7YS_L0BT6YKJ[9 MMN%AC'6GAD\B6ZC4="R8@4=;E9FHL7."-I:BTM127[;&HAUK^:::%\HS08W) MZ)!@R>VC&HLW6L:5L<"%BT?CZS<@$:TG1QZ)A&/K2B.)H*.C)1FW`HPN8E?[ M6#1,0M.@1E3,)`Q+]R*#U.BQYHXL8+>"#!RO]Y43\1INN8UM(Z%K-`%5N7.% MYW?"?OV@$>^=S7XC<_7_FW@GQDKOX4[":2+9I_9`=K;-$(=JH4.)Y5+L>'Z@ M4Z>!H]N14-4`%(9>XU&;D?QD(VYR>QW!7-4Z83BXE[H$%J4.@LHARC!\/)<( MZK.11`AP,U_G%GN@]5T-9]EJ-O7O_IXL>>O9E7>UV8VD6YX38,Q M%=IU.R;%7AMQEGXXL.KZ?T6!VN/^/[=X>Z9-W7OO@TR]C.`;>!1B)/]TS3U;!/ M72.((K=NQ;9U<_K(TNND=9FIV,-%E&T71_M"QQ)/JZHH)62UK`^%8TFP#K0] M/3#EGGM$'"OKE&-L),HFB_YEF687$N02XL?%*HBSNT+V^!_1_SPL'N,E/X-J M:A2S#^IXQ-*P1;!N.*[CU\`LBN53XR!H@,?I'$Z7/#>,!R0RWH.3WR7W_?[8 M=((X]G+$6_ZP8\6067`9UMOFPT$].A+I[='@8SGR'JB&$'AO-DL>"BC?DISQ MTN&S)%YGEVS&"HS72_:-Y5,K,`BAH6EXD>,[`0WM(*I!F@81.E&K7V30>YDV M"%':H)J@-CYCQ=,5!HO'UB4NP`BR'Q9/Q;A+DF?IX[CV[89&;H;4-\*=&HX#1:J MF:V6;4$!@.?T-T#@8H0`VTI0?#5XFE*::'X4XPHX1:@'V',]RL%6#"JB-@617`@FP_I:( M4(5E@C;0X+18QA7*11G8"]#J7+EL@W_CNO$*]6NRU2AV!R=^/.GN8JR\AG>F M&$+,+]*D^#%_YB??\`5(GCVZYPN3?&1O6S:EQ/`CS_6P'^E&Z&W7#TE@`,EZ M)TS``D\73_P.%!CMGQ@4$@[3'8E+]ZZQ?625;+'4;DNQ53W0MVU`M>W`\,G8;-R3'VA MDDM@*.`9EQH2>%20<@1`#@;6!_#9F!<.&[GLO\&WJB2-O",_GLAWLK9+XJ8K MR6`IG,T);$J)N*="QT.;#,\X%'J3N0Y'>C2/'63A&A*1-3/%&V0-3L#4J.J%47`D>B M1IU,2-3U)_AZYHOXN3Q!$3L.+?[Q3,WT'(L0SXH:1!IVH!*AHC#ZJE2^K_#` M5RBWYE_Y3!J2>NC9=..GB_?\-/2,^@7+:NN)15TW$G7MP]+NE<)RY`)I=5K\ M_TX@F6I!8#ENZ+B>28+0(2$AI"FXT+$#)]>B2(`56TH[N`UHQPA0F1=V'832 M0WJM![%O[[`1Z/T+KI5)OJP//Z3J2QO;2?B[40Q=I+R'3'>\@%([(%KA#,N. M-!+4R%QB096TR<+I9>5KMJE]7?:A[-*.@5D2`_9)/\MC=?'RAU#Z`[2K+V.6 M\>G'T_S.%JLI:)8G6R;G*Y:#]C4<$<,,#*+AXH_(]YRFA,YT'5]D@0T,1"^K M;/(*#T>^<'9Y.-[E4]#C7WF3);A=0AO&9R-1:W@[#Z?&(8EM=WIVM2HH"XG7 MPQ$[M*+0]'4GH(1@VPFW67U"=+N-/O<$!5BEO_$3,YNU^OFN+B3-^7XBQT[W MX)SC^CU"OTB53OQY!_U?9.3\G2KC05PG<+[XN%PH=QIY3ZYL=WYY9T+?"+P] M>VH,9Z/W:&TRR.L@.$EJ#I8]OZE.FN6G@B6K^Y3=L76V>&2;3^L5=4-S'2_R ML6M@1_="$OJ8VC@,;.K;3A2US:JK;A9.SQND_,W?I$]V@:(*Z7!%(X)4'AE_ M0SEE),-N,/.2?OJVX)M]R98%COE%G.;/W]-XG15M\>%@TVYH63ZEMJ];IDY" M3,/0"30-ZU'@>B2TVA[9V;D=N'=W`PV5V-`NN.%>U_?H.O)^*F-Z)"^D.GL2 MH"XI&DQG=VS^L&3G-X<0^,][?U,6/MAZ:!F11S5*(M,JWGHM;,`8MB=48P"# M`'A5J0;-(^SA5W;"+X#8_VNYV]V!O-1RX#.X@P2'/V"^@1D,R=![;$@$ZJZ1 MZ#"PD2^'1SU0*J'8_!"%_/DKR^^2.3\]+M!H08GN+5>'VIS<]NK;QBZ8[DF#@+?UHANAKI>MQHZ MIB^BR!V;&E1SY6Z[[DIN.UWMD5>5RCG,_=3'R3JBCHI8'HG^J;(F`>F*(JO? MY_EJQK#`*8$ZZ=09%"U+[$_ZRS&DYA`[,"++-OE1*]3$Q&H0^,02 MFE\K;!9815^DT62FSRHY[K8(!$QOE^6@0>;"[7F26`?J0/9(QGD0EK5<&^I, MGI0";D::Q`P=/<`ZP88?XC#4`]^J6PJ,0&C>*O'X?A5-;G(JPYJX=@$0UDFC MAIEUOF:DI1H)TC="U1&UX(BZ2)'1*1.V&;EATW"-0K@H-73=='W/MJ)&MT)? MZ':5#LT,D@$3G5>IH%,^[P7`I(JB0"DM:9+BDR&FM M2\'=@MU$3VSVD"\>V?G-S6+&TDV3(25%8]BS-<<-W<"-(KT94-F$")VXUJ4= MZ/'.8G87IW/TGY]1R"X6\3J15:5.9+:3I;YX%-.E$A5J8*$-KJ&$Z0A)1Y1) M!;4CD28EIB3J>YZ:Y-/98LV^Y&R530/'=C3-\@PMHIY.`P='7MVN9U&J(.74 MOK%>IV4["-%O'",J02I*/0DPW"GA!$-NERF<.*]])IX:OL333>)4CT3+U-G3 M+K4D2U2'J2!?+O%N;U-V6P`*DBR?1K[A8LN*"'4LAQ;R:KJD;MJT<-1M3BC> M'K"V;6&A.[:A5QTK8E9TBPA+;?:Y878/6($0D M"Y2D?B;XI->G=^617NCJJW/F/=:$.=XO["U;TVG4>W[*I31S;"FWJ^3IU M#*=`HC<9-ZK;=G>MDVD5NOBBAH3N&TQ*E$Z*X2YZ!TVN*M7;,G[1@O$>M>\- M`H45L(L31JV#G0QKI8;=J6NMB=5.TK,DRVAA_MMPLJD;$K^8/1/-]#7">Q+1 MC:IQ0@P5JLX7?S!YG2Q MCM>S1;S\LKY)TE5UVFQU?Y?.!Y\1-4,[M"T]-1'?[L+35^!.`7%"% MWCT*EF+7"GW#=<-BF.S9--1,MX9E\N.%@&5:!`NP5LO?FP#N!#C5AN*_/^D> M[DSMCGPK%G$93WY@)9-1L*K MWU&LWH*>^\#"+6JI`LV6(K>U7%^DR8RQ>9F?V2M'9]?YU.<;6G3LFD[QKQ=B M1].BNDV/8D\L%=RI*?`,L#=_+*@OWO!XQ2^:0^FF+N>^K,O)MP4:@EK!V M:ML;LV)Z6L.JTL#[A4X<6L]R>8RE(X*HA-R12)X:6Q*`WB=T)\#F+LA+-F.+ M1W[@UQ6;/:3%L/:/4C&W*VG\U+#Z.U-*B5&0IMG4+023!I9CALV`U[#;'Z$` MU#YT-K<2N'?U;;)3$L#/\4L;"X3.EP?RT7%!'(M[Q'2RN3=WBP;M0Y[L%`U4 M9RN.R2:JIJ M.-^)X':C^;ZX%0M2!_W M!F[N]_VR>5MW,4P=,_**#F#:Q#8PMG'@A<7\`=M$=T/+HZUV@*II"5BSJOL3 MX\V5VK5R3?952V2HUYW:%@/M7ED54ZL1$BHP2NZ56+GQ<$>"VPU\W^/AT!!7 M&7]C&,RJ,R:!Z&+"-'&$2XX[L-AN%-H7?6*Z7J-"&UB3_;1R[Q7%!SDZ6D?#RG-=WU?-J.1=TFF>#LZ]LWBU*?)\S\;=8%)^9=_+%2#02Q+1V,W<% M]+6O^XK3]6)]FUVP].HN3K<7%KI^B"/=)0:V38R=T+0C?BZZ[UA.2"AM71\J M^WS`>J$-))[X1R6HX2X*/$3/L4J?KHR.Y`7K;L?+*ATUQ,A<*_6B93_.%C/_ M.4A6JV0=+.,LJ^ZW"@(M\@)?]PU?HX%'G6@+1+/,0/(N*46M0Q=([EPR]_H5 MG*`2=GG'7(4#:C,;^VT<%B7B8GD$-Z"OIBJ'>E' MI!?.@2/19$`##]\[!4*E^-WH95/G-V4==W4R>.3KCDNI%1'3M(COA9I?-V@1 M+*;6TJT`JW+UAA8O>8E(\B(_>0I;"FDIOTQNCOM;`X2CRR;&HYKFHYG!Z;IN[9KU2U1.Q#*4TD\OF>UD;LE M0(:V=D(#S%@WA1GFFH#7E!P1EP[\C415NECP\NC;KF1()W'*(=19]C5^9$>DVX'3M!IAL0LSNS4%K"^J9BIGTD?C=G6%7%8-T`M=3M(G(]%!5=:\DZ/K1)+(;KF;1<[/,YH2LQC!^53WC,C">A3Z@>[6 M+82:+C2^$G@LL.Y]8SG:.\)K]^VZ2-+R8&HOS]/%_[)WK;UQXUCVKPA88-$- MN!NB'A0Y\XD4R9DL.IV@D\5^Z`^%ZK)L"U,N>4KE=/SOAWI6^:7B4Z4&%@@2 MQR[KGGLH'I*7Y+U_/![:0_"'*OA5O@G5[B!M;IN/?3`[TZ##K9JX>:)53\CF M8=37A;F>OPFU,B!Y(G%4W3%*&\Q6>'WB3%"-WECEA/3:;&I:N,P6TY/2-W)+GCH2'#VY"AK9;2%2?@'')S-=SD>]\D`BC1\QKFA(8X9Y M"@04"0=Y0HY&4D:T9J]Z3YYA`MNHN:9>:[*CIKG^B+&<@BY#$9_1,Z%J9C0N M1)D,P5FMM:GFW9Y77]Z/-2']:Y9M;1+ M[15AE&,$.7?B[)I43FA?'Z:9"'*Z,FY:HZWVB+)5KN+\^FAG1#R M[\5^4];%]2H$*.>,029P#I.H*6'(6L-I@GB6:!6AL;?F64&?YX7J-B5[C,$( MTB+-EB'%RD'%&=G5DT9+8KUGW7J3K^G8HB.N%Z)Y#AV:2,+E@BJU&_R=C/Y6 MU,7^6W$MJKUX/#SN"_Y]7BXW80%6;A_E=U]-I%G?I#`NF$6,F7VYIY:H,`1C8;[_7FWB23M'7>1/A?[-EC10EK!/`]S MFD:"YAAD&2`X)@,,$$.MNR6N;<^R=_]L._B(^=EF<'.&L,7="8#57KZ#)C'9 ML9^W-:SWY6T;8H8M^+.,*F^TNVN;A6BN-_HF\S"QXUN5WK]"XN(ET MGCXU%?7/G)Y"&I`VW^VA"3VSXW$A6F7IA,H5(4U*W*[;3X,)*P`S(II;WRQD M64PIA'0\:R#E3BFYM3_KBUJ[]\C]K=[U&L;A^MU;F_ALVJ[B MC5IH(7KJT4&3E;P%E;[6\L\@,<32.,0H@PAB(#B,T'%HH`CJYI_VAT1'"8SR M4]LL%-VIM>/F\[*N]]9N\ZWLEZ/G6FR[6]T;M>$B-=Z3JW8K?`MZC=?XO,I0`FD?R_TFE-)Y8\GMD\X@N.`(,!H5)>;&_\ZAS@G)UG MPV.<#OA6/,VIPLB[9SJ=TKF(DYUN/:J\O7M:.M9<&*#KNKC.J_NFZDK[,HXF MTPRD/,VA``QA#IL+4I0##F%.D<`I4Q(P.Q,>E:L!]M,?#;+@%)JI9%E2J:-5 M\U%J*%(VU"JJTR0'[\J2&^86H4>.7*G<\@4L MOQ6?Y3M6M[+XM,HA@"$1410*R@2&(,O2!@I)6,@(TMI#\6'?\\JOA?Q&![OJ M;_T%Z]UU,`(/6N3='.$I^+W_]VOQ_1!0^3[]2SM;MX\&4UM)7KJM-(>8N9K) M3VYP?:XG5JT^6VXA*UJO+K[,-.Z=3MLB>G43'MQ6]>.^:-[A]A5>103'*,PP MBCBF`""0X4S0B!(L(@B0BR)Z1G8]Z_6[M=QTTQ4YY5I-LEA,K?"BM"1B%!'$!,",QS`3+:8P@ MBV*1J1;,L[#@KW\ZBE6YZ8M:\2R'M"ZDI[GPI'+^SFFG-?SSQ.B^VLDO-VWM ME5K.?_+V9G3]87?ZF7*W*1^V17WLXSC/4R[!,0F&L013BAC+\SR)XY`3KI2F M8E9`GN5G7K2KE=Z/H-P]_^#@BN(0>\$F51/1Q;6FGMS.UI">$D3: MDS^AY+.V[4(T?UZ?7V6QG)UP]0I:U?U]>1BQM.=9;HM=,X0=9X7C8,8H3P3) M44:Q7#^GC$&"6(9P*$0.4:J:4\&M47\R:RFDQ.:$)?EID M(9W?DW,OJU5YI-"@I'*7).=CN2OO'^]_:_:PMI_73RT\4>W[\VJ[VU^*=5UT M!4*/6D.:K`YROLK2*(HQ#1F*\@$<0T#K>N\\B'QO.)P4\^W<"'H_@LZ18/"D M32PU^A)TSAC75_;:B(I;#HMK/\U-"+NFZXLN7W(?PD4#3.U,S-K`"QD29G;Z MW=K-\U&N/H04MXW]L3S#.&3A+(K3.$M`1*(4HY#S#+(<)EF6Q1&@RGN8IL_W MJ!$=I&#$=+D)W7OL3'5@6T*7TB>M_7C9S=P08S#Y>FGYPTZ.+??M'B5]ZG_8 M%66'498QG@/$6=.%>1*E9(#"&-8*P?FP/^/$ZG4O/('=EK\6Y\KC\[ MX^<7G9IT+44US,"_O;PTHD#M?A*O-^MMM M(2H7L6F:4,YXQG,$TD0,1@D7D9I*N+'E735ZA,$`,3C!&/S>H=2ZLV1/[[2T MS,^KGM0LD%"-:V"S$FMV$>SK71%,DOS#?_\7BJ+P[SQG[5?@[S\&=3\`2"VK MRUK.+N4JG.V+/X,OF[(YU'Y3;JZ:6Q,_7[5[TJ7\1/#G7;7=/@75G[OB.J@? M_ZC+ZW*];S:I_X=\.;78_>9H5_YTM-L\C);5IKHN@G\^;63;#I_JOSM\\N=` MP@VNBV_%MGKH-L;K8KNM@\W@XO5H,"AW]6'?4B=M[XOU[;B9+M>&]]*_%N7Y METWM6MRY=^*-`M"[K5KKHOKGO;O:&,@CR"/$ISEO($ M4TD0&`UAM=0FYD_W'1#M,/TTR(:)#)NQIC"6>2=,63'N_7VOMI6MT\_!\V8.#QFO6]CS#<29-`@ MKO\6D)^^;-9-LBXZ?/'/\O8N$/OBWX_%;O,T?'\6M1GQO++%J\"6,'W8.5*[>?>V#C/N':K\^%+T9GH0P@VG"0(H)1](, MC08S8:H7TM5]MNG)VUH,#[<8X,%VG*!,:S?(A4'? M<\ZI/=[@]P9GT`(U#-1:LJT5OYV/:+.PK@W'LQPX>HLWC<-'5K0O1-/<^G3F M4)(#PM35;[UM"JE^*W:/Q3^JZKI)5KI*LPCDA(<)07D:,@@PR,;Y&."IEMJ9 M&/"L;I_WU?7CYA#L.UBZ$F9$F:)D^69+4Z(:.$&/YRIH$;5)D^=6I#=HF5(@ M&Q:7HCA6/KQ4&'M"C!2E,1/E:8)0)%*2QX"(''(ZFF$H#76*(.L^6TM'](L< M]TADE]A-=0DW-.D+B&N&]+1C5(W+RH6Z4NC0M4"1T((_H0_Z-&@$9.K#IYM6 M@+Y4V^L5B2$"$*0DCJF0,QN4I'#<((^Y5NXCW6=[#\C4;66!VP904$M$V@$9 M3:Y4`S+^:-(-R'0,M5B"+Y,,>0K(/*-B,B!C1MI"5,(8_JN`C`T-&@&9K?SI M[3^*7;%?;\GNFES?E[MF7WC=Y&_CWYOD;L6*0YRDC(!;<=TG9W8_T,JW8\Q@W9JA&9V7G6C23K0G[X3MIEW:9L$R<:C"+" M4X89S2@#:13S$!PG:3G/D%[F2!M+GG5O`-=VQNLC/.U,D59LJBG!C&D)IM2+VCU"B,&6)R(.$,A M)BB.HI`/=CAI@DCJ\67MAWL.,']M?B78-*C:@;OH<1G$DO0X4P\F>:-+/YK4 M<<3/Y3JR8?)\S\K18.AJWU9C'5)-U3!B34TX?!.FIQW'!%_/2@?/+"!O M<#*A(38,+D1&K%RHW+U0NDN==;EKGO]IQ\KZH:K+MLS(#:GKXE"O0DX93O(L MCA-"XP3*_['QF`XDN>:*Q\J6]X5/*S(_W$J0/P;5+JC;TR+53;!N\>FN@>QX M55P*S4:HYHI(XAHJEDLF3\`U?)(S?/I9'$U1-;5&?:J=)/4*2B>&^H7IGR.G'I' M`5U2IJR$'W;?BKI-R]W-%C_LI&[([ZPP)%E3TI-1D>8\Y%'$T;C\C)G6N6=C M(Y[U;L`1E"TL34DSITY-Q69A34^XCI#ZY6&3,*%#-;-.O4?.A#19\[D0-;+W MHW+\HFEK3O?\81\N(Y0@#!'*1!ZR1$"!>+I:E?7'DZ8\(V)22LPH6XR"&,)_)1PV-*@7YE5DVOJK#7;$/?NAWO7XTF[)8 M,*FF)?.0J*:(&HVIRQ!2%]*] MKHK1HS3^:=Q8HL5-M2^ZSWU=?R]J_OVP7TMNR]UZ_]3>7Y6H)6,'2=VVQ=W/ MMJ(\B2FB``@"(TS0LPV_/,[U5ER7P^EYT=;'3=KD;EUG_J-U)3@T7FA/J2[8 MGJK3L[]&4^I.]4YV%[O-V:-KP=&WH7'[S[?N707/'.P2`UP%SWV\W,+46W-- M3D@O_Y(L9)19!!6O)LH+P&0RTDDH_8A*BUUQ4QY6-`1>0AK6]L$/ M/:JYI^#OD'-67,WI7)0P6KCQIJC9TJ(L2)_WE7QZ>YJEJ>26Q#F/TS1*"4H1 M0_$89VCKD:@O^S4>ZWF=_VMQ"'[8'N=#FD+CI;,,E=IR`B#$61P*`00%>9+F$0=,Q"3#0#W3CH4%?T-& M#RHX076YNH/O,S31+QS0NI!^XL*35U>S')%CT8\^5]MR\W0L&9I`FA*"!$(I M11G`61BCQC#,<9JD4*O:H+TUSW&4-_K75=!A#'[O_U4JZ^N+;%/M\LFSM829 M43R3IKU@3DO:3%E?K,(9.W16Z.RH4BL-0#`KZWX&65P?XPRCR*8)C**$@)0R ME@D6'+Y(\XQG&+,DSE*!^8`K)K'6G1KO M8'PK^693/3;UWN3:H"B_-?6]KQH1J?O-[',J<:$64A/U136.GK3K"WKKP4F; M7>:6HBWE$S(_6VLN1.SG\[>Z4+?Q)_Q##IQ5V&R&I%DFY,)!+A^R)`G1`(6S M5*D2H4_[GN5]P.%/P-69=J[97DCV+=/G6^32NCP@="/%VHWTUU-??1?-!=>0 M3I^AD:/\KS@D)$(93#..XQ"1+$N34?ACH)4"U2\2S[HKD?PTS,/:@Q07BY/H MM(ZW4(FGAIDO6J*R%%I*P.2(U6W,Q*`1%Z+E,SEK'SDQIMBGOJ\2@E-`HSPF MD2`1HS1B8H#"PDRKV*(/^[,$NY??[]WV=F76_[I]7-U%^YZM2:=Z?^[C=Y_7 M3TWL;@B]9E'(,$`TC6@:\QBR/(O'T&N,B5:7-3,Q5^#RH8.E.Y,RY$UQBN2? M,LVYS\!6C^AB^S]O$C.E7'9,+D6<++UXJ3\N2-&1F+V4LE_*]1_EMCR413T8 M3!,696D48A"F":5A1H^:%HF,Z]W#,;>CTV^,;N+TT((3;`H]R#6;RMHS`XW: M\F/`GR\%>IN>:1&RI'0Y.F3KR&LI)XTG>">N=N9,C;1*[TWPD(ZK7\_JYG?;JU#Q.U:RQ124SPU M25D$4Q%&`-`XHCE&V;@;B7&LU/%G@C+;L3W_Y\7>.TUKR^&[QVUG:YQ%G,>= MS]OJ(CW`*%/`E\/ZT&8J'0\0)P#$*&%"6H,<1]*(2,(P$B+$.(7IN1L&MH_W M-Z/N+[./D"YW+?$=;B8&;ELV%S(N6[OQYEUV6UK4R_H^KS$^F@.(8)0T)K,D MS,,4APSUY@B%A&K5\36TX7MWMC@$^PY5_3?=`KVFM*DIS1R,Z2E-#^8J:%B[ MF,J\P\N$RM@RN1"5L7;C905=)[2HEWIJ#@B^L+F".24",2$PXB*,Y>#/!D4C M42*T=B>,#'C6E^XH;J\PNE6>C`A3$Q?O7.DI2T?3J;[,7>+I#3XF%,6*OH7( MB9T/+ZL\V1-B7&=R%"[25&:!))*S(B0`8RE!>+`'.=2:KQ@;\2PH^:N*D[K3 M%G/ZU*1E%N;TY.5U"HV=";:P978CBV/MQIDJE(3%Z4YANH73,*,A)R1/ M4@1"P!(2=<9)".4RT#S=MZE%SQ+6P9+*%7S:/&[7^^!KL2WNBO7V_I2MWN>>TAO8XWEM4I_F)E=5296TR/,81_IJR.'@V+ MJ&61D)Q`1`3):(13D4&0BP$RSSC4R=![29Q:0Z)9RM_M6)W^S82_BM4M_K^6 M@=/V7HRB+("*&6L9Z#6/=2T#%"+Y?$)1'B<492&&.1[,41+'^E-P?1N>)]T] MC.;<47E2TN`OFW-?EHMJ?UY)F&X;F+P9UR,-$7S+A:2`\P!/^RT)L%!5`W$&?N%N\Q--%#_D/>U3:WC6OGOX*9SK1W9]R4($$"G/N)!(C==+QK3Y*V MT\D'#2/1-F=ET5>4LG%_?0%2E&0GDO%*,>V73=9)>)[S`'@.<``<6),ZD<%B M[T?CN+=9#J&\;.OYWB@.:0@I#G$>(<@Q96&\7\C2/-"ZS&YGR?>L2X+1W9RQ MY$YM;V8\VO2V9@9<0``#';(KT&&[W-;,6:HTQ,B,XHDJDJ$S;\B2#45VVC1+ M,.$LX$&P_@.CFT@ MUV;0+)3[),\^F._032>3?)3[-,9&"/XNK9W2"?]-I.8&;"3L!0S&`0Q6*%P?.(Q(,YPF%J,]-7M?'_ M;*Z_HT4_MBH3.9&A9^V&6BS5I$5YR/Q75=\_R%C]58S9^^J/[>.7:BWOEQ]& M:WNSW;2;-"J<2"GF*9JQ>?#K.8"CX"\:NP2]XJ^Z+_08]YK!T.\+E#8I:Q:JOYN_OF MZ[\)Q_H`+G[S.FY_Y_0/^KLY,1?NX1;`&]L^H=&+NQ'367G.OM7M+*%1&#`J MJR?"O.!!$6>9,`'CB*2H")4VJTV^ZWG^VNMWCT=(MT"D&@6-2'I[L/OD1V^X M:U'C8,2_\OS$F#?E9P*CWAAZ8]\]=./7,VL>RWHU(R@2"^D@A"B.(I)G>0"' M[^BLPWYED_5MTTNW/YS5C`A M6D0+SL<^K2>V>3PV$83V>?PZ6$S6H?7V>WXT<74PU&D M+.`P@ED8LBQ'11K!G#&*4T0C4M`$JNQW6!GP-X0/L`X5Y$VW/.PXU-CT&(U+ MLVT/^L.+^0=.W]EN?)SS_]36AQ/.IK#YX<:1QG5WTA&;[I;[W@*)""T"CB.< M4X9Y4@1I4,`B*B@+LY2_M0-B\$5_X!IG4C;IME/7\^3%CBB"$&<986,4&,1!RFN;"'(D)@P!*M MM]:-C7A>G.W*)`I@5Z"'!C[O?C5?AYDSJK;:&H5,/06UY=%O08Y7/)U9)%E3 M.Y&ED+T?IVIRV!&CK$J\K-?_62ZWE3QMO6S:[?I("7F4!F$>YX<#'AE2G"?-#R&?`6^/!__X.TC5",UBIK^7;0]]#310U/X>45( MD](S^NFM=2:BJ?[\>_T@D5\BM7?.CNQUAWURBL,4%Y0$'.50B#W&9#`7%[@P MV1[3M3'6'MB+$:IS+L^:1+V-+)_\&>Y6Z5#G=3?J%3<*6TZF;$Y$J:S=.+%Y M9$>+E>[(WZZK:GF\X2&*M:A?VUBZ@15=@P*A[ M?M`AR>8*Y8]?>ZW2HG8TW7K!F*:"F;$]82TS=$A!U6RH4MN4RNMFWBRJWY[G MU7+Y>R5O',Y(G&.$4AJB*"0YS(BP,-A)$%,Z;V3\<=_JU4,"/2;PN4>EM6-E M1)G";IYOMC2UZ$)$:6SP^2;,;)M/FSBUW;X?.'MJS\^&ERGL_%GA;QQU$/M) MXO714=*$A%F1($@X27D*@T,R$B>1TG41)X8NLDR]UCY.[H94X_F@'SY=+%N5 MJ!QK$KBG26_^I\_N=*=^!KZ\/>LS)4BQP,/!T,U=UK;51M:/F6;H M%85GE7NQ.'O:HY:I]:<=;O`D@8.['7*96V\[[%JU)+RVE,*$=#*-I">=QXHI MVJ0'?@5N7[34`!YTZ,$`'^3/X./$6DJG+LA46LQLZNR[Y10+C%B0>&I*/DK# M3&'N/HZCS=A]7NN%9$1*4\8`$09#E*4E)A)E2=5$/9CW'T`XLR'_[#2P$7-!L#\70RAXQ MJ(<'*>L=9JU3Q6[;0"%87HY^O>CXDS&O<][[8BU@>![\=$MHM(#B67$=;DX% M,3\$3R%J>?*L\=X[-;-4'ZJG\KE[-?GF[KI9W7^JUH\2T`QG41B00L0\7J`4 M4Q1A*NUEC.`L++1V,(V->(XY!UQR&BF1_:OXRB.0V#034^8\JB6E1J%0+VZ8 ML>C<=S3-!7HU[)>M;(2>-7>K(IO&Z&!8O;^(!'< MW'6&DRP@'"5)E+`LARCD699(PRP7TW(!2D>*[*UYUJ0.(/A;#_$7(-:]+U'* ML6:@3PY85A.J<0G64RQ[;KVHUYN4G9$Q=W1/1,\<.M3XZIF:"G>LHH?[Q.+S M*>,\C+(T9C@HA)YR6:.9\)3$7'5>8/1M?R/LY2S@"OR'F+Z6;5O?U9=\P^=' M))T94U:<3F08V?G0..QDQO=I:/E4BQ52_3]]&2:!8;/#L#M4GJ(DI&&!,TP2 MS&,21\4`((XB:':1QM:JY^G!RP$F_K,IZZ5"I6'?7*NIU65HUI.PXXLQ+U%> MO5KD7/Q&S!LDGI$X]PTQ$=WSX-C)RR]NJ5/;2OA8WZ]$-)V7J\W+.S=_E(\" MTNL#\"Q($*)%&J$<\PA%B#(V0*`143IGY,.N9Y4\0OO]G3:)N-M,-+TYXZ4A M%#84+M@&FA+Z\]&OL:MPP68PVU9PWAQJ.PQZ/)W:8O#$]A3V&'RYUOCOK'Y" MUNY60TQHC"BD<CRT!*^@]G_1)*0%A%$2QGD2$I8D M.8%\,)=G2/U>AX6-<5/I'3B3NVG65"H(XD@LVFSV79!`#1$=B4@S4;4@5$UH M3WM_2G@=\#4%(7;A1N.V&UE>T:--NQE^OZL*L9@%B.008Y@E:41($!+Y#O3. M=@&94FU!IP8]2_B``Y0=+,L;6F:4*JCW)=C4D_(3]ZPDRL/_#W5GM$[_.^/9 M[M*;=[Z=WF_3YMWX'MN/>#D5"US3.H7`X-RG-RZB.2#,.&1\6I>KMIS+'TD8 M[2RB<099%+`D1W$:H")+T6`7QX'28X;.C(T1*G8C;2X!68J8/IEF@<(KCTZ" MQ!'"3KC&9]8N-'AEV&E8T&#:.""\9D,C&!@3.=%`8.[/&T'`DBBG:P9:M@^W M9;V8)7$>X#PL2)Y2'&4D#.@^6PYAJE0TUXMAWYNNY;)J=^4YGLIG>7(+U")& M"'@>YKGJ=+M;5WAAVN?Z0OR!@`PDYHLV@?LEAY>F&&/IH=0D3E\\ MZ6[`"QA@AV/T.[4'"GX@2%9,3>0NF1GV[^[.&A.@K`=R%_K]JMVLNU!X6ZWK M9E'/;_LR'K.,I0'+>LG3G3P[`NHJ;'32PPS:RVISEZ8S\N.%W(GKDR)G&1Q>T M4JRAV-F'&+:MPY$I4%STE+3%+]W'AV5@H= MDJ=XM^2'YGM%GA6Q/!2"DJ0(BB0*\R2,]P8SS-4O15I9&4OUGCHX73*S?-8Z M4&!'HD*2C##`U-55OJV9RW>UP$%\D:"A0:K$:6M MO,XYLM1;B<J29R*K\HIJ8:G$R/0G5@W]:.`UH,)'+/[;R M&N/-75XNETVSVN47VF*UN+GK(%"80S&3SDE>Y#S(@S@C^S-PB&;JY\\056'?3N%:G=S\SUQ9Y^;8$>E7E+\?YC3_4.[9#G%,T@`,L_ ML--W>_Z-M7_4=G`4%ZS;PR1TO$646EAQ1O?T0HX[UTZ'(\?T*6>DBW*]JE?W M\J6HCP_ENOI4?=OD@H<_9XQ&`0TXS<*8%T'"$(X21O.(A#2+,-$J/V]NQ7,8 M&H#);`'HH('/$ASHT.D6EK4@4RWA/`Z/>D'%F$(OV>23#)U)'MNS.I%-L32?=UMCE&0X3#!"6$98P7*8 MEK?XOK\!U*'J'G0\PJ54-=XQ@SHOSH_$I.'+\\:,*CY!?]K[4Y,E%X1-86;D MQ(_&<4_2TYC5G^OMTV;^?+MNYE4E'Q]K;YZJ=2E?QNC3J&R[%K^_KO^QK1?] M8,@#81U'01'2'),L(&(NQCDO8(`C%',X^UJMOS1*ZW0_`'0&U3%6]07[`F6S<:#'C!$>`KL(>\V]@"/6APA'H"#:(50B[=,(;5BHX&PEM[ MC*KAQ(")TX'&)ZW3"$%>/6Q&ZZ/:A\<$.VVSW)F1[SK=K.7#3MECLUUM9C'E M"4R+A*!,3,HI+^)D;S;-LF2VJN[E<8Y/.@?'[$PJC<:T'XW?H=-(H[U`>04D MSOZ]LU^N0`]5^RR9)==JZ_E1^#5,%=MPZNF@V%FRSIX.V!F5&);PU.%%07C]T:.Y.^&="0SK],&(F MDY\>*E"T\W(IJVJ)?U*+WP)6E_>KIMW4\Q;\[9__B81A\'=!8?<[^/=?0%O= M=V?CY$2A;ON;9EU-](_S6OQ*?_W[..QQ?Y?[NV*/]W;E1_+ZV;>+"KPV_-K_]*FROJ_*^NSPG_\W\H7H4_G4H M795[WS?^J0"AWSNF$`P,4#=60T)SV?Q!](75MFIG8I::441"F&5YB&F>!MWW M14,)@P@I/5RA_5'OIU5[')K+6W5.U-:Q7NC0$_JWF?"R*!W,GEE]:I,SD66F M/N[&LE=HCNQ/ZV;[95DMY$F:#Y64\OFF2\;)'S1K*HM1#%<[^Z=)61%CPI(H MP8P@&B`8I"0(,"R2)`B"0JMHA'OKGK5B`-Q7V7\!^0KTH*_`#O:PR6#VP+*' MAE'3H6D.+QJGS>H9,?370A-138\.-F-U=H\Z?'UX,"*%D401(!8% MD-`LS_``1JSLM%N(/-L\S M&/(BH##F*6$\YZ%\2U+8+G"&@H@2]8<>71GTK,<[F&!]P`GNFC5H)5+PT$/] M%U!U8'5RBP]#@`NA\ MZ/9$>B_`L1M@[\<5Z.MA=ZY<@W_>/OIW,>= M6#L:7M(=J3T5K^[:-.!NUD/?W"[KC;EMQFB&'F4@-(,UZ(@/18;[H35`(,[>+7?;6:UU4K MX]FR:;?'E\8SE").:4S%^C.+2,1AE#!,TH!S&L9AH!,<')OV'`F.T';*\0*O MIJZ[)EU-Q"_(MYYBGZ4:'+!>LDR%'IEG1-A3JTQ$<7UYUXS2M77GWOW9V@_5 M4[/>[!8$KTU'G!1IA"*2YHPCG+`\2!A-$*8L#`A+M6;7#NSYGC_OCAOO,>K. M@%U0JCC''9E-S5GL:R(GHH,*K)V;@3KD?"**Y]2EU[-(YW2I[1!\G#]4BZV8 ME-Y):947>K;E\N;+LK[O8'B""8XPJEY^-(EU0I)^O%9UE2\21.LD44?GVBS/+D3PM62X$J4 MG$ISN^5S"HELQQXUWCJ?]GN/;?MB,IX__U%N1+CJT?0_?LZ^U>TLS@.",\(+ M!%-2\)!P%`\("$ZTYL4.S7H.(A+IT?+V&?0XP6<)3O=\J$NVU:;,%R):+XZ8 MS1*:"VLY#ADL($DH MSM-P+\0$:SZ*:VYG9-V[V@_*'I^=]&E2:J)U_MBT$S<-(D?0MQ3 M5#!#5\Y*E@T]RAIU6ZWOFO5C*7S^=5NNR]6FJG:WO%'`6,*"*(*(DBPB6$SM M!XL12[4DRL*,9X4Z0@;VT'0+4;A@4TV=1B)23YQ,.?2B3*<9.B-,#FB=B"ZY M\*1QWN=<)B&O]W=N((YPQK(T#UB",>8DP.E@G:6)^F%D=R:GD(R\UKYYZ)IW M!UE)/Y1[R$Q>GFV'*4H_K'M,4RJQ[R97>7WF.J8G@1XK&*X`#FB!@"M6_'+S_]-? MU?*K^!MBL#R,74))C]@STVU/+321*;@O[YI1NKD?^7R_^O17\]]5N6YG!4YI MQ(J,AWG&&4(\9&0`@K)$JYR(>^O^113Y$5$=AIWJJ"=R/4GIE=124*^$D#:@ M0SU-$3VP:J^C!BWTB2VQYY/OR!% M4NJ;A`,"%/V02J=C\_SQ!_GCP2$N(5,H`IPV356 M_1CL':R-[)FC=7#6"5SA_?3#X=6BB=:`M;73/6*5?BKV2F*1J"Q,$R0E%U3$ M!&?#YS=MO!_"FH?W#]C4%V`!'COFJQ][?>.U43UON@Z^NH`KO)-^-+9:M-`6 MK;9F>B#KZFO'>,9"S&(2$QFE:<)QDJ9'2K`GLAJ']T_6S!M9S3UV358O]GHG MJU8]<[+VOCHA*[B3?CBRPEMH359+,UV3]R5K2:=<4FP'O2-YZI%__Q86+5I MH!U5K:UT#=5%F)$(Y11ED:"QH$2V2.^83E.=HU9UL7:*TK,Q00`=Y)D#M/DK M?MAYWDZGQ'3JI,7-.D&JLG3,AT^AF/%YOY,06&'G89OF^F0J\EM^^E)M=N8A)%F:2DTCDH<0R M0T<+FW`:&9WI.RZ"9^HT8H)RK\6&,G#'`(SQ:M;89*EU3IYSSA]C'IMSCC#6 M9LZ)+_:->(XN(RTQ6S'4K4JJMD?SQH>52LN'^=9"DI"RD$0X%7E.>)(R%@X+ M*163QHN&G$;US""YJU=W15TN@V*S:191K!M5P9=]N@E9M^+6Z].DNJS-,'H- M,H_7IUP=ED,N@T=\NYSI@/5"%S/?;LG0TU?(D?_MK_H1]U5P>"38_I%X\/_' M+B:"&/?,:\6?^7-84N2G897O^W;<]A_LYF:K;S->;+??]:_^IU@?YN9CE="0 M(B%"SI,F$M&[J%EIS<=<6>> M6>[.<'OZ6:X1T!Z:H@<)+0.&8@021#1;U>5(I32C64@TE%6.69+R%,MSHUTW M0?P]H/BWH-7V:RLN.%8'KTXZN M,96/>PR8P`%.?WI??BTWS3<;+,.09E&2X3Q)\U`(U*U13Z,L)48[DG@,[[W2 MV.5Z/+A[>_M[52UWU]5ZN4"QE&%*DCA&49(JG'(4]I)R',:>.`O6X1FXC9YF M>YQ/C2!_Q(7;[QR]7IWWS>!6?--/K?R@T3]?'C]VV@V8K?OOQR.T?5/M43W2 M7O?GAY=K?95/OY<;_8LUVRS9\FZU637Y>KWZ6O8?`Z,F9<\B3"G)1,(4IGAX ML^A72[SX6FX_5L[/$W]'7?RP6>?G/\RBJST=-CY]ET]V]+B+KG=_$KF1X2_5 MLB[7LW,H?EVP];9GEOOH!.>YQ/MR5^J+?F[.T-4CTG7UI7D^>W$JTH/3C&3)'W(MQ>7`N4Y4&>IQ?(R-YQFR),US'^RW9'O7C4 M%L_IP,C>]),%3->K4[W\[7O7^1O_I+D.7O1N.N\'>[\[:K3E:]VEY3ZJNDDRHA"RO]*D#].:V7'+9%0L;,'1K!CP6=N$] MX;RPZ[43?+^E#_--+[-*883/;LJZUKWWXY5U[9MJ7]8=::]7>.L_5MV5S>RQ MA9:0I9S3"',>YX322,A>E7ZI>.]?+?GO[[!_-R]MJ6^YU?BB^+9(,96D4H;29$HPRDF>2]S*QI,CL(]ZE MU'G_BM?.P*\VP7KUS_O5.[NN7_M+'MEG]"T8W;/JWB\MN.?VZN<@-,)_WSV6:__2% M=,%N&/>&.KP8.Z'GY3$5)U$4HEA)GF#.(B228;24*@$;8M,T737B17/A7G+S@GG8O# MN^WC7ALZGKR]+6_J%UYI"R(ESVA$<9Z('!.J.$V'[R$R1,"IY!X4>)XP8,*) M*?T>0?I)K7;#=2TYV&M^>:0P!WZ?LQ9*:V==-67NK M5IMB<[,JUN^JW>K!VF_&B(R22&"&%5(R9`+3,,09"TD2*V:Z"MA)+'_9PR"O M21(&@4&O\')[L9KX=N+Q=VK[3)YLMVVJ/-ZGML_CAP8#"ZY';B%)98Y1%G,D M]%@.]5$R@D%['0`O[7E$='C:_FSU0#>'AAH%1)1[CVQA=-8>O\QIHYO0!>;8 MW#@"5/\2,6Q,@+/A^J;<%-M5Q;ZM=HLDSAB.$(\3@B+"EGX7:V'6R(#Y!R2'-^N``#&URB\^CMTPH8B5>W.#B5TC7F+*"$O, MT=+%^,=F]Z6\6=VNRJ6H[HK59A&+-.&Y8BH+!9=AQ$*&^X`HDJ!=0.RC^$9, M)^PJ.)(6_+D7!\:,O9>&J)G$1CO<0!WT0Y^7##I%H-&FSH5"XQORF$2.K($G M.J]7F_*5_G&W"$7(4"KUR"J,$8TQR\0PW"()!GU!LKC\=(.A1E/0BK).;P"N M`7,;/X99CXR,O/*;WPR.F"0WZ<&NK^6'ZXF?@(<6G+C[+;V:R9UOJ[YR8[3F&`Q/%XI">$W/C2"Y_N_D]--]?Y/X&O3TC2S M-Z=_OV`OS[V>82/ZRWW3>-:8LQ2Q-7)6,+%NQ+-,&6>),5IXL6O6NC?_DO^\ M7WTMULT1FJQ^L(?]@E%!F(I)3I1*>8Z2$`]<(RP!G6_I)J)O]&AU[3KRF^:' M\J`3""%']II!:7IG89`:3&U_.))X%13UHS,U)L:6D74G,.;6^IE@S7&C*I]W M*S2CNKFI[G6X]^5-J4-_7)=ORKH_JB/B`DLD2"Y91$F*TW2(F=($F%B-">1[ M?-%I"[:#.)OMY\=Y:9AO364C,.WJ'7Q_Y.";9M_1RYP(=,JF4TF8"W=G`BTW M;7F[JP8,3U+"R:B:4L-/^9!*HM0'&%'A;?RZW M#T:$"X:E'OMQK!@A*5,J220=(DD&^F1B<7G/1&@5!37L5AI3/5Y$$44YD5FDI%(\Y`RQ(4B. M10A9)@*[,@@C@KD M.=?HM>UW#.V%V0Q%QMEI!I+)G(1QI9=U%;3"6B_EP;C_7-1IWV@3.CIF$F.>I8BG:4;B3(9IIH:PBH!FL8Z-Y1U6J[LR$*OB MTZ;:U:N;X[*MBXHMQ-4115M/AKJJVQ[DS:%T>U`#K=Y:V#P3=CEKCDD-U]HF M8X(UQ\K]:[5>+W+!,QZE+`KC-!0L%S+*A^NG"D-097Q1STSJ=0#Y8^Z)&6B\ MV`$CRGDGO%"C#WL"#V!S9L(!N.YJY%T!_D"S+&]7FU5=OEY]+9>O-K6^(5:: M*_L!G/S6[5D[Z)"AIDHR;%AVVQ+.^*[5_[ MXQGJYC^#37$'WC3/O>NF'X8N:#CTXU$O]==6:W`0VY6+@Y\'O4$O>.KMN:&& MGOP2Y:EO9H)"?^U[\D7+JY'&:%4O:V@&FV$414+%"@N)8YY%F6('H!/8%["1 MH7P/^HIZ/T$.7I(:ZZ$9%B>T#P9!=1*`EZA+G;;J!-X<>3P3F+EJ3>7E1H2< MP\FKK^6FV.A!9/VAXM7=E[(NFQF-][NZNBNWKU>[?6E,!TEQ''&2,D8YEAP- MH5F:&^[Q[S(BY*FSVK>_UQELJCJHJ^!F+W4_H[H3&ZRU6A#9G)I^&F^70&W[8ZL-+ZYVWO[M['G49KY\LSKPX>K M&GR3!)&@L11Q@4BN4JT%UU\G,6@K0"=!?4\ MK'W]BN6O7K_Z\$I>!^R-"*[_SM[+O[]]+>3[ZY\"^=__>/7A_X"<<.>W&4DN M8C6,-4<2AUD9]??+K0TVM>P$J)R[/A.4N6]7Y?EVM?W*_/5!(71'@S$>@J'FTSYKC,U@@X.7+3+#EJVO M\P.5=4M>1M,X<\QA5&T^?2BW=Z+\.*SB$RK,&&VV=%6$)H*+*.I#9;',8&F8 MQ?4GPD^[^?S^%,VU5OFKOM1=L-0ZH2RRL=`00I[=`])G<*G14^098>9IR]Z[XWLPT>U^NB[I76 MQ6[7;K?82T@I521/B(I40O,(Y8E.PCH),HQ`RWM=QO4,I4Y>\*5H)N%OM'#] MXW>+":U.O3:CU*5LAM&K51ET,J^"WO!.Z:46`P&\.X$V'STP$^1Y:5KE_P:& MS^[?WI?+IPG@@F&4XS3AC-$\$0E5M%U.P%3&D102-%G6/HIG_'7"@O+;EW*S MFSR1>-&74X7BT5[.Y`EST)"G\\N=6&-34FD/K6L/G_Y]6]U_>;7IYFD]>S!5 M+RMF`K&(X1QS/;3B<:12.>0].,XLZRY>M/BN1Q]52O7(:'E\DF0U'.AE7Z[Q MTS_@FL[%N\:^?KT_W[/5'K3BVU.=NRFL+YT/>IGL9J3A9F4DKUTY$T9/UMR7 M"U(3V#RBA+Y06903EN4GF370[^AP5#@?73<_ M;YQMO=RI9^/KY!3\YJTHN=+5QD?40>'N`DOA7LRE?MZFU9K[;M02*B M68I4+O-RHW^HFUTG=D>4/!(G1!9S1@5*>983@6,N^].*LHQQT"80TRB:J+"D M$]?ZUX/\X.->.#1_FJB7S)`XOPZ"$;33WT[(VN_@][`)0=>&H&M$NZN.3N@> M9'<7VZ7"B?LGF#QM[\X$X1,W^O&V/A>PW&;,>Q0L3@2GS51=$4:8*BD/!TME MG.2YY;`7$&&2D>]A@H:3L2_$0/#PUY-W(T;`%V,DE'GC7)P)PT8VXN71L+4E M-HQ9I$0PQ6E,6"Q5S@G+PJ%T%[+(EBQGKSL-3UQ0Y+Q%8'8X=<>:&)>CA!D; MC%V:'Q',I;_,`6#S`6?2OC@57B$9*RP127,29S@4F`VS'KCN5MC9M-9A/`\6 MKS\7V[)3UFZ"6G^'3DP?XZ$9+2:R#P:/8U$_]:MK6%UO5Q_OZV9:3;,Z^%UQ MV?GJ5LML'-@]$PJY:,F3DVX=F0/8K+F\+74.M%^WLS\8*U-91I3,9(92AO*0 M8)GVH9*(`?=HAE_?,Y4&2<&NT705_$?X6QBB9JIH\+41^+<`7X5AV/P3[!J$ M[8+BOOY<;5?_+I=_"S95_]O5;G=?+L'[.5LX;EC`\FPVL!PU^'R]][D5=!6\ M.N.:IYV;GUASJE8TPLB9T&E4$YYLSSS6#O-#0ZN[NVIS%"S\L8BI)3',JN$IQ>Q5'8<:BM^U;W]:[6/S3?S8HZ M^*_[31E$X570/!;M'SC^#8(>.0KN'#-N>>T7&+2Z+ID!L1Z;<@)7UO[-A%7V M^A\?_#G."&-*_6^QW1;-D:*;Y?O5I\_U[NWAL5LT&\(BJ1"A%/.(9$CB(5-C MB(/V8AT5:$)Z!?_JA`*),LY(,[I,YB&,-+VLELI[8<&1LHEI<\JD$^1QXNU, M*.2F+96'FP^Z]F6Y7#7SC8KUNV*U?+7AQ9=57:P7@C$N5$H$32FB489"/LSZ MRF68@U:^6,;P/3UAD*7SJ-7RU]4FN-DK@^X-9>NA&9.FL`^&HR/G&DF!=HZ? M<\[/VJ'GK3D!H;%FSH0_HYOQ>-60$UN,J?.^K(OF@[XLMAL-MQV[N;F_NV\7 M_S6?^F]6]4(0#3EM#<><2RF%3'@\C!EI#IH(ZB"<_ZE2O:)@N9<$A)`+2\UX M-+&;,#3UXH)>7?#SL;>=P*DWF3]OV0ED.?1[)O1RV:+*V\T)7T7<1VIG,#7; M=F[+S\VTIJ_EJ\U-=5>^KG;-+M!O;S\4WQ9,HEB$BL4R1)R'2FE5O0P44P)< M6^PT]H2TJ_8'+1\+#M9:*_PL,;?N&^9F%S0>F+,=>;Z?\/E`:[`7&_S*G;E[$Z&D1YYVSG0[AU#1OTR`N/OI]G6 MG1V@:+S+9F":U&`8II[?#7EF6R";304=9^U,:.6N/<"MCH%&F9T%=,C'WI7; M=DKE,"D,12I%E%&&X@ASQ$.6YA+)"*E$T1!)DZ-H1ES>WQ/U8.02:&%!J\QH MKJ-;!P''S$SDI-W1,F,<-3M-YN7F/X,>5X;-X=08%\VHW-Y'P$RIKZSU\=Y5 MZ]7-]P_EMSK7K?QKP7F>"X5PZUA#C7EX M1*Z"O<3@S^[?C=:@%6M*(6<^FZ5*4UH,X[HK=[UD4&=L.Y%`N3)\)OF3L^94 M?NY+<)FIJ-LEQV]O3TRPCREF0@N@$4K#6/^@@ZH\2D-%9*1_-*Z?N`CFLZ32 MZ6M*P<_65RZXGL3`NI-E%I?6S^19=-RH)\48]Y;!G\M]N*8(76V:,XG9M]5N M(9!2F:*()#JHC'*J9-0')7D(.C5A7"3/&<<@[JI_`@_Z],.H%4+3C)'&`D'G MW5-@B@'VT"_,GK/'!&*C;)T;O,8UYB5H.;#(?(CT,):H[HK59L%93"+5?`_+ M12XS@@2/]\&H3ELD;&!D%<$SG/9EX^L'9>(^3]@K!(^![(PT'/EX]W`4Z.,.K>Z;,\:JKX,^])BA7+"PS8XI?MV`\`1KE>V':7L`)CMA[-Q.& MC&C`RVO3K*R`+D[K@H1IQ'F81R'B$>8"Q5'(^R`"T=!B-9KAE:=DQK"8RA(> M0,_,P.'/+A@T.AV7XL4#&TZPPLZNF7#"4OSSJ\6L+!B[/*P+FA(1IC03,M;I M#$^XRC#M@TJ)I(-%8H:1///CT8*G7P\+GFPA,M)8,ZA,YRD,,J/LG'(AV5D. MN7%X)EQRU!BSI656%EDO,.NBJ51PQ&F6$I6$1(DPR\(^&E:P-1>6(7R3ZNEB M)UM$V7IHQJ8)[(-!Z>G*L0NQZ'EG3D!HI)4SH<_85IQ9"&9EBLO%7YT`QF2L M$LJ;];1,J8Q1BGH!.0U!56!W42>DTMG%1_]/WK4M-XXCV5_A8W6$>Q8D2)#< M-UP[*J9[[*GR[,;&/"AHB79Q1B5Z=*DNS]?K>B1FO#$Z1%*LNJ7RX&G MQIV\DR1+G2.#:(P'U^\DJ9$A/RR:.G[G18#\$'`N`O6%C2$*TF7-%0?0=>"T@ M(ZF0UH^_Y/O3]8!%R#%#<1)S6,E50*J?(-C/W5'*%IO\J0X!Y'1#[=M2HR!M M1\$Y#.G!4)`",#Z34K( M8:"R9I\)HN4%_A'Y\173Y8NW/Z%5G+SG:D.Y".`/T'QJ881$+9BN<3O'O#// MFCO,9[YY)^=F+")CIY4&!'[F;N'(3#$W"Z538U7EWO;)S.Z^?.?$K,M;X=^? MBVV^6O@$^C!%&*+ZQG@`"0I8AR,,!>D"NOOKDY,U#!J!W[W&/6+?HZW+Z+Q?`/;FE%YU1#U[8RCOZJFZFJ>;SO^IKB^T*_;YYWS[K5CF M=\U.XJ=\63YMFJ^T;S90@E&((T'K@X@D06%"DAYW!)3>3Y@=K/TDV!ZQEW^O M?SYPZN!H>TJ>S,Z-TXF9N/'PY\9%[]S'&Z_WTCNZZ;5^>F>.3IZ!9[?)!I/X M'.DMCBSCW.'C32JA*\!&GV\G29H*@#A+.8XIQGX8Q'V^-H+!\22/;R3WXS5, MJ!_D=6C^CY]MRQ+GR'`=X\'ULVTU,D:<;8,PB$1`",2<"4`(HJC/+8$D\)5' MA+*%Z0;$]7-M!P]L9>ES95CH.W#UP%:-BIF.KTC^6/V;MB0W]A$'24"J.8R$ M"8LHX!%+_!I[@I5>$)\+X__7`RR%5ISC!,M.`[ISA/70^/>'/\+JFVFR,RSU MCN'(O#$[#59/L72;1:4:Q6ND_#2G[**;AQXW6'`0X'Q-8$\XX(IA%7WA;` M,$2/M'")K-@VNT"LV"VKX7JH>NBIW&BED"$G@C":"$PAY"GA@@1<)=N!<`6N?KNV?)+OCJL\]O'UV622;8KEE7PQXKUH4ZFJ:?&$YS* M9LQ\"),ZW1:%*,$I8I3`),"$Q(G2J\ZV,%C6MPYV'41@&^6A$?XU;AM MX@O]2N[66DM.)EUH*#4!M=M&=K96]4@>VH"UW&R.J+)U-U]OYDY"J[22WU5] M,*]6[^T#0=4"YG;;E*Q=-7-*!VTA&$4I"GV"(Y\F84AI2%%4_::`:412I?#3 MD$G+.MVC]'8US!OO.=MZWVJ$BNIKBF$YL9V!7#5M/?'ZN>6UPEB-0Q; M>ZV=6$7EV!L03&>5$J24X3?2U-2*UYX1>UF/<)3RJ3.KHWA621VI="TV#TOP.8&ZO69* M6M6T*792S?2]&52QD22-4J^/N]VALL@JBYR*$,3(QWY(&*T"QTXO?1^.52Y) M,S.I5M&@,Z!8LFSJJY4%(LTHU<1+@ MW7".I""@C.$P(`PGQ.T M?45UM]:0$KP-G\L:8]T113/JTOL/%1BB2T?CW@1[493$`D".4@BKF`]CP<*3 MK&*JJ6W*=B;5M+'+Q5&$*FN:52[':-GC,<83Q*&V2M#&'+FDM"+5)U-0C"_R-UZ*;>1:" M[Y"C(D**=+HJ0*IN7!,?+5KTA>?\YHH@I%IJ$N*'*8M2'R"0D-XF%?[B6[Y] M*+7U1\64RB`Z1S5.ADJ9-44)%N$FE"E^2J/#M&DHD\Z[+HJ4EJ^7%,J M?8(T-Y]W"S7A]IPG5A7;O;%IM+,V^=\V]QHV+5)P?WS MOL>+E9^_Y/D>;U:GR^$7T_)82$-"0)#ZW$8D.8E6;T?]ZR+;5K+)^$<6F M0E-DZX^;QW+[M4%\L@XX#"/`-WN4 M7@_3.\,I>4/$*N=R<]X,=*M-4V:8MC*+R'$W(/R&R7=$JTU[55KML:HO,63[ M2GEO'T^ZO0CB%`B$0`1AI;01(SPBC,9IR")?4*!T%4?C\Y:5KD54!XDG3&/D M38=`.2FSS)V:;(V@S<[[%F_(&="E$4PZHD%C/'C]W,58,N3JAK-CP>`JUN-5 M;+A_.5,U_+#;;[/E?D%)2"%)TOI8"X`H(B0)VHT;'\I("M\F+1&"NJ-6F]M;-`E*9!7.DAH]6:-(YB0&AG@$9^+!,3 MJ7_5G\MM_5-ZULW?UD]>3]AO/+XP+?79F[O\C@)=C M.X9J?W[YE#\5]9C9[/^2?"\RKD55K_)57 M8U-0#WW^K@O()-2I:8@>:P9TY#TNWI&2T=0YH";C?2@-]B7E.$04ZWQ+*Q-/ MY?9E$3,,DR`E'(?$3P&+H],RGZ-8<;FB]NUI8I`&D]>!4@Y`%.F2#3_L,:45 M?,B29"SR^,'_P;A#CRD'=&(4_#42-T75OZH93WH-[)K,`HZH$;,=0&PQHGF*B'@:IJJ'Y_*MTX7T0WR#240YD[>>VP29NF>B@P M9E`_7A%Q14%T:7-(0[1=N*`BX^C0T)%6MEICU6S1HJ8.LHP8T(,?7'Y'`_1H<6#<:P(OQ_8(]9R)H2OJ@(6,Q1SY`:F/ M1H`?A6&O*A"K)1".,S51-L6ETE52=1FLT"M[U#$9LUHG'_JDFLO"4"MP89A9 M!_3(I#=ODS7,D:2@7/^=K]=_WI2_;S[GV:[-ZJ:V4:O:K1_?S/&I[7X6N+6VV5E4J;3EF1FH))+7W2(=&8,KW# MRJ`HC672&3T:[<@;*3)#C8(*_5>Y/FSVV;8]/=XM4AAQ$08)XW$2`4:K_]-> M[H*`J:F/ZM>G49T>59O4H++=HDF:K,;8Y$M+6^2I,J8HKS@85!)=OIQ1$&T' MWBC'."I45EQM/MJG_+G<[JL(J2XVD8F6F4=4RE[=%X+3WUUI4FE]+K*/HMZ*RIE`LVMI"Y2,KR&&L>B,UHSUH^W MZR83Q"@HS]WA85TLQ;K,]@L8P)0BY`-.&>,!B&DB^H#(#Z3>`=/[\C0:TR+R M&DC*NJ)$E*R8V.)(2T'DZ#&F&F>^#TJ%#D?.Z(,6^#>BH$^!7(D+6GY]SC8O MM]_R[;R7/U> MK-=XL_I8]:+-4_&PSO%NE^]W=V4E6R^GTE\I30FB<4S]`*6``A[ZO$9`1`(` M"I7>C#%HUG+TT2%M2KFO]_?BC?@4ODRTQK.PS-X*:WMO@WTHI M,'DV+VBAQ29QI'28#<]*Z_U9M8SAX>M#ONV+FE4+P/RIGIUW"Y0@"`'B/L`D MJ19]L6`4@#IOD&!!D=*C-OI6+&ME"^RL.E^]CW'$IEK/4)]).?&;AD0UK=/C MSTYAP_?H&1"O\90ZHE4&''E=[=`0-=)*=+$8]B]9L?FUW.U$Y7%71+LII_WV MKY+\L=SF;?'L^^S[(HX"1@4,DDC$Q/<92%,D2"`@B5'@,Z7'4*?&9CM"K)![ M]3,Z65OU/VMFG(G'JV%.!T;Y7*WGB#;,YG[IQB!2?;RF*[Q_^TBSW1>Q+G_? MG>HE`H;2$":5S`F:,%0M90&/6.(+GS`67[O@8\2&O=F\AU6+0@W,:Y#I[+48 M>IYC@*>!`6^$7D=&KQE?7K],88X@^95&OJ]MW6W+;\4J7Y&7O^WR:M73QQ=X MN2^^-:4<>R0)YX"@@*.`@8`"Q`+?[Y"("$9*2Q#SYBW/TF<#L.X69Q'V">M_ MJBY2+#2"Y.IE7OX5ES7YOM6_#J[W\.)]J!%[Q>:GBRTQGTBJ,SNT(K+73(X( MJDT/7Z^A;).I(KYMX%3'6@M,(`NIH$',`4M"PD!X,@(Q57LQ5.W;*H-6ZXG0 M>NQ^6%=0?II^')YX&!YB&GRY,WITP+\=&-H42/=YO/K'8;=O]BSNRT]Y[6"Q MSG\P?5^JCD\:ABB`W$\9Q`E(<`I0TF&M_B!5"4EF`6@Y:#GSR=N7WK;SRMM4 MP[(>E?7O+NNI]?EL:BW["34[3:C5&N2X"*S_H.Q?W5"->>;I!W)1D?-=0"UN M>M7ZO4->+YJB)!SCUV5,_N\N+7:/MG%$E';SC!BT'`J?8VQR@;(S<(HQK!F"Y6+2R;E5BS'/X=UX M/<#VF7$IANT<9TJP-G1&:9)T1X33K$^O3Q/-$R:?@GH\M+S=M$>6S8/=M\70_0>O]D5Z.N%AU7 M5AQ&297-;[#.IVIF0T/5UOO;IMA[+3*OAN8=L4V>V'")H,&4AE&,.J)*8[UX MD\9@@!25G95MGNUREK<_?MS<5>;:J..NW.VW50BR;;,J'M;%T_&):.H'(2:" MQ-AGB.(`1H"U8`),XU0IC=H.`MLJ]J7Z5>X5582^7&[K;9)JXMC_?,+J/>2; M_+%03KBVU!YR"C=_4Z@)8(?7^]`A_JENDB/H9O'T(VSO#/?TNUGJW`[O7%EL M*T>DU;*3;W>DK%.JN>7-_W4H]B^_Y?LOY>KCYEM^W+A?1,"'B"0@3L.`X`"D M$16=<4`B?\QVMJY-ZUO5[:+LT;M='M;9UKO/U_F7/%OOOWB_99OLJ6FA&^_7 M7^FL&];OT">]&3V6?G>&L$FG!C>1S5`V(G;JC\9H]ESLLW5_+H81A,PG'":0 MH8"$(19^AX"D?&3`I&UVLBCI+!>B658W<_.ZR!Z*M5;*ITGJ=6.C25@W$A"= M$@^.4.?+.I"G42GV&=T6[JBE<<^N1CF&R!NAFWBY+`^54G_*EWGQK3[E6]0K MW2J>8LCG083C^K%`T-LF`5".;,:;M![8=)CJ#+,CJ)LZQVRT..KPJRN+MH@U M*8@]T2>0L^O@6]Z4%'`$[:,)&Z%T=G&XJLJO(9Y$0SD)$POKE M@=BG*4Y$;]0/&!DK="JV)L@R:L&\F-$U)1YU!Z_Y-M3MF=['@H#ACFEE%/,_`"G(8W"SGJ2^'RL7&D9 MM:Y;#2IO>2P/VRQ>R\W3S]6:^.O5?`"K;&LO7JW1;'3AVM!^EC<_1^J%''EJ MR]4Q[#LK?>.\NKY,'4^:@27J7?92QXIU4E9[\O?K:1=K03'V4R`PHS2I_O.3 MZE<=&B2(/VZ;SP@$RUM^_STB/Z1[CM=),8XQ=X4[6#F;7O'=G M+7,$[ITAGUU=9>C56AH;:2]GU=>LE]++9X.D6JBZ0?N[EJ=+!0O*(D!BQA.$ M`Y\D*(&(=JB"-.*+?;G/UG(J;1F*DEKWJ*6EHK[!V-Q;_7#H+BE>O+7:W`JZ M>&_56JD.O9:3DW2'&DU-VC5*>-QX)Q^\6XEVF[F6,ULTV;O5S!H*G`88H(IFD(0=)GNB,?*>UN6S!O.YGU M5>72'JKYRJ6C&F&4DD[%OU%%O=02SE4N'6!6761--)/;8FO$0SG1-4>FM/C> M92_'PEMX^:]#41>`KQ2I0O%Q\_GPL"M615:G>M2;ZH^/Q;K(]G7>1P*X']&0 M092DU2S`0!KW>1\(I&J9%U8@3)(_UM[J:-(#]"\`3=@LN*>U?]_I[[2I?*EJHS;6KPJ?OT#65&TF5A77^Q;.[E"$DHC1@ M22)`D"84G%V)B(G2,9EE*-.?DQ7]PG/"7`EC+6=ZH\!ZHUG?-'`Z5T*2<2.; M":.:TA$MG\I;[4T&`R2/RI6X`.F=8[M(4!0'`:-)0##F7(`PZ$!A$(=C%(\IJPS/MJ%N1 MO+&:*8I-MEE>/ESTA0]3!&G`@H!"GR3`C_I-;(Z`@;V5,>8GSJ?HH9K/IQC5 M"*.4="K^C2KJI99P+I]B@%EUD3713&Z+K1$/Y437')GRYW;'A71=!/)36TO^ M+MON7UC^L%]$6$34YR$F24A!S#C`26.P"7BPI4A)U%$6J*)`B05/TTH/A.G)JK&T9EK-H_WY)298=QU%(F9247A+# M+<(W;S1O2,Z(?+:;<#A2?ZO@@4V^SPZO9/==8&JAK*VV9(/ID<2D'5O.*TKV M"-*.LR_9MJYCW2YN\LWCUVRW+L?C!&(:R)]4CLNH("%I3@I$)/7,RN*=AW%? M#=\MI;1M9RMP0*ANASF>!?,@4?8<7Z^1U1);5_,[DKBZWH[<\H/G;-%PL5A` M,24!#/W`)S[Q0NXEHD$5>)Y19G,,I:^-^7H_!BR:.6R/I5EK?K.]YG#N,N?K MCU&79C49M[(NN#=R]Q&[1A]V+KL.XSUK1]7(F&&_159MNPZ*K M?3>.)!/T9*Q&T=45Q0[6`M/(IQ`F">5(YB$8([FB;UX)A8(&%HJN78;MJ^AZ MJNS'`NPEC7MGV*Q MR.;[VX7X-2^O'?HRVV>W&P4JWCRH7^IVJ/]FJ_)&*,%(0OU4CHLI2]*`1DE3 M!`ZI9S1MMCJPXUERA55U&68U6B#36@:JS^5F9BFQZHV]\D-VQ&XHIG;]H2>G M@[G"3%"/7C@`!0JI8C\YL%]^$#KL.U%4$R9;--6)0T:BJFYLRWMXHCOL4+P< M[2[;+=4U>\\/AITR2-((8E_P..8,4B)$U,R.I=*;S$VM#MS#[/3#P\F!R_4A MS$M[BFK7#_J;"H.XH,,>PB79G(`**[AP*O8`&P:Z5+ZQ/V#=(R.15#>V75C] M.R+P2DF-Y1QZM_LMI\O?9JNG;.HGE(6^+[P0\00Q+%+4')PJ>!I.MR7H^_UL MM[]&44W'-8GCEXX^<4)KB?_\P>GJJW39LV?'""VK3OWAKQ M>HN2(3@W6X\\H_LBQ<,UU&NRUZ*+MOD?B3):-RMW^]@:WVE6G:MU-UL^3'T: MXP@&$8I20B'TXSC@QWD2\3*"YW M.JAO5WGQM,N^9K_V3!K\[Y2BD.`DP20EGA\D84@03YF7XI@QCB*C=Q:=@W&L M-<9]2`.Y1$^I1N4-,W4[0`<5]@EHT+_6*U8UD546@._*!E`:T?=<[%K26_2T M-W^.1(/[LSG&W6\ZS)%]O\XV?,LWRL"RRP.(PS+'&Z) MT@LIO&]G#9S!>S:]Y/#*G![S@*XWG>=Q!XX<*)./UH>]97,'OAPXG[_ITSXR>@7"34XW=-G[ MS^JF!MO+ZYVHULOL%T8KB^;[9)47$N+G;/TCVTT3B*(`1Q##Q,/8BP+$V6'H M-$61=NZV-)[K^O2EF)[4[?![4&,%WRNT1L)MBW"-]#H`UX9UZ?'3;)`!!Z"[ M6XZS1KM>"M/CY;4D99G5,:0AVR;E[AY"TY:G['%]S%=Q2C#V18!@&J4A]D/" M836(_"XBPJBQR>@ONTX/%1CS29ZEEIE3+MH:8SIQ-I("2D?PYTTN5U"@7\;. MI$U%OEH^E#K\40YUN[O)BR)>YT^;_50(PF@<(\H\XB5"!AB,Y+!R"L<@CX31 M3<77CN5Z6^,YO`E0`,$'!?"O":@P]EW4;&>LK69IB>N11)0U<\XKCE9ITL\U M==OH[:(.\B_9-M^IX[5/NMC8[_H?C_5-3N(@$(*%`0LXCZ%,@XPG`0D99MQ' M1CTCKC"XSE\G';>'7-8@/VT+G:BS%>K_8=J$Z\H]>OTC8_",X6*HBU/`]Z_J M$%TP7,](1Z+;IBV.73<2.79NYOE4J!=:37K_ZM:3VX5:JF2;HD10'QZ@UGPSA1NUEP-/XS+B&Y=YVK7L%K M.&]O%>S%FR/)`[V9^[)1L$>:M?/"3?8X6WV>[94.JE?WROK(8[:9+[.3P2.6 M8(]0%$EHV*G?YM+Y0PM,'Z$9^DE\>OI(_5*Z7W_P/ M4$L#!!0````(`-&+;D$R(Z&UL550)``.*&Z10BAND4'5X"P`!!"4.```$.0$``.Q=6W/;N))^WZK] M#]Z<9\<`B.O4S)["==95GC@59_:3HB\^+-)O^\@Z^!^^._'24C=/I]2_O?K\X MEA?Z]/3=W__SW__MY_\X/OZG^G1V9++1[-9/RR.=^Z3TXZ.O:7ES]`]_Z=)) MZ%8<'S^V/GKX6_CQC\ND\$??BO2G8G3C;Y.S;)24\R?>E.7=3RQB;N)Q.BW*9#KR[P(&1T<_Y]G$ M?_)71]6?OW\Z?2;`%Z-DDDUO_?C]*+L]J9JML6@9LP]"D MO@AZ5.K\=)/[JU_>^>)V%*R'"(@(5+;_K4;7\O[.__*N2&_O)@&!D\Y5-+Y, MTLDNFKZ0T+?"GY/+R4[(/A?0D;K3L9\6OGI0D4W2Y MOPEMTB_^+"MJZ-]68E<&+9^JDDGU=ES<>%_6T7MSQW[5^YCD`9X;7Z:A4VM= M5TKI7/'E:)Y?G8>'Y<]&]#2X]EO?Q((&XOHSI2)F4MRX2?:U$54V"NA5W?,[ MG\]GN-;ZOI;0J\(7-X&=-]ED'$(!^Z]96M[/'=PS;Y#4E# M5GH(3%J,YI/LS(_KOU)U^O:NI"P*/X\2SM+D,@3&98@1SJ]6MU4W_Q5>C2IV MOI`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``I_Z^8E62FH=_6K.&0^TN=7I],0VEVG`;V'O&P71C40W]C4IR6D MXL'2J;^NUCQGR:5_41JVJM\DSY]UJ\I6156V"NGK]6N17>J;EQ& MWQ9D*%^K6&/D[Y[D@VE2$TMCI(D(=`(+PI3@RA+#N`#.:8.P>0[%I#K+D.4+ M_-\6B\]A8%1X_A^[@K$4%$LLL-.::,&-C'CD8$07:"""P#8TGO)1YJ.C+!_[ M_)=W\-U1^#]7/L\?I[L-9S7FW"Q?.9(D'[UB]?..CRU.[N:EU\>CFW0R7O2^ MRK/;05B2#0A_,'CI"$Y>>H)>_]!NPG+3,0UUT$I`[EB"D3&.699,SB\GZ?63W9P51M7O'".@E5`8,Q91 M@H$@TD8+2QC"?]I7O/8(9SU#_N2U[NTEJK9\G@&B[C\D98#CP9"'G^_EM[38 M\`;5%Q(3!3B3W%D,!;<.<8?)`@'.J/CQ2=<'';*!\!Z><8^*F^PV2:>U*?:L M5TRU"N8IA@RTD%,=IF6TA)$S_>-SJL^!W\BM78`>@DQA=3P_H3,=^5]G29Y, M2^]_\[>7/M_`I?6=8@R,H09$$<2:A\"+A5EY86%DQ,%2J>4X9ST!6Y\ZA1^] MO\Z^G(Q]^L":\)>79`D_Q?-"IH=#76LFLQ6M8J0DP2'0AX1+Y1PT@*N%UL3` MMB$2VA\Z]#A;[0YH]S1X4&7M;/.R29C7+)">'059Z_+7-8T%"SZ.4EJ9Z()S8D#9A8:6\@.(0]L/2M8I M=JU&=YM'.DNG_K3TMZL<>3,!,601DT8*!0QEC+D`CEA88P2E+9D0[0\3>O3Q MO6(]1`#Y6!\SO3[S2>$+-ZO"H-_2:7H[N_V8W#]43,V\GN45PAN"RF:"8A51 MACD!F@+'&8,,1W"!!!7"_?C^IR]J9`/BOD<,/)U^_IK]CT_R31LQC67%E@D= M&2M=F/.=P=@APQ=X8$G1GR3"'8R'K:'?+RJ&I_KNR+B4%@/"N"(1(B$:8$`Z MC$=-DL[XR/2V$Q-L0Q0`FT5AMA,$=LN1$2AKPM M'?%?=.P:^_UB8_JE.^^X%!9+"9#$8=UF(TJ)1H32)XB@MFPD?[&Q:^SWB(V? M;WSNDZMRXXYX8UDQ)$YC%$D9(0LB@V'DEL&+$(2WY"+]BXL=0[]'5-R=@#%@ M/()*!+"-P$9P.W\+'U]#0=NZ0-:8=J_J!0^3=@T!'R1_/%=XJ7^-`I\U/6*, M)>(Z(L&U4X7#:Q6%Q=BC;8ZYMLD^_J?S8=T`/!AYY'3\J1JWB?U6G3_9Y)=6 MMH\Q9_,=],@H8)%E\$E^%-%(_OB;=YV-["JF[(AGJX3"8SXZRY\0?YFC'C_W MANMR"DUDQ)8#(0&/$#5*<4UHB""7.^E.MLT<[M'&6M<AI!A5);96$8X(@]((HXBCQ&CJ%&76LHWO M4$\C5N>+&<,/C$NG09DTO`E9,;_0H-EHK.T>2\EM1"*#)'+062`-$@`@%L)" M$M[CK6ZL9\O7'=-9W3#62`?%J54(,JRAL9K`A36,HP-RRMT.[DM?O`NJ0RP3 ME@I>C/PTR=-LRP&;E>UC@IE$$=28<-8PZ,"D@@A`WGEDEGM%[RFS%U@!ZCQ3!F'6(X'!L>-[5JD^)%^]@Z M%'P<1(:&I:E"%'-DEO!0?D"GQML.Z$I>[`;C$/2H/I57K7?#']6WVKXDD_F. M2?EL2W33UEV=_K$4ICHTPA5WCFH%"4!+%+DD;7.N>SC1=$2?/F`=Q-L\7-%6 M5-?[!JW#7/O!E]MS'YNZQ9$VR$+#E961X!11NK22"M+:]^QAMJ,KW],=FD-P MYG3ZQ5>YO_N@Y0:./&T6(VL!CXAT0G*M!:,B_/!HA2.HK4/9HQ+=CCFQ`WJ# MU))5WYM]-F=N*AM[U3B6R(:I5",G.:?2.4*L6%ID9=N5S!X5R7;,AYTQ'"YV MG7\5[2XKDLFO>3:[.YV.)K/YAU-6?7:LQES36FBLF0H+?0<$=XI8PR)"\0(A M"&C;XWM[5/[:2Q0\`-:#KZ3JKJ#B*!)0!!J^7]QTGR\,WH$)_?59L)F\.73=UB3;AQ"+J`.A6.0(2X7%C) ME6N[I[]'-:D=DZ1#--]L6?0AFX[:K8R^]XR914@S"C6EC&-F`65N::OC;;?Y MQ<$RIUM`AR#/KUDV_II.)AM8LF@2*Z.9CJB,`*;`R(!0I);:4]?V8'=U^&#XQ2;"EED! MJ.)DD8^CQ+BVYYGAX>XC#XGW<+S<2K`8A3F90*<=4L0BA3`GR[2)DF)ST>\& MIC3?8?ZQ]G$:`C?(::TTN4PG:9GZZF3`_,-D-]DD#$=1[2*4]W7.%M<442TJ M"(@,QQ'3U;7RCB"PL!XQW+:T=P\#GPYK:GI"=V!NU2^Y6=\I!I9:1QQ%,KQJ M6HF(?\_6(@@.J-BW^T%?SZK=4![F1.GT^K//;XV_K%$^L:)U;!Q@4E25C8X+ M8K2)HH5-+,R^!^1Y^F?.SO`.09GJ$\#%Q^2^VM)\\G'VBNZ3I"CFE%N;T3K'^8!\RO?%H0/UZK^<=8L6C MZ@@F)MPJP(B6`"S*LIFRH.UVP!ZNQGHG5"<(#\2=/*P67\_.F^FSND\L$52( M!KND4,2$Y::8I_ZD8QI:8]OF/_:P#F@(!G4"\L!A=\?50CM*CK$T4$8R+'QU M""PUCARURS@!X;;[!GM8,C1D`#_`4+S-:K'1*C%V+%)<*F4IM%)`PCAARTA` M@*TW8?PXM45OL#ILB.[0J\):N^.K.\0<(@&0@R12FD#FB+$+D)BAK>_;WL-R MHT'7AJT1'J1LK;K+(@S7=#PO_?V8!<-]F>;S/3M39:[]6/EI^$M9%5453Y"K M1;5.Y,?&,*S#NAI6GQ_C!F%M%V=L&9/Z@,J9>F?F6PS(P)-F/1^XTBY,C!95 M.L*`"`EG[?>]:::Y:GW8M7FAU$'-G:T1'I@Y]?@24VZDTP)SB:U3FDL&EB$C MD%%KEC3??S\HEC3$=9BK%%JD`3>@Y*#%#E7?T50<,P0,DLM-NNH;TP=4\M0[ M9CC`8^C,]=ZV_'I%:UCYACCSC++()50`8XL7=A$(GE`.;\N!O;5P8!= M`1WDU'UV>YM-:S'D9=.8<&ILI(U05&K)&0]1V<(:X41;>NRA8^F!'CNB.00W M_I'DU;W'E2_]E%[?E,7YK"S*9%KM;VW@R:9N<578#JV#7`BD(\Z@14NX)-1M MJ[GW,%/7`VF!--Z`.09A/ODRJS0";Y-/JD[]R-)K=SN8YZ&J; M8)1N"H&W=XX-#^]%&!2-M+;6&DLT7DZ_0AW`!ZQZI%'G^`Z4TUTH.=][6G&; M;G5O\`=?GE]]3KYMSO0VD11+"[$!+BPK`=0:.!>@66`!L3B`#U3UZ;)Z!?MM M5O&-5N^Q!`P&=TRQ,!Q`":05BU>)*\;;KMKW,*'6`WUVQG,?BK]W*/J.@<$B M+"$$99IK;@@(8>'"6H-QVXFN^6FFP]HM[`+L)]0:]`;VCW,T;WR9CKZ'X`=W M'3N%Q*E(`,*E44R!2$OZ<"-^)`3??LJA9\N;7L?N>#!`.,@TI48)!B.YL,:0 M+??[_V#[;UT.[I;KV!NA.DRPT,5U[%`XJK5R*(*D^B@19F1I%R6N[;>8]IDM M#0>TUG7LS6`'&6$XBX&P$*>0\6M@G&3ZH3?V=QK?V=>S-$!W4 MH9RUNXY=$LD%5!'BD"!#M!55F>V#11:K@]K9[]:5M,5P^(1@"`C/\[G>XWD" MXJ//+VX"9K5SA.L$Q"X8*2B&2A*H.<9:8[VPG"AQB!-1BV'?F"[L"-OA6377 MLI"S\B;+T__SX]IL>MDQAM0Y;*R(L%/2*4TDL@M+M6I]Q>4^^Z"N6;0CIF_% MGM.BF#5FSD.GV`0+K788,`HE#$CIR"W?#PC;%J+O97ZQ5]:TPG/@BH464UB- MWK$2`&EC)$;*2*Z@%789SU57.!Y2MK$S#G4/[,!D:C!S;>@5$\*9`Y&E(HJ" MIY72&?S]A9%MCR+O98ZQ#_+L".B;D&;KA+6F1VPC:9D"&$`KN7%A#8G!$B\J M94NR[&62L#^RM`+S38A2KX!J4[?8*16F8J4@#@M2`0$%7"VMU&ZPQ.`0]]3U M29KVF`Z8P7FR+;XN#_[6J9R!/WD,(JD@5P(K2+52@0966V(X=$!1";>N"OQGESKJ<9P#].KH!3R8'V)FL.&`ULKU-(/QQ\OU4"R=PIIH*2@.Q[3)-V MXUL[U],,T1\AUP.PU=Q@#B(F)#/2A776]S<*MEV#[/,^:T>NI"V&0[#B@R^_ MUTEN(,2S=K'D6-M(.,RH(@+9R&BWL(-`<\F18A_'HXK3__U^1A,,?_.RO*"B_EKT*?S;72/3TQEK:ZQ15P MI`@(7IB']1]88*O:W]Z_SZYJ=WKNQV`,M-WRTL@:A?T;>L5&$\,$C61D*9]_ M)%G;A8V(JK9A]AZ6T79(N.X`?8N=EN+\JOK6L9MD7XOGV@R_M[)4I-E&RJMN ML0;F_]F[UB:W=>3ZCQ*\'Q_Q3+G6>\=E3[*53RA9PQDKT4@32>/8^^L#2B+G M)5$41$*4G*K=O;Y>@D*?/FQT-X!N)@D6ABD?='**Q\.&NXUI95< MD*DK3I&T56BK%,EQ,%Y>BB1&?0!9[P`@FFCC471D*OFDM:G5R8=,DS3]MDZ1 M'(?H):1(J(GNCE`2>(I3KZD M-V!6)=#A8[*E7YP'G)S3V!+C#>(.6$&T!>1%#IQ\LNAHON38^>]3SK%L%O\SZ=MZ=(>OCYX(AA"'LH+18"1`_>\!$A6K\ M/U+SR@-<0#,2=P":RL'_5]G*B/;.NNIU(0BU6BTFWY]7I?-28O(T7Y1RNCB@ M\4)]9[\1J.0(>@8IRK16KUP_+P$_-#T^CPIS M?`*VB,H?3]9"Q#]/BVV&7CV6$__G^N\;V-UF>#!:4(<9EYY"A3E43KA*:D63 M:R,-T$0/BK8]Z"8'(ZO6X9\>GT:3Q=JU;W9E=P\(A@O!&:;*(^\]==*!^EL# M,KG*^C"[+@^)=YWH(PO31I-9.;6;V:;1RKHDQ,W]P6ZYC>,"E!@9!DF9Q-#0 M&\-UG=B``*=N(;2_XO-VF;[]LXQ>E[K)5LSKYJF<9=F@P/UZ*F;+Y@VK70." M0M8X2ZSA0")9-KI7OO;T@;JB^H.#HELGVL@4ZBR*T;*PQ>:?GV8OK3/>=LVX M^3Z=/&RW]1( M^WNQ^C&/N/TLMG"WCL7WC`\40,RT`%P2I!4"DE;'[)`J#]HEDK3]-:C_C[.[ M4\]Y;&N-SK8@2G\GKA26E?7A%5-("VO3"8)2"$GAEC1'Q/U#$?ZN085ZGQB(#K!=TU@6U0QT,ZWB9 MV>Q4QK][V:KLY*C9KA<'8RG0W#K!%():,(&9J9!"DJ9:S^,;V_9^IV50@4E6 MK66Y;=5.FMT[\0WT/NF]`5"M-;644\Q4V3<"&5SAY(!,/B1W?#?=/RONSJFU M85GO3BQUT%IP3)!C5CL/%,0D>EL5`L:EUAP<8G_?0?&V-Q6=D:2;1&Q')]@; M7A8<1]Y(KXAD6AE),!#UY@.#[+KO8W=\@KT[G',P+_KBVP]8C?_G>;*(;GI4 M0A3@T^S;\_?EY&XR6FP:YJC[^^BC1_2:#&7*ZX(0P$%JB,5,R/@Q6B!YG0!A MH/]B%1G3`'V2YGTQX/YU<1:&1NSNGDN8BH-YJ(-C@W5(6QL_=4.C[\(YP;Y. MAD384\M,#S+3>4[NG0C\L!;A;N+\EB\.TC+FJ416"`^0%`:\VG3@.C42&F`E M](P$S:J3CB8$\A<@2R&@%@=&I#DN-/;_8>H0_2H!Z)_QD9N.U@ MV$W\W?"R$-T@+!DVR"(4HU$M0!6"1J_;)9JW+;XW<:QI6*#*4P,=45H0`[AU0(E*2JYX:DPSP'H$?5+@ M0VN=SA#/P:NOQ=,V!+NY_SR?/=P6B\<#G-HW)%@"L&#Q?T644@M'.*EW@"'Q MJ<6'+RE&[H-1'>$]K/6QF]"XY8N#P((PP"FCA!+$+3*N1HHA=$5-PC+R,JM. MSA4:[Y"FD]"X]7L#I8X+["P4BB"H,(B?>ZT>*%-;LUY.:-P'=W.J9%B&MQ,C M&R05`!@C+(R?+E`P.B_UUBAP(K6(WN6$QN7,S(PAXUD&L1_SC1+\5B4EY8>WO4],":W?8U00/B)<#46:6L!H(X)VNH MXY>9R,.C6[1=E37L40/GXZ&*\"T6OR-2ZT:I1Q/PW?A`C=`\NB.(0VN@QL[# M^I2HLSZU^M31EPZ?UFKYMAHM5M?-O],4<#W$(Q!9RPT&QD/(.-%&U>E_ZF3J MAMW1A\HWQ'.SJ\GV]`%_EI(IST]/TW7&?C2M2M=_FMW/%X\;';=H:-#N#<%Y MZQTF4D.`+)<>HI=/CCN6FLP98$#WFLCG37D^H78V) M72.BC8=8$!L-O&9.(D6$)P`@[X&4E-&#=JXG.Q\7I.77XFRZ/\+>QZ[M' M!!C-F""EC)P``Z@$5FSE4YJIU,OC`_Q(3];P>V/>":)9O()7,RTK$)8565M2 MI7H\.$(L@IPSAZ)P%%J(="45I#CYILSP>'*R7AMXD@AG#I*L;Y^_D[V!)+L> M#\QHY87U7@KG`696V>I34HCX:VIJVC%).H`SMR5I;T36LE!H.(RP(&L\]EPJ MYRI9`%&I>Q5#[.G7H_TX'LDLR8[Y3-F6>&QS[&[?D*`,QY@I%!=AX:&U M5`E92<<B.(^1$\&.TKB, M5K)X#%/O/@[0#3E=G3OXD0YEEM6EF,9W/OQ;,8O!X[2\ZG;W.)E-2KG+NT@M M"@"W>D%02B'D(//`<4B)!)36"!K%4GW9`=J8SDG4"\)YCE@NB_@[95;7QK5T M.G\JC>YA2C6."P9;:1%&AGHGC?%<45![:(RGIK@&>*2MP%0 M3TAT_;RE1$!OL`9UY.>,3CV?>W3B/$?OA\HA$HY` MJ:U3RE?2<*532T4-\%A7+S[."5AFR;-4-4Y:]2+<\720)!I$H@GR@%!-!':L M3@LH"+-U;^F?'UV'2*>CF2T3MYGA<4%U\\`0%U+I5#2/UD@F>%Q&):P3!]2D M.BL#W++MG#==`IO%6=FV>MG>?;J=?YZLMLT+OA6KU6:OLLEW:3,^,&,]B]X9 MMH0C[HP@QM:?CDV^"#G`8+PK`NSIR-,ES'E.`^1H-B$IX!K$%=L0*B"`EJAM M@D*!:*-32VD,,$SOB5Y]P)R'7M7L-A)4QQ\:&;5[2##1YS.44CI<%;GW9,!6@\\DAP23JA#FA)E*UF\U:DK66IC MNLODR2F09KF>-9_-WP8`AXFR=TR`0B/BG!4$:LXPP@;B2CXNU!5%Z3T1IBMH M\SL\NV[2ZN)^7A;M*Y^['?TJENY7A"!PM)*/^5&*[<>IBUEQ/SG,V@\C M@@`B"J.T,)AHP8%D1E:R:8533XP/\)Y@/XP[%=%,!7+BQ`[D-%\>"E+Y&&T0 MI*R6A@-.$'"UI3[H`._L=[[^__5:QN[B.GU6JUF'Q_7I5- M1LK"Y$]E!_;9@XL#5K];+XXG_$:@B%)CH&0<(R"DY=;I"C]L5&J%N0'V#.QW M*FXLHG5>Q6B0>ME\@)LNIZOZ`'=.`78868O"E$<+NYP&QH6WP`/*D"1` M2<)4]<5!2&$JHP9XB*H?1G6!ZCG88B?3YU5QE^"&O1L9K!4&*!>=5R)X65Z$ MD&K?'#)D4YWX"[!)G3MBIT$[&%=L*T8GSMCK=P5+N-8^PA"C87?:)_QL7V^$4V1*&`)=1"@>4+S&@E:R11\TM3A1RGRS\CXA^*OY\?OQ>+F?CWKYZB*(<<_:/>$Z23"G$<[7KT M7CS!WI$ZL)$F8T&"RW/?^@3ZC(1[;5Q?BW$\Y?:]*4CM,(-.4D611[8\ZE%_ M?-Z2;)?_KH=T'4']BG8YRZ2MI_UC/HU:7&[.9Y=5)^>/\;=^%+/EY&=T#4;+ M\]10J^<9I[F:C__[[31;5!QK,SX0B90U6DL,&2#Q#Z5Z-&;`"X?C'P]]$3W+ M?EMN5[<1CM-.W\<369-X=&NYX-11&#O/1;::L<%M(9LY)*NK+Y^A30Y3;_O0Z,. M4,U31.#Q<3Y;F]>_%Z6[T\"4#\\&J8Q0V$LE2ZDHAIC22AXI6&H(/4"6G*C/ M#S4$3D,R2P0S6BQ&L]5!5KQY+@"&C0$:`V@P,A:2LG+Y5@X+9:IW,L1T7:>, M.`7%'&Q0=W>34B>C:5D@^M/,C)XFJ]'T(#L:QP4F+&"2VQBN.VZH\1S)2D[G M8.JFPQ`3))VRI4M4<[#G:[&*XA9W5<1^D#:[!P3/K(%&8V^B4+YW`F<7,C,?/C\_K2@7K*X%O\A2;C8S#)J?M.X)2CG@J35GH M7D4_3TD)*_FU!*E.[O$7U"Z,3GTAG#6J_ERUVF@32M M]3HZ$,K5GNL4I7[@QXEH9N''$1LV'_<)(`%.$42`D5X0#EA9MG0K#_`NU-*JSS2HFS.4R^--+G=<_O8)V,]D`X)<0J(.SO>D%[8YJJ7[]319[#QRE?JJ`#4NNR@JS!00`F%='CO:2DAB3-)[)/;6 M&-Y>`NDR@9TGNWA8BK4G\'VT+-:'%^+7M5;VUR*ZC,O)JOA6+'Y.QL6F;?#7 M8CQ_F*W?L-6.L6-4C#&ZO6>`4M>L(^NAQ6`X_``4$T>@>:URVJ@9: M,\/J-!S6*+6E36+W\$OBQHE0]GSFS\['S^N2![.[39&35QUACSS0M\O@3=];LMB_"\/\Y__>E=,-E]: M_,/[#RS^55C/;E(L]YW$^_!,8,9(Q(F-$T42N?;@3<<[9NQU-!0FJ(-Y1H1`"SBBIIJUE3YJ^@]_0)FIIWA5OW MVMY,9>^YN/>/!.BH(HXK@K4D3`,/.*_FJS"\@D(5)VGI_5>=!EM?:GYEL)HV M_)H'!,DX80AX%9=]&UU":3RK9)$"9TO@#_U3[PS"ONCPM7A8-Y*;K?X:/38N M]>\>#8H:;SQV2CK.'"CSS/4J9P2Y@F/W72GP`Q].0K(O)IB(Q&(T_12=XE]_ M*W;%VGN?#58I800NZY\J!J.9Q*"&PEI]!5TC>N/":5!V3X9-.G[E)V5T]9_% M:!QO#QSU\V/=X`)YQSPQE@`)IK?74N1=K*?(US+HD2G2$9E\FPD^FQ<+$ M^3S,%\T&XLV3@5N%!9+:*:*A!);3EX#(,=Y_IX=+Y,+I0'9/@RK\O8WOWZ/_ MUX\$IH!Q)DZ38T\9I9YR6LW7&YUZ/'5`YPE[4/P)"/:G\2]5HK)A+=CY;,`B MSMQ;"+&21)2=(1FH)$!4I&:&!K3=TR,'3H&R/S*\K$\^_LV^\''/T\$#)1'@ M&@E'(51ETU%128%A\GW\X^O/7R(A3@.S;TILZ-J>%*^>#W'.`),82&M*J;'4 M(*1KQSQCR_C?DD$.`7"WC()+YYNNX MH,":^%]9\QRAY`H.?T*6\C0L>UMH-NFRNJ]->SX9]GD^>[@M%H^V^+YZ^\/U2;#JU[OZ&5M>,I^> MIY#H^PDM3RJ$:"?5G&3W@IJ#]7F;CQC^+N>5K%@!;FV[PAE.7UDD..*"\8]%12["@.*<>I!T0%YDMU0X/TQ MT9X`3KK*\W_L75MSVSBR_D=G<6_T(ZZS4Y6:227SSO+(2D:U6BEKV=G-OS^@ M9-))QI9,B!>84N7!LD-"0'\?@$:C+Q]7GS>K3ZO%S>;>+`[.\/N*L=_JV_?? M/WWWMQ>!^?2B3UU6 M.Y743@I'G<0H$8/`R&TSMJ2$YUZG%<2I01'/8U66[+-X95?;Q?9V^<]OBW0& M?S&KRTN/5A8$\:$N`"^HH>D74*+I(2,FM];SVV5'5^2VO0JX%*]LQV3PA`?C M4-;.1,32=GIXS,ZY7I#58_B-Z'RY3N^UC4"A#JTC((Z1?K=;M%(WNOOF\_^]C.4%>]WI%A+84@!J%7&O"=%U9XW$D@?H9 M))3N#_7B*O**5RONI*&>$Z^LD$A$2'.I&0'([$1[!6T= M8Q'D3-$.N8JXF]U?=:J/,U>3IIE*25O[#`9MT0$WFA'7[IF4X@S23$^YJF2* M>4@"O5O=_+E:[X,9?]TLZ@O;<[GT3(N5%M%Z\,`BY3RD?A+>KJ;,BMS`X(+N M3:>DU?D2'R,OR[MM6D7?WWP[<0/W_6-53*J[CEP)L-I1EN:(;4>!QN=Z7Q04 M)M(W;WH0XQADJ$?ZZV9W?_==,,-JD?I;_WJ$'4??JXQ'XJUU4G#P(2"M*Z`W MIX5T@LBD2T$1)4/1I4^YCL^?7S=)XLO=_8>;^^4^I=%M&L&B1O+SL:7F]8U4 M7DA#!$`:LO62":%I>]WMK<[5BPH*31F'63T*.<^B^FQO#GQ_T<9ZY)TJ["M: M"G4(SV=).++MLX&8N^04%)PRB&;3HTQ[X$$]HM>A7S]9<28",TX[PJE*?27& M/?4ODES,"XI'&0'S#$GV@'13J-;>K-?;[>9Q@]N%S>WOGU[/@E.M5(Y:FE8P MJVVPD5@BC6X-!,*9W.VBI)"4$2C2LY@']B/];7N_I,2O=HOMYGZU>5C>_OYE M>;=O:AI/S^>[8C:WZ3^^;'XJ*6F7-*!J&\D=D8QP(*L^8-SZ6>]> M_>&>=$HW].D6)^V`::H%>)/V#C\Q=6>_=>+X*=?WD7I0.2FH%$9K2I1B1DI)H9$_ACE5 MPAV,F=NW@-P89J#A1WZB@OPX':@4D>@YBRQ0X9F@)C!L)"^)GM&<*8[+H\^U M#,!'L;AV&4/M6EV$_4\E(IW1[Q$)^A% M):-+YQJT"W(5NZH7YZ(^QLQ[M&2>:2!LU0EHIR1@IM+E&.*Z`@B+XRB M9K'8/J11U$;BO1VX]OWZL%PLT_#29O3;\H3YM+_OJ81CB#$=)DP`"RYZY4(C M1\XP=R4N4),8G[J]B[\P&O^Z^9KD_GP"^7.:JP"L4CPPJEVT(AU5&+12B83G MGN8*X=RU(=\90@Q[ZA4D+%.EP@ M&&VD#91Y\Z3_H\M-R%Z0^_UT5.U1\(61]M>$^.;S*JDD!ZGVQM5G&JZTCK). M+4JU<-HJQVR=E>P1J9A=2*0@E_\I]_9SY5T8,_?;0^_;^^-&HSCQM>,ZY1&I M!ZY>KUP[HI&VS4VL5,T1)D*"",$(9#S2T MLS)]S(V3ZQZ%L+V_6;\%[@TOY%%"*I\<_EZ3RO7O3U?($:*J4^`08,AJ)8,U M8PI4YF8Q+=!>\Q;LYN;RL_AQON$Q3^#E4?+NX8>8^=Y8^5.[%7%.@/:@#4?G`3TBMJ8'*G,3ZQ6X MN$Y'S/-D7A@WOS=?]4[0%QJO2-JH7(S*(4G("Q4(ND9B&K.K[A5H'9^(I?T( M?F1]LJ_33&Z3E24R)#P<0R+3CV`-M#H4US!>RIC!CS1]TG(D<>=E)-J?N7)[ M^+P5L9^&*U1>!,\M!1<1I0+_)&Y$FIL*N?L:.#C92CX&30+F&PG<"XO;O'"] MER8COM"GE^T(KWJODD(Q)@R5UGN(G@>/B:96>2-`R-/)YM^J3V\IX77>2BY( MX")M&T(!"HW0R-\(FKMO%G0:[IF'$P73=<-I'G[O9033H3>@C(PL>$:Y`I+V MBT;R3/,9)$HOELO3!--U`_RR@NFB1Z*(!@T81+"$4MG*!CC-+FEXB9.A&]EZ M"J;K!N`\]I%WA<5/>4*-=,)Q&YF).EI1)UQ]Q#S8&572N>XHN:@79FHN*&;` M!:,EIQ")(,)8PK5M5S!)?>[LN<@M*(.=@P8D=,.VL#DR6$""!2ZB#@X=,*J8 M(-KH=G5+TKKN%X4R/A?"PH@]8K0#>&*M4-JC8A:D`@D-*!KS5:,";Q=G1O6S ML2S4\_)Q2/TZ8#XV6B76<&5$,-8[&JG7,LGL44*:\-S3=(&Q/6^![:,!6=CR M/G'4D`[!>^:<0HE*URYBNETF0+'<);_`J*&W,`FF0;6P&;'?S'[;'HKC#*#S M_-QT%>I:D])!`$0O.,B(H9$6-SS7J:K`L*29S8$^X"R,_+]LM[?_7:W7_?"] M::TB@KM0NP(C(SQX$.D,U,BD#KF=3[S3S"B>B6!AK!XURE1$%XTV24S<,U08 M@W2-I!@5N1DD"JKR,E.NGP]FH>#* MNZ?+-,TQ.\7\]68T3_OH`Z61^/?3)'D5!9]_IY+",Y",("526$O`/BE0+$+V M8MGYQG)NJ;//X&$O4%U:N#!72;Z1.T0:`L4Z%=G3]11ZD4ODZZUC%HU'PG%N M<J9D)(Q2RYEUJ*%5=Q!Y-HNO]X:=6#P)FA,&(O]0E^>WF[OZSU^7EUD> M%!5S1"I)C$)$YJP)C^D%@0?/3NKE;S6FII3X9:H-,,^<%TXJ@FGN\-#(WW@W MK]);PS!SHHCF;LB]7D'=+1?_]WG[]1^WR]5APJ0//\^3]*?JW?+SS3JDSMU_ M>R'0^)FG*B80M9;!2D^]H-1[FO:&NG)]6BV)R]YRR^-;<3S8]H5*_UPZ=.7% MJ-N?'ZF<"#*IJ@$55[8V5B4MX[&_$5'EYM$LB$5GH;3M16Q9VOZ9E2`%&&-( MK.V0*O+@=+#ZT$-G`V#V)6%9P.:!^H>[]/G=ZC\/J]N7KA/S&ZLL\4$`)R$=4D`;HJF7[4(EXV@G M^;E=B+^:/=N1(1Q%&5XFV>RVZ\<>_I)VQ-_OWFUW._/OVNODF-)[_,U*NJ@H M!J6%,2S]$J1JQXK&#)]Z"@]TW2P_)Q;=_C&#%3F?L\.`-N'%X+[GFX\WZ\S+ MP!>6>7?XIH3`ZQ,/'WNG,HI93R-&*H@T4C!O:)1)4S1$6>9.ZM]O53$LY=+. M2@C<4,X,3VLM@HPD-O)'S6>0PJM'#DYT/=<-HWD-;)*#WN^8_WM\M[V_^=V0^G=UV);E6Q@)WU!MNI66!\T9>M?_) M?+:"(EFXG1;/-V[&12L\!BT<80Z]H^ESNTD3GEO`_6K&/8?"_8(VH1GWPW+W ML+Y_J;9<[Z7EJ+W9K=*WO?^>E*?JRAU[J8J":4-]<#1Z%IQQ7A#O$I@FR9_* MDQ?.;U41+<6^*X$K)KWVC(DZ2UQ=\'LO?\VUH.E1+)>G,?!V`_RR#+PB$)2:&V.28@`@ M++&AD4VP^8E-+G$R="-;3P;>;@`.;>#E@H'U@L=82%Z.K>^,BC3;MO?.A MT^!X/6_@[2;@>:@-I1EXI0`>D8`R*)F-V@G?0F@MS54@+MC`6ZX"D8OZ&#/O MP_+K,O7VV+1H'JEJSV179TPVQC)P%LE^W4@MIX5$B!G=O!7)B6TOL!1KE/HQ M)\EEIB)QSC%'//C(36"2@9#^X":JN'"GLP&]U=VY%*N7%EH18[6AE`DOI0V! M-_*G5.6&N12XP@W&S(E,8=V0FX=.6X8IC-FD=A$1G)&<*JZ%Y;*1O)1T!I[` MQ7)Y(E_'3H!?EBG,@P&F@A&.HF8<;%HV&]D8FQV<C*%=0-PBLAS M#(SS(+@"KU2@EO/HFAYR#MGY_2@5I1G*0%H734)!:$@( M"+!H6C"=S#4Z7+"AK%SU(A?UT76,X^-XM,R\5KUX56,5JY=>XR`.P,$J[[:XVW-6%)'[YQ;L8;ZHXFAI!,X0-7AI(D/6K@5I,>=T.G-+.=*5Z47` M.S3Y/R2NI._XJS;NIKUHO=U7>.^/\T?;KR)/VQXX(`:)(A"]<[HU'(N8J[=T M+C=SV4OZE)@6ILJTR81>G@$]M%JQM`($SRE7%+5(=`+=GK*"Q-S8I.[5:;;W M-^N+Y?WX2);*]@-*=2Q+SX1_:KA*8@'E''+FG+!UQ1,?&DFEE2&7\]UKV5PY M/S:8(]'^[UUO0@ICPJ@9\0L>)G;Y:7NW/`SQCZ.AJ3U_4R6!0E+]J)*660K: M0F@-R2Q@;HI!N.K[V5-C0GPGFRM/L_MQC+W/D>[?4)DH).>$BAB<9&X?GM]N MKRKFWF?IZZ;1V\P8'-7)9D3J:OCT:;FX?V&B=^7_J?8J'8(#Y,BL])9IC`Y5 M>W0*)'V]XSA>-?"1R?H[K=E&E`:F[F_OUO]^7!?WP7^L?VP_+*] MVY]V]@5A3E[Z]O`=50CI0$6I5T(JM$I[]*TO(6+(3@A&KDM^SB28"MAR/=&S M\R.\=?]S;KTQA%@G:$`T`;SST;+(K0(O[37KPL"N&=PZI%)*BND\0;@F)FE- MC_)7GEVP__FKF3F1_WDWY.;A*E:&_WFD0>K(1)W@C=49F9W`@^1!H=,S\H!YJ0VD>YD93"5YXCPD%IGD( MT$YQA2-D8IS1FEFZ`I&+>F&W^H-XF#.-"3;'11H])T0(JV0C$2WE-4__L#P[ MW\.\&X"%47HD#W/NA9`"TYX;@HY*!R)"*R/&KN%$I9+\3"0OS<-P[PKTXN`=^8>YHS8B()I[U04&GE"HI4%RES]_<(] MS(I^8%J;*C.1A;CE2981T1IFT"&#:]*#=`)7*M?5=N(?Y"*K,F4B6RO8Q M/,R9CX)&YY!`4&AXX+%%AUD@5P_STCF?#>;5P_R8OR5(YEWD3,L(EE)/$-L- MDU&?ZSG0V1H_PFZ`7Y8?H39:4A.%-Y$H'C4WT$)'O)[1!E(:V7KR(^P&X!1Y;"62 M=&0`*:P-,G`KG==-#YG3N::\`BDV.(:G\MAV$_703J5:!1NH]6B,"^`CT_)I M*C@WH]KVHP*?*^!YZ)"E.95:SP$I=SJD)9^88`*T4RXH/2.27[7)7-3'F'D? M%W\M;Q_6R[VA^?5#RA#:'\O_9^]:F]O6D>P_VL7[\1'/J53EQJDD6UO[":78 MM*T:64]TCN/G_/_5"T;ENGE6V/`&&?%>XJ.GW!"O"ZN_^NN M_/[?-\5\NS#$/[Q>#^*/0O5*?UX.)J>#V-(L9#$H0MXN72" MMLJ^<&N_@W7BZ,^#YQJO/PF"8.$A0#"E&Q):1:N@'F\T@'GN[=[$])RMI;(7 MV(92\[OE;;EZJ)?1@_;[\0:!"X*8%AZCZ-YBCXE3M*8]%]D'MQ,RM?N9ZKU! M.(;=JA_7<73KM8U[Z&K^K=+-\F;/OMG&[.S>67`VS@9.N(,T6C,D@@M]C8C# M,#>H>&+K2A^4*$?&^DSV65Y"H$-'I[_W?^06OJE)D%I`H2A$TB%O*(PK>`11 M`<4M,\XWKH!#NYZ?B[MDM>_21;T@G/[Y])=-5^<9O05C#4?&>"\NHY0`$Q!,PI M"*6+0\=,D)W\5%W0C<:@[,A].=6+5L[`RH/.3F]]!T:=MMHBP)V%$HBX?[L: M@[C#7D#QL-'9TA]+LW24Q=,]O]S,UO=J8Q9EM-KNCM_@M6L=#("281GM-X,P M1I)!JVLYO(?R[;MC9^7:(%JXC#O`:<21>`/B-/5&X:C0GQ M?TPK8-+*^[-BPI0VTAFL@=4>8DL%YZS&AE"8FU)@0D;$5,G64TQ8-P4.'09$ M?97151B;'C-)82T3V]$XAK3Z3ZW/H>ETDCY&B5W8(?9TIOBTDS1M]$?;!<*0 MM-P`0Z`QU=&(A[6'3\6_'N>K:@+YK MVUUZE]I,.+)+'FP3*,522L,HAH`"1)S`9">?IKE;XQ1-\R%XUC?`64O9EY3F M0M_?V^+KYNIQO9DM$\_5]?4J4OS=,D);K#=;_A?[DKQV[R0PQ[@0U$=,1/1A MJ2*BNCDQRGA)3.XU_Q0MJL&6IR$1'V,ABI#,?E8DO[I]7R[OOA2KAR3+D77H M4)-@L(AR*>PD!\8R'?V;R@;UB!D/4>YM:??$>F^33SWC.P9[4FJF=U-$\VY=+N8WNQ1@5ZLD@WHH'_<:[2U;!N>B^M<%)S5U-N1>.O+VG<,BEB?L=!08>5]!I' MGX[ZX,1 MG8<_#@B[Z'((0"100`L037Y12\2@R3V>FN"5<4^T.A7",4CA'KXMRI]%\;E8 M?9^G"-:]4V%1:3/^Z>KV4W%=WBWG_XX3H5C-RZV9\KY%)%7/ORGE2X#(&DVA M(\0B9"1'-9:2N@LJ^WC^7?N\NIO,//A0+K\7ZVB;5Y"NJPO6EW^?I(PN\_\5 MFV?Y3YT1.;\S&"01Y83XN*Q8&;T#[=ANR<+J`E)=G)V9.3-D!%V.9B-_?2U< M]=.U>MSD_*W M1MU19(BD@.2>5T]PCYK*/'R;FA_E;&0+?G&S7S?-A2W;=1``\@IK8;U6!#!( M+'7/C@_%N:$V$XSXFPKG!U',")J#SVJ4T8--FV[;QYZO MVP0M">31(";>&0258%Z!6C[HV`75,!E0]X>>>9Z(]AAL>CG$QK/UWS\.T?!2 M&-L4E!JE(-;25(Y\*Y%#V?6UI\B?T[5:]@SG*,$)D&U'UKAZ<;VF_!X7&$><0%CB8:,QAK4>6CW$KDH]E^0?PY7:O- M#D\W.-^RPR,<$((+1=.;*.U=59BBEM31BTQY.?3"TROD8Y#KXZJ\G6_2T[DC M1'K^*$@<9YCV4"%'*'16&RAJ"2RXI'22?:FR[`G+\;+]IL'YB,>!U)3%YNKV MR^R'VFQ6\Z^/FS1?OI2[=YZN*DYRA$R]_8Z@*:5"1*2Q6CY+@I-L_B':'C+]\%#32VTE'H630FH"'J60YJ5>[R-L6; M[6$H=0J<8]#B571'G71G&SUR];BI-U0-*Q&-+&M@%`89RUS'II&$&I MO*NMY*5$.$XN*/7-<$99KQ!GY>#:DOE35,7J>W'CRY5_W#RN"O?C^CY%JNUA M2)MF@1J-),+482FB#R.0!PS$?SA.I;AY[E.A">:QZ9D<`Z![QAW.SA>/=?S8 MRQ6S^QYWJ*>@L<)`$0"5$=(;3B&CNU,83'+C@+HGMTE!UV^):>,`/KX#:;;N M1!SJLS\1(:O0^B4X>A*/8^N1]<3=; M/!WWOSC]/#%;Z.MNCR6B;&@1'&(4FHB/5(8E4Y`898VTG&#C'&BDZ3#3N!KN M7[--(F]4]]:BO2N6U_.B55K@5NV#U`8C(J"2P&MNA%0$)-F5(,98<0$%LGK3 M?CD\OF>8CWFO)L:8EMI[197S4E#N*-%1)7RK&!U1!<=WU['@ZS.E?*_H$0L] M%TXCC["1C%-&R18]8H0!YTE[3%_7*#B+"?AZ$"U,P$--@D&<$@(X@(;$G5XH M;B+,C'!C4;2X&^-,QI'P.2MN*W.ON77`7CB)"1926T\XLQJPG=S"7E`ZS--5 MWU""\W1X1]@V?INY'V:K=';Q_:S/[OJB='N5Q?R@26'&&*.8%((2H%<(YOUTS.,8*Z\0YEZ-.8UL6=6YW$M"\5 MS5"TFYV!PEFI@74$457C8JW\$[;JUM0XG-9_(+A'?3V[KT;],;(=K6T/`7>$ M`D>`\^ETF7D+MG(*Y"6]H!Q4@[+@T#O:'C`?A5O;X37GY'_Y75":6<@\,LP2 M&/\/0Z%K.>`)5S]3O%7L2:/[G8@L/+-BI=W6V##QRWG\DYW/[I;E>C._/ISV MOE6[('1A'-?_ MOF\#U]`@YA`UECHB=802[L8HL^?_!-\1]J#Q'A`<):M"N8J[8ESK&LM@O/HR MQ,6/\70\":E43D19-*IE`33;DIA@',!I;.@'OQ&M@J.E:#NX>'LKV0ID@++` MI4*V%CK#I)*UU)B(W)IF4UQ#QK0_^X=^%,+-%NG-T/=B^5C\HRQO4D#5,8+M M^3Q0'F>=4![57);]FT.G8CLV8]F1)LB!#B8C6.54& MPW3"Y_1.%BMH;F6[[@O/X(^N1N-)=UC'L6C6FZO;BL.?R\6Q$,=77P:%F8`, M4I6RC41D!*%LM[-C=T%)#0:ER&FPCF/H+&*?=_\HEL5JME#+&W7S$!VS=.R8 M[L::ZS^TZR`X)@FU#FA,HYD/"&;U=BZ09#)WS9E@.H-AUYPAT!Z#9^DY=/P] M]RGN+RZ9B_);`JF97D?;!:$,BDU43S&(P**OZ!'D, M,J4%]>_Y8O'NX=MLODIC;$8$Z4Q8?&_[`XSEEVMLW,R M@+>_.?4(\YAT^E0L4OFV+^7[..*[;<7"8K-95'>Q+6AUM'V0AD4O00J/&([+ MK39$[^2&PF7?6DXP,<`H[.H3[?&?:KM_/IE<0N^@`G^N@=4\+\.97L2'P'H=G]>BV$KQ;Q@D??W*46ON; M!,D4IQQ2JSTU#CB$G-A9BMAF7W!,\*_J$1NL=T-]EL#,M$,$!I"'_4FE?CE;,7DEYWZ MTT[(IZ.C\>9!E.)IJNIB6=S.FSG\6XN@#91&JFAZ&J\0\U+8W84GYSA[%?WS MCMC[07@,]G2M#Q,1L2E5`:84426HL`+W\0[C3SM8SX;T'"_ZSIA`J<\G>QH8 M2:&WP@@/(?<*\JT5K)'1UI\I\TK'>,M."90Z]1@L48PYISG3S%H%&);;".%4 M\87"W+"/-Q"2V)TBISW=RX1\A+G/GHY&/\Y6FY]?5K/E.L*23*:SS/Y#@VFQ M"C0U#4P09S1A"&D:H68^KKY>(ZVD1PB*,SW@/33L;CDU.O02D))8`"ZC_2JC M72L@E[S&@4%Q017?^J/$;R$Y0\%]SAE_SI?Z0TY\2XCVGFE(,)26>FNKHE71 M>!/1=B.-@41#FP&'!-`_?_F;UF_W._07&+0$.>6!EPX3YC6P.VP04[G/7-[B M8M":)@=-@>&`'R78^#DGY-[[J]]_6A0?9@]%TS/_$[H-F%%!HXW$L61.662B M6FJ4-,>79*$.RZ+#^3^'5LH8U#TTW,:\`<<;!AVM`$X$IL9H!B3$MJH[44F: M(OV&),3K!--]HI_UU/QJ\W#\??GN@V"01`H1(X!%+#U\E2FEPG8TCM`+ M>K_7EUK*'G`^%W8IC:8 M"L8F8>.V]?O'06++H:%04J0MM19&O[:6R"!S05O5$&H^PJ0L?,]E]#0FQSC< M*%",!(IH>8\@Q$(K1MP.+*LO:(,[1;TM3)@L/$=Y7W,_+V[=C^+Z,3U'O+J] MG5\7J^9\*H=;!>MEE(XJ!KA(9^C.P=T$8U+F%I::X%;6(V?Z`_2,UM'[%HE6 MFIH&PQD'@"@$G%W2RYG>KN;E4%:*9W:9VV MM=]:!Z>1H(0XZ3GA/DXT+&0M,R;-&9C?YOYVFOH;=[M383X?M:[^7D9%W,^_ M?2Q6UTFO>RNR=^XC,,D9LSQ8O0E$:G[OF=QI@6MF=QY991J`3F@%5(T29R0T1G&#VF)%7O`'0GRH_ MW_]_>5?6W#:.A'_2XCZJ]@57SZ1J9IRU4_O*8B0F5JTB9B4KB>?7#R"%\B6) M%,U#5AY2%3ML!/BZT=U`'YCE'V?SV=WL:->'5XZ<`5?,1_]$^6@M3&J&3%6% M%0VA;;3[#//MSTI2V[/@7,5U2].QI&YI,A>\CF!HXY1FW!&.G*X0BJ:'M132 MDY/R?S$A;87^0!G[Z?FUC9/RY!:J^'CL2'R,++/I6AQS167\8SR/*(=JE09X MVY=Z3D[J?]/^8X<(MPI>F\FD7$<7];J8%+-OZ<+HIIBLEU'/_KUAS,,Y*=TZ M5=\E7 MQ(DJXY8+XATP*I$DJ0XUT)TJ9J3MRT(G]]AY@Z+5/;RM--2'5+,5)7RY+J95 M1>7C*1W2175TF:3I;35,A1:$<\&=\>E)>Z&Q\LQ`V[C3.?;'Z4?M=(SP",TF M:N2H`54F+/+*`:%<8NN!(P\[&QTTM(YXGV7_FQZOT;I">$0S9;YLK/#5IT>_ M.]UL[1LEXVG_1$2]$\`4-P3L3L\R(5K7V_Q*$8'^\!Z@X$8FOVUQ-[]_MUI% M=?O3XTL/9][EBVF^G(Y3E6]0;'.8*!-(:A`$&14`:V]H:AGB M+%7"$PJR]G*MGU7^57Q_-.=EN8A_G6Q?*36+J;O-%Y^+U;O%XV]FB\GLZ[Q8 M-2F\ZV+X3#O'0X3.1ZB\9]I:Y;USCE&*@@D7](1F%^+SO(7-\!PX"YU1`7@1 MNH/YJ/Z#AU1HQ0T"XBF`)1Y39X/1Q[-7Q^/!B'T2NN8`XM9KZIRUF%HGG<24 M5-L/F#ON"_?%`07Y;/G??+XN_BSR5%;[)'H^*-Z[F3S4^#9!_!A99@5#%EG+ ML,7I@M!SETJ#`V@42/SE.!9SWY2;F,*C=!E8QH(%ZYT"XR@-VH9JK9+A"[)Q MW;"\[`_<`S;6?ME;U_]%/SFO)F0V6&8,0YTL$+B;FU06!9(>($_55V>6/! M.%B6VPO>0]RO[)EX3>7<`8HL>B%$IR>&$3"+(XQ2JFIM/,@+RM?MC^UE'U"/ M)4;IK\NBOJB[EC:#@&6TOA@,U][S:(0]5.M%@E]0"YQ7<[R!!+T&VU9A)3LK M)^6T^/U^4LSGQ^NW]WR:*6XE8]H11HFRV*@XMVJ&@OG6;5??!O=;?']8ZKQDSHQ%(XHS6W`#AV(1`=UN2 MQ$UZT>JI!>O+<8!OGQ!A;V]3BMC5>I7N$5,WRJ=Q^'>+R7R=3L3'LB.:#I(% M%\\@2A`%)A#%#*!HZ)&Q6FE%I;^@>J3NQ:E/I(<)=G_-[S=7+U>?_B@7GS\4 MRR\U::.'2#)I*$$JQ)T`@6GI&$WMT8PU7DE#+NG1Z4[EJ&-M^+#"=>`A^PI_M&/G*K6TN3:68#QNXK0`# MA]IVGCHC![,_H7DUG&.I[W:AO*&T>.!(,XA>=X01P"!&=#*N.$1<`4.MC]'/ M1ONP+-GK>'!8KB>1^W$%Z1?ETJV720CC>7563NLB/E?G`I?+1 M*Y!>,8<81EI5F"#4^M'K-Z7;&\M%.2S:PS6FN(D,W`3C;3Y/MQ\WMT5Q9Q93 M,YUN'-1\_BB>:>^W;S+G\]\B`%]7VY-N6G;\9HMS,7T$\_$XWS`3R!CS)GC' M?``"P`"QU(QVBSS1YH+"ACU*Y=Y.&6?&NB$VS4EK:-1QNN6(&07O??0K/$8F M8&*=0V['.MSZV'R&8GUNPE:.P#=U]D&$$P5,?`0A1#0C'M1;5 M;!P2%Z0E>^=7V0'`0^BR4\Q%DT!IJ_$RHC%-M@?%[--LDB_N'J?31+^V6N\J!7A2?.=JLZZK9?4/[Y?%7?[C6++V:\?.F#/> M1$[QN'5MH#I((!5>%).V[='.,,0[C""/Q9FWDIKB/#+$":V)MQ!<$,SHN"IN MM>8LB`MJ'#F@XNR3!6\M9X6(X*1V!"G%)$:>2K([PP7=NK#Z#/L]#JO0.@+\ M[2>S.**\1A*H!\4U<=K274"!2=.V@\P9]FH<5L"Z1GZL,&FK`O&AHJ3>(,`4 M&T*\L2QHBJW?1)H=5<&)XTVT^H`Q^DD[-^EYH7HW&#[QQ$XHH&].G*D()6-4 M0>!<.D*HBV85>\\QY\#U<:=F:%0[#>,/`*YUGAJD",=*F1"=82_T%ES)6(#C M1^VAP7WH+Q_5XLUM5+/="O/+\>M`/DR180H":Z,-9I0X[)`1-N!`,7#0"(]4 MRQSRY2(B^A3`^R89;S646>ITX0$3(17C8`QA&J7U:8D,_U"K;*XQ:VDS)BPW M1H%2W"J)M43148QK%DYSQL4%=7?H@O$OSLS=PCNBXMQ$@6R^VMZU%XM5_HKM M?4B=[OT_:O7H4:J,2\P#=P*P5SH(K41()D\(9Q5H7FOT>PH*)"OZ8M)77S=3 M7TRC"8],G'TKWL_SQ=9H'6MXVV*T+![V!#(0[0I$TZT%EI(G7`SSR!O5NIWR M^6SL3J7C^?5^[XB/N->[O,$8PD5*Q70T.498:6TIHD15+A*)/Y^5B_0A_]&U M%[H9L@[*)Q]%R)0+""25\70M002T]=>#\\1HJ(W"])FN'&?:W($Y1))QZIG' MTNB0'A]2%+!.&YM1I3#R0EV(>FO)UKVYOJ]&<425E=IR;57PIW=Q^,7G651A M/YL!=+K9DKK/%_=7WXKEMUGQO?XR=N_G6834$F&I$\$1)#!E&[N#I4J5H&BD MQLF_E>7T^VP^WUBP/2@VVI+-!\FTTU8X*1TF0B.'`L,AH6!!(238Y=2GO%(( MGD=*^D*X;@/_^U_IXX_1[8D__`-02P,$%`````@`T8MN0?J1L]0.#@``%:(` M`!$`'`!E`L``00E#@`` M!#D!``#M75MSXR@6?M^J_0^L7[:G:GV+DW0GU9FI7+M3E8Y3<69GWJ:PA&UV M9/``2N+Y]0M(LB1;$D)6.NZR^J4=Z9R/<_C@<$!(?/[E=>Z!9\0XIN2LU>_T M6@`1A[J83,]:OX[:YZ/+V]O6+S__\Q^?_]5N_W[Q>`>NJ.//$1'@DB$HD`M> ML)B!W]#X!GM2C;?;H30(?KUR]Y0[,S2'``K!\-@7Z(:R^16:0-\39RV?_.5# M#T\P7CJ(.]"C9([_Z!W,I`>21\)/T5\[MC(2V?^3,F_CIG7H6PJ)7N#KKH]AAQ%XH02XL^S M%5S!NF*Y0%TIU)92B&%GI6=62BLH`5>L=))6'76#FTE17.`#)EQ`XJQ\>-WP M^66@I?LG)R==?7VKU^>]!O@:#=W%$'"MU`DSYG*G:1)WATI1U#=:0-+="UM(=1#_&: M#-)86UND&D1=%FFL2A85M:0<>S95U%_M2*^M+K6E)=N9$7=*.S,BO5K,..E" MYBBZ)7..:*/7A0<)%)0M;^3?Y4SS&$NA7,<@RL8396/_>!L;-31!4Q7"R]N4 MU*K7$(N*B32V-R`[,)>Q(ZEY'RC6:4XU4[:P(WL8*=F+(@55\I%EF1PYG2E] M[CK4)X(M2\>V++WHCTI!+8WJ,R83H0KF)!57?VUOD(NPM2V1COJQO07HU9E9 MF[!2TK^V-P*39\2%M1D)M?#W]J80B!T]%/=M+(FU@I_M&*"B'1P[UE9$.NI' M#1:(!;,W(5+2OXJ,@(10H9'TM>CJ8H')A(:7Y$4UAI]&`_DCF@"=KYZ&HVAQ M5MM=,+I`3&"97"42>PTP8VARUE*SAW8T1?A#3APZ,@^.1#8*2*<8>KR2*H[O M:3?N8B,C!!6_SUI'(N>_NU3MJC\+AFS] MD2I4:%V*%*DN=:[RRNF.U"V7G@U8J(B05=(0.S5PU.$54C78>_38>_` MBB[P(43^J2%N52E/<.S5U+]"J$+:!KU/@U[?DK8`>`]9(RXB4EW^X-3#KIH7 MCZ1'>A&3#R>RVJ27,RF#G]$=Y58T6F,7\2HCYU%/1\\5AJ8U+`0D2XE%.!A. M0*H@\$$5M8],KZKG`GIJS6HT0TC8$9H#8>"MG\E;S%8(!@*TAIFP6A^@G'N+ M&1)8FEH#36D\$V='.H:6Y`Q\2('O=>]:5=EP,I05PE+1YY9(GE`U,LL`&U@] M-O3$^`:=`%W(6O`,BFGH#4B_05!L.$M)!E]=\KZUB&B[AJ3A6D[9Q/*63"B;:\/*TUV(4L1E M;Y6^KO:-)'Y*.!#@@03@OE%T1\GT":D-+V-1GI*4EF'=["ACW4SIMQ4`4`C[ M7.?6*V-9RH:EL*/#S365-`/[N_9U3P7J]U35Z$4E7^)42#(*48K[QT%6_U!X MH-_K@"3D'J<61?5[SCG2JXUW&(ZQA]73C.$D6_9B]E6.U&JGX.A\9-WUWM2* MXCY\(/OPH6TK`1\"JW0ZDK!+31#S5-K@XBN(S/L/&'7..Z.?FO"P+>77COMN MS2U1MKF1'5LWL@IM[/KRJFE2QLAP#YFZ_(QJ;3G%19@;R,9#-7,4RHPHJZ*; MZ)+)TQ>(R9",H%C-XN$1<=\3>3&[[N&B=&GF MQO#1NC&$A:L1P4V*T$BD&1`J$O>&^6R5@LV-9V`_>"1:3Y.SOG5[^KYQQRXS M/7JCMB-C3]-8,NFQW?Q3`JMX]\_!4<;N'S/->[H!2%?W!>18]J^'A#>6A&4A M%"]9]?.6K#J@#S2<'>VP:.EBUI>`\$$/G^9C7 M>;+(:7I-LH:KY(PY&(9\\6/>A#F;I#W.%0_OT!1Z#XPZ"*F%0CMV-K0-D>TD M+[(==H"&`HL55L,&F58*;'D@AL!VDA?8,KC9[[BV7L%5XEH.AB&NG>3%M4R. M]CBL'8W05&UG?43J:PG6<6U3W;!;K9<7V(YD2AU@@1580XBLA.VV<9CA#$]. M>GG1+HNP9EM&+HWAWSS['9)ZN"U7AIGP[,>LV81'929?:Z#)UUB:AI`FJ!S6RQL%LZG05?4O MIV^69!5\B$IJNFDF$54RF=*HAM3F8)`S+2E-[AYG.Y]N(&;_A9Z/OB&H*D^G M[79$YF`8(NT@+])^Z@`%"#0B2$(V!$4U42G#*88RI#>#O/0FGZ[]SFU.@F^+ M^3+65'T/-!O"T*\.]*K-F*W6J0B1#GSK,W5.70U73HS:J MNDKF401D2#8.U:1\,R8(:`>)SQAF`Q8_L;$8NJ._@^F_K"9;0'I-Z>5X!OF(D?'VQ^ M?,#`<%!8^,%.\!!O0=G;.7D1-?42;4'KQK!HZK@-?1D5_HB>$?'1(W+H-"BR M7D(+\,T4;R2K!HK#PD"BM(;V3%JR]R;72[VA##/]&Q_T,-`?[(L>9^R+;MI` M!C^V,YD26(;)S/%@\QU\4]1N9C,9E?U:][B;AC1WS8TWF@TT:ORF'V;6O5K( MU!8.)[?223+%LL4'GR:JE^0R!9FIW]BA8Z!^5:K:FQ.7&WU\:2_:Q.?N^ME+ MX97T&4WZA*;P*%<`QUPPZ(BSEF`^:NEFI,ZT^>,\ZQW-\U"ZI4^=.FN9A+#G MJ<`:@7-?WL+"5U)?&/479RU]"NHI%FC>`L%9-\$5"2'YO977E8,M$%Q=((:I M^Z3E7)^%+S-V;=S*>6%JPS.SW`XZM[Z7F&^X522Q@PZ=Y'S=;=TML]R[.1<[ M$X0MKI[>XF=ES`@Y/I-=_>\@9T5,/=:%4S2>!80?= M8***="^6(^1YB!74C`W&#H:#Q,Y!Q3$O\#1#]#W(+AGPW?_Y/#B6ZXF>NZ[V M1`Z^LO/>DDNXP`)ZOZG7":3`]>LB%04KJ>YP56CVUK_%NJ`<>MHRV7D]7[^B MEC6.WZ-XI*\!:&?#PP4D?S)_(9QE(D$+C=*1^B#@-S0?QQ$]^U:E0$V)BM4NG4/\%K1@ZE`7?5TZ MD\K:[['I3Z',^\^*+NDSDDF* MN*?BB>J9MD#J5!HY_-$Y8G>8BT3X+RV]LS%>G29Q*P69/F3EE@@D(Y@(PG/D MI4'F'2-VCAOWONKPP\D%]#PJYZ)PJ5.7:^(.)^H,C6S'2FA5=W7A,[1ULIJV M-]^3K:VMD9CRV="C'#JAG"W(#G2%GI%'%PI*II/JT-&5H_7A[5QZFAM9+9Q6 M7PKG>K*EPI&TDXCS5\PK5%\^4KF*<\6IB^?J.*V@'7V?06@[!Z_T*%]/9:VP MWB_KV*Y6;O!KL-BLW=FJ4C:@WK#O.7+RN##/G[AP3 MK%JF>B._>N0J#?P#A;""0^'6D\22LKN7`5\Q])*>AZ2N[.#TX]IQTP8G+^RB MO<'3WTO9/=3AQU<83@F55CE\S0VSW`Z$Y2\^5$MFE`W''IX&LZ'P&EJ%`S*] M0S`.(Y8Z.Q=H^&,OT<^FORT-;(F_+B]3?*K5O?4,S3$21Y80<#84;"J9[$G8M+ MCW+)?MJ9TM*[Z*DS0Z[OH>%$+1XI$1]ZB>"WT:ML%'8O:IBL?TH^A2\K7'K& M-ENJ!VO^&-4^8XL=5(%;G32"V#-R98BX\87/9%+KS""9QJX9Q;;@3F._`7=X M2G(WHJV/9F6%=["))BU?/1/E%\M[Z=APDKB67'JPUMKE98;RSJ27%"KH[6)( MID0F8FZ89*\--=GW=M&+4COO?L!]=WK?\;H?ZQ??/[U\H@)Z,O3)\MWHH4+R M\U`KR\UR.[<.DG;R8C93*?[05XFI6O59\R98#8JW6]@J?<=\.MC"RV7>,8?R MS_\#4$L!`AX#%`````@`T8MN03.V"<$8I0``Y=$)`!$`&````````0```*2! M`````&5S;6,M,C`Q,C`Y,S`N>&UL550%``.*&Z10=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`T8MN0;:9T,`J%0``&40!`!4`&````````0```*2!8Z4` M`&5S;6,M,C`Q,C`Y,S!?8V%L+GAM;%54!0`#BAND4'5X"P`!!"4.```$.0$` M`%!+`0(>`Q0````(`-&+;D&&2Y7V&DH``&:Z`P`5`!@```````$```"D@=RZ M``!E`L``00E#@``!#D! M``!02P$"'@,4````"`#1BVY!6TVK&ZB```"\M`8`%0`8```````!````I(%% M!0$`97-M8RTR,#$R,#DS,%]L86(N>&UL550%``.*&Z10=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`T8MN03(CIR<<70``5;$$`!4`&````````0```*2! M/(8!`&5S;6,M,C`Q,C`Y,S!?<')E+GAM;%54!0`#BAND4'5X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`-&+;D'ZD;/4#@X``!6B```1`!@```````$```"D M@:?C`0!E XML 49 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note. 1 Basis of Presentation (Details) (USD $)
 3 Months Ended
Dec. 31, 2012
Sep. 30, 2012
segment
Sep. 30, 2011
Segment Reporting Information [Line Items]      
Minimum requirement for stock holders' equity   $ 2,500,000  
Number of Operating Segments   2  
Total BHH debt oustanding, accrued interest included   4,367,604  
Repayments of Long-term Debt 2,487,480 0 88,555
Gains (Losses) on Extinguishment of Debt 1,880,124    
ECD [Member]
      
Segment Reporting Information [Line Items]      
Disposal Group, Including Discontinued Operation, Sales Price, Fixed Component   6,500,000  
Deconsolidation, Gain (Loss), Amount (4,200,000)    
Sales Price Component, Cash at Closing [Member] | ECD [Member]
      
Segment Reporting Information [Line Items]      
Disposal Group, Including Discontinued Operation, Sales Price, Fixed Component   $ 6,500,000  
XML 50 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements Of Shareholders' Equity and Comprehensive Loass (USD $)
Total
Common Stock [Member]
Common Stock Warrants [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Balance at Jun. 30, 2012 $ 644,865 $ 7,526 $ 132,114 $ 69,369,658 $ (68,348,811) $ (515,622)
Balance, shares at Jun. 30, 2012   7,526,430        
Net loss 433,436 0 0 0 433,436 0
Foreign currency translation (61,829) 0   0 0 (61,829)
Compensation expense 16,485 0 0 16,485 0 0
Balance at Sep. 30, 2012 $ 166,085 $ 7,526 $ 132,114 $ 69,386,143 $ (68,782,247) $ (577,451)
Balance, shares at Sep. 30, 2012   7,526,430        
XML 51 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 3. Earning per Share
 3 Months Ended
Sep. 30, 2012
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]  
Earnings Per Share [Text Block]
The following table sets forth the computation of basic and diluted net loss per share:
 
 
Three Months Ended September 30,
 
 
2012
 
2011
 
 
 
 
 
Numerator:
 
 
 
 
  Numerator for basic and diluted earnings per share
 
 
 
 
(Loss) from continuing operations
 
$
(624,396
)
 
$
(501,030
)
Income (Loss) from discontinued operations
 
190,960

 
(288,619
)
 Net (loss)
 
$
(433,436
)
 
$
(789,649
)
Denominator:
 
 
 
 
  Denominator for basic earnings per share - weighted average shares
 
7,526,430

 
7,526,430

  Effect of dilutive securities:
 
 
 
 
    Stock options and warrants
 
—

 
—

    Shares reserved for future exchange
 
—

 
—

 Denominator for diluted earnings per share - weighted average and assumed conversion

 
7,526,430

 
7,526,430

 
 
 
 
 
Net (loss) income per share
 
 
 
 
   Basic:
 
 
 
 
      Continuing operations
 
$
(0.08
)
 
$
(0.06
)
      Discontinued operations
 
0.02

 
(0.04
)
 
 
$
(0.06
)
 
$
(0.10
)
   Diluted:
 
 
 
 
      Continuing operations
 
$
(0.08
)
 
$
(0.06
)
      Discontinued operations
 
0.02

 
(0.04
)
 
 
$
(0.06
)
 
$
(0.10
)
XML 52 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 2. Stock-Based Compensation (Details) (USD $)
 3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized $ 38,271 $ 104,212
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Remaining Contractual Term 1 year 3 months 22 days  
Stock Options [Member]
    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Allocated Share-based Compensation Expense $ 16,485 $ 23,898
XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 48 160 1 false 16 0 false 5 false false R1.htm 0001000 - Document - Document And Entity Information Sheet http://www.escalonmed.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 1001000 - Statement - Consolidated Balance Sheets Sheet http://www.escalonmed.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 1001501 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.escalonmed.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 1002000 - Statement - Consolidated Statements Of Operations Sheet http://www.escalonmed.com/role/ConsolidatedStatementsOfOperations Consolidated Statements Of Operations false false R5.htm 1003000 - Statement - Consolidated Statements Of Shareholders' Equity and Comprehensive Loass Sheet http://www.escalonmed.com/role/ConsolidatedStatementsOfShareholdersEquityAndComprehensiveLoass Consolidated Statements Of Shareholders' Equity and Comprehensive Loass false false R6.htm 1004000 - Statement - Consolidated Statements Of Cash Flows Sheet http://www.escalonmed.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements Of Cash Flows false false R7.htm 1006000 - Statement - Consolidated Statement of Other Comprehensive Income Sheet http://www.escalonmed.com/role/ConsolidatedStatementOfOtherComprehensiveIncome Consolidated Statement of Other Comprehensive Income false false R8.htm 2115100 - Disclosure - Note. 1 Basis of Presentation Sheet http://www.escalonmed.com/role/Note1BasisOfPresentation Note. 1 Basis of Presentation false false R9.htm 2116101 - Disclosure - Note 2. Stock-Based Compensation Sheet http://www.escalonmed.com/role/Note2StockBasedCompensation Note 2. Stock-Based Compensation false false R10.htm 2117100 - Disclosure - Note 3. Earning per Share Sheet http://www.escalonmed.com/role/Note3EarningPerShare Note 3. Earning per Share false false R11.htm 2119100 - Disclosure - Note 4. Legal proceeding Sheet http://www.escalonmed.com/role/Note4LegalProceeding Note 4. Legal proceeding false false R12.htm 2120100 - Disclosure - Note 5. Segment Reporting Sheet http://www.escalonmed.com/role/Note5SegmentReporting Note 5. Segment Reporting false false R13.htm 2121100 - Disclosure - Note 6. Related Party Transactions Sheet http://www.escalonmed.com/role/Note6RelatedPartyTransactions Note 6. Related Party Transactions false false R14.htm 2122100 - Disclosure - Note 7. Recently Issued Accounting Standards Sheet http://www.escalonmed.com/role/Note7RecentlyIssuedAccountingStandards Note 7. Recently Issued Accounting Standards false false R15.htm 2123100 - Disclosure - Note 8. Fair Value Measurements Sheet http://www.escalonmed.com/role/Note8FairValueMeasurements Note 8. Fair Value Measurements false false R16.htm 2124100 - Disclosure - Note. 9 Continuing operations Sheet http://www.escalonmed.com/role/Note9ContinuingOperations Note. 9 Continuing operations false false R17.htm 2125100 - Disclosure - Note 10. Discontinued Operations Sheet http://www.escalonmed.com/role/Note10DiscontinuedOperations Note 10. Discontinued Operations false false R18.htm 2226202 - Disclosure - Sigificant accounting policies Revenue Recognition (Policies) Sheet http://www.escalonmed.com/role/SigificantAccountingPoliciesRevenueRecognitionPolicies Sigificant accounting policies Revenue Recognition (Policies) false false R19.htm 2226203 - Disclosure - Sigificant accounting policies Valuation of Intangible Assets (Policies) Sheet http://www.escalonmed.com/role/SigificantAccountingPoliciesValuationOfIntangibleAssetsPolicies Sigificant accounting policies Valuation of Intangible Assets (Policies) false false R20.htm 2226204 - Disclosure - Sigificant accounting policies Income (Loss) Per Share (Policies) Sheet http://www.escalonmed.com/role/SigificantAccountingPoliciesIncomeLossPerSharePolicies Sigificant accounting policies Income (Loss) Per Share (Policies) false false R21.htm 2226205 - Disclosure - Sigificant accounting policies Taxes (Policies) Sheet http://www.escalonmed.com/role/SigificantAccountingPoliciesTaxesPolicies Sigificant accounting policies Taxes (Policies) false false R22.htm 2226206 - Disclosure - Sigificant accounting policies Stock-based Compensation (Policies) Sheet http://www.escalonmed.com/role/SigificantAccountingPoliciesStockBasedCompensationPolicies Sigificant accounting policies Stock-based Compensation (Policies) false false R23.htm 2317301 - Disclosure - Note 3. Earning per Share (Tables) Sheet http://www.escalonmed.com/role/Note3EarningPerShareTables Note 3. Earning per Share (Tables) false false R24.htm 2320301 - Disclosure - Note 5. Segment Reporting (Tables) Sheet http://www.escalonmed.com/role/Note5SegmentReportingTables Note 5. Segment Reporting (Tables) false false R25.htm 2325301 - Disclosure - Note 10. Discontinued Operations (Tables) Sheet http://www.escalonmed.com/role/Note10DiscontinuedOperationsTables Note 10. Discontinued Operations (Tables) false false R26.htm 2415402 - Disclosure - Note. 1 Basis of Presentation (Details) Sheet http://www.escalonmed.com/role/Note1BasisOfPresentationDetails Note. 1 Basis of Presentation (Details) false false R27.htm 2416402 - Disclosure - Note 2. Stock-Based Compensation (Details) Sheet http://www.escalonmed.com/role/Note2StockBasedCompensationDetails Note 2. Stock-Based Compensation (Details) false false R28.htm 2417402 - Disclosure - Note 3. Earning per Share (Details) Sheet http://www.escalonmed.com/role/Note3EarningPerShareDetails Note 3. Earning per Share (Details) false false R29.htm 2420402 - Disclosure - Note 5. Segment Reporting (Narrative) (Details) Sheet http://www.escalonmed.com/role/Note5SegmentReportingNarrativeDetails Note 5. Segment Reporting (Narrative) (Details) false false R30.htm 2420403 - Disclosure - Note 5. Segment Reporting (Segments Statements of Operations) (Details) Sheet http://www.escalonmed.com/role/Note5SegmentReportingSegmentsStatementsOfOperationsDetails Note 5. Segment Reporting (Segments Statements of Operations) (Details) false false R31.htm 2421401 - Disclosure - Note 6. Related Party Transactions (Details) Sheet http://www.escalonmed.com/role/Note6RelatedPartyTransactionsDetails Note 6. Related Party Transactions (Details) false false R32.htm 2423401 - Disclosure - Note 8. Fair Value Measurements (Details) Sheet http://www.escalonmed.com/role/Note8FairValueMeasurementsDetails Note 8. Fair Value Measurements (Details) false false R33.htm 2424402 - Disclosure - Note. 9 Continuing operations (Details) Sheet http://www.escalonmed.com/role/Note9ContinuingOperationsDetails Note. 9 Continuing operations (Details) false false R34.htm 2425402 - Disclosure - Note 10. Discontinued Operations (BH Holdings, S.A.S) (Narrative) (Details) Sheet http://www.escalonmed.com/role/Note10DiscontinuedOperationsBhHoldingsSASNarrativeDetails Note 10. Discontinued Operations (BH Holdings, S.A.S) (Narrative) (Details) false false R35.htm 2425403 - Disclosure - Note 10. Discontinued Operations (Results of Discontinued Operations - BH Holdings, S.A.S) (Details) Sheet http://www.escalonmed.com/role/Note10DiscontinuedOperationsResultsOfDiscontinuedOperationsBhHoldingsSASDetails Note 10. Discontinued Operations (Results of Discontinued Operations - BH Holdings, S.A.S) (Details) false false R36.htm 2425404 - Disclosure - Note 10. Discontinued Operations (Assets and Liabilities of Discontinued Operations - BH Holdings, S.A.S) (Details) Sheet http://www.escalonmed.com/role/Note10DiscontinuedOperationsAssetsAndLiabilitiesOfDiscontinuedOperationsBhHoldingsSASDetails Note 10. Discontinued Operations (Assets and Liabilities of Discontinued Operations - BH Holdings, S.A.S) (Details) false false R37.htm 2425405 - Disclosure - Note 10. Discontinued Operations (Results of Discontinued Operations - ECD) (Details) Sheet http://www.escalonmed.com/role/Note10DiscontinuedOperationsResultsOfDiscontinuedOperationsEcdDetails Note 10. Discontinued Operations (Results of Discontinued Operations - ECD) (Details) false false R38.htm 2425406 - Disclosure - Note 10. Discontinued Operations Assets and Liabilities of Discontinued Operations -ECD (Details) Sheet http://www.escalonmed.com/role/Note10DiscontinuedOperationsAssetsAndLiabilitiesOfDiscontinuedOperationsEcdDetails Note 10. Discontinued Operations Assets and Liabilities of Discontinued Operations -ECD (Details) false false R39.htm 2425408 - Disclosure - Note 10. Discontinued Operations Gain on sale (Details) Sheet http://www.escalonmed.com/role/Note10DiscontinuedOperationsGainOnSaleDetails Note 10. Discontinued Operations Gain on sale (Details) false false All Reports Book All Reports 'Monetary' elements on report '2425406 - Disclosure - Note 10. Discontinued Operations Assets and Liabilities of Discontinued Operations -ECD (Details)' had a mix of different decimal attribute values. Process Flow-Through: 1001000 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Sep. 30, 2011' Process Flow-Through: Removing column 'Jun. 30, 2010' Process Flow-Through: 1001501 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 1002000 - Statement - Consolidated Statements Of Operations Process Flow-Through: 1004000 - Statement - Consolidated Statements Of Cash Flows Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: 1006000 - Statement - Consolidated Statement of Other Comprehensive Income esmc-20120930.xml esmc-20120930.xsd esmc-20120930_cal.xml esmc-20120930_def.xml esmc-20120930_lab.xml esmc-20120930_pre.xml true true XML 54 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 10. Discontinued Operations Assets and Liabilities of Discontinued Operations -ECD (Details) (USD $)
Sep. 30, 2012
Jun. 30, 2012
Sep. 30, 2011
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Accounts receivable, net $ 1,621,000 $ 1,555,000  
Inventory 1,997,000 2,348,000  
Other Assets, Current 112,000 110,000  
Assets of discontinued operations 3,730,051 4,012,725 4,012,725
Fixed Assets 287,000 323,000  
Accounts Receivable, Gross, Noncurrent 69,000 69,000  
Goodwill 93,000 93,000  
Intangible Assets 553,000 627,000  
Non-current from discontinued operations 1,001,687 1,111,883 1,111,883
Assets 8,462,000 9,137,000  
Accounts payable 536,000 691,000  
Disposal Group, Including Discontinued Operation, Accrued Liabilities 609,000 589,000  
Accounts payable 672,991 660,274  
Accrued Liabilities, Current 1,118,724 1,335,744  
Liabilities 1,144,000 1,280,000  
Assets of Disposal Group, Including Discontinued Operation, Current $ 7,317,000 $ 7,858,000  
XML 55 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Sigificant accounting policies Income (Loss) Per Share (Policies)
 3 Months Ended
Sep. 30, 2012
Income (Loss) Per Share [Abstract]  
Earnings Per Share, Policy [Policy Text Block]
Income/(Loss) Per Share
The Company computes net income/(loss) per share under the provisions of FASB issued authoritative guidance.
Under the provisions of FASB issued authoritative guidance, basic and diluted net income/(loss) per share is computed by dividing the net income/(loss) for the period by the weighted average number of shares of common stock outstanding during the period. The calculation of diluted net income/(loss) per share excludes potential common shares if the impact is anti-dilutive. Basic earnings per share are computed by dividing net income/(loss) by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share are determined in the same manner as basic earnings per share, except that the number of shares is increased by assuming exercise of dilutive stock options and warrants using the treasury stock method.